id	sid	tid	token	lemma	pos
admet-2740	1	1	metabolic	metabolic	NOUN
admet-2740	1	2	insights	insight	NOUN
admet-2740	1	3	into	into	ADP
admet-2740	1	4	the	the	DET
admet-2740	1	5	warfarin	warfarin	NOUN
admet-2740	1	6	-	-	PUNCT
admet-2740	1	7	mango	mango	NOUN
admet-2740	1	8	interaction	interaction	NOUN
admet-2740	1	9	:	:	PUNCT
admet-2740	1	10	a	a	DET
admet-2740	1	11	pilot	pilot	NOUN
admet-2740	1	12	study	study	NOUN
admet-2740	1	13	integrating	integrate	VERB
admet-2740	1	14	clinical	clinical	ADJ
admet-2740	1	15	observations	observation	NOUN
admet-2740	1	16	and	and	CCONJ
admet-2740	1	17	metabolomics	metabolomic	NOUN
admet-2740	1	18	doi	doi	NOUN
admet-2740	1	19	:	:	PUNCT
admet-2740	1	20	https://doi.org/10.5599/admet.2740	https://doi.org/10.5599/admet.2740	NOUN
admet-2740	1	21	1	1	NUM
admet-2740	1	22	admet	admet	X
admet-2740	1	23	&	&	CCONJ
admet-2740	1	24	dmpk	dmpk	PROPN
admet-2740	1	25	13(3	13(3	NUM
admet-2740	1	26	)	)	PUNCT
admet-2740	1	27	(	(	PUNCT
admet-2740	1	28	2025	2025	NUM
admet-2740	1	29	)	)	PUNCT
admet-2740	1	30	2740	2740	NUM
admet-2740	1	31	;	;	PUNCT
admet-2740	1	32	doi	doi	NOUN
admet-2740	1	33	:	:	PUNCT
admet-2740	1	34	https://doi.org/10.5599/admet.2740	https://doi.org/10.5599/admet.2740	NOUN
admet-2740	1	35	open	open	ADJ
admet-2740	1	36	access	access	NOUN
admet-2740	1	37	:	:	PUNCT
admet-2740	1	38	issn	issn	PROPN
admet-2740	1	39	:	:	PUNCT
admet-2740	1	40	1848	1848	NUM
admet-2740	1	41	-	-	SYM
admet-2740	1	42	7718	7718	NUM
admet-2740	1	43	http://www.pub.iapchem.org/ojs/index.php/admet/index	http://www.pub.iapchem.org/ojs/index.php/admet/index	NOUN
admet-2740	1	44	original	original	ADJ
admet-2740	1	45	scientific	scientific	ADJ
admet-2740	1	46	paper	paper	NOUN
admet-2740	1	47	metabolic	metabolic	NOUN
admet-2740	1	48	insights	insight	NOUN
admet-2740	1	49	into	into	ADP
admet-2740	1	50	the	the	DET
admet-2740	1	51	warfarin	warfarin	NOUN
admet-2740	1	52	-	-	PUNCT
admet-2740	1	53	mango	mango	NOUN
admet-2740	1	54	interaction	interaction	NOUN
admet-2740	1	55	:	:	PUNCT
admet-2740	1	56	a	a	DET
admet-2740	1	57	pilot	pilot	NOUN
admet-2740	1	58	study	study	NOUN
admet-2740	1	59	integrating	integrate	VERB
admet-2740	1	60	clinical	clinical	ADJ
admet-2740	1	61	observations	observation	NOUN
admet-2740	1	62	and	and	CCONJ
admet-2740	1	63	metabolomics	metabolomic	NOUN
admet-2740	1	64	piyapat	piyapat	NOUN
admet-2740	1	65	rattanasuwan1	rattanasuwan1	ADJ
admet-2740	1	66	,	,	PUNCT
admet-2740	1	67	prem	prem	PROPN
admet-2740	1	68	lertpongpipat1	lertpongpipat1	PROPN
admet-2740	1	69	,	,	PUNCT
admet-2740	1	70	natthapat	natthapat	PROPN
admet-2740	1	71	hiranchatchawal1	hiranchatchawal1	PROPN
admet-2740	1	72	,	,	PUNCT
admet-2740	1	73	konwalin	konwalin	PROPN
admet-2740	1	74	wannaphueak1	wannaphueak1	PROPN
admet-2740	1	75	,	,	PUNCT
admet-2740	1	76	sakonwan	sakonwan	PROPN
admet-2740	1	77	pounghom2	pounghom2	PROPN
admet-2740	1	78	,	,	PUNCT
admet-2740	1	79	parinya	parinya	ADJ
admet-2740	1	80	thongkhao	thongkhao	PROPN
admet-2740	1	81	-	-	PUNCT
admet-2740	1	82	on2	on2	PROPN
admet-2740	1	83	,	,	PUNCT
admet-2740	1	84	matchuda	matchuda	NOUN
admet-2740	1	85	suwanthai2	suwanthai2	NOUN
admet-2740	1	86	,	,	PUNCT
admet-2740	1	87	duangthip	duangthip	NOUN
admet-2740	1	88	sompradee2	sompradee2	NOUN
admet-2740	1	89	,	,	PUNCT
admet-2740	1	90	auiporn	auiporn	NOUN
admet-2740	1	91	saithongdee2	saithongdee2	NOUN
admet-2740	1	92	,	,	PUNCT
admet-2740	1	93	churdsak	churdsak	ADJ
admet-2740	1	94	jaikang3,4	jaikang3,4	PROPN
admet-2740	1	95	and	and	CCONJ
admet-2740	1	96	preechaya	preechaya	NOUN
admet-2740	2	1	tajai3,4	tajai3,4	PROPN
admet-2740	2	2	,	,	PUNCT
admet-2740	2	3	*	*	PROPN
admet-2740	2	4	1faculty	1faculty	NUM
admet-2740	2	5	of	of	ADP
admet-2740	2	6	medicine	medicine	NOUN
admet-2740	2	7	,	,	PUNCT
admet-2740	2	8	chiang	chiang	PROPN
admet-2740	2	9	mai	mai	PROPN
admet-2740	2	10	university	university	PROPN
admet-2740	2	11	,	,	PUNCT
admet-2740	2	12	chiang	chiang	PROPN
admet-2740	2	13	mai	mai	PROPN
admet-2740	2	14	50200	50200	NUM
admet-2740	2	15	,	,	PUNCT
admet-2740	2	16	thailand	thailand	PROPN
admet-2740	2	17	2hua	2hua	PROPN
admet-2740	2	18	hin	hin	PROPN
admet-2740	2	19	hospital	hospital	NOUN
admet-2740	2	20	,	,	PUNCT
admet-2740	2	21	prachuap	prachuap	NOUN
admet-2740	2	22	khiri	khiri	PROPN
admet-2740	2	23	khan	khan	PROPN
admet-2740	2	24	77110	77110	NUM
admet-2740	2	25	,	,	PUNCT
admet-2740	2	26	thailand	thailand	PROPN
admet-2740	2	27	3department	3department	NUM
admet-2740	2	28	of	of	ADP
admet-2740	2	29	forensic	forensic	ADJ
admet-2740	2	30	medicine	medicine	NOUN
admet-2740	2	31	,	,	PUNCT
admet-2740	2	32	faculty	faculty	NOUN
admet-2740	2	33	of	of	ADP
admet-2740	2	34	medicine	medicine	NOUN
admet-2740	2	35	,	,	PUNCT
admet-2740	2	36	chiang	chiang	PROPN
admet-2740	2	37	mai	mai	PROPN
admet-2740	2	38	university	university	PROPN
admet-2740	2	39	,	,	PUNCT
admet-2740	2	40	chiang	chiang	PROPN
admet-2740	2	41	mai	mai	PROPN
admet-2740	2	42	,	,	PUNCT
admet-2740	2	43	50200	50200	NUM
admet-2740	2	44	,	,	PUNCT
admet-2740	2	45	thailand	thailand	PROPN
admet-2740	2	46	4metabolomic	4metabolomic	PROPN
admet-2740	2	47	research	research	NOUN
admet-2740	2	48	group	group	NOUN
admet-2740	2	49	for	for	ADP
admet-2740	2	50	forensic	forensic	ADJ
admet-2740	2	51	medicine	medicine	NOUN
admet-2740	2	52	and	and	CCONJ
admet-2740	2	53	toxicology	toxicology	NOUN
admet-2740	2	54	,	,	PUNCT
admet-2740	2	55	department	department	NOUN
admet-2740	2	56	of	of	ADP
admet-2740	2	57	forensic	forensic	ADJ
admet-2740	2	58	medicine	medicine	NOUN
admet-2740	2	59	,	,	PUNCT
admet-2740	2	60	faculty	faculty	NOUN
admet-2740	2	61	of	of	ADP
admet-2740	2	62	medicine	medicine	NOUN
admet-2740	2	63	,	,	PUNCT
admet-2740	2	64	chiang	chiang	PROPN
admet-2740	2	65	mai	mai	PROPN
admet-2740	2	66	university	university	PROPN
admet-2740	2	67	,	,	PUNCT
admet-2740	2	68	chiang	chiang	PROPN
admet-2740	2	69	mai	mai	PROPN
admet-2740	2	70	50200	50200	NUM
admet-2740	2	71	,	,	PUNCT
admet-2740	2	72	thailand	thailand	PROPN
admet-2740	2	73	corresponding	correspond	VERB
admet-2740	2	74	author	author	NOUN
admet-2740	2	75	:	:	PUNCT
admet-2740	2	76	e	e	NOUN
admet-2740	2	77	-	-	NOUN
admet-2740	2	78	mail	mail	NOUN
admet-2740	2	79	:	:	PUNCT
admet-2740	2	80	*	*	PUNCT
admet-2740	2	81	preechaya.ta@cmu.ac.th	preechaya.ta@cmu.ac.th	NUM
admet-2740	2	82	;	;	PUNCT
admet-2740	3	1	tel	tel	PROPN
admet-2740	3	2	.	.	PROPN
admet-2740	3	3	:	:	PUNCT
admet-2740	3	4	+6685	+6685	NUM
admet-2740	3	5	-	-	PUNCT
admet-2740	3	6	038	038	NUM
admet-2740	3	7	-	-	PUNCT
admet-2740	3	8	6500	6500	NUM
admet-2740	3	9	received	receive	VERB
admet-2740	3	10	:	:	PUNCT
admet-2740	3	11	april	april	PROPN
admet-2740	3	12	1	1	NUM
admet-2740	3	13	,	,	PUNCT
admet-2740	3	14	2025	2025	NUM
admet-2740	3	15	;	;	PUNCT
admet-2740	3	16	revised	revise	VERB
admet-2740	3	17	:	:	PUNCT
admet-2740	3	18	june	june	PROPN
admet-2740	3	19	4	4	NUM
admet-2740	3	20	,	,	PUNCT
admet-2740	3	21	2025	2025	NUM
admet-2740	3	22	;	;	PUNCT
admet-2740	3	23	published	publish	VERB
admet-2740	3	24	:	:	PUNCT
admet-2740	3	25	june	june	PROPN
admet-2740	3	26	8	8	NUM
admet-2740	3	27	,	,	PUNCT
admet-2740	3	28	2025	2025	NUM
admet-2740	3	29	abstract	abstract	ADJ
admet-2740	3	30	background	background	NOUN
admet-2740	3	31	and	and	CCONJ
admet-2740	3	32	purpose	purpose	NOUN
admet-2740	3	33	:	:	PUNCT
admet-2740	3	34	warfarin	warfarin	NOUN
admet-2740	3	35	is	be	AUX
admet-2740	3	36	a	a	DET
admet-2740	3	37	widely	widely	ADV
admet-2740	3	38	prescribed	prescribe	VERB
admet-2740	3	39	oral	oral	ADJ
admet-2740	3	40	anticoagulant	anticoagulant	NOUN
admet-2740	3	41	for	for	ADP
admet-2740	3	42	the	the	DET
admet-2740	3	43	prevention	prevention	NOUN
admet-2740	3	44	and	and	CCONJ
admet-2740	3	45	treatment	treatment	NOUN
admet-2740	3	46	of	of	ADP
admet-2740	3	47	thromboembolic	thromboembolic	ADJ
admet-2740	3	48	events	event	NOUN
admet-2740	3	49	,	,	PUNCT
admet-2740	3	50	frequently	frequently	ADV
admet-2740	3	51	used	use	VERB
admet-2740	3	52	in	in	ADP
admet-2740	3	53	patients	patient	NOUN
admet-2740	3	54	with	with	ADP
admet-2740	3	55	atrial	atrial	ADJ
admet-2740	3	56	fibrillation	fibrillation	NOUN
admet-2740	3	57	.	.	PUNCT
admet-2740	4	1	however	however	ADV
admet-2740	4	2	,	,	PUNCT
admet-2740	4	3	its	its	PRON
admet-2740	4	4	effectiveness	effectiveness	NOUN
admet-2740	4	5	is	be	AUX
admet-2740	4	6	often	often	ADV
admet-2740	4	7	challenged	challenge	VERB
admet-2740	4	8	by	by	ADP
admet-2740	4	9	a	a	DET
admet-2740	4	10	narrow	narrow	ADJ
admet-2740	4	11	therapeutic	therapeutic	ADJ
admet-2740	4	12	range	range	NOUN
admet-2740	4	13	and	and	CCONJ
admet-2740	4	14	significant	significant	ADJ
admet-2740	4	15	inter	inter	ADJ
admet-2740	4	16	-	-	ADJ
admet-2740	4	17	patient	patient	ADJ
admet-2740	4	18	variability	variability	NOUN
admet-2740	4	19	in	in	ADP
admet-2740	4	20	dosage	dosage	NOUN
admet-2740	4	21	requirements	requirement	NOUN
admet-2740	4	22	and	and	CCONJ
admet-2740	4	23	treatment	treatment	NOUN
admet-2740	4	24	responses	response	NOUN
admet-2740	4	25	.	.	PUNCT
admet-2740	5	1	drug	drug	NOUN
admet-2740	5	2	interactions	interaction	NOUN
admet-2740	5	3	remain	remain	VERB
admet-2740	5	4	a	a	DET
admet-2740	5	5	critical	critical	ADJ
admet-2740	5	6	concern	concern	NOUN
admet-2740	5	7	,	,	PUNCT
admet-2740	5	8	as	as	SCONJ
admet-2740	5	9	they	they	PRON
admet-2740	5	10	heighten	heighten	VERB
admet-2740	5	11	the	the	DET
admet-2740	5	12	risk	risk	NOUN
admet-2740	5	13	of	of	ADP
admet-2740	5	14	supratherapeutic	supratherapeutic	ADJ
admet-2740	5	15	anticoagulation	anticoagulation	NOUN
admet-2740	5	16	.	.	PUNCT
admet-2740	6	1	reports	report	NOUN
admet-2740	6	2	of	of	ADP
admet-2740	6	3	interactions	interaction	NOUN
admet-2740	6	4	between	between	ADP
admet-2740	6	5	warfarin	warfarin	NOUN
admet-2740	6	6	and	and	CCONJ
admet-2740	6	7	mango	mango	NOUN
admet-2740	6	8	have	have	AUX
admet-2740	6	9	documented	document	VERB
admet-2740	6	10	cases	case	NOUN
admet-2740	6	11	of	of	ADP
admet-2740	6	12	elevated	elevated	ADJ
admet-2740	6	13	international	international	ADJ
admet-2740	6	14	normalized	normalize	VERB
admet-2740	6	15	ratio	ratio	NOUN
admet-2740	6	16	(	(	PUNCT
admet-2740	6	17	inr	inr	PROPN
admet-2740	6	18	)	)	PUNCT
admet-2740	6	19	following	follow	VERB
admet-2740	6	20	mango	mango	PROPN
admet-2740	6	21	consumption	consumption	NOUN
admet-2740	6	22	,	,	PUNCT
admet-2740	6	23	although	although	SCONJ
admet-2740	6	24	the	the	DET
admet-2740	6	25	underlying	underlie	VERB
admet-2740	6	26	molecular	molecular	ADJ
admet-2740	6	27	mechanisms	mechanism	NOUN
admet-2740	6	28	remain	remain	VERB
admet-2740	6	29	unclear	unclear	ADJ
admet-2740	6	30	.	.	PUNCT
admet-2740	7	1	experimental	experimental	ADJ
admet-2740	7	2	approach	approach	NOUN
admet-2740	7	3	:	:	PUNCT
admet-2740	7	4	this	this	DET
admet-2740	7	5	study	study	NOUN
admet-2740	7	6	investigates	investigate	VERB
admet-2740	7	7	the	the	DET
admet-2740	7	8	molecular	molecular	ADJ
admet-2740	7	9	basis	basis	NOUN
admet-2740	7	10	of	of	ADP
admet-2740	7	11	the	the	DET
admet-2740	7	12	warfarin	warfarin	NOUN
admet-2740	7	13	-	-	PUNCT
admet-2740	7	14	mango	mango	NOUN
admet-2740	7	15	interaction	interaction	NOUN
admet-2740	7	16	using	use	VERB
admet-2740	7	17	proton	proton	NOUN
admet-2740	7	18	nuclear	nuclear	ADJ
admet-2740	7	19	magnetic	magnetic	ADJ
admet-2740	7	20	resonance	resonance	NOUN
admet-2740	7	21	(	(	PUNCT
admet-2740	7	22	1h	1h	NUM
admet-2740	7	23	-	-	PUNCT
admet-2740	7	24	nmr)based	nmr)based	ADJ
admet-2740	7	25	metabolomics	metabolomic	NOUN
admet-2740	7	26	.	.	PUNCT
admet-2740	8	1	in	in	ADP
admet-2740	8	2	a	a	DET
admet-2740	8	3	pre	pre	ADJ
admet-2740	8	4	-	-	ADJ
admet-2740	8	5	post	post	ADJ
admet-2740	8	6	design	design	NOUN
admet-2740	8	7	study	study	NOUN
admet-2740	8	8	,	,	PUNCT
admet-2740	8	9	plasma	plasma	NOUN
admet-2740	8	10	samples	sample	NOUN
admet-2740	8	11	were	be	AUX
admet-2740	8	12	collected	collect	VERB
admet-2740	8	13	from	from	ADP
admet-2740	8	14	patients	patient	NOUN
admet-2740	8	15	on	on	ADP
admet-2740	8	16	long	long	ADJ
admet-2740	8	17	-	-	PUNCT
admet-2740	8	18	term	term	NOUN
admet-2740	8	19	warfarin	warfarin	NOUN
admet-2740	8	20	therapy	therapy	NOUN
admet-2740	8	21	(	(	PUNCT
admet-2740	8	22	>	>	SYM
admet-2740	8	23	6	6	NUM
admet-2740	8	24	months	month	NOUN
admet-2740	8	25	)	)	PUNCT
admet-2740	8	26	who	who	PRON
admet-2740	8	27	exhibited	exhibit	VERB
admet-2740	8	28	supratherapeutic	supratherapeutic	ADJ
admet-2740	8	29	inr	inr	PROPN
admet-2740	8	30	levels	level	NOUN
admet-2740	8	31	after	after	ADP
admet-2740	8	32	consuming	consume	VERB
admet-2740	8	33	mango	mango	NOUN
admet-2740	8	34	.	.	PUNCT
admet-2740	9	1	after	after	ADP
admet-2740	9	2	a	a	DET
admet-2740	9	3	two	two	NUM
admet-2740	9	4	-	-	PUNCT
admet-2740	9	5	week	week	NOUN
admet-2740	9	6	discontinuation	discontinuation	NOUN
admet-2740	9	7	of	of	ADP
admet-2740	9	8	mango	mango	NOUN
admet-2740	9	9	consumption	consumption	NOUN
admet-2740	9	10	,	,	PUNCT
admet-2740	9	11	additional	additional	ADJ
admet-2740	9	12	plasma	plasma	NOUN
admet-2740	9	13	samples	sample	NOUN
admet-2740	9	14	were	be	AUX
admet-2740	9	15	collected	collect	VERB
admet-2740	9	16	once	once	SCONJ
admet-2740	9	17	inr	inr	PROPN
admet-2740	9	18	levels	level	NOUN
admet-2740	9	19	returned	return	VERB
admet-2740	9	20	to	to	ADP
admet-2740	9	21	the	the	DET
admet-2740	9	22	therapeutic	therapeutic	ADJ
admet-2740	9	23	range	range	NOUN
admet-2740	9	24	.	.	PUNCT
admet-2740	10	1	key	key	ADJ
admet-2740	10	2	results	result	NOUN
admet-2740	10	3	and	and	CCONJ
admet-2740	10	4	conclusion	conclusion	NOUN
admet-2740	10	5	:	:	PUNCT
admet-2740	10	6	this	this	PRON
admet-2740	10	7	is	be	AUX
admet-2740	10	8	the	the	DET
admet-2740	10	9	first	first	ADJ
admet-2740	10	10	study	study	NOUN
admet-2740	10	11	to	to	PART
admet-2740	10	12	utilize	utilize	VERB
admet-2740	10	13	1h	1h	NUM
admet-2740	10	14	-	-	PUNCT
admet-2740	10	15	nmr	nmr	NOUN
admet-2740	10	16	metabolomics	metabolomic	NOUN
admet-2740	10	17	to	to	PART
admet-2740	10	18	explore	explore	VERB
admet-2740	10	19	warfarin	warfarin	NOUN
admet-2740	10	20	-	-	PUNCT
admet-2740	10	21	mango	mango	NOUN
admet-2740	10	22	interactions	interaction	NOUN
admet-2740	10	23	,	,	PUNCT
admet-2740	10	24	integrating	integrate	VERB
admet-2740	10	25	clinical	clinical	ADJ
admet-2740	10	26	observations	observation	NOUN
admet-2740	10	27	with	with	ADP
admet-2740	10	28	metabolic	metabolic	NOUN
admet-2740	10	29	insights	insight	NOUN
admet-2740	10	30	.	.	PUNCT
admet-2740	11	1	findings	finding	NOUN
admet-2740	11	2	suggest	suggest	VERB
admet-2740	11	3	that	that	SCONJ
admet-2740	11	4	a	a	DET
admet-2740	11	5	reduction	reduction	NOUN
admet-2740	11	6	in	in	ADP
admet-2740	11	7	glycerol	glycerol	NOUN
admet-2740	11	8	3	3	NUM
admet-2740	11	9	-	-	PUNCT
admet-2740	11	10	phosphate	phosphate	NOUN
admet-2740	11	11	may	may	AUX
admet-2740	11	12	impair	impair	VERB
admet-2740	11	13	glycolysis	glycolysis	NOUN
admet-2740	11	14	,	,	PUNCT
admet-2740	11	15	disrupting	disrupt	VERB
admet-2740	11	16	platelet	platelet	NOUN
admet-2740	11	17	activation	activation	NOUN
admet-2740	11	18	and	and	CCONJ
admet-2740	11	19	contributing	contribute	VERB
admet-2740	11	20	to	to	ADP
admet-2740	11	21	the	the	DET
admet-2740	11	22	elevated	elevated	ADJ
admet-2740	11	23	inr	inr	PROPN
admet-2740	11	24	levels	level	NOUN
admet-2740	11	25	observed	observe	VERB
admet-2740	11	26	in	in	ADP
admet-2740	11	27	all	all	DET
admet-2740	11	28	patients	patient	NOUN
admet-2740	11	29	.	.	PUNCT
admet-2740	12	1	these	these	DET
admet-2740	12	2	results	result	NOUN
admet-2740	12	3	underscore	underscore	VERB
admet-2740	12	4	the	the	DET
admet-2740	12	5	potential	potential	NOUN
admet-2740	12	6	for	for	ADP
admet-2740	12	7	1h	1h	NUM
admet-2740	12	8	-	-	PUNCT
admet-2740	12	9	nmr	nmr	NOUN
admet-2740	12	10	metabolomics	metabolomic	NOUN
admet-2740	12	11	to	to	PART
admet-2740	12	12	elucidate	elucidate	VERB
admet-2740	12	13	drug	drug	NOUN
admet-2740	12	14	-	-	PUNCT
admet-2740	12	15	food	food	NOUN
admet-2740	12	16	interactions	interaction	NOUN
admet-2740	12	17	,	,	PUNCT
admet-2740	12	18	advancing	advance	VERB
admet-2740	12	19	personalized	personalized	ADJ
admet-2740	12	20	anticoagulant	anticoagulant	ADJ
admet-2740	12	21	management	management	NOUN
admet-2740	12	22	and	and	CCONJ
admet-2740	12	23	improving	improve	VERB
admet-2740	12	24	patient	patient	ADJ
admet-2740	12	25	safety	safety	NOUN
admet-2740	12	26	.	.	PUNCT
admet-2740	13	1	©	©	X
admet-2740	13	2	2025	2025	NUM
admet-2740	13	3	by	by	ADP
admet-2740	13	4	the	the	DET
admet-2740	13	5	authors	author	NOUN
admet-2740	13	6	.	.	PUNCT
admet-2740	14	1	this	this	DET
admet-2740	14	2	article	article	NOUN
admet-2740	14	3	is	be	AUX
admet-2740	14	4	an	an	DET
admet-2740	14	5	open	open	ADJ
admet-2740	14	6	-	-	PUNCT
admet-2740	14	7	access	access	NOUN
admet-2740	14	8	article	article	NOUN
admet-2740	14	9	distributed	distribute	VERB
admet-2740	14	10	under	under	ADP
admet-2740	14	11	the	the	DET
admet-2740	14	12	terms	term	NOUN
admet-2740	14	13	and	and	CCONJ
admet-2740	14	14	conditions	condition	NOUN
admet-2740	14	15	of	of	ADP
admet-2740	14	16	the	the	DET
admet-2740	14	17	creative	creative	ADJ
admet-2740	14	18	commons	common	NOUN
admet-2740	14	19	attribution	attribution	NOUN
admet-2740	14	20	license	license	NOUN
admet-2740	14	21	(	(	PUNCT
admet-2740	14	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	PROPN
admet-2740	14	23	)	)	PUNCT
admet-2740	14	24	.	.	PUNCT
admet-2740	15	1	keywords	keyword	NOUN
admet-2740	15	2	biomarker	biomarker	VERB
admet-2740	15	3	;	;	PUNCT
admet-2740	15	4	drug	drug	NOUN
admet-2740	15	5	interaction	interaction	NOUN
admet-2740	15	6	;	;	PUNCT
admet-2740	15	7	1h	1h	NUM
admet-2740	15	8	-	-	PUNCT
admet-2740	15	9	nmr	nmr	NOUN
admet-2740	15	10	-	-	PUNCT
admet-2740	15	11	based	base	VERB
admet-2740	15	12	metabolomics	metabolomic	NOUN
admet-2740	15	13	;	;	PUNCT
admet-2740	15	14	metabolites	metabolite	NOUN
admet-2740	15	15	;	;	PUNCT
admet-2740	15	16	personalized	personalize	VERB
admet-2740	15	17	anticoagulant	anticoagulant	ADJ
admet-2740	15	18	introduction	introduction	NOUN
admet-2740	15	19	warfarin	warfarin	NOUN
admet-2740	15	20	remains	remain	VERB
admet-2740	15	21	a	a	DET
admet-2740	15	22	widely	widely	ADV
admet-2740	15	23	prescribed	prescribe	VERB
admet-2740	15	24	oral	oral	ADJ
admet-2740	15	25	anticoagulant	anticoagulant	NOUN
admet-2740	15	26	for	for	ADP
admet-2740	15	27	the	the	DET
admet-2740	15	28	prevention	prevention	NOUN
admet-2740	15	29	and	and	CCONJ
admet-2740	15	30	treatment	treatment	NOUN
admet-2740	15	31	of	of	ADP
admet-2740	15	32	thromboembolism	thromboembolism	NOUN
admet-2740	15	33	events	event	NOUN
admet-2740	15	34	,	,	PUNCT
admet-2740	15	35	frequently	frequently	ADV
admet-2740	15	36	used	use	VERB
admet-2740	15	37	in	in	ADP
admet-2740	15	38	patients	patient	NOUN
admet-2740	15	39	with	with	ADP
admet-2740	15	40	atrial	atrial	ADJ
admet-2740	15	41	fibrillation	fibrillation	NOUN
admet-2740	15	42	(	(	PUNCT
admet-2740	15	43	af	af	NOUN
admet-2740	15	44	)	)	PUNCT
admet-2740	16	1	[	[	X
admet-2740	16	2	1,2	1,2	NUM
admet-2740	16	3	]	]	PUNCT
admet-2740	16	4	.	.	PUNCT
admet-2740	17	1	however	however	ADV
admet-2740	17	2	,	,	PUNCT
admet-2740	17	3	its	its	PRON
admet-2740	17	4	effectiveness	effectiveness	NOUN
admet-2740	17	5	is	be	AUX
admet-2740	17	6	challenged	challenge	VERB
admet-2740	17	7	by	by	ADP
admet-2740	17	8	a	a	DET
admet-2740	17	9	narrow	narrow	ADJ
admet-2740	17	10	therapeutic	therapeutic	ADJ
admet-2740	17	11	range	range	NOUN
admet-2740	17	12	and	and	CCONJ
admet-2740	17	13	significant	significant	ADJ
admet-2740	17	14	variability	variability	NOUN
admet-2740	17	15	in	in	ADP
admet-2740	17	16	dosage	dosage	NOUN
admet-2740	17	17	requirements	requirement	NOUN
admet-2740	17	18	and	and	CCONJ
admet-2740	17	19	treatment	treatment	NOUN
admet-2740	17	20	responses	response	NOUN
admet-2740	17	21	among	among	ADP
admet-2740	17	22	patients	patient	NOUN
admet-2740	17	23	[	[	X
admet-2740	17	24	1	1	NUM
admet-2740	17	25	]	]	PUNCT
admet-2740	17	26	.	.	PUNCT
admet-2740	18	1	the	the	DET
admet-2740	18	2	emergence	emergence	NOUN
admet-2740	18	3	of	of	ADP
admet-2740	18	4	new	new	ADJ
admet-2740	18	5	effective	effective	ADJ
admet-2740	18	6	,	,	PUNCT
admet-2740	18	7	safe	safe	ADJ
admet-2740	18	8	anticoagulants	anticoagulant	NOUN
admet-2740	18	9	,	,	PUNCT
admet-2740	18	10	specifically	specifically	ADV
admet-2740	18	11	non	non	ADJ
admet-2740	18	12	-	-	ADJ
admet-2740	18	13	vitamin	vitamin	ADJ
admet-2740	18	14	k	k	PROPN
admet-2740	18	15	antagonist	antagonist	NOUN
admet-2740	18	16	https://doi.org/10.5599/admet.2740	https://doi.org/10.5599/admet.2740	NOUN
admet-2740	18	17	https://doi.org/10.5599/admet.2740	https://doi.org/10.5599/admet.2740	NOUN
admet-2740	18	18	http://www.pub.iapchem.org/ojs/index.php/admet/index	http://www.pub.iapchem.org/ojs/index.php/admet/index	PROPN
admet-2740	18	19	mailto:preechaya.ta@cmu.ac.th	mailto:preechaya.ta@cmu.ac.th	NOUN
admet-2740	18	20	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	PROPN
admet-2740	18	21	p.	p.	PROPN
admet-2740	18	22	rattanasuwan	rattanasuwan	PROPN
admet-2740	18	23	et	et	PROPN
admet-2740	18	24	al	al	PROPN
admet-2740	18	25	.	.	PROPN
admet-2740	18	26	admet	admet	PROPN
admet-2740	18	27	&	&	CCONJ
admet-2740	18	28	dmpk	dmpk	PROPN
admet-2740	18	29	13(3	13(3	NUM
admet-2740	18	30	)	)	PUNCT
admet-2740	18	31	(	(	PUNCT
admet-2740	18	32	2025	2025	NUM
admet-2740	18	33	)	)	PUNCT
admet-2740	18	34	2740	2740	NUM
admet-2740	18	35	2	2	NUM
admet-2740	18	36	oral	oral	ADJ
admet-2740	18	37	anticoagulants	anticoagulant	NOUN
admet-2740	18	38	(	(	PUNCT
admet-2740	18	39	noacs	noac	NOUN
admet-2740	18	40	)	)	PUNCT
admet-2740	18	41	,	,	PUNCT
admet-2740	18	42	has	have	AUX
admet-2740	18	43	resulted	result	VERB
admet-2740	18	44	in	in	ADP
admet-2740	18	45	their	their	PRON
admet-2740	18	46	recommendation	recommendation	NOUN
admet-2740	18	47	in	in	ADP
admet-2740	18	48	international	international	ADJ
admet-2740	18	49	guidelines	guideline	NOUN
admet-2740	18	50	[	[	X
admet-2740	18	51	1,2	1,2	NUM
admet-2740	18	52	]	]	PUNCT
admet-2740	18	53	.	.	PUNCT
admet-2740	19	1	nonetheless	nonetheless	ADV
admet-2740	19	2	,	,	PUNCT
admet-2740	19	3	noacs	noac	NOUN
admet-2740	19	4	still	still	ADV
admet-2740	19	5	present	present	VERB
admet-2740	19	6	challenges	challenge	NOUN
admet-2740	19	7	in	in	ADP
admet-2740	19	8	terms	term	NOUN
admet-2740	19	9	of	of	ADP
admet-2740	19	10	cost	cost	NOUN
admet-2740	19	11	-	-	PUNCT
admet-2740	19	12	effectiveness	effectiveness	NOUN
admet-2740	19	13	,	,	PUNCT
admet-2740	19	14	particularly	particularly	ADV
admet-2740	19	15	in	in	ADP
admet-2740	19	16	resource	resource	NOUN
admet-2740	19	17	-	-	PUNCT
admet-2740	19	18	limited	limit	VERB
admet-2740	19	19	healthcare	healthcare	NOUN
admet-2740	19	20	settings	setting	NOUN
admet-2740	19	21	,	,	PUNCT
admet-2740	19	22	including	include	VERB
admet-2740	19	23	community	community	NOUN
admet-2740	19	24	hospitals	hospital	NOUN
admet-2740	19	25	in	in	ADP
admet-2740	19	26	thailand	thailand	PROPN
admet-2740	20	1	[	[	X
admet-2740	20	2	2,3	2,3	NUM
admet-2740	20	3	]	]	PUNCT
admet-2740	20	4	.	.	PUNCT
admet-2740	21	1	the	the	DET
admet-2740	21	2	primary	primary	ADJ
admet-2740	21	3	complication	complication	NOUN
admet-2740	21	4	regarding	regard	VERB
admet-2740	21	5	treatment	treatment	NOUN
admet-2740	21	6	lies	lie	VERB
admet-2740	21	7	in	in	ADP
admet-2740	21	8	the	the	DET
admet-2740	21	9	risk	risk	NOUN
admet-2740	21	10	of	of	ADP
admet-2740	21	11	supratherapeutic	supratherapeutic	ADJ
admet-2740	21	12	anticoagulation	anticoagulation	NOUN
admet-2740	21	13	,	,	PUNCT
admet-2740	21	14	which	which	PRON
admet-2740	21	15	can	can	AUX
admet-2740	21	16	arise	arise	VERB
admet-2740	21	17	as	as	ADP
admet-2740	21	18	a	a	DET
admet-2740	21	19	consequence	consequence	NOUN
admet-2740	21	20	of	of	ADP
admet-2740	21	21	various	various	ADJ
admet-2740	21	22	factors	factor	NOUN
admet-2740	21	23	[	[	X
admet-2740	21	24	2,4	2,4	NUM
admet-2740	21	25	]	]	X
admet-2740	21	26	.	.	PUNCT
admet-2740	22	1	genetic	genetic	ADJ
admet-2740	22	2	factors	factor	NOUN
admet-2740	22	3	and	and	CCONJ
admet-2740	22	4	drug	drug	NOUN
admet-2740	22	5	interactions	interaction	NOUN
admet-2740	22	6	predominantly	predominantly	ADV
admet-2740	22	7	contribute	contribute	VERB
admet-2740	22	8	to	to	ADP
admet-2740	22	9	this	this	DET
admet-2740	22	10	complication	complication	NOUN
admet-2740	22	11	risk	risk	NOUN
admet-2740	22	12	[	[	X
admet-2740	22	13	4	4	NUM
admet-2740	22	14	-	-	SYM
admet-2740	22	15	8	8	NUM
admet-2740	22	16	]	]	PUNCT
admet-2740	22	17	.	.	PUNCT
admet-2740	23	1	warfarin	warfarin	NOUN
admet-2740	23	2	disrupts	disrupt	VERB
admet-2740	23	3	the	the	DET
admet-2740	23	4	conversion	conversion	NOUN
admet-2740	23	5	of	of	ADP
admet-2740	23	6	vitamin	vitamin	NOUN
admet-2740	23	7	k	k	PROPN
admet-2740	23	8	and	and	CCONJ
admet-2740	23	9	its	its	PRON
admet-2740	23	10	epoxide	epoxide	NOUN
admet-2740	23	11	form	form	NOUN
admet-2740	23	12	,	,	PUNCT
admet-2740	23	13	which	which	PRON
admet-2740	23	14	is	be	AUX
admet-2740	23	15	essential	essential	ADJ
admet-2740	23	16	for	for	ADP
admet-2740	23	17	the	the	DET
admet-2740	23	18	carboxylation	carboxylation	NOUN
admet-2740	23	19	of	of	ADP
admet-2740	23	20	glutamate	glutamate	ADJ
admet-2740	23	21	residues	residue	NOUN
admet-2740	23	22	into	into	ADP
admet-2740	23	23	γ	γ	NOUN
admet-2740	23	24	-	-	PUNCT
admet-2740	23	25	carboxyglutamates	carboxyglutamate	NOUN
admet-2740	23	26	(	(	PUNCT
admet-2740	23	27	gla	gla	PROPN
admet-2740	23	28	)	)	PUNCT
admet-2740	23	29	on	on	ADP
admet-2740	23	30	vitamin	vitamin	NOUN
admet-2740	23	31	k	k	NOUN
admet-2740	23	32	-	-	ADJ
admet-2740	23	33	dependent	dependent	ADJ
admet-2740	23	34	proteins	protein	NOUN
admet-2740	23	35	,	,	PUNCT
admet-2740	23	36	including	include	VERB
admet-2740	23	37	coagulation	coagulation	NOUN
admet-2740	23	38	factors	factor	NOUN
admet-2740	23	39	ii	ii	PROPN
admet-2740	23	40	,	,	PUNCT
admet-2740	23	41	vii	vii	PROPN
admet-2740	23	42	,	,	PUNCT
admet-2740	23	43	ix	ix	ADV
admet-2740	23	44	,	,	PUNCT
admet-2740	23	45	and	and	CCONJ
admet-2740	23	46	x	x	SYM
admet-2740	24	1	[	[	X
admet-2740	24	2	9	9	NUM
admet-2740	24	3	]	]	PUNCT
admet-2740	24	4	.	.	PUNCT
admet-2740	25	1	this	this	DET
admet-2740	25	2	γ	γ	PROPN
admet-2740	25	3	-	-	PUNCT
admet-2740	25	4	carboxylation	carboxylation	NOUN
admet-2740	25	5	process	process	NOUN
admet-2740	25	6	requires	require	VERB
admet-2740	25	7	the	the	DET
admet-2740	25	8	reduced	reduce	VERB
admet-2740	25	9	form	form	NOUN
admet-2740	25	10	of	of	ADP
admet-2740	25	11	vitamin	vitamin	NOUN
admet-2740	25	12	k	k	NOUN
admet-2740	25	13	,	,	PUNCT
admet-2740	25	14	known	know	VERB
admet-2740	25	15	as	as	ADP
admet-2740	25	16	vitamin	vitamin	NOUN
admet-2740	25	17	k	k	X
admet-2740	25	18	hydroquinone	hydroquinone	PROPN
admet-2740	25	19	(	(	PUNCT
admet-2740	25	20	vitamin	vitamin	NOUN
admet-2740	25	21	kh2	kh2	PROPN
admet-2740	25	22	)	)	PUNCT
admet-2740	25	23	,	,	PUNCT
admet-2740	25	24	and	and	CCONJ
admet-2740	25	25	facilitates	facilitate	VERB
admet-2740	25	26	the	the	DET
admet-2740	25	27	binding	binding	NOUN
admet-2740	25	28	of	of	ADP
admet-2740	25	29	these	these	DET
admet-2740	25	30	coagulation	coagulation	NOUN
admet-2740	25	31	factors	factor	NOUN
admet-2740	25	32	to	to	ADP
admet-2740	25	33	phospholipid	phospholipid	NOUN
admet-2740	25	34	surfaces	surface	NOUN
admet-2740	25	35	,	,	PUNCT
admet-2740	25	36	thereby	thereby	ADV
admet-2740	25	37	enhancing	enhance	VERB
admet-2740	25	38	blood	blood	NOUN
admet-2740	25	39	coagulation	coagulation	NOUN
admet-2740	26	1	[	[	X
admet-2740	26	2	9	9	NUM
admet-2740	26	3	]	]	PUNCT
admet-2740	26	4	.	.	PUNCT
admet-2740	27	1	warfarin	warfarin	NOUN
admet-2740	27	2	inhibits	inhibit	VERB
admet-2740	27	3	the	the	DET
admet-2740	27	4	synthesis	synthesis	NOUN
admet-2740	27	5	of	of	ADP
admet-2740	27	6	vitamin	vitamin	NOUN
admet-2740	27	7	kh2	kh2	NOUN
admet-2740	27	8	by	by	ADP
admet-2740	27	9	targeting	target	VERB
admet-2740	27	10	the	the	DET
admet-2740	27	11	enzyme	enzyme	NOUN
admet-2740	27	12	vitamin	vitamin	NOUN
admet-2740	27	13	k	k	X
admet-2740	27	14	epoxide	epoxide	NOUN
admet-2740	27	15	reductase	reductase	NOUN
admet-2740	27	16	complex	complex	NOUN
admet-2740	27	17	1	1	NUM
admet-2740	27	18	(	(	PUNCT
admet-2740	27	19	vkorc1	vkorc1	NOUN
admet-2740	27	20	)	)	PUNCT
admet-2740	27	21	,	,	PUNCT
admet-2740	27	22	thus	thus	ADV
admet-2740	27	23	limiting	limit	VERB
admet-2740	27	24	the	the	DET
admet-2740	27	25	γ	γ	NOUN
admet-2740	27	26	-	-	NOUN
admet-2740	27	27	carboxylation	carboxylation	NOUN
admet-2740	27	28	of	of	ADP
admet-2740	27	29	vitamin	vitamin	NOUN
admet-2740	27	30	k	k	ADJ
admet-2740	27	31	-	-	ADJ
admet-2740	27	32	dependent	dependent	ADJ
admet-2740	27	33	coagulation	coagulation	NOUN
admet-2740	27	34	proteins	protein	NOUN
admet-2740	27	35	(	(	PUNCT
admet-2740	27	36	figure	figure	NOUN
admet-2740	27	37	1	1	NUM
admet-2740	27	38	)	)	PUNCT
admet-2740	28	1	[	[	X
admet-2740	28	2	9	9	NUM
admet-2740	28	3	]	]	PUNCT
admet-2740	28	4	.	.	PUNCT
admet-2740	28	5	impaired	impaired	ADJ
admet-2740	28	6	clearance	clearance	NOUN
admet-2740	28	7	of	of	ADP
admet-2740	28	8	warfarin	warfarin	NOUN
admet-2740	28	9	results	result	NOUN
admet-2740	28	10	in	in	ADP
admet-2740	28	11	elevated	elevated	ADJ
admet-2740	28	12	plasma	plasma	NOUN
admet-2740	28	13	concentrations	concentration	NOUN
admet-2740	28	14	,	,	PUNCT
admet-2740	28	15	as	as	SCONJ
admet-2740	28	16	indicated	indicate	VERB
admet-2740	28	17	by	by	ADP
admet-2740	28	18	an	an	DET
admet-2740	28	19	increase	increase	NOUN
admet-2740	28	20	in	in	ADP
admet-2740	28	21	international	international	ADJ
admet-2740	28	22	normalized	normalize	VERB
admet-2740	28	23	ratio	ratio	NOUN
admet-2740	28	24	(	(	PUNCT
admet-2740	28	25	inr	inr	PROPN
admet-2740	28	26	)	)	PUNCT
admet-2740	29	1	[	[	X
admet-2740	29	2	4,7,9	4,7,9	X
admet-2740	29	3	]	]	X
admet-2740	29	4	.	.	PUNCT
admet-2740	30	1	such	such	ADJ
admet-2740	30	2	disruptions	disruption	NOUN
admet-2740	30	3	may	may	AUX
admet-2740	30	4	lead	lead	VERB
admet-2740	30	5	to	to	ADP
admet-2740	30	6	severe	severe	ADJ
admet-2740	30	7	adverse	adverse	ADJ
admet-2740	30	8	effects	effect	NOUN
admet-2740	30	9	,	,	PUNCT
admet-2740	30	10	including	include	VERB
admet-2740	30	11	an	an	DET
admet-2740	30	12	elevated	elevated	ADJ
admet-2740	30	13	risk	risk	NOUN
admet-2740	30	14	of	of	ADP
admet-2740	30	15	bleeding	bleeding	NOUN
admet-2740	30	16	and	and	CCONJ
admet-2740	30	17	significant	significant	ADJ
admet-2740	30	18	haemorrhage	haemorrhage	NOUN
admet-2740	30	19	[	[	X
admet-2740	30	20	4,7,9	4,7,9	X
admet-2740	30	21	]	]	PUNCT
admet-2740	30	22	.	.	PUNCT
admet-2740	31	1	warfarin	warfarin	NOUN
admet-2740	31	2	is	be	AUX
admet-2740	31	3	a	a	DET
admet-2740	31	4	racemic	racemic	ADJ
admet-2740	31	5	mixture	mixture	NOUN
admet-2740	31	6	composed	compose	VERB
admet-2740	31	7	of	of	ADP
admet-2740	31	8	rand	rand	NOUN
admet-2740	31	9	s	s	NOUN
admet-2740	31	10	-	-	PUNCT
admet-2740	31	11	enantiomers	enantiomer	NOUN
admet-2740	31	12	,	,	PUNCT
admet-2740	31	13	with	with	SCONJ
admet-2740	31	14	their	their	PRON
admet-2740	31	15	metabolism	metabolism	NOUN
admet-2740	31	16	predominantly	predominantly	ADV
admet-2740	31	17	mediated	mediate	VERB
admet-2740	31	18	by	by	ADP
admet-2740	31	19	cytochrome	cytochrome	ADJ
admet-2740	31	20	p450	p450	PROPN
admet-2740	31	21	(	(	PUNCT
admet-2740	31	22	cyp	cyp	ADJ
admet-2740	31	23	)	)	PUNCT
admet-2740	31	24	enzymes	enzyme	NOUN
admet-2740	31	25	,	,	PUNCT
admet-2740	31	26	including	include	VERB
admet-2740	31	27	cyp2c9	cyp2c9	NOUN
admet-2740	31	28	,	,	PUNCT
admet-2740	31	29	cyp2c19	cyp2c19	PROPN
admet-2740	31	30	,	,	PUNCT
admet-2740	31	31	cyp1a2	cyp1a2	NOUN
admet-2740	31	32	and	and	CCONJ
admet-2740	31	33	cyp3a4	cyp3a4	PROPN
admet-2740	31	34	(	(	PUNCT
admet-2740	31	35	figure	figure	NOUN
admet-2740	31	36	1	1	NUM
admet-2740	31	37	)	)	PUNCT
admet-2740	32	1	[	[	X
admet-2740	32	2	4,6,7	4,6,7	NOUN
admet-2740	32	3	]	]	PUNCT
admet-2740	32	4	.	.	PUNCT
admet-2740	33	1	s	s	X
admet-2740	33	2	-	-	PUNCT
admet-2740	33	3	warfarin	warfarin	NOUN
admet-2740	33	4	,	,	PUNCT
admet-2740	33	5	the	the	DET
admet-2740	33	6	more	more	ADV
admet-2740	33	7	potent	potent	ADJ
admet-2740	33	8	enantiomer	enantiomer	NOUN
admet-2740	33	9	,	,	PUNCT
admet-2740	33	10	is	be	AUX
admet-2740	33	11	primarily	primarily	ADV
admet-2740	33	12	metabolized	metabolize	VERB
admet-2740	33	13	by	by	ADP
admet-2740	33	14	cyp2c9	cyp2c9	NOUN
admet-2740	33	15	into	into	ADP
admet-2740	33	16	6and	6and	NUM
admet-2740	33	17	7	7	NUM
admet-2740	33	18	-	-	NUM
admet-2740	33	19	hydroxywarfarin	hydroxywarfarin	NOUN
admet-2740	34	1	[	[	X
admet-2740	34	2	4,7,10	4,7,10	NUM
admet-2740	34	3	]	]	PUNCT
admet-2740	34	4	.	.	PUNCT
admet-2740	35	1	in	in	ADP
admet-2740	35	2	contrast	contrast	NOUN
admet-2740	35	3	,	,	PUNCT
admet-2740	35	4	r	r	NOUN
admet-2740	35	5	-	-	PUNCT
admet-2740	35	6	warfarin	warfarin	NOUN
admet-2740	35	7	undergoes	undergo	VERB
admet-2740	35	8	metabolism	metabolism	NOUN
admet-2740	35	9	via	via	ADP
admet-2740	35	10	cyp1a2	cyp1a2	NOUN
admet-2740	35	11	to	to	PART
admet-2740	35	12	form	form	VERB
admet-2740	35	13	6and	6and	NUM
admet-2740	35	14	8	8	NUM
admet-2740	35	15	-	-	PUNCT
admet-2740	35	16	hydroxywarfarin	hydroxywarfarin	NOUN
admet-2740	35	17	,	,	PUNCT
admet-2740	35	18	and	and	CCONJ
admet-2740	35	19	by	by	ADP
admet-2740	35	20	cyp3a4	cyp3a4	NOUN
admet-2740	35	21	to	to	PART
admet-2740	35	22	produce	produce	VERB
admet-2740	35	23	10	10	NUM
admet-2740	35	24	-	-	PUNCT
admet-2740	35	25	hydroxywarfarin	hydroxywarfarin	NOUN
admet-2740	36	1	[	[	X
admet-2740	36	2	4,7,10	4,7,10	NUM
admet-2740	36	3	]	]	X
admet-2740	36	4	.	.	PUNCT
admet-2740	37	1	additionally	additionally	ADV
admet-2740	37	2	,	,	PUNCT
admet-2740	37	3	r	r	NOUN
admet-2740	37	4	-	-	PUNCT
admet-2740	37	5	warfarin	warfarin	NOUN
admet-2740	37	6	is	be	AUX
admet-2740	37	7	metabolized	metabolize	VERB
admet-2740	37	8	by	by	ADP
admet-2740	37	9	carbonyl	carbonyl	NOUN
admet-2740	37	10	reductases	reductase	NOUN
admet-2740	37	11	into	into	ADP
admet-2740	37	12	diastereoisomeric	diastereoisomeric	ADJ
admet-2740	37	13	alcohols	alcohol	NOUN
admet-2740	37	14	[	[	X
admet-2740	37	15	4,7,10	4,7,10	NUM
admet-2740	37	16	]	]	PUNCT
admet-2740	37	17	.	.	PUNCT
admet-2740	38	1	cyp2c19	cyp2c19	PROPN
admet-2740	38	2	is	be	AUX
admet-2740	38	3	involved	involve	VERB
admet-2740	38	4	in	in	ADP
admet-2740	38	5	the	the	DET
admet-2740	38	6	conversion	conversion	NOUN
admet-2740	38	7	of	of	ADP
admet-2740	38	8	both	both	DET
admet-2740	38	9	rand	rand	NOUN
admet-2740	38	10	s	s	NOUN
admet-2740	38	11	-	-	NOUN
admet-2740	38	12	warfarin	warfarin	NOUN
admet-2740	38	13	into	into	ADP
admet-2740	38	14	6-	6-	PROPN
admet-2740	38	15	,	,	PUNCT
admet-2740	38	16	7-	7-	NOUN
admet-2740	38	17	,	,	PUNCT
admet-2740	38	18	and	and	CCONJ
admet-2740	38	19	8	8	NUM
admet-2740	38	20	-	-	PUNCT
admet-2740	38	21	hydroxywarfarin	hydroxywarfarin	NOUN
admet-2740	38	22	,	,	PUNCT
admet-2740	38	23	though	though	SCONJ
admet-2740	38	24	it	it	PRON
admet-2740	38	25	plays	play	VERB
admet-2740	38	26	a	a	DET
admet-2740	38	27	more	more	ADV
admet-2740	38	28	significant	significant	ADJ
admet-2740	38	29	role	role	NOUN
admet-2740	38	30	in	in	ADP
admet-2740	38	31	the	the	DET
admet-2740	38	32	hepatic	hepatic	ADJ
admet-2740	38	33	metabolism	metabolism	NOUN
admet-2740	38	34	of	of	ADP
admet-2740	38	35	r	r	NOUN
admet-2740	38	36	-	-	PUNCT
admet-2740	38	37	warfarin	warfarin	NOUN
admet-2740	38	38	,	,	PUNCT
admet-2740	38	39	with	with	ADP
admet-2740	38	40	minimal	minimal	ADJ
admet-2740	38	41	impact	impact	NOUN
admet-2740	38	42	on	on	ADP
admet-2740	38	43	s	s	NOUN
admet-2740	38	44	-	-	NOUN
admet-2740	38	45	warfarin	warfarin	NOUN
admet-2740	38	46	[	[	X
admet-2740	38	47	4,7,10	4,7,10	NUM
admet-2740	38	48	]	]	PUNCT
admet-2740	38	49	.	.	PUNCT
admet-2740	39	1	dietary	dietary	ADJ
admet-2740	39	2	supplements	supplement	NOUN
admet-2740	39	3	,	,	PUNCT
admet-2740	39	4	herbs	herb	NOUN
admet-2740	39	5	,	,	PUNCT
admet-2740	39	6	and	and	CCONJ
admet-2740	39	7	foods	food	NOUN
admet-2740	39	8	can	can	AUX
admet-2740	39	9	interfere	interfere	VERB
admet-2740	39	10	with	with	ADP
admet-2740	39	11	the	the	DET
admet-2740	39	12	pharmacological	pharmacological	ADJ
admet-2740	39	13	actions	action	NOUN
admet-2740	39	14	of	of	ADP
admet-2740	39	15	warfarin	warfarin	NOUN
admet-2740	39	16	through	through	ADP
admet-2740	39	17	two	two	NUM
admet-2740	39	18	principal	principal	ADJ
admet-2740	39	19	mechanisms	mechanism	NOUN
admet-2740	39	20	:	:	PUNCT
admet-2740	39	21	by	by	ADP
admet-2740	39	22	altering	alter	VERB
admet-2740	39	23	the	the	DET
admet-2740	39	24	pharmacokinetics	pharmacokinetic	NOUN
admet-2740	39	25	(	(	PUNCT
admet-2740	39	26	absorption	absorption	NOUN
admet-2740	39	27	,	,	PUNCT
admet-2740	39	28	distribution	distribution	NOUN
admet-2740	39	29	,	,	PUNCT
admet-2740	39	30	or	or	CCONJ
admet-2740	39	31	metabolism	metabolism	NOUN
admet-2740	39	32	)	)	PUNCT
admet-2740	39	33	or	or	CCONJ
admet-2740	39	34	by	by	ADP
admet-2740	39	35	affecting	affect	VERB
admet-2740	39	36	the	the	DET
admet-2740	39	37	pharmacodynamics	pharmacodynamic	NOUN
admet-2740	39	38	(	(	PUNCT
admet-2740	39	39	the	the	DET
admet-2740	39	40	pharmacological	pharmacological	ADJ
admet-2740	39	41	effects	effect	NOUN
admet-2740	39	42	resulting	result	VERB
admet-2740	39	43	from	from	ADP
admet-2740	39	44	interactions	interaction	NOUN
admet-2740	39	45	with	with	ADP
admet-2740	39	46	other	other	ADJ
admet-2740	39	47	substances	substance	NOUN
admet-2740	39	48	)	)	PUNCT
admet-2740	40	1	[	[	X
admet-2740	40	2	7,11	7,11	X
admet-2740	40	3	]	]	X
admet-2740	40	4	.	.	PUNCT
admet-2740	41	1	the	the	DET
admet-2740	41	2	most	most	ADV
admet-2740	41	3	prevalent	prevalent	ADJ
admet-2740	41	4	cause	cause	NOUN
admet-2740	41	5	of	of	ADP
admet-2740	41	6	these	these	DET
admet-2740	41	7	interactions	interaction	NOUN
admet-2740	41	8	involves	involve	VERB
admet-2740	41	9	the	the	DET
admet-2740	41	10	inhibition	inhibition	NOUN
admet-2740	41	11	or	or	CCONJ
admet-2740	41	12	induction	induction	NOUN
admet-2740	41	13	of	of	ADP
admet-2740	41	14	the	the	DET
admet-2740	41	15	cyp2c9	cyp2c9	NOUN
admet-2740	41	16	and	and	CCONJ
admet-2740	41	17	cyp3a4	cyp3a4	PROPN
admet-2740	41	18	,	,	PUNCT
admet-2740	41	19	which	which	PRON
admet-2740	41	20	play	play	VERB
admet-2740	41	21	a	a	DET
admet-2740	41	22	key	key	ADJ
admet-2740	41	23	role	role	NOUN
admet-2740	41	24	in	in	ADP
admet-2740	41	25	the	the	DET
admet-2740	41	26	metabolism	metabolism	NOUN
admet-2740	41	27	of	of	ADP
admet-2740	41	28	warfarin	warfarin	NOUN
admet-2740	41	29	[	[	X
admet-2740	41	30	7	7	NUM
admet-2740	41	31	]	]	PUNCT
admet-2740	41	32	.	.	PUNCT
admet-2740	42	1	the	the	DET
admet-2740	42	2	mango	mango	NOUN
admet-2740	42	3	(	(	PUNCT
admet-2740	42	4	mangifera	mangifera	NOUN
admet-2740	42	5	indica	indica	PROPN
admet-2740	42	6	;	;	PUNCT
admet-2740	42	7	anacardiaceae	anacardiaceae	PROPN
admet-2740	42	8	family	family	NOUN
admet-2740	42	9	)	)	PUNCT
admet-2740	42	10	,	,	PUNCT
admet-2740	42	11	originating	originate	VERB
admet-2740	42	12	from	from	ADP
admet-2740	42	13	southern	southern	ADJ
admet-2740	42	14	asia	asia	PROPN
admet-2740	42	15	,	,	PUNCT
admet-2740	42	16	can	can	AUX
admet-2740	42	17	also	also	ADV
admet-2740	42	18	be	be	AUX
admet-2740	42	19	found	find	VERB
admet-2740	42	20	in	in	ADP
admet-2740	42	21	thailand	thailand	PROPN
admet-2740	43	1	[	[	X
admet-2740	43	2	5,6	5,6	NUM
admet-2740	43	3	]	]	X
admet-2740	43	4	.	.	PUNCT
admet-2740	44	1	mango	mango	PROPN
admet-2740	44	2	fruit	fruit	NOUN
admet-2740	44	3	is	be	AUX
admet-2740	44	4	popular	popular	ADJ
admet-2740	44	5	due	due	ADP
admet-2740	44	6	to	to	ADP
admet-2740	44	7	its	its	PRON
admet-2740	44	8	sweet	sweet	ADJ
admet-2740	44	9	taste	taste	NOUN
admet-2740	44	10	,	,	PUNCT
admet-2740	44	11	but	but	CCONJ
admet-2740	44	12	is	be	AUX
admet-2740	44	13	also	also	ADV
admet-2740	44	14	advantageous	advantageous	ADJ
admet-2740	44	15	with	with	ADP
admet-2740	44	16	regard	regard	NOUN
admet-2740	44	17	to	to	ADP
admet-2740	44	18	diet	diet	NOUN
admet-2740	44	19	due	due	ADP
admet-2740	44	20	to	to	ADP
admet-2740	44	21	its	its	PRON
admet-2740	44	22	richness	richness	NOUN
admet-2740	44	23	in	in	ADP
admet-2740	44	24	vitamins	vitamin	NOUN
admet-2740	44	25	a	a	DET
admet-2740	44	26	,	,	PUNCT
admet-2740	44	27	c	c	NOUN
admet-2740	44	28	and	and	CCONJ
admet-2740	44	29	fibre	fibre	NOUN
admet-2740	44	30	[	[	X
admet-2740	44	31	5	5	NUM
admet-2740	44	32	]	]	PUNCT
admet-2740	44	33	.	.	PUNCT
admet-2740	45	1	however	however	ADV
admet-2740	45	2	,	,	PUNCT
admet-2740	45	3	previous	previous	ADJ
admet-2740	45	4	studies	study	NOUN
admet-2740	45	5	have	have	AUX
admet-2740	45	6	reported	report	VERB
admet-2740	45	7	a	a	DET
admet-2740	45	8	potential	potential	ADJ
admet-2740	45	9	interaction	interaction	NOUN
admet-2740	45	10	between	between	ADP
admet-2740	45	11	mango	mango	NOUN
admet-2740	45	12	fruit	fruit	NOUN
admet-2740	45	13	and	and	CCONJ
admet-2740	45	14	warfarin	warfarin	NOUN
admet-2740	45	15	based	base	VERB
admet-2740	45	16	on	on	ADP
admet-2740	45	17	real	real	ADJ
admet-2740	45	18	case	case	NOUN
admet-2740	45	19	practice	practice	NOUN
admet-2740	45	20	[	[	X
admet-2740	45	21	5,6	5,6	NUM
admet-2740	45	22	]	]	X
admet-2740	45	23	.	.	PUNCT
admet-2740	46	1	one	one	NUM
admet-2740	46	2	case	case	NOUN
admet-2740	46	3	report	report	NOUN
admet-2740	46	4	described	describe	VERB
admet-2740	46	5	problems	problem	NOUN
admet-2740	46	6	in	in	ADP
admet-2740	46	7	patients	patient	NOUN
admet-2740	46	8	who	who	PRON
admet-2740	46	9	experienced	experience	VERB
admet-2740	46	10	supratherapeutic	supratherapeutic	ADJ
admet-2740	46	11	inr	inr	PROPN
admet-2740	46	12	levels	level	NOUN
admet-2740	46	13	after	after	ADP
admet-2740	46	14	consuming	consume	VERB
admet-2740	46	15	mangoes	mango	NOUN
admet-2740	46	16	daily	daily	ADV
admet-2740	46	17	for	for	ADP
admet-2740	46	18	up	up	ADP
admet-2740	46	19	to	to	PART
admet-2740	46	20	1	1	NUM
admet-2740	46	21	month	month	NOUN
admet-2740	46	22	before	before	ADP
admet-2740	46	23	their	their	PRON
admet-2740	46	24	regular	regular	ADJ
admet-2740	46	25	anticoagulation	anticoagulation	NOUN
admet-2740	46	26	clinic	clinic	NOUN
admet-2740	46	27	follow	follow	NOUN
admet-2740	46	28	-	-	PUNCT
admet-2740	46	29	up	up	NOUN
admet-2740	46	30	,	,	PUNCT
admet-2740	46	31	with	with	ADP
admet-2740	46	32	no	no	DET
admet-2740	46	33	additional	additional	ADJ
admet-2740	46	34	factors	factor	NOUN
admet-2740	46	35	contributing	contribute	VERB
admet-2740	46	36	to	to	ADP
admet-2740	46	37	the	the	DET
admet-2740	46	38	elevated	elevated	ADJ
admet-2740	46	39	inr	inr	PROPN
admet-2740	46	40	.	.	PUNCT
admet-2740	47	1	after	after	ADP
admet-2740	47	2	a	a	DET
admet-2740	47	3	2	2	NUM
admet-2740	47	4	-	-	PUNCT
admet-2740	47	5	week	week	NOUN
admet-2740	47	6	follow	follow	NOUN
admet-2740	47	7	-	-	PUNCT
admet-2740	47	8	up	up	NOUN
admet-2740	47	9	during	during	ADP
admet-2740	47	10	which	which	PRON
admet-2740	47	11	mango	mango	NOUN
admet-2740	47	12	ingestion	ingestion	NOUN
admet-2740	47	13	ceased	cease	VERB
admet-2740	47	14	,	,	PUNCT
admet-2740	47	15	the	the	DET
admet-2740	47	16	average	average	ADJ
admet-2740	47	17	inr	inr	PROPN
admet-2740	47	18	decreased	decrease	VERB
admet-2740	47	19	by	by	ADP
admet-2740	47	20	17.7	17.7	NUM
admet-2740	47	21	%	%	NOUN
admet-2740	47	22	,	,	PUNCT
admet-2740	47	23	returning	return	VERB
admet-2740	47	24	to	to	ADP
admet-2740	47	25	the	the	DET
admet-2740	47	26	therapeutic	therapeutic	ADJ
admet-2740	47	27	range	range	NOUN
admet-2740	47	28	.	.	PUNCT
admet-2740	48	1	subsequent	subsequent	ADJ
admet-2740	48	2	rechallenges	rechallenge	NOUN
admet-2740	48	3	involving	involve	VERB
admet-2740	48	4	mango	mango	NOUN
admet-2740	48	5	fruit	fruit	NOUN
admet-2740	48	6	in	in	ADP
admet-2740	48	7	two	two	NUM
admet-2740	48	8	patients	patient	NOUN
admet-2740	48	9	yielded	yield	VERB
admet-2740	48	10	consistent	consistent	ADJ
admet-2740	48	11	results	result	NOUN
admet-2740	48	12	,	,	PUNCT
admet-2740	48	13	suggesting	suggest	VERB
admet-2740	48	14	a	a	DET
admet-2740	48	15	correlation	correlation	NOUN
admet-2740	48	16	between	between	ADP
admet-2740	48	17	mango	mango	NOUN
admet-2740	48	18	consumption	consumption	NOUN
admet-2740	48	19	and	and	CCONJ
admet-2740	48	20	supratherapeutic	supratherapeutic	ADJ
admet-2740	48	21	anticoagulation	anticoagulation	NOUN
admet-2740	48	22	[	[	X
admet-2740	48	23	5,7	5,7	NUM
admet-2740	48	24	]	]	PUNCT
admet-2740	48	25	.	.	PUNCT
admet-2740	49	1	a	a	DET
admet-2740	49	2	medium	medium	ADJ
admet-2740	49	3	-	-	PUNCT
admet-2740	49	4	sized	sized	ADJ
admet-2740	49	5	mango	mango	NOUN
admet-2740	49	6	(	(	PUNCT
admet-2740	49	7	130	130	NUM
admet-2740	49	8	g	g	NOUN
admet-2740	49	9	without	without	ADP
admet-2740	49	10	seed	seed	NOUN
admet-2740	49	11	)	)	PUNCT
admet-2740	49	12	contains	contain	VERB
admet-2740	49	13	significant	significant	ADJ
admet-2740	49	14	vitamin	vitamin	NOUN
admet-2740	49	15	content	content	NOUN
admet-2740	49	16	,	,	PUNCT
admet-2740	49	17	especially	especially	ADV
admet-2740	49	18	vitamin	vitamin	VERB
admet-2740	49	19	a	a	PRON
admet-2740	49	20	(	(	PUNCT
admet-2740	49	21	8061	8061	NUM
admet-2740	49	22	iu	iu	ADP
admet-2740	49	23	)	)	PUNCT
admet-2740	50	1	[	[	X
admet-2740	50	2	5	5	NUM
admet-2740	50	3	]	]	PUNCT
admet-2740	50	4	.	.	PUNCT
admet-2740	51	1	several	several	ADJ
admet-2740	51	2	studies	study	NOUN
admet-2740	51	3	suggest	suggest	VERB
admet-2740	51	4	that	that	SCONJ
admet-2740	51	5	mango	mango	PROPN
admet-2740	51	6	contains	contain	VERB
admet-2740	51	7	various	various	ADJ
admet-2740	51	8	bioactive	bioactive	ADJ
admet-2740	51	9	compounds	compound	NOUN
admet-2740	51	10	,	,	PUNCT
admet-2740	51	11	including	include	VERB
admet-2740	51	12	retinol	retinol	NOUN
admet-2740	51	13	and	and	CCONJ
admet-2740	51	14	polyphenols	polyphenol	NOUN
admet-2740	51	15	[	[	X
admet-2740	51	16	5,7,12	5,7,12	NUM
admet-2740	51	17	]	]	PUNCT
admet-2740	51	18	.	.	PUNCT
admet-2740	52	1	there	there	PRON
admet-2740	52	2	are	be	VERB
admet-2740	52	3	reports	report	NOUN
admet-2740	52	4	suggesting	suggest	VERB
admet-2740	52	5	that	that	SCONJ
admet-2740	52	6	concurrent	concurrent	ADJ
admet-2740	52	7	administration	administration	NOUN
admet-2740	52	8	of	of	ADP
admet-2740	52	9	warfarin	warfarin	NOUN
admet-2740	52	10	and	and	CCONJ
admet-2740	52	11	vitamin	vitamin	VERB
admet-2740	52	12	a	a	PRON
admet-2740	52	13	may	may	AUX
admet-2740	52	14	lead	lead	VERB
admet-2740	52	15	to	to	ADP
admet-2740	52	16	an	an	DET
admet-2740	52	17	increased	increase	VERB
admet-2740	52	18	anticoagulant	anticoagulant	ADJ
admet-2740	52	19	effect	effect	NOUN
admet-2740	52	20	,	,	PUNCT
admet-2740	52	21	particularly	particularly	ADV
admet-2740	52	22	in	in	ADP
admet-2740	52	23	the	the	DET
admet-2740	52	24	case	case	NOUN
admet-2740	52	25	of	of	ADP
admet-2740	52	26	high	high	ADJ
admet-2740	52	27	doses	dose	NOUN
admet-2740	52	28	of	of	ADP
admet-2740	52	29	vitamin	vitamin	NOUN
admet-2740	52	30	a	a	PRON
admet-2740	52	31	[	[	X
admet-2740	52	32	5	5	NUM
admet-2740	52	33	]	]	PUNCT
admet-2740	52	34	.	.	PUNCT
admet-2740	53	1	additionally	additionally	ADV
admet-2740	53	2	,	,	PUNCT
admet-2740	53	3	an	an	DET
admet-2740	53	4	in	in	ADP
admet-2740	53	5	vitro	vitro	X
admet-2740	53	6	study	study	NOUN
admet-2740	53	7	has	have	AUX
admet-2740	53	8	shown	show	VERB
admet-2740	53	9	that	that	SCONJ
admet-2740	53	10	retinol	retinol	NOUN
admet-2740	53	11	strongly	strongly	ADV
admet-2740	53	12	inhibits	inhibit	VERB
admet-2740	53	13	human	human	ADJ
admet-2740	53	14	cyp2c9	cyp2c9	NOUN
admet-2740	53	15	and	and	CCONJ
admet-2740	53	16	cyp2c19	cyp2c19	PROPN
admet-2740	53	17	,	,	PUNCT
admet-2740	53	18	potentially	potentially	ADV
admet-2740	53	19	leading	lead	VERB
admet-2740	53	20	to	to	ADP
admet-2740	53	21	increased	increase	VERB
admet-2740	53	22	warfarin	warfarin	NOUN
admet-2740	53	23	concentration	concentration	NOUN
admet-2740	54	1	[	[	X
admet-2740	54	2	5	5	NUM
admet-2740	54	3	-	-	SYM
admet-2740	54	4	7,13,14	7,13,14	NUM
admet-2740	54	5	]	]	PUNCT
admet-2740	54	6	.	.	PUNCT
admet-2740	55	1	polyphenols	polyphenol	NOUN
admet-2740	55	2	in	in	ADP
admet-2740	55	3	mango	mango	NOUN
admet-2740	55	4	also	also	ADV
admet-2740	55	5	interact	interact	VERB
admet-2740	55	6	with	with	ADP
admet-2740	55	7	intestinal	intestinal	ADJ
admet-2740	55	8	and	and	CCONJ
admet-2740	55	9	hepatic	hepatic	ADJ
admet-2740	55	10	enzyme	enzyme	NOUN
admet-2740	55	11	systems	system	NOUN
admet-2740	55	12	,	,	PUNCT
admet-2740	55	13	particularly	particularly	ADV
admet-2740	55	14	by	by	ADP
admet-2740	55	15	inhibiting	inhibit	VERB
admet-2740	55	16	cyp3a4	cyp3a4	NOUN
admet-2740	55	17	and	and	CCONJ
admet-2740	55	18	cyp2d6	cyp2d6	NOUN
admet-2740	55	19	[	[	X
admet-2740	55	20	5,6,14,15	5,6,14,15	PROPN
admet-2740	55	21	]	]	PUNCT
admet-2740	55	22	.	.	PUNCT
admet-2740	56	1	additionally	additionally	ADV
admet-2740	56	2	,	,	PUNCT
admet-2740	56	3	mango	mango	PROPN
admet-2740	56	4	may	may	AUX
admet-2740	56	5	affect	affect	VERB
admet-2740	56	6	platelet	platelet	NOUN
admet-2740	56	7	aggregation	aggregation	NOUN
admet-2740	56	8	,	,	PUNCT
admet-2740	56	9	potentially	potentially	ADV
admet-2740	56	10	complicating	complicate	VERB
admet-2740	56	11	the	the	DET
admet-2740	56	12	anticoagulant	anticoagulant	ADJ
admet-2740	56	13	effects	effect	NOUN
admet-2740	56	14	of	of	ADP
admet-2740	56	15	warfarin	warfarin	NOUN
admet-2740	57	1	[	[	X
admet-2740	57	2	6,7	6,7	NUM
admet-2740	57	3	]	]	PUNCT
admet-2740	57	4	.	.	PUNCT
admet-2740	58	1	the	the	DET
admet-2740	58	2	interaction	interaction	NOUN
admet-2740	58	3	between	between	ADP
admet-2740	58	4	admet	admet	PROPN
admet-2740	58	5	&	&	CCONJ
admet-2740	58	6	dmpk	dmpk	PROPN
admet-2740	58	7	13(3	13(3	NUM
admet-2740	58	8	)	)	PUNCT
admet-2740	58	9	(	(	PUNCT
admet-2740	58	10	2025	2025	NUM
admet-2740	58	11	)	)	PUNCT
admet-2740	58	12	2740	2740	NUM
admet-2740	58	13	metabolic	metabolic	NOUN
admet-2740	58	14	insights	insight	NOUN
admet-2740	58	15	into	into	ADP
admet-2740	58	16	the	the	DET
admet-2740	58	17	warfarin	warfarin	NOUN
admet-2740	58	18	-	-	PUNCT
admet-2740	58	19	mango	mango	NOUN
admet-2740	58	20	interaction	interaction	NOUN
admet-2740	58	21	doi	doi	NOUN
admet-2740	58	22	:	:	PUNCT
admet-2740	58	23	https://doi.org/10.5599/admet.2740	https://doi.org/10.5599/admet.2740	NOUN
admet-2740	58	24	3	3	NUM
admet-2740	58	25	warfarin	warfarin	NOUN
admet-2740	58	26	and	and	CCONJ
admet-2740	58	27	mango	mango	NOUN
admet-2740	58	28	was	be	AUX
admet-2740	58	29	determined	determine	VERB
admet-2740	58	30	using	use	VERB
admet-2740	58	31	the	the	DET
admet-2740	58	32	naranjo	naranjo	PROPN
admet-2740	58	33	probability	probability	NOUN
admet-2740	58	34	scale	scale	NOUN
admet-2740	58	35	,	,	PUNCT
admet-2740	58	36	results	result	NOUN
admet-2740	58	37	indicating	indicate	VERB
admet-2740	58	38	it	it	PRON
admet-2740	58	39	as	as	ADP
admet-2740	58	40	“	"	PUNCT
admet-2740	58	41	probable	probable	ADJ
admet-2740	58	42	”	"	PUNCT
admet-2740	58	43	,	,	PUNCT
admet-2740	58	44	suggesting	suggest	VERB
admet-2740	58	45	that	that	SCONJ
admet-2740	58	46	mango	mango	PROPN
admet-2740	58	47	ingestion	ingestion	NOUN
admet-2740	58	48	might	might	AUX
admet-2740	58	49	contribute	contribute	VERB
admet-2740	58	50	to	to	ADP
admet-2740	58	51	supratherapeutic	supratherapeutic	ADJ
admet-2740	58	52	anticoagulation	anticoagulation	NOUN
admet-2740	58	53	[	[	X
admet-2740	58	54	5	5	NUM
admet-2740	58	55	]	]	PUNCT
admet-2740	58	56	.	.	PUNCT
admet-2740	59	1	nevertheless	nevertheless	ADV
admet-2740	59	2	,	,	PUNCT
admet-2740	59	3	the	the	DET
admet-2740	59	4	molecular	molecular	ADJ
admet-2740	59	5	mechanism	mechanism	NOUN
admet-2740	59	6	behind	behind	ADP
admet-2740	59	7	this	this	DET
admet-2740	59	8	interaction	interaction	NOUN
admet-2740	59	9	remains	remain	VERB
admet-2740	59	10	unexplained	unexplained	ADJ
admet-2740	59	11	.	.	PUNCT
admet-2740	60	1	this	this	DET
admet-2740	60	2	study	study	NOUN
admet-2740	60	3	aims	aim	VERB
admet-2740	60	4	to	to	PART
admet-2740	60	5	understand	understand	VERB
admet-2740	60	6	the	the	DET
admet-2740	60	7	interaction	interaction	NOUN
admet-2740	60	8	between	between	ADP
admet-2740	60	9	warfarin	warfarin	NOUN
admet-2740	60	10	and	and	CCONJ
admet-2740	60	11	mango	mango	NOUN
admet-2740	60	12	further	far	ADV
admet-2740	60	13	,	,	PUNCT
admet-2740	60	14	bridging	bridge	VERB
admet-2740	60	15	the	the	DET
admet-2740	60	16	gap	gap	NOUN
admet-2740	60	17	from	from	ADP
admet-2740	60	18	clinical	clinical	ADJ
admet-2740	60	19	practice	practice	NOUN
admet-2740	60	20	to	to	ADP
admet-2740	60	21	molecular	molecular	ADJ
admet-2740	60	22	mechanisms	mechanism	NOUN
admet-2740	60	23	through	through	ADP
admet-2740	60	24	metabolomic	metabolomic	ADJ
admet-2740	60	25	analysis	analysis	NOUN
admet-2740	60	26	using	use	VERB
admet-2740	60	27	proton	proton	NOUN
admet-2740	60	28	nuclear	nuclear	ADJ
admet-2740	60	29	magnetic	magnetic	ADJ
admet-2740	60	30	resonance	resonance	NOUN
admet-2740	60	31	(	(	PUNCT
admet-2740	60	32	1h	1h	NUM
admet-2740	60	33	-nmr	-nmr	NUM
admet-2740	60	34	)	)	PUNCT
admet-2740	60	35	.	.	PUNCT
admet-2740	61	1	figure	figure	NOUN
admet-2740	61	2	1	1	NUM
admet-2740	61	3	.	.	PUNCT
admet-2740	62	1	summary	summary	NOUN
admet-2740	62	2	of	of	ADP
admet-2740	62	3	the	the	DET
admet-2740	62	4	warfarin	warfarin	NOUN
admet-2740	62	5	-	-	PUNCT
admet-2740	62	6	mango	mango	NOUN
admet-2740	62	7	interaction	interaction	NOUN
admet-2740	62	8	mechanism	mechanism	NOUN
admet-2740	62	9	in	in	ADP
admet-2740	62	10	the	the	DET
admet-2740	62	11	context	context	NOUN
admet-2740	62	12	of	of	ADP
admet-2740	62	13	vitamin	vitamin	NOUN
admet-2740	62	14	k	k	PROPN
admet-2740	62	15	metabolism	metabolism	NOUN
admet-2740	62	16	and	and	CCONJ
admet-2740	62	17	warfarin	warfarin	NOUN
admet-2740	62	18	metabolism	metabolism	NOUN
admet-2740	62	19	.	.	PUNCT
admet-2740	63	1	abbreviations	abbreviation	NOUN
admet-2740	63	2	used	use	VERB
admet-2740	63	3	:	:	PUNCT
admet-2740	63	4	dtt	dtt	PROPN
admet-2740	63	5	(	(	PUNCT
admet-2740	63	6	dithiothreitol	dithiothreitol	PROPN
admet-2740	63	7	)	)	PUNCT
admet-2740	63	8	;	;	PUNCT
admet-2740	64	1	qr	qr	X
admet-2740	64	2	(	(	PUNCT
admet-2740	64	3	quinone	quinone	NOUN
admet-2740	64	4	reductase	reductase	NOUN
admet-2740	64	5	)	)	PUNCT
admet-2740	64	6	;	;	PUNCT
admet-2740	64	7	vkdp	vkdp	X
admet-2740	64	8	(	(	PUNCT
admet-2740	64	9	vitamin	vitamin	NOUN
admet-2740	64	10	k	k	NOUN
admet-2740	64	11	-	-	ADJ
admet-2740	64	12	dependent	dependent	ADJ
admet-2740	64	13	protein	protein	NOUN
admet-2740	64	14	)	)	PUNCT
admet-2740	64	15	;	;	PUNCT
admet-2740	64	16	vkor	vkor	NOUN
admet-2740	64	17	(	(	PUNCT
admet-2740	64	18	vitamin	vitamin	NOUN
admet-2740	64	19	k	k	X
admet-2740	64	20	epoxide	epoxide	NOUN
admet-2740	64	21	reductase	reductase	NOUN
admet-2740	64	22	)	)	PUNCT
admet-2740	64	23	experimental	experimental	ADJ
admet-2740	64	24	reagents	reagent	NOUN
admet-2740	64	25	methanol	methanol	NOUN
admet-2740	64	26	,	,	PUNCT
admet-2740	64	27	chloroform	chloroform	NOUN
admet-2740	64	28	,	,	PUNCT
admet-2740	64	29	deuterium	deuterium	NOUN
admet-2740	64	30	oxide	oxide	NOUN
admet-2740	64	31	(	(	PUNCT
admet-2740	64	32	d2o	d2o	NOUN
admet-2740	64	33	)	)	PUNCT
admet-2740	64	34	,	,	PUNCT
admet-2740	64	35	and	and	CCONJ
admet-2740	64	36	trimethylsilyl	trimethylsilyl	ADJ
admet-2740	64	37	propanoic	propanoic	ADJ
admet-2740	64	38	acid	acid	NOUN
admet-2740	64	39	(	(	PUNCT
admet-2740	64	40	tsp	tsp	NOUN
admet-2740	64	41	)	)	PUNCT
admet-2740	64	42	were	be	AUX
admet-2740	64	43	purchased	purchase	VERB
admet-2740	64	44	from	from	ADP
admet-2740	64	45	sigma	sigma	PROPN
admet-2740	64	46	-	-	PUNCT
admet-2740	64	47	aldrich	aldrich	PROPN
admet-2740	64	48	st	st	PROPN
admet-2740	64	49	.	.	PROPN
admet-2740	64	50	louis	louis	PROPN
admet-2740	64	51	,	,	PUNCT
admet-2740	64	52	mo	mo	PROPN
admet-2740	64	53	,	,	PUNCT
admet-2740	64	54	usa	usa	PROPN
admet-2740	64	55	.	.	PROPN
admet-2740	65	1	all	all	DET
admet-2740	65	2	chemicals	chemical	NOUN
admet-2740	65	3	used	use	VERB
admet-2740	65	4	were	be	AUX
admet-2740	65	5	of	of	ADP
admet-2740	65	6	analytical	analytical	ADJ
admet-2740	65	7	grade	grade	NOUN
admet-2740	65	8	.	.	PUNCT
admet-2740	66	1	ethical	ethical	ADJ
admet-2740	66	2	approval	approval	NOUN
admet-2740	66	3	and	and	CCONJ
admet-2740	66	4	informed	inform	VERB
admet-2740	66	5	consent	consent	NOUN
admet-2740	66	6	the	the	DET
admet-2740	66	7	study	study	NOUN
admet-2740	66	8	was	be	AUX
admet-2740	66	9	conducted	conduct	VERB
admet-2740	66	10	in	in	ADP
admet-2740	66	11	line	line	NOUN
admet-2740	66	12	with	with	ADP
admet-2740	66	13	the	the	DET
admet-2740	66	14	declaration	declaration	NOUN
admet-2740	66	15	of	of	ADP
admet-2740	66	16	helsinki	helsinki	PROPN
admet-2740	66	17	and	and	CCONJ
admet-2740	66	18	was	be	AUX
admet-2740	66	19	approved	approve	VERB
admet-2740	66	20	by	by	ADP
admet-2740	66	21	the	the	DET
admet-2740	66	22	institutional	institutional	ADJ
admet-2740	66	23	review	review	PROPN
admet-2740	66	24	board	board	NOUN
admet-2740	66	25	(	(	PUNCT
admet-2740	66	26	human	human	ADJ
admet-2740	66	27	ethics	ethic	NOUN
admet-2740	66	28	committee	committee	PROPN
admet-2740	66	29	)	)	PUNCT
admet-2740	66	30	of	of	ADP
admet-2740	66	31	the	the	DET
admet-2740	66	32	faculty	faculty	NOUN
admet-2740	66	33	of	of	ADP
admet-2740	66	34	medicine	medicine	NOUN
admet-2740	66	35	,	,	PUNCT
admet-2740	66	36	chiang	chiang	PROPN
admet-2740	66	37	mai	mai	PROPN
admet-2740	66	38	university	university	PROPN
admet-2740	66	39	,	,	PUNCT
admet-2740	66	40	thailand	thailand	PROPN
admet-2740	66	41	.	.	PUNCT
admet-2740	67	1	the	the	DET
admet-2740	67	2	ethical	ethical	ADJ
admet-2740	67	3	approval	approval	NOUN
admet-2740	67	4	reference	reference	NOUN
admet-2740	67	5	number	number	NOUN
admet-2740	67	6	is	be	AUX
admet-2740	67	7	no	no	PRON
admet-2740	67	8	.	.	PUNCT
admet-2740	68	1	201/2023	201/2023	NUM
admet-2740	68	2	(	(	PUNCT
admet-2740	68	3	study	study	NOUN
admet-2740	68	4	code	code	PROPN
admet-2740	68	5	:	:	PUNCT
admet-2740	68	6	for-2566	for-2566	PROPN
admet-2740	68	7	-	-	PUNCT
admet-2740	68	8	0144	0144	NUM
admet-2740	68	9	)	)	PUNCT
admet-2740	68	10	.	.	PUNCT
admet-2740	69	1	eligible	eligible	ADJ
admet-2740	69	2	patients	patient	NOUN
admet-2740	69	3	were	be	AUX
admet-2740	69	4	those	those	PRON
admet-2740	69	5	who	who	PRON
admet-2740	69	6	had	have	AUX
admet-2740	69	7	been	be	AUX
admet-2740	69	8	taking	take	VERB
admet-2740	69	9	warfarin	warfarin	NOUN
admet-2740	69	10	continuously	continuously	ADV
admet-2740	69	11	for	for	ADP
admet-2740	69	12	more	more	ADJ
admet-2740	69	13	than	than	ADP
admet-2740	69	14	6	6	NUM
admet-2740	69	15	months	month	NOUN
admet-2740	69	16	and	and	CCONJ
admet-2740	69	17	had	have	AUX
admet-2740	69	18	experienced	experience	VERB
admet-2740	69	19	a	a	DET
admet-2740	69	20	warfarin	warfarin	NOUN
admet-2740	69	21	-	-	PUNCT
admet-2740	69	22	mango	mango	NOUN
admet-2740	69	23	interaction	interaction	NOUN
admet-2740	69	24	,	,	PUNCT
admet-2740	69	25	resulting	result	VERB
admet-2740	69	26	in	in	ADP
admet-2740	69	27	their	their	PRON
admet-2740	69	28	inr	inr	NOUN
admet-2740	69	29	being	be	AUX
admet-2740	69	30	out	out	ADP
admet-2740	69	31	of	of	ADP
admet-2740	69	32	the	the	DET
admet-2740	69	33	therapeutic	therapeutic	ADJ
admet-2740	69	34	range	range	NOUN
admet-2740	69	35	during	during	ADP
admet-2740	69	36	the	the	DET
admet-2740	69	37	study	study	NOUN
admet-2740	69	38	period	period	NOUN
admet-2740	69	39	.	.	PUNCT
admet-2740	70	1	before	before	ADP
admet-2740	70	2	enrolment	enrolment	NOUN
admet-2740	70	3	,	,	PUNCT
admet-2740	70	4	written	write	VERB
admet-2740	70	5	informed	informed	ADJ
admet-2740	70	6	consent	consent	NOUN
admet-2740	70	7	was	be	AUX
admet-2740	70	8	acquired	acquire	VERB
admet-2740	70	9	from	from	ADP
admet-2740	70	10	all	all	DET
admet-2740	70	11	patients	patient	NOUN
admet-2740	70	12	,	,	PUNCT
admet-2740	70	13	and	and	CCONJ
admet-2740	70	14	the	the	DET
admet-2740	70	15	study	study	NOUN
admet-2740	70	16	results	result	NOUN
admet-2740	70	17	were	be	AUX
admet-2740	70	18	reported	report	VERB
admet-2740	70	19	anonymously	anonymously	ADV
admet-2740	70	20	.	.	PUNCT
admet-2740	71	1	study	study	NOUN
admet-2740	71	2	design	design	NOUN
admet-2740	71	3	,	,	PUNCT
admet-2740	71	4	setting	set	VERB
admet-2740	71	5	and	and	CCONJ
admet-2740	71	6	population	population	NOUN
admet-2740	71	7	this	this	PRON
admet-2740	71	8	was	be	AUX
admet-2740	71	9	a	a	DET
admet-2740	71	10	pre	pre	ADJ
admet-2740	71	11	-	-	ADJ
admet-2740	71	12	post	post	ADJ
admet-2740	71	13	study	study	NOUN
admet-2740	71	14	design	design	NOUN
admet-2740	71	15	conducted	conduct	VERB
admet-2740	71	16	at	at	ADP
admet-2740	71	17	a	a	DET
admet-2740	71	18	tertiary	tertiary	ADJ
admet-2740	71	19	care	care	NOUN
admet-2740	71	20	hospital	hospital	NOUN
admet-2740	71	21	in	in	ADP
admet-2740	71	22	thailand	thailand	PROPN
admet-2740	71	23	.	.	PUNCT
admet-2740	72	1	for	for	ADP
admet-2740	72	2	the	the	DET
admet-2740	72	3	pre	pre	ADJ
admet-2740	72	4	-	-	ADJ
admet-2740	72	5	study	study	ADJ
admet-2740	72	6	data	datum	NOUN
admet-2740	72	7	,	,	PUNCT
admet-2740	72	8	patients	patient	NOUN
admet-2740	72	9	aged	age	VERB
admet-2740	72	10	18	18	NUM
admet-2740	72	11	-	-	SYM
admet-2740	72	12	70	70	NUM
admet-2740	72	13	years	year	NOUN
admet-2740	72	14	who	who	PRON
admet-2740	72	15	had	have	AUX
admet-2740	72	16	been	be	AUX
admet-2740	72	17	continuously	continuously	ADV
admet-2740	72	18	taking	take	VERB
admet-2740	72	19	warfarin	warfarin	NOUN
admet-2740	72	20	for	for	ADP
admet-2740	72	21	more	more	ADJ
admet-2740	72	22	than	than	ADP
admet-2740	72	23	6	6	NUM
admet-2740	72	24	months	month	NOUN
admet-2740	72	25	and	and	CCONJ
admet-2740	72	26	had	have	VERB
admet-2740	72	27	https://doi.org/10.5599/admet.2740	https://doi.org/10.5599/admet.2740	NOUN
admet-2740	72	28	p.	p.	NOUN
admet-2740	72	29	rattanasuwan	rattanasuwan	PROPN
admet-2740	72	30	et	et	PROPN
admet-2740	72	31	al	al	PROPN
admet-2740	72	32	.	.	PROPN
admet-2740	72	33	admet	admet	PROPN
admet-2740	72	34	&	&	CCONJ
admet-2740	72	35	dmpk	dmpk	PROPN
admet-2740	72	36	13(3	13(3	NUM
admet-2740	72	37	)	)	PUNCT
admet-2740	72	38	(	(	PUNCT
admet-2740	72	39	2025	2025	NUM
admet-2740	72	40	)	)	PUNCT
admet-2740	72	41	2740	2740	NUM
admet-2740	72	42	4	4	NUM
admet-2740	72	43	experienced	experienced	ADJ
admet-2740	72	44	warfarin	warfarin	NOUN
admet-2740	72	45	-	-	PUNCT
admet-2740	72	46	mango	mango	NOUN
admet-2740	72	47	interaction	interaction	NOUN
admet-2740	72	48	were	be	AUX
admet-2740	72	49	recruited	recruit	VERB
admet-2740	72	50	.	.	PUNCT
admet-2740	73	1	their	their	PRON
admet-2740	73	2	monitored	monitored	ADJ
admet-2740	73	3	inr	inr	PROPN
admet-2740	73	4	levels	level	NOUN
admet-2740	73	5	were	be	AUX
admet-2740	73	6	supratherapeutic	supratherapeutic	ADJ
admet-2740	73	7	.	.	PUNCT
admet-2740	74	1	patients	patient	NOUN
admet-2740	74	2	taking	take	VERB
admet-2740	74	3	other	other	ADJ
admet-2740	74	4	anticoagulants	anticoagulant	NOUN
admet-2740	74	5	,	,	PUNCT
admet-2740	74	6	those	those	PRON
admet-2740	74	7	with	with	ADP
admet-2740	74	8	acute	acute	ADJ
admet-2740	74	9	or	or	CCONJ
admet-2740	74	10	chronic	chronic	ADJ
admet-2740	74	11	infections	infection	NOUN
admet-2740	74	12	,	,	PUNCT
admet-2740	74	13	and	and	CCONJ
admet-2740	74	14	patients	patient	NOUN
admet-2740	74	15	evaluated	evaluate	VERB
admet-2740	74	16	by	by	ADP
admet-2740	74	17	pharmacists	pharmacist	NOUN
admet-2740	74	18	as	as	ADP
admet-2740	74	19	non	non	ADJ
admet-2740	74	20	-	-	ADJ
admet-2740	74	21	compliant	compliant	ADJ
admet-2740	74	22	were	be	AUX
admet-2740	74	23	excluded	exclude	VERB
admet-2740	74	24	from	from	ADP
admet-2740	74	25	this	this	DET
admet-2740	74	26	study	study	NOUN
admet-2740	74	27	.	.	PUNCT
admet-2740	75	1	the	the	DET
admet-2740	75	2	post	post	ADJ
admet-2740	75	3	-	-	ADJ
admet-2740	75	4	study	study	ADJ
admet-2740	75	5	data	datum	NOUN
admet-2740	75	6	were	be	AUX
admet-2740	75	7	recorded	record	VERB
admet-2740	75	8	after	after	SCONJ
admet-2740	75	9	patients	patient	NOUN
admet-2740	75	10	discontinued	discontinue	VERB
admet-2740	75	11	mango	mango	ADJ
admet-2740	75	12	consumption	consumption	NOUN
admet-2740	75	13	and	and	CCONJ
admet-2740	75	14	returned	return	VERB
admet-2740	75	15	for	for	ADP
admet-2740	75	16	a	a	DET
admet-2740	75	17	follow	follow	VERB
admet-2740	75	18	-	-	PUNCT
admet-2740	75	19	up	up	NOUN
admet-2740	75	20	period	period	NOUN
admet-2740	75	21	of	of	ADP
admet-2740	75	22	at	at	ADV
admet-2740	75	23	least	least	ADV
admet-2740	75	24	two	two	NUM
admet-2740	75	25	weeks	week	NOUN
admet-2740	75	26	.	.	PUNCT
admet-2740	76	1	during	during	ADP
admet-2740	76	2	this	this	DET
admet-2740	76	3	period	period	NOUN
admet-2740	76	4	,	,	PUNCT
admet-2740	76	5	their	their	PRON
admet-2740	76	6	inr	inr	PROPN
admet-2740	76	7	levels	level	NOUN
admet-2740	76	8	decreased	decrease	VERB
admet-2740	76	9	to	to	ADP
admet-2740	76	10	within	within	ADP
admet-2740	76	11	the	the	DET
admet-2740	76	12	therapeutic	therapeutic	ADJ
admet-2740	76	13	range	range	NOUN
admet-2740	76	14	.	.	PUNCT
admet-2740	77	1	a	a	DET
admet-2740	77	2	specific	specific	ADJ
admet-2740	77	3	sample	sample	NOUN
admet-2740	77	4	size	size	NOUN
admet-2740	77	5	was	be	AUX
admet-2740	77	6	not	not	PART
admet-2740	77	7	calculated	calculate	VERB
admet-2740	77	8	for	for	ADP
admet-2740	77	9	the	the	DET
admet-2740	77	10	study	study	NOUN
admet-2740	77	11	,	,	PUNCT
admet-2740	77	12	given	give	VERB
admet-2740	77	13	the	the	DET
admet-2740	77	14	rarity	rarity	NOUN
admet-2740	77	15	of	of	ADP
admet-2740	77	16	the	the	DET
admet-2740	77	17	incidence	incidence	NOUN
admet-2740	77	18	of	of	ADP
admet-2740	77	19	warfarin	warfarin	NOUN
admet-2740	77	20	-	-	PUNCT
admet-2740	77	21	mango	mango	NOUN
admet-2740	77	22	interaction	interaction	NOUN
admet-2740	77	23	.	.	PUNCT
admet-2740	78	1	all	all	DET
admet-2740	78	2	patients	patient	NOUN
admet-2740	78	3	who	who	PRON
admet-2740	78	4	met	meet	VERB
admet-2740	78	5	the	the	DET
admet-2740	78	6	inclusion	inclusion	NOUN
admet-2740	78	7	criteria	criterion	NOUN
admet-2740	78	8	and	and	CCONJ
admet-2740	78	9	were	be	AUX
admet-2740	78	10	identified	identify	VERB
admet-2740	78	11	during	during	ADP
admet-2740	78	12	the	the	DET
admet-2740	78	13	study	study	NOUN
admet-2740	78	14	period	period	NOUN
admet-2740	78	15	were	be	AUX
admet-2740	78	16	considered	consider	VERB
admet-2740	78	17	eligible	eligible	ADJ
admet-2740	78	18	.	.	PUNCT
admet-2740	79	1	sample	sample	NOUN
admet-2740	79	2	preparation	preparation	NOUN
admet-2740	79	3	plasma	plasma	NOUN
admet-2740	79	4	samples	sample	NOUN
admet-2740	79	5	were	be	AUX
admet-2740	79	6	combined	combine	VERB
admet-2740	79	7	with	with	ADP
admet-2740	79	8	an	an	DET
admet-2740	79	9	equal	equal	ADJ
admet-2740	79	10	volume	volume	NOUN
admet-2740	79	11	of	of	ADP
admet-2740	79	12	acetonitrile	acetonitrile	NOUN
admet-2740	79	13	and	and	CCONJ
admet-2740	79	14	mixed	mix	VERB
admet-2740	79	15	for	for	ADP
admet-2740	79	16	10	10	NUM
admet-2740	79	17	min	min	NOUN
admet-2740	79	18	.	.	PROPN
admet-2740	79	19	subsequently	subsequently	ADV
admet-2740	79	20	,	,	PUNCT
admet-2740	79	21	the	the	DET
admet-2740	79	22	mixture	mixture	NOUN
admet-2740	79	23	was	be	AUX
admet-2740	79	24	centrifuged	centrifuge	VERB
admet-2740	79	25	at	at	ADP
admet-2740	79	26	4000	4000	NUM
admet-2740	79	27	rpm	rpm	NOUN
admet-2740	79	28	for	for	ADP
admet-2740	79	29	10	10	NUM
admet-2740	79	30	min	min	NOUN
admet-2740	79	31	,	,	PUNCT
admet-2740	79	32	and	and	CCONJ
admet-2740	79	33	the	the	DET
admet-2740	79	34	supernatant	supernatant	NOUN
admet-2740	79	35	was	be	AUX
admet-2740	79	36	collected	collect	VERB
admet-2740	79	37	and	and	CCONJ
admet-2740	79	38	lyophilized	lyophilize	VERB
admet-2740	79	39	.	.	PUNCT
admet-2740	80	1	a	a	DET
admet-2740	80	2	0.6	0.6	NUM
admet-2740	80	3	ml	ml	NOUN
admet-2740	80	4	solution	solution	NOUN
admet-2740	80	5	containing	contain	VERB
admet-2740	80	6	0.1	0.1	NUM
admet-2740	80	7	m	m	NOUN
admet-2740	80	8	tsp	tsp	NOUN
admet-2740	80	9	in	in	ADP
admet-2740	80	10	d2o	d2o	PROPN
admet-2740	80	11	was	be	AUX
admet-2740	80	12	then	then	ADV
admet-2740	80	13	prepared	prepare	VERB
admet-2740	80	14	.	.	PUNCT
admet-2740	81	1	finally	finally	ADV
admet-2740	81	2	,	,	PUNCT
admet-2740	81	3	metabolite	metabolite	NOUN
admet-2740	81	4	levels	level	NOUN
admet-2740	81	5	were	be	AUX
admet-2740	81	6	quantified	quantify	VERB
admet-2740	81	7	using	use	VERB
admet-2740	81	8	500	500	NUM
admet-2740	81	9	mhz	mhz	ADJ
admet-2740	81	10	nmr	nmr	NOUN
admet-2740	81	11	,	,	PUNCT
admet-2740	81	12	employing	employ	VERB
admet-2740	81	13	a	a	DET
admet-2740	81	14	method	method	NOUN
admet-2740	81	15	specifically	specifically	ADV
admet-2740	81	16	designed	design	VERB
admet-2740	81	17	to	to	PART
admet-2740	81	18	mitigate	mitigate	VERB
admet-2740	81	19	interference	interference	NOUN
admet-2740	81	20	from	from	ADP
admet-2740	81	21	water	water	NOUN
admet-2740	81	22	resonance	resonance	NOUN
admet-2740	81	23	.	.	PUNCT
admet-2740	82	1	acquisition	acquisition	NOUN
admet-2740	82	2	parameters	parameter	NOUN
admet-2740	82	3	the	the	DET
admet-2740	82	4	proton	proton	NOUN
admet-2740	82	5	nmr	nmr	NOUN
admet-2740	82	6	spectra	spectra	NOUN
admet-2740	82	7	were	be	AUX
admet-2740	82	8	acquired	acquire	VERB
admet-2740	82	9	using	use	VERB
admet-2740	82	10	a	a	DET
admet-2740	82	11	bruker	bruker	ADJ
admet-2740	82	12	avance	avance	NOUN
admet-2740	82	13	500	500	NUM
admet-2740	82	14	mhz	mhz	NOUN
admet-2740	82	15	spectrometer	spectrometer	NOUN
admet-2740	82	16	(	(	PUNCT
admet-2740	82	17	bruker	bruker	PROPN
admet-2740	82	18	,	,	PUNCT
admet-2740	82	19	bremen	bremen	PROPN
admet-2740	82	20	,	,	PUNCT
admet-2740	82	21	germany	germany	PROPN
admet-2740	82	22	)	)	PUNCT
admet-2740	82	23	,	,	PUNCT
admet-2740	82	24	equipped	equip	VERB
admet-2740	82	25	with	with	ADP
admet-2740	82	26	a	a	DET
admet-2740	82	27	carr	carr	PROPN
admet-2740	82	28	-	-	PUNCT
admet-2740	82	29	purcell	purcell	PROPN
admet-2740	82	30	-	-	PUNCT
admet-2740	82	31	meiboom	meiboom	NOUN
admet-2740	82	32	-	-	PUNCT
admet-2740	82	33	gill	gill	NOUN
admet-2740	82	34	(	(	PUNCT
admet-2740	82	35	cpmg	cpmg	NOUN
admet-2740	82	36	,	,	PUNCT
admet-2740	82	37	rd	rd	PROPN
admet-2740	82	38	90	90	NUM
admet-2740	82	39	°	°	NOUN
admet-2740	82	40	,	,	PUNCT
admet-2740	82	41	(	(	PUNCT
admet-2740	82	42	t	t	PROPN
admet-2740	82	43	180	180	NUM
admet-2740	82	44	°	°	NUM
admet-2740	82	45	)	)	PUNCT
admet-2740	82	46	,	,	PUNCT
admet-2740	83	1	n	n	PRON
admet-2740	83	2	acquire	acquire	VERB
admet-2740	83	3	)	)	PUNCT
admet-2740	83	4	pulse	pulse	NOUN
admet-2740	83	5	sequence	sequence	NOUN
admet-2740	83	6	for	for	ADP
admet-2740	83	7	1h	1h	NUM
admet-2740	83	8	-	-	PUNCT
admet-2740	83	9	nmr	nmr	NOUN
admet-2740	83	10	measurements	measurement	NOUN
admet-2740	83	11	.	.	PUNCT
admet-2740	84	1	the	the	DET
admet-2740	84	2	spectra	spectra	NOUN
admet-2740	84	3	were	be	AUX
admet-2740	84	4	recorded	record	VERB
admet-2740	84	5	at	at	ADP
admet-2740	84	6	27	27	NUM
admet-2740	84	7	°	°	NOUN
admet-2740	84	8	c	c	NOUN
admet-2740	84	9	with	with	ADP
admet-2740	84	10	water	water	NOUN
admet-2740	84	11	suppression	suppression	NOUN
admet-2740	84	12	via	via	ADP
admet-2740	84	13	pre	pre	NOUN
admet-2740	84	14	-	-	NOUN
admet-2740	84	15	saturation	saturation	NOUN
admet-2740	84	16	.	.	PUNCT
admet-2740	85	1	the	the	DET
admet-2740	85	2	experimental	experimental	ADJ
admet-2740	85	3	parameters	parameter	NOUN
admet-2740	85	4	included	include	VERB
admet-2740	85	5	16	16	NUM
admet-2740	85	6	scans	scan	NOUN
admet-2740	85	7	,	,	PUNCT
admet-2740	85	8	a	a	DET
admet-2740	85	9	1	1	NUM
admet-2740	85	10	-	-	PUNCT
admet-2740	85	11	second	second	ADJ
admet-2740	85	12	relaxation	relaxation	NOUN
admet-2740	85	13	delay	delay	NOUN
admet-2740	85	14	,	,	PUNCT
admet-2740	85	15	a	a	DET
admet-2740	85	16	3.95	3.95	NUM
admet-2740	85	17	-	-	PUNCT
admet-2740	85	18	second	second	NOUN
admet-2740	85	19	acquisition	acquisition	NOUN
admet-2740	85	20	time	time	NOUN
admet-2740	85	21	,	,	PUNCT
admet-2740	85	22	an	an	DET
admet-2740	85	23	8278.146	8278.146	NUM
admet-2740	85	24	hz	hz	PRON
admet-2740	85	25	spectral	spectral	ADJ
admet-2740	85	26	window	window	NOUN
admet-2740	85	27	,	,	PUNCT
admet-2740	85	28	a	a	DET
admet-2740	85	29	0.126	0.126	PRON
admet-2740	85	30	hz	hz	VERB
admet-2740	85	31	free	free	ADJ
admet-2740	85	32	induction	induction	NOUN
admet-2740	85	33	decay	decay	NOUN
admet-2740	85	34	(	(	PUNCT
admet-2740	85	35	fid	fid	NOUN
admet-2740	85	36	)	)	PUNCT
admet-2740	85	37	resolution	resolution	NOUN
admet-2740	85	38	,	,	PUNCT
admet-2740	85	39	and	and	CCONJ
admet-2740	85	40	a	a	DET
admet-2740	85	41	60.40	60.40	NUM
admet-2740	85	42	dwell	dwell	NOUN
admet-2740	85	43	time	time	NOUN
admet-2740	85	44	(	(	PUNCT
admet-2740	85	45	dw	dw	NOUN
admet-2740	85	46	)	)	PUNCT
admet-2740	85	47	.	.	PUNCT
admet-2740	86	1	a	a	DET
admet-2740	86	2	90	90	NUM
admet-2740	86	3	°	°	PROPN
admet-2740	86	4	pulse	pulse	NOUN
admet-2740	86	5	with	with	ADP
admet-2740	86	6	16	16	NUM
admet-2740	86	7	signal	signal	NOUN
admet-2740	86	8	averages	average	NOUN
admet-2740	86	9	(	(	PUNCT
admet-2740	86	10	nsas	nsas	PROPN
admet-2740	86	11	)	)	PUNCT
admet-2740	86	12	was	be	AUX
admet-2740	86	13	applied	apply	VERB
admet-2740	86	14	.	.	PUNCT
admet-2740	87	1	baseline	baseline	NOUN
admet-2740	87	2	and	and	CCONJ
admet-2740	87	3	phase	phase	NOUN
admet-2740	87	4	corrections	correction	NOUN
admet-2740	87	5	were	be	AUX
admet-2740	87	6	conducted	conduct	VERB
admet-2740	87	7	using	use	VERB
admet-2740	87	8	topspin	topspin	NOUN
admet-2740	87	9	4.0.7	4.0.7	NUM
admet-2740	87	10	software	software	NOUN
admet-2740	87	11	[	[	X
admet-2740	87	12	16	16	NUM
admet-2740	87	13	]	]	PUNCT
admet-2740	87	14	.	.	PUNCT
admet-2740	88	1	the	the	DET
admet-2740	88	2	spectra	spectra	NOUN
admet-2740	88	3	,	,	PUNCT
admet-2740	88	4	recorded	record	VERB
admet-2740	88	5	over	over	ADP
admet-2740	88	6	a	a	DET
admet-2740	88	7	chemical	chemical	ADJ
admet-2740	88	8	shift	shift	NOUN
admet-2740	88	9	range	range	NOUN
admet-2740	88	10	of	of	ADP
admet-2740	88	11	0	0	NUM
admet-2740	88	12	to	to	PART
admet-2740	88	13	12	12	NUM
admet-2740	88	14	ppm	ppm	NOUN
admet-2740	88	15	and	and	CCONJ
admet-2740	88	16	normalized	normalize	VERB
admet-2740	88	17	to	to	ADP
admet-2740	88	18	the	the	DET
admet-2740	88	19	total	total	ADJ
admet-2740	88	20	integrated	integrate	VERB
admet-2740	88	21	area	area	NOUN
admet-2740	88	22	,	,	PUNCT
admet-2740	88	23	were	be	AUX
admet-2740	88	24	analysed	analyse	VERB
admet-2740	88	25	for	for	ADP
admet-2740	88	26	metabolite	metabolite	NOUN
admet-2740	88	27	identification	identification	NOUN
admet-2740	88	28	.	.	PUNCT
admet-2740	89	1	metabolite	metabolite	NOUN
admet-2740	89	2	resonances	resonance	NOUN
admet-2740	89	3	were	be	AUX
admet-2740	89	4	identified	identify	VERB
admet-2740	89	5	through	through	ADP
admet-2740	89	6	human	human	ADJ
admet-2740	89	7	databases	database	NOUN
admet-2740	89	8	[	[	X
admet-2740	89	9	17	17	NUM
admet-2740	89	10	]	]	PUNCT
admet-2740	89	11	.	.	PUNCT
admet-2740	90	1	tsp	tsp	NOUN
admet-2740	90	2	was	be	AUX
admet-2740	90	3	employed	employ	VERB
admet-2740	90	4	as	as	ADP
admet-2740	90	5	an	an	DET
admet-2740	90	6	internal	internal	ADJ
admet-2740	90	7	standard	standard	NOUN
admet-2740	90	8	,	,	PUNCT
admet-2740	90	9	enabling	enable	VERB
admet-2740	90	10	the	the	DET
admet-2740	90	11	quantification	quantification	NOUN
admet-2740	90	12	of	of	ADP
admet-2740	90	13	24	24	NUM
admet-2740	90	14	energy	energy	NOUN
admet-2740	90	15	-	-	PUNCT
admet-2740	90	16	related	relate	VERB
admet-2740	90	17	metabolites	metabolite	NOUN
admet-2740	90	18	across	across	ADP
admet-2740	90	19	all	all	DET
admet-2740	90	20	samples	sample	NOUN
admet-2740	90	21	.	.	PUNCT
admet-2740	91	1	internal	internal	ADJ
admet-2740	91	2	standard	standard	ADJ
admet-2740	91	3	tsp	tsp	NOUN
admet-2740	91	4	was	be	AUX
admet-2740	91	5	selected	select	VERB
admet-2740	91	6	as	as	ADP
admet-2740	91	7	the	the	DET
admet-2740	91	8	internal	internal	ADJ
admet-2740	91	9	standard	standard	NOUN
admet-2740	91	10	(	(	PUNCT
admet-2740	91	11	is	be	AUX
admet-2740	91	12	)	)	PUNCT
admet-2740	91	13	based	base	VERB
admet-2740	91	14	on	on	ADP
admet-2740	91	15	its	its	PRON
admet-2740	91	16	specific	specific	ADJ
admet-2740	91	17	chemical	chemical	NOUN
admet-2740	91	18	properties	property	NOUN
admet-2740	91	19	,	,	PUNCT
admet-2740	91	20	where	where	SCONJ
admet-2740	91	21	all	all	DET
admet-2740	91	22	14	14	NUM
admet-2740	91	23	protons	proton	NOUN
admet-2740	91	24	are	be	AUX
admet-2740	91	25	equivalent	equivalent	ADJ
admet-2740	91	26	.	.	PUNCT
admet-2740	92	1	this	this	DET
admet-2740	92	2	homogeneity	homogeneity	NOUN
admet-2740	92	3	guarantees	guarantee	VERB
admet-2740	92	4	that	that	SCONJ
admet-2740	92	5	the	the	DET
admet-2740	92	6	tsp	tsp	NOUN
admet-2740	92	7	signal	signal	NOUN
admet-2740	92	8	consistently	consistently	ADV
admet-2740	92	9	appears	appear	VERB
admet-2740	92	10	at	at	ADP
admet-2740	92	11	0	0	NUM
admet-2740	92	12	ppm	ppm	NOUN
admet-2740	92	13	at	at	ADP
admet-2740	92	14	500	500	NUM
admet-2740	92	15	mhz	mhz	NOUN
admet-2740	92	16	and	and	CCONJ
admet-2740	92	17	originates	originate	NOUN
admet-2740	92	18	from	from	ADP
admet-2740	92	19	a	a	DET
admet-2740	92	20	region	region	NOUN
admet-2740	92	21	with	with	ADP
admet-2740	92	22	higher	high	ADJ
admet-2740	92	23	magnetic	magnetic	ADJ
admet-2740	92	24	field	field	NOUN
admet-2740	92	25	intensity	intensity	NOUN
admet-2740	92	26	compared	compare	VERB
admet-2740	92	27	to	to	ADP
admet-2740	92	28	other	other	ADJ
admet-2740	92	29	protons	proton	NOUN
admet-2740	92	30	.	.	PUNCT
admet-2740	93	1	a	a	DET
admet-2740	93	2	further	further	ADJ
admet-2740	93	3	advantage	advantage	NOUN
admet-2740	93	4	is	be	AUX
admet-2740	93	5	that	that	SCONJ
admet-2740	93	6	tsp	tsp	NOUN
admet-2740	93	7	is	be	AUX
admet-2740	93	8	chemically	chemically	ADV
admet-2740	93	9	inert	inert	ADJ
admet-2740	93	10	and	and	CCONJ
admet-2740	93	11	has	have	VERB
admet-2740	93	12	a	a	DET
admet-2740	93	13	low	low	ADJ
admet-2740	93	14	boiling	boiling	NOUN
admet-2740	93	15	point	point	NOUN
admet-2740	93	16	in	in	ADP
admet-2740	93	17	organic	organic	ADJ
admet-2740	93	18	solvents	solvent	NOUN
admet-2740	93	19	,	,	PUNCT
admet-2740	93	20	facilitating	facilitate	VERB
admet-2740	93	21	its	its	PRON
admet-2740	93	22	efficient	efficient	ADJ
admet-2740	93	23	extraction	extraction	NOUN
admet-2740	93	24	from	from	ADP
admet-2740	93	25	samples	sample	NOUN
admet-2740	93	26	.	.	PUNCT
admet-2740	94	1	quality	quality	NOUN
admet-2740	94	2	control	control	PROPN
admet-2740	94	3	distinct	distinct	ADJ
admet-2740	94	4	protocols	protocol	NOUN
admet-2740	94	5	were	be	AUX
admet-2740	94	6	implemented	implement	VERB
admet-2740	94	7	for	for	ADP
admet-2740	94	8	the	the	DET
admet-2740	94	9	quality	quality	NOUN
admet-2740	94	10	control	control	NOUN
admet-2740	94	11	(	(	PUNCT
admet-2740	94	12	qc	qc	PROPN
admet-2740	94	13	)	)	PUNCT
admet-2740	94	14	samples	sample	NOUN
admet-2740	94	15	on	on	ADP
admet-2740	94	16	the	the	DET
admet-2740	94	17	1h	1h	NUM
admet-2740	94	18	-	-	PUNCT
admet-2740	94	19	nmr	nmr	NOUN
admet-2740	94	20	platforms	platform	NOUN
admet-2740	94	21	.	.	PUNCT
admet-2740	95	1	these	these	DET
admet-2740	95	2	protocols	protocol	NOUN
admet-2740	95	3	were	be	AUX
admet-2740	95	4	important	important	ADJ
admet-2740	95	5	for	for	ADP
admet-2740	95	6	calibrating	calibrate	VERB
admet-2740	95	7	the	the	DET
admet-2740	95	8	system	system	NOUN
admet-2740	95	9	before	before	ADV
admet-2740	95	10	,	,	PUNCT
admet-2740	95	11	during	during	ADP
admet-2740	95	12	,	,	PUNCT
admet-2740	95	13	and	and	CCONJ
admet-2740	95	14	after	after	ADP
admet-2740	95	15	the	the	DET
admet-2740	95	16	analysis	analysis	NOUN
admet-2740	95	17	,	,	PUNCT
admet-2740	95	18	ensuring	ensure	VERB
admet-2740	95	19	consistent	consistent	ADJ
admet-2740	95	20	results	result	NOUN
admet-2740	95	21	and	and	CCONJ
admet-2740	95	22	minimizing	minimize	VERB
admet-2740	95	23	analytical	analytical	ADJ
admet-2740	95	24	variations	variation	NOUN
admet-2740	95	25	.	.	PUNCT
admet-2740	96	1	the	the	DET
admet-2740	96	2	qc	qc	PROPN
admet-2740	96	3	samples	sample	NOUN
admet-2740	96	4	were	be	AUX
admet-2740	96	5	prepared	prepare	VERB
admet-2740	96	6	by	by	ADP
admet-2740	96	7	combining	combine	VERB
admet-2740	96	8	and	and	CCONJ
admet-2740	96	9	thoroughly	thoroughly	ADV
admet-2740	96	10	mixing	mix	VERB
admet-2740	96	11	equal	equal	ADJ
admet-2740	96	12	amounts	amount	NOUN
admet-2740	96	13	from	from	ADP
admet-2740	96	14	each	each	DET
admet-2740	96	15	sample	sample	NOUN
admet-2740	96	16	.	.	PUNCT
admet-2740	97	1	these	these	DET
admet-2740	97	2	samples	sample	NOUN
admet-2740	97	3	underwent	undergo	VERB
admet-2740	97	4	the	the	DET
admet-2740	97	5	same	same	ADJ
admet-2740	97	6	procedural	procedural	ADJ
admet-2740	97	7	steps	step	NOUN
admet-2740	97	8	as	as	ADP
admet-2740	97	9	the	the	DET
admet-2740	97	10	test	test	NOUN
admet-2740	97	11	samples	sample	NOUN
admet-2740	97	12	,	,	PUNCT
admet-2740	97	13	adhering	adhere	VERB
admet-2740	97	14	to	to	ADP
admet-2740	97	15	the	the	DET
admet-2740	97	16	previously	previously	ADV
admet-2740	97	17	established	establish	VERB
admet-2740	97	18	methods	method	NOUN
admet-2740	97	19	.	.	PUNCT
admet-2740	98	1	an	an	DET
admet-2740	98	2	analysis	analysis	NOUN
admet-2740	98	3	of	of	ADP
admet-2740	98	4	non	non	ADJ
admet-2740	98	5	-	-	ADJ
admet-2740	98	6	targeted	targeted	ADJ
admet-2740	98	7	metabolites	metabolite	NOUN
admet-2740	98	8	was	be	AUX
admet-2740	98	9	conducted	conduct	VERB
admet-2740	98	10	using	use	VERB
admet-2740	98	11	the	the	DET
admet-2740	98	12	procedures	procedure	NOUN
admet-2740	98	13	described	describe	VERB
admet-2740	98	14	.	.	PUNCT
admet-2740	99	1	peak	peak	NOUN
admet-2740	99	2	assignment	assignment	NOUN
admet-2740	99	3	,	,	PUNCT
admet-2740	99	4	chemical	chemical	NOUN
admet-2740	99	5	identification	identification	NOUN
admet-2740	99	6	and	and	CCONJ
admet-2740	99	7	1h	1h	NUM
admet-2740	99	8	-	-	PUNCT
admet-2740	99	9	nmr	nmr	NOUN
admet-2740	99	10	data	datum	NOUN
admet-2740	99	11	analysis	analysis	NOUN
admet-2740	99	12	chemical	chemical	NOUN
admet-2740	99	13	structures	structure	NOUN
admet-2740	99	14	were	be	AUX
admet-2740	99	15	identified	identify	VERB
admet-2740	99	16	using	use	VERB
admet-2740	99	17	the	the	DET
admet-2740	99	18	human	human	ADJ
admet-2740	99	19	metabolome	metabolome	PROPN
admet-2740	99	20	database	database	NOUN
admet-2740	100	1	[	[	X
admet-2740	100	2	18	18	NUM
admet-2740	100	3	]	]	PUNCT
admet-2740	100	4	and	and	CCONJ
admet-2740	100	5	referenced	reference	VERB
admet-2740	100	6	from	from	ADP
admet-2740	100	7	a	a	DET
admet-2740	100	8	previous	previous	ADJ
admet-2740	100	9	study	study	NOUN
admet-2740	100	10	[	[	X
admet-2740	100	11	16,18	16,18	NOUN
admet-2740	100	12	]	]	PUNCT
admet-2740	100	13	.	.	PUNCT
admet-2740	101	1	peak	peak	PROPN
admet-2740	101	2	acquisition	acquisition	NOUN
admet-2740	101	3	and	and	CCONJ
admet-2740	101	4	j	j	PROPN
admet-2740	101	5	-	-	PUNCT
admet-2740	101	6	coupling	couple	VERB
admet-2740	101	7	values	value	NOUN
admet-2740	101	8	were	be	AUX
admet-2740	101	9	analysed	analyse	VERB
admet-2740	101	10	utilizing	utilize	VERB
admet-2740	101	11	bruker	bruker	NOUN
admet-2740	101	12	topspin	topspin	PROPN
admet-2740	101	13	version	version	NOUN
admet-2740	101	14	4.0.7	4.0.7	NUM
admet-2740	101	15	software	software	NOUN
admet-2740	101	16	.	.	PUNCT
admet-2740	102	1	nmr	nmr	NOUN
admet-2740	102	2	spectra	spectra	ADJ
admet-2740	102	3	interpretation	interpretation	NOUN
admet-2740	102	4	was	be	AUX
admet-2740	102	5	primarily	primarily	ADV
admet-2740	102	6	based	base	VERB
admet-2740	102	7	on	on	ADP
admet-2740	102	8	chemical	chemical	ADJ
admet-2740	102	9	shift	shift	NOUN
admet-2740	102	10	values	value	NOUN
admet-2740	102	11	,	,	PUNCT
admet-2740	102	12	essential	essential	ADJ
admet-2740	102	13	for	for	ADP
admet-2740	102	14	signal	signal	ADJ
admet-2740	102	15	identification	identification	NOUN
admet-2740	102	16	,	,	PUNCT
admet-2740	102	17	integration	integration	NOUN
admet-2740	102	18	,	,	PUNCT
admet-2740	102	19	spin	spin	NOUN
admet-2740	102	20	–	–	PUNCT
admet-2740	102	21	spin	spin	VERB
admet-2740	102	22	coupling	couple	VERB
admet-2740	102	23	analysis	analysis	NOUN
admet-2740	102	24	,	,	PUNCT
admet-2740	102	25	signal	signal	NOUN
admet-2740	102	26	pattern	pattern	NOUN
admet-2740	102	27	examination	examination	NOUN
admet-2740	102	28	,	,	PUNCT
admet-2740	102	29	and	and	CCONJ
admet-2740	102	30	coupling	couple	VERB
admet-2740	102	31	constant	constant	ADJ
admet-2740	102	32	admet	admet	PROPN
admet-2740	102	33	&	&	CCONJ
admet-2740	102	34	dmpk	dmpk	PROPN
admet-2740	102	35	13(3	13(3	NUM
admet-2740	102	36	)	)	PUNCT
admet-2740	102	37	(	(	PUNCT
admet-2740	102	38	2025	2025	NUM
admet-2740	102	39	)	)	PUNCT
admet-2740	102	40	2740	2740	NUM
admet-2740	102	41	metabolic	metabolic	NOUN
admet-2740	102	42	insights	insight	NOUN
admet-2740	102	43	into	into	ADP
admet-2740	102	44	the	the	DET
admet-2740	102	45	warfarin	warfarin	NOUN
admet-2740	102	46	-	-	PUNCT
admet-2740	102	47	mango	mango	NOUN
admet-2740	102	48	interaction	interaction	NOUN
admet-2740	102	49	doi	doi	NOUN
admet-2740	102	50	:	:	PUNCT
admet-2740	102	51	https://doi.org/10.5599/admet.2740	https://doi.org/10.5599/admet.2740	NOUN
admet-2740	102	52	5	5	NUM
admet-2740	102	53	assessment	assessment	NOUN
admet-2740	102	54	.	.	PUNCT
admet-2740	103	1	each	each	DET
admet-2740	103	2	peak	peak	NOUN
admet-2740	103	3	of	of	ADP
admet-2740	103	4	non	non	ADJ
admet-2740	103	5	-	-	ADJ
admet-2740	103	6	targeted	targeted	ADJ
admet-2740	103	7	metabolites	metabolite	NOUN
admet-2740	103	8	was	be	AUX
admet-2740	103	9	carefully	carefully	ADV
admet-2740	103	10	adjusted	adjust	VERB
admet-2740	103	11	to	to	PART
admet-2740	103	12	ensure	ensure	VERB
admet-2740	103	13	deviations	deviation	NOUN
admet-2740	103	14	of	of	ADP
admet-2740	103	15	less	less	ADJ
admet-2740	103	16	than	than	ADP
admet-2740	103	17	0.01	0.01	NUM
admet-2740	103	18	ppm	ppm	NOUN
admet-2740	103	19	relative	relative	ADJ
admet-2740	103	20	to	to	ADP
admet-2740	103	21	the	the	DET
admet-2740	103	22	hmdb	hmdb	PROPN
admet-2740	103	23	database	database	NOUN
admet-2740	103	24	.	.	PUNCT
admet-2740	104	1	for	for	ADP
admet-2740	104	2	data	data	NOUN
admet-2740	104	3	export	export	NOUN
admet-2740	104	4	and	and	CCONJ
admet-2740	104	5	spectrum	spectrum	NOUN
admet-2740	104	6	visualization	visualization	NOUN
admet-2740	104	7	,	,	PUNCT
admet-2740	104	8	mestrenova	mestrenova	VERB
admet-2740	104	9	software	software	NOUN
admet-2740	104	10	(	(	PUNCT
admet-2740	104	11	version	version	NOUN
admet-2740	104	12	12.0.0	12.0.0	PROPN
admet-2740	104	13	,	,	PUNCT
admet-2740	104	14	mestrelab	mestrelab	PROPN
admet-2740	104	15	research	research	PROPN
admet-2740	104	16	,	,	PUNCT
admet-2740	104	17	santiago	santiago	PROPN
admet-2740	104	18	de	de	PROPN
admet-2740	104	19	compostela	compostela	PROPN
admet-2740	104	20	,	,	PUNCT
admet-2740	104	21	spain	spain	PROPN
admet-2740	104	22	)	)	PUNCT
admet-2740	104	23	was	be	AUX
admet-2740	104	24	employed	employ	VERB
admet-2740	104	25	[	[	X
admet-2740	104	26	16,19	16,19	NUM
admet-2740	104	27	]	]	PUNCT
admet-2740	104	28	.	.	PUNCT
admet-2740	105	1	data	datum	NOUN
admet-2740	105	2	were	be	AUX
admet-2740	105	3	presented	present	VERB
admet-2740	105	4	using	use	VERB
admet-2740	105	5	median	median	ADJ
admet-2740	105	6	values	value	NOUN
admet-2740	105	7	,	,	PUNCT
admet-2740	105	8	and	and	CCONJ
admet-2740	105	9	normality	normality	NOUN
admet-2740	105	10	was	be	AUX
admet-2740	105	11	evaluated	evaluate	VERB
admet-2740	105	12	using	use	VERB
admet-2740	105	13	the	the	DET
admet-2740	105	14	kolmogorov	kolmogorov	ADJ
admet-2740	105	15	–	–	PUNCT
admet-2740	105	16	smirnov	smirnov	ADJ
admet-2740	105	17	test	test	NOUN
admet-2740	106	1	[	[	X
admet-2740	106	2	16,19	16,19	NUM
admet-2740	106	3	]	]	PUNCT
admet-2740	106	4	.	.	PUNCT
admet-2740	107	1	bioinformatics	bioinformatic	NOUN
admet-2740	107	2	and	and	CCONJ
admet-2740	107	3	statistical	statistical	ADJ
admet-2740	107	4	analysis	analysis	NOUN
admet-2740	107	5	metaboanalyst	metaboanalyst	NOUN
admet-2740	107	6	[	[	X
admet-2740	107	7	20	20	NUM
admet-2740	107	8	]	]	PUNCT
admet-2740	107	9	was	be	AUX
admet-2740	107	10	employed	employ	VERB
admet-2740	107	11	to	to	PART
admet-2740	107	12	analyze	analyze	VERB
admet-2740	107	13	differences	difference	NOUN
admet-2740	107	14	in	in	ADP
admet-2740	107	15	plasma	plasma	NOUN
admet-2740	107	16	metabolites	metabolite	NOUN
admet-2740	107	17	during	during	ADP
admet-2740	107	18	the	the	DET
admet-2740	107	19	warfarin	warfarin	NOUN
admet-2740	107	20	-	-	PUNCT
admet-2740	107	21	mango	mango	NOUN
admet-2740	107	22	interaction	interaction	NOUN
admet-2740	107	23	and	and	CCONJ
admet-2740	107	24	after	after	ADP
admet-2740	107	25	mango	mango	NOUN
admet-2740	107	26	discontinuation	discontinuation	NOUN
admet-2740	107	27	(	(	PUNCT
admet-2740	107	28	control	control	NOUN
admet-2740	107	29	)	)	PUNCT
admet-2740	107	30	.	.	PUNCT
admet-2740	108	1	pathway	pathway	NOUN
admet-2740	108	2	enrichment	enrichment	NOUN
admet-2740	108	3	and	and	CCONJ
admet-2740	108	4	analysis	analysis	NOUN
admet-2740	108	5	were	be	AUX
admet-2740	108	6	conducted	conduct	VERB
admet-2740	108	7	using	use	VERB
admet-2740	108	8	metaboanalyst	metaboanalyst	NOUN
admet-2740	108	9	,	,	PUNCT
admet-2740	108	10	in	in	ADP
admet-2740	108	11	combination	combination	NOUN
admet-2740	108	12	with	with	ADP
admet-2740	108	13	metascape	metascape	NOUN
admet-2740	108	14	[	[	X
admet-2740	108	15	21	21	NUM
admet-2740	108	16	]	]	PUNCT
admet-2740	108	17	which	which	PRON
admet-2740	108	18	was	be	AUX
admet-2740	108	19	utilized	utilize	VERB
admet-2740	108	20	for	for	ADP
admet-2740	108	21	the	the	DET
admet-2740	108	22	construction	construction	NOUN
admet-2740	108	23	of	of	ADP
admet-2740	108	24	metabolitemetabolite	metabolitemetabolite	NOUN
admet-2740	108	25	networks	network	NOUN
admet-2740	108	26	.	.	PUNCT
admet-2740	109	1	metaboanalyst	metaboanalyst	NOUN
admet-2740	109	2	version	version	NOUN
admet-2740	109	3	6.0	6.0	NUM
admet-2740	109	4	was	be	AUX
admet-2740	109	5	also	also	ADV
admet-2740	109	6	used	use	VERB
admet-2740	109	7	to	to	PART
admet-2740	109	8	evaluate	evaluate	VERB
admet-2740	109	9	alterations	alteration	NOUN
admet-2740	109	10	in	in	ADP
admet-2740	109	11	metabolic	metabolic	NOUN
admet-2740	109	12	profiles	profile	NOUN
admet-2740	109	13	during	during	ADP
admet-2740	109	14	the	the	DET
admet-2740	109	15	warfarin	warfarin	NOUN
admet-2740	109	16	-	-	PUNCT
admet-2740	109	17	mango	mango	NOUN
admet-2740	109	18	interaction	interaction	NOUN
admet-2740	109	19	through	through	ADP
admet-2740	109	20	heatmaps	heatmap	NOUN
admet-2740	109	21	,	,	PUNCT
admet-2740	109	22	along	along	ADP
admet-2740	109	23	with	with	ADP
admet-2740	109	24	pearson	pearson	PROPN
admet-2740	109	25	correlation	correlation	NOUN
admet-2740	109	26	coefficient	coefficient	NOUN
admet-2740	109	27	calculations	calculation	NOUN
admet-2740	109	28	to	to	PART
admet-2740	109	29	explore	explore	VERB
admet-2740	109	30	metabolic	metabolic	NOUN
admet-2740	109	31	changes	change	NOUN
admet-2740	109	32	.	.	PUNCT
admet-2740	110	1	key	key	ADJ
admet-2740	110	2	metabolites	metabolite	NOUN
admet-2740	110	3	identified	identify	VERB
admet-2740	110	4	as	as	ADP
admet-2740	110	5	potential	potential	ADJ
admet-2740	110	6	biomarkers	biomarker	NOUN
admet-2740	110	7	were	be	AUX
admet-2740	110	8	further	far	ADV
admet-2740	110	9	assessed	assess	VERB
admet-2740	110	10	via	via	ADP
admet-2740	110	11	univariate	univariate	ADJ
admet-2740	110	12	receiver	receiver	NOUN
admet-2740	110	13	operating	operate	VERB
admet-2740	110	14	characteristic	characteristic	NOUN
admet-2740	110	15	(	(	PUNCT
admet-2740	110	16	roc	roc	PROPN
admet-2740	110	17	)	)	PUNCT
admet-2740	110	18	curve	curve	NOUN
admet-2740	110	19	analyses	analysis	NOUN
admet-2740	110	20	,	,	PUNCT
admet-2740	110	21	with	with	ADP
admet-2740	110	22	95	95	NUM
admet-2740	110	23	%	%	NOUN
admet-2740	110	24	confidence	confidence	NOUN
admet-2740	110	25	intervals	interval	NOUN
admet-2740	110	26	calculated	calculate	VERB
admet-2740	110	27	using	use	VERB
admet-2740	110	28	metaboanalyst	metaboanalyst	NOUN
admet-2740	110	29	version	version	NOUN
admet-2740	110	30	6.0	6.0	NUM
admet-2740	110	31	for	for	ADP
admet-2740	110	32	individual	individual	ADJ
admet-2740	110	33	biomarkers	biomarker	NOUN
admet-2740	110	34	.	.	PUNCT
admet-2740	111	1	roc	roc	PROPN
admet-2740	111	2	curve	curve	NOUN
admet-2740	111	3	analyses	analysis	NOUN
admet-2740	111	4	were	be	AUX
admet-2740	111	5	also	also	ADV
admet-2740	111	6	performed	perform	VERB
admet-2740	111	7	to	to	PART
admet-2740	111	8	evaluate	evaluate	VERB
admet-2740	111	9	the	the	DET
admet-2740	111	10	area	area	NOUN
admet-2740	111	11	under	under	ADP
admet-2740	111	12	the	the	DET
admet-2740	111	13	curve	curve	NOUN
admet-2740	111	14	(	(	PUNCT
admet-2740	111	15	auc	auc	NOUN
admet-2740	111	16	)	)	PUNCT
admet-2740	111	17	for	for	ADP
admet-2740	111	18	inr	inr	PROPN
admet-2740	111	19	values	value	NOUN
admet-2740	111	20	in	in	ADP
admet-2740	111	21	comparison	comparison	NOUN
admet-2740	111	22	to	to	ADP
admet-2740	111	23	glycerol	glycerol	NOUN
admet-2740	111	24	3	3	NUM
admet-2740	111	25	-	-	PUNCT
admet-2740	111	26	phosphate	phosphate	NOUN
admet-2740	111	27	concentrations	concentration	NOUN
admet-2740	111	28	during	during	ADP
admet-2740	111	29	the	the	DET
admet-2740	111	30	warfarin	warfarin	NOUN
admet-2740	111	31	-	-	PUNCT
admet-2740	111	32	mango	mango	NOUN
admet-2740	111	33	interaction	interaction	NOUN
admet-2740	111	34	.	.	PUNCT
admet-2740	112	1	these	these	DET
admet-2740	112	2	analyses	analysis	NOUN
admet-2740	112	3	were	be	AUX
admet-2740	112	4	conducted	conduct	VERB
admet-2740	112	5	by	by	ADP
admet-2740	112	6	graphpad	graphpad	NOUN
admet-2740	112	7	prism	prism	NOUN
admet-2740	112	8	,	,	PUNCT
admet-2740	112	9	version	version	NOUN
admet-2740	112	10	8.3.0	8.3.0	NUM
admet-2740	112	11	for	for	ADP
admet-2740	112	12	windows	window	NOUN
admet-2740	112	13	[	[	X
admet-2740	112	14	22	22	NUM
admet-2740	112	15	]	]	PUNCT
admet-2740	112	16	.	.	PUNCT
admet-2740	113	1	descriptive	descriptive	ADJ
admet-2740	113	2	statistics	statistic	NOUN
admet-2740	113	3	were	be	AUX
admet-2740	113	4	used	use	VERB
admet-2740	113	5	to	to	PART
admet-2740	113	6	calculate	calculate	VERB
admet-2740	113	7	the	the	DET
admet-2740	113	8	demographic	demographic	ADJ
admet-2740	113	9	characteristics	characteristic	NOUN
admet-2740	113	10	of	of	ADP
admet-2740	113	11	the	the	DET
admet-2740	113	12	15	15	NUM
admet-2740	113	13	patients	patient	NOUN
admet-2740	113	14	.	.	PUNCT
admet-2740	114	1	the	the	DET
admet-2740	114	2	data	datum	NOUN
admet-2740	114	3	are	be	AUX
admet-2740	114	4	presented	present	VERB
admet-2740	114	5	as	as	ADP
admet-2740	114	6	the	the	DET
admet-2740	114	7	number	number	NOUN
admet-2740	114	8	(	(	PUNCT
admet-2740	114	9	%	%	NOUN
admet-2740	114	10	)	)	PUNCT
admet-2740	114	11	of	of	ADP
admet-2740	114	12	patients	patient	NOUN
admet-2740	114	13	and	and	CCONJ
admet-2740	114	14	the	the	DET
admet-2740	114	15	mean	mean	ADJ
admet-2740	114	16	 	 	SPACE
admet-2740	114	17	±	±	NOUN
admet-2740	114	18	 	 	SPACE
admet-2740	114	19	standard	standard	ADJ
admet-2740	114	20	deviation	deviation	NOUN
admet-2740	114	21	(	(	PUNCT
admet-2740	114	22	sd	sd	NOUN
admet-2740	114	23	)	)	PUNCT
admet-2740	114	24	.	.	PUNCT
admet-2740	115	1	statistical	statistical	ADJ
admet-2740	115	2	analysis	analysis	NOUN
admet-2740	115	3	,	,	PUNCT
admet-2740	115	4	using	use	VERB
admet-2740	115	5	a	a	DET
admet-2740	115	6	wilcoxon	wilcoxon	ADJ
admet-2740	115	7	signed	sign	VERB
admet-2740	115	8	-	-	PUNCT
admet-2740	115	9	rank	rank	NOUN
admet-2740	115	10	test	test	NOUN
admet-2740	115	11	to	to	PART
admet-2740	115	12	compare	compare	VERB
admet-2740	115	13	the	the	DET
admet-2740	115	14	difference	difference	NOUN
admet-2740	115	15	between	between	ADP
admet-2740	115	16	inr	inr	PROPN
admet-2740	115	17	levels	level	NOUN
admet-2740	115	18	during	during	ADP
admet-2740	115	19	mango	mango	NOUN
admet-2740	115	20	ingestion	ingestion	NOUN
admet-2740	115	21	and	and	CCONJ
admet-2740	115	22	after	after	ADP
admet-2740	115	23	discontinuation	discontinuation	NOUN
admet-2740	115	24	,	,	PUNCT
admet-2740	115	25	was	be	AUX
admet-2740	115	26	performed	perform	VERB
admet-2740	115	27	with	with	ADP
admet-2740	115	28	graphpad	graphpad	NOUN
admet-2740	115	29	prism	prism	NOUN
admet-2740	115	30	version	version	NOUN
admet-2740	115	31	8.3.0	8.3.0	NUM
admet-2740	115	32	for	for	ADP
admet-2740	115	33	windows	window	NOUN
admet-2740	115	34	[	[	X
admet-2740	115	35	22	22	NUM
admet-2740	115	36	]	]	PUNCT
admet-2740	115	37	.	.	PUNCT
admet-2740	116	1	results	result	VERB
admet-2740	116	2	demographic	demographic	ADJ
admet-2740	116	3	characteristics	characteristic	NOUN
admet-2740	116	4	of	of	ADP
admet-2740	116	5	patients	patient	NOUN
admet-2740	116	6	the	the	DET
admet-2740	116	7	fifteen	fifteen	NUM
admet-2740	116	8	eligible	eligible	ADJ
admet-2740	116	9	cases	case	NOUN
admet-2740	116	10	included	include	VERB
admet-2740	116	11	5	5	NUM
admet-2740	116	12	males	male	NOUN
admet-2740	116	13	(	(	PUNCT
admet-2740	116	14	33.33	33.33	NUM
admet-2740	116	15	%	%	NOUN
admet-2740	116	16	)	)	PUNCT
admet-2740	116	17	and	and	CCONJ
admet-2740	116	18	10	10	NUM
admet-2740	116	19	females	female	NOUN
admet-2740	116	20	(	(	PUNCT
admet-2740	116	21	66.67	66.67	NUM
admet-2740	116	22	%	%	NOUN
admet-2740	116	23	)	)	PUNCT
admet-2740	116	24	.	.	PUNCT
admet-2740	117	1	the	the	DET
admet-2740	117	2	underlying	underlying	ADJ
admet-2740	117	3	conditions	condition	NOUN
admet-2740	117	4	indicating	indicate	VERB
admet-2740	117	5	the	the	DET
admet-2740	117	6	need	need	NOUN
admet-2740	117	7	for	for	ADP
admet-2740	117	8	warfarin	warfarin	NOUN
admet-2740	117	9	therapy	therapy	NOUN
admet-2740	117	10	included	include	VERB
admet-2740	117	11	atrial	atrial	ADJ
admet-2740	117	12	fibrillation	fibrillation	NOUN
admet-2740	117	13	(	(	PUNCT
admet-2740	117	14	af	af	NOUN
admet-2740	117	15	)	)	PUNCT
admet-2740	117	16	in	in	ADP
admet-2740	117	17	12	12	NUM
admet-2740	117	18	patients	patient	NOUN
admet-2740	117	19	(	(	PUNCT
admet-2740	117	20	80.00	80.00	NUM
admet-2740	117	21	%	%	NOUN
admet-2740	117	22	)	)	PUNCT
admet-2740	117	23	and	and	CCONJ
admet-2740	117	24	mitral	mitral	ADJ
admet-2740	117	25	valve	valve	NOUN
admet-2740	117	26	replacement	replacement	NOUN
admet-2740	117	27	(	(	PUNCT
admet-2740	117	28	mvr	mvr	PROPN
admet-2740	117	29	)	)	PUNCT
admet-2740	117	30	in	in	ADP
admet-2740	117	31	3	3	NUM
admet-2740	117	32	patients	patient	NOUN
admet-2740	117	33	(	(	PUNCT
admet-2740	117	34	20.00	20.00	NUM
admet-2740	117	35	%	%	NOUN
admet-2740	117	36	)	)	PUNCT
admet-2740	117	37	.	.	PUNCT
admet-2740	118	1	all	all	DET
admet-2740	118	2	patients	patient	NOUN
admet-2740	118	3	experienced	experience	VERB
admet-2740	118	4	an	an	DET
admet-2740	118	5	increase	increase	NOUN
admet-2740	118	6	in	in	ADP
admet-2740	118	7	inr	inr	PROPN
admet-2740	118	8	following	follow	VERB
admet-2740	118	9	mango	mango	PROPN
admet-2740	118	10	consumption	consumption	NOUN
admet-2740	118	11	,	,	PUNCT
admet-2740	118	12	with	with	ADP
admet-2740	118	13	reported	report	VERB
admet-2740	118	14	intake	intake	NOUN
admet-2740	118	15	ranging	range	VERB
admet-2740	118	16	from	from	ADP
admet-2740	118	17	1	1	NUM
admet-2740	118	18	to	to	PART
admet-2740	118	19	3	3	NUM
admet-2740	118	20	mangoes	mango	NOUN
admet-2740	118	21	per	per	ADP
admet-2740	118	22	day	day	NOUN
admet-2740	118	23	over	over	ADP
admet-2740	118	24	a	a	DET
admet-2740	118	25	period	period	NOUN
admet-2740	118	26	of	of	ADP
admet-2740	118	27	5	5	NUM
admet-2740	118	28	days	day	NOUN
admet-2740	118	29	to	to	ADP
admet-2740	118	30	1	1	NUM
admet-2740	118	31	month	month	NOUN
admet-2740	118	32	prior	prior	ADV
admet-2740	118	33	to	to	ADP
admet-2740	118	34	the	the	DET
admet-2740	118	35	observed	observe	VERB
admet-2740	118	36	drug	drug	NOUN
admet-2740	118	37	interaction	interaction	NOUN
admet-2740	118	38	.	.	PUNCT
admet-2740	119	1	other	other	ADJ
admet-2740	119	2	factors	factor	NOUN
admet-2740	119	3	that	that	PRON
admet-2740	119	4	could	could	AUX
admet-2740	119	5	contribute	contribute	VERB
admet-2740	119	6	to	to	ADP
admet-2740	119	7	an	an	DET
admet-2740	119	8	increase	increase	NOUN
admet-2740	119	9	in	in	ADP
admet-2740	119	10	inr	inr	PROPN
admet-2740	119	11	,	,	PUNCT
admet-2740	119	12	such	such	ADJ
admet-2740	119	13	as	as	ADP
admet-2740	119	14	noncompliance	noncompliance	NOUN
admet-2740	119	15	,	,	PUNCT
admet-2740	119	16	were	be	AUX
admet-2740	119	17	not	not	PART
admet-2740	119	18	recorded	record	VERB
admet-2740	119	19	.	.	PUNCT
admet-2740	120	1	after	after	SCONJ
admet-2740	120	2	mango	mango	PROPN
admet-2740	120	3	fruit	fruit	NOUN
admet-2740	120	4	was	be	AUX
admet-2740	120	5	identified	identify	VERB
admet-2740	120	6	as	as	ADP
admet-2740	120	7	a	a	DET
admet-2740	120	8	possible	possible	ADJ
admet-2740	120	9	cause	cause	NOUN
admet-2740	120	10	of	of	ADP
admet-2740	120	11	the	the	DET
admet-2740	120	12	supratherapeutic	supratherapeutic	ADJ
admet-2740	120	13	inr	inr	PROPN
admet-2740	120	14	,	,	PUNCT
admet-2740	120	15	patients	patient	NOUN
admet-2740	120	16	were	be	AUX
admet-2740	120	17	instructed	instruct	VERB
admet-2740	120	18	to	to	PART
admet-2740	120	19	discontinue	discontinue	VERB
admet-2740	120	20	mango	mango	NOUN
admet-2740	120	21	consumption	consumption	NOUN
admet-2740	120	22	.	.	PUNCT
admet-2740	121	1	the	the	DET
admet-2740	121	2	average	average	ADJ
admet-2740	121	3	inr	inr	PROPN
admet-2740	121	4	decreased	decrease	VERB
admet-2740	121	5	from	from	ADP
admet-2740	121	6	4.57	4.57	NUM
admet-2740	121	7	±	±	NUM
admet-2740	121	8	1.46	1.46	NUM
admet-2740	121	9	to	to	ADP
admet-2740	121	10	2.45	2.45	NUM
admet-2740	121	11	±	±	NUM
admet-2740	121	12	0.39	0.39	NUM
admet-2740	121	13	,	,	PUNCT
admet-2740	121	14	the	the	DET
admet-2740	121	15	difference	difference	NOUN
admet-2740	121	16	between	between	ADP
admet-2740	121	17	inr	inr	PROPN
admet-2740	121	18	levels	level	NOUN
admet-2740	121	19	during	during	ADP
admet-2740	121	20	mango	mango	NOUN
admet-2740	121	21	ingestion	ingestion	NOUN
admet-2740	121	22	and	and	CCONJ
admet-2740	121	23	after	after	ADP
admet-2740	121	24	discontinuation	discontinuation	NOUN
admet-2740	121	25	being	be	AUX
admet-2740	121	26	statistically	statistically	ADV
admet-2740	121	27	significant	significant	ADJ
admet-2740	121	28	(	(	PUNCT
admet-2740	121	29	p	p	X
admet-2740	121	30	<	<	X
admet-2740	121	31	0.0001	0.0001	NUM
admet-2740	121	32	)	)	PUNCT
admet-2740	121	33	,	,	PUNCT
admet-2740	121	34	suggesting	suggest	VERB
admet-2740	121	35	that	that	SCONJ
admet-2740	121	36	mango	mango	PROPN
admet-2740	121	37	intake	intake	NOUN
admet-2740	121	38	may	may	AUX
admet-2740	121	39	have	have	AUX
admet-2740	121	40	influenced	influence	VERB
admet-2740	121	41	warfarin	warfarin	NOUN
admet-2740	121	42	metabolism	metabolism	NOUN
admet-2740	121	43	(	(	PUNCT
admet-2740	121	44	table	table	NOUN
admet-2740	121	45	1	1	NUM
admet-2740	121	46	)	)	PUNCT
admet-2740	121	47	.	.	PUNCT
admet-2740	122	1	table	table	NOUN
admet-2740	122	2	1	1	NUM
admet-2740	122	3	.	.	PUNCT
admet-2740	123	1	patient	patient	ADJ
admet-2740	123	2	characteristics	characteristics	PROPN
admet-2740	123	3	variable	variable	ADJ
admet-2740	123	4	warfarin	warfarin	NOUN
admet-2740	123	5	-	-	PUNCT
admet-2740	123	6	mango	mango	NOUN
admet-2740	123	7	interaction	interaction	NOUN
admet-2740	123	8	following	follow	VERB
admet-2740	123	9	mango	mango	PROPN
admet-2740	123	10	discontinuation	discontinuation	NOUN
admet-2740	123	11	*	*	PUNCT
admet-2740	124	1	mean	mean	NOUN
admet-2740	124	2	±	±	NUM
admet-2740	124	3	sd	sd	NOUN
admet-2740	124	4	(	(	PUNCT
admet-2740	124	5	range	range	NOUN
admet-2740	124	6	)	)	PUNCT
admet-2740	124	7	international	international	ADJ
admet-2740	124	8	normalized	normalize	VERB
admet-2740	124	9	ratio	ratio	NOUN
admet-2740	124	10	4.57	4.57	NUM
admet-2740	124	11	±	±	NUM
admet-2740	124	12	1.46	1.46	NUM
admet-2740	124	13	*	*	PUNCT
admet-2740	124	14	*	*	PUNCT
admet-2740	124	15	(	(	PUNCT
admet-2740	124	16	3.17	3.17	NUM
admet-2740	124	17	-	-	SYM
admet-2740	124	18	8.67	8.67	NUM
admet-2740	124	19	)	)	PUNCT
admet-2740	124	20	2.45	2.45	NUM
admet-2740	124	21	±	±	NUM
admet-2740	124	22	0.39	0.39	NUM
admet-2740	124	23	(	(	PUNCT
admet-2740	124	24	1.73	1.73	NUM
admet-2740	124	25	-	-	SYM
admet-2740	124	26	3.10	3.10	NUM
admet-2740	124	27	)	)	PUNCT
admet-2740	124	28	underlying	underlie	VERB
admet-2740	124	29	disease	disease	NOUN
admet-2740	124	30	requiring	require	VERB
admet-2740	124	31	warfarin	warfarin	NOUN
admet-2740	124	32	therapy	therapy	NOUN
admet-2740	124	33	n	n	PROPN
admet-2740	124	34	(	(	PUNCT
admet-2740	124	35	share	share	NOUN
admet-2740	124	36	,	,	PUNCT
admet-2740	124	37	%	%	INTJ
admet-2740	124	38	)	)	PUNCT
admet-2740	124	39	atrial	atrial	ADJ
admet-2740	124	40	fibrillation	fibrillation	NOUN
admet-2740	124	41	12	12	NUM
admet-2740	124	42	(	(	PUNCT
admet-2740	124	43	80.00	80.00	NUM
admet-2740	124	44	)	)	PUNCT
admet-2740	124	45	mitral	mitral	ADJ
admet-2740	124	46	valve	valve	NOUN
admet-2740	124	47	replacement	replacement	NOUN
admet-2740	124	48	3	3	NUM
admet-2740	124	49	(	(	PUNCT
admet-2740	124	50	20.00	20.00	NUM
admet-2740	124	51	)	)	PUNCT
admet-2740	124	52	gender	gender	NOUN
admet-2740	124	53	n	n	CCONJ
admet-2740	124	54	(	(	PUNCT
admet-2740	124	55	share	share	NOUN
admet-2740	124	56	,	,	PUNCT
admet-2740	124	57	%	%	INTJ
admet-2740	124	58	)	)	PUNCT
admet-2740	124	59	male	male	NOUN
admet-2740	124	60	5	5	NUM
admet-2740	124	61	(	(	PUNCT
admet-2740	124	62	33.33	33.33	NUM
admet-2740	124	63	)	)	PUNCT
admet-2740	124	64	female	female	NOUN
admet-2740	124	65	10	10	NUM
admet-2740	124	66	(	(	PUNCT
admet-2740	124	67	66.67	66.67	NUM
admet-2740	124	68	)	)	PUNCT
admet-2740	124	69	*	*	PUNCT
admet-2740	124	70	control	control	NOUN
admet-2740	124	71	;	;	PUNCT
admet-2740	124	72	*	*	PUNCT
admet-2740	124	73	*	*	PUNCT
admet-2740	124	74	wilcoxon	wilcoxon	ADJ
admet-2740	124	75	signed	sign	VERB
admet-2740	124	76	-	-	PUNCT
admet-2740	124	77	rank	rank	NOUN
admet-2740	124	78	test	test	NOUN
admet-2740	124	79	(	(	PUNCT
admet-2740	124	80	p	p	X
admet-2740	124	81	<	<	X
admet-2740	124	82	0.0001	0.0001	NUM
admet-2740	124	83	)	)	PUNCT
admet-2740	124	84	https://doi.org/10.5599/admet.2740	https://doi.org/10.5599/admet.2740	NOUN
admet-2740	124	85	p.	p.	NOUN
admet-2740	124	86	rattanasuwan	rattanasuwan	PROPN
admet-2740	124	87	et	et	PROPN
admet-2740	124	88	al	al	PROPN
admet-2740	124	89	.	.	PROPN
admet-2740	124	90	admet	admet	PROPN
admet-2740	124	91	&	&	CCONJ
admet-2740	124	92	dmpk	dmpk	PROPN
admet-2740	124	93	13(3	13(3	NUM
admet-2740	124	94	)	)	PUNCT
admet-2740	124	95	(	(	PUNCT
admet-2740	124	96	2025	2025	NUM
admet-2740	124	97	)	)	PUNCT
admet-2740	124	98	2740	2740	NUM
admet-2740	124	99	6	6	NUM
admet-2740	124	100	determination	determination	NOUN
admet-2740	124	101	of	of	ADP
admet-2740	124	102	differences	difference	NOUN
admet-2740	124	103	in	in	ADP
admet-2740	124	104	plasma	plasma	NOUN
admet-2740	124	105	metabolites	metabolite	NOUN
admet-2740	124	106	between	between	ADP
admet-2740	124	107	warfarin	warfarin	NOUN
admet-2740	124	108	interaction	interaction	NOUN
admet-2740	124	109	and	and	CCONJ
admet-2740	124	110	control	control	NOUN
admet-2740	124	111	using	use	VERB
admet-2740	124	112	1h	1h	NUM
admet-2740	124	113	-	-	PUNCT
admet-2740	124	114	nmr	nmr	NOUN
admet-2740	124	115	the	the	DET
admet-2740	124	116	500	500	NUM
admet-2740	124	117	mhz	mhz	ADJ
admet-2740	124	118	¹h	¹h	NOUN
admet-2740	124	119	-	-	PUNCT
admet-2740	124	120	nmr	nmr	NOUN
admet-2740	124	121	spectrum	spectrum	NOUN
admet-2740	124	122	of	of	ADP
admet-2740	124	123	the	the	DET
admet-2740	124	124	plasma	plasma	NOUN
admet-2740	124	125	sample	sample	NOUN
admet-2740	124	126	obtained	obtain	VERB
admet-2740	124	127	from	from	ADP
admet-2740	124	128	patient	patient	ADJ
admet-2740	124	129	1	1	NUM
admet-2740	124	130	is	be	AUX
admet-2740	124	131	illustrated	illustrate	VERB
admet-2740	124	132	in	in	ADP
admet-2740	124	133	figure	figure	NOUN
admet-2740	124	134	2	2	NUM
admet-2740	124	135	.	.	PUNCT
admet-2740	125	1	the	the	DET
admet-2740	125	2	chromatogram	chromatogram	NOUN
admet-2740	125	3	overlay	overlay	NOUN
admet-2740	125	4	highlights	highlight	NOUN
admet-2740	125	5	distinctions	distinction	NOUN
admet-2740	125	6	between	between	ADP
admet-2740	125	7	the	the	DET
admet-2740	125	8	plasma	plasma	NOUN
admet-2740	125	9	samples	sample	NOUN
admet-2740	125	10	collected	collect	VERB
admet-2740	125	11	during	during	ADP
admet-2740	125	12	the	the	DET
admet-2740	125	13	warfarinmango	warfarinmango	NOUN
admet-2740	125	14	interaction	interaction	NOUN
admet-2740	125	15	and	and	CCONJ
admet-2740	125	16	those	those	PRON
admet-2740	125	17	obtained	obtain	VERB
admet-2740	125	18	after	after	ADP
admet-2740	125	19	mango	mango	NOUN
admet-2740	125	20	discontinuation	discontinuation	NOUN
admet-2740	125	21	(	(	PUNCT
admet-2740	125	22	control	control	NOUN
admet-2740	125	23	)	)	PUNCT
admet-2740	125	24	.	.	PUNCT
admet-2740	126	1	untargeted	untargete	VERB
admet-2740	126	2	metabolomics	metabolomic	NOUN
admet-2740	126	3	analysis	analysis	NOUN
admet-2740	126	4	was	be	AUX
admet-2740	126	5	used	use	VERB
admet-2740	126	6	to	to	PART
admet-2740	126	7	screen	screen	VERB
admet-2740	126	8	the	the	DET
admet-2740	126	9	metabolites	metabolite	NOUN
admet-2740	126	10	in	in	ADP
admet-2740	126	11	plasma	plasma	NOUN
admet-2740	126	12	samples	sample	NOUN
admet-2740	126	13	,	,	PUNCT
admet-2740	126	14	and	and	CCONJ
admet-2740	126	15	208	208	NUM
admet-2740	126	16	metabolites	metabolite	NOUN
admet-2740	126	17	were	be	AUX
admet-2740	126	18	detected	detect	VERB
admet-2740	126	19	in	in	ADP
admet-2740	126	20	both	both	CCONJ
admet-2740	126	21	the	the	DET
admet-2740	126	22	warfarin	warfarin	NOUN
admet-2740	126	23	interaction	interaction	NOUN
admet-2740	126	24	and	and	CCONJ
admet-2740	126	25	control	control	NOUN
admet-2740	126	26	groups	group	NOUN
admet-2740	126	27	.	.	PUNCT
admet-2740	127	1	identification	identification	NOUN
admet-2740	127	2	of	of	ADP
admet-2740	127	3	metabolites	metabolite	NOUN
admet-2740	127	4	was	be	AUX
admet-2740	127	5	achieved	achieve	VERB
admet-2740	127	6	by	by	ADP
admet-2740	127	7	referencing	reference	VERB
admet-2740	127	8	the	the	DET
admet-2740	127	9	human	human	ADJ
admet-2740	127	10	metabolome	metabolome	PROPN
admet-2740	127	11	database	database	NOUN
admet-2740	127	12	[	[	X
admet-2740	127	13	20	20	NUM
admet-2740	127	14	]	]	PUNCT
admet-2740	127	15	.	.	PUNCT
admet-2740	128	1	the	the	DET
admet-2740	128	2	sparse	sparse	ADJ
admet-2740	128	3	partial	partial	ADJ
admet-2740	128	4	least	least	ADJ
admet-2740	128	5	squares	square	NOUN
admet-2740	128	6	discriminant	discriminant	ADJ
admet-2740	128	7	analysis	analysis	NOUN
admet-2740	128	8	(	(	PUNCT
admet-2740	128	9	spls	spls	NOUN
admet-2740	128	10	-	-	PUNCT
admet-2740	128	11	da	da	NOUN
admet-2740	128	12	)	)	PUNCT
admet-2740	128	13	scores	score	NOUN
admet-2740	128	14	plot	plot	NOUN
admet-2740	128	15	(	(	PUNCT
admet-2740	128	16	figure	figure	NOUN
admet-2740	128	17	s1a	s1a	NOUN
admet-2740	128	18	)	)	PUNCT
admet-2740	128	19	demonstrates	demonstrate	VERB
admet-2740	128	20	a	a	DET
admet-2740	128	21	notable	notable	ADJ
admet-2740	128	22	separation	separation	NOUN
admet-2740	128	23	between	between	ADP
admet-2740	128	24	the	the	DET
admet-2740	128	25	two	two	NUM
admet-2740	128	26	groups	group	NOUN
admet-2740	128	27	:	:	PUNCT
admet-2740	128	28	warfarin	warfarin	NOUN
admet-2740	128	29	interaction	interaction	NOUN
admet-2740	128	30	(	(	PUNCT
admet-2740	128	31	group	group	NOUN
admet-2740	128	32	1	1	NUM
admet-2740	128	33	,	,	PUNCT
admet-2740	128	34	shown	show	VERB
admet-2740	128	35	in	in	ADP
admet-2740	128	36	red	red	ADJ
admet-2740	128	37	)	)	PUNCT
admet-2740	128	38	and	and	CCONJ
admet-2740	128	39	control	control	NOUN
admet-2740	128	40	(	(	PUNCT
admet-2740	128	41	group	group	NOUN
admet-2740	128	42	2	2	NUM
admet-2740	128	43	,	,	PUNCT
admet-2740	128	44	shown	show	VERB
admet-2740	128	45	in	in	ADP
admet-2740	128	46	green	green	NOUN
admet-2740	128	47	)	)	PUNCT
admet-2740	128	48	,	,	PUNCT
admet-2740	128	49	indicating	indicate	VERB
admet-2740	128	50	a	a	DET
admet-2740	128	51	distinct	distinct	ADJ
admet-2740	128	52	difference	difference	NOUN
admet-2740	128	53	in	in	ADP
admet-2740	128	54	their	their	PRON
admet-2740	128	55	metabolic	metabolic	NOUN
admet-2740	128	56	profiles	profile	NOUN
admet-2740	128	57	.	.	PUNCT
admet-2740	129	1	the	the	DET
admet-2740	129	2	loadings	loading	NOUN
admet-2740	129	3	plot	plot	NOUN
admet-2740	129	4	(	(	PUNCT
admet-2740	129	5	supplementary	supplementary	ADJ
admet-2740	129	6	material	material	NOUN
admet-2740	129	7	,	,	PUNCT
admet-2740	129	8	fig	fig	NOUN
admet-2740	129	9	.	.	PUNCT
admet-2740	129	10	s1b	s1b	NOUN
admet-2740	129	11	)	)	PUNCT
admet-2740	129	12	illustrates	illustrate	VERB
admet-2740	129	13	the	the	DET
admet-2740	129	14	metabolites	metabolite	NOUN
admet-2740	129	15	selected	select	VERB
admet-2740	129	16	by	by	ADP
admet-2740	129	17	the	the	DET
admet-2740	129	18	spls	spls	PROPN
admet-2740	129	19	-	-	PUNCT
admet-2740	129	20	da	da	PROPN
admet-2740	129	21	model	model	NOUN
admet-2740	129	22	for	for	ADP
admet-2740	129	23	each	each	DET
admet-2740	129	24	component	component	NOUN
admet-2740	129	25	,	,	PUNCT
admet-2740	129	26	ranked	rank	VERB
admet-2740	129	27	by	by	ADP
admet-2740	129	28	the	the	DET
admet-2740	129	29	absolute	absolute	ADJ
admet-2740	129	30	magnitude	magnitude	NOUN
admet-2740	129	31	of	of	ADP
admet-2740	129	32	their	their	PRON
admet-2740	129	33	loadings	loading	NOUN
admet-2740	129	34	.	.	PUNCT
admet-2740	130	1	the	the	DET
admet-2740	130	2	top	top	ADJ
admet-2740	130	3	10	10	NUM
admet-2740	130	4	metabolites	metabolite	NOUN
admet-2740	130	5	are	be	AUX
admet-2740	130	6	cyclic	cyclic	ADJ
admet-2740	130	7	amp	amp	NOUN
admet-2740	130	8	,	,	PUNCT
admet-2740	130	9	n	n	CCONJ
admet-2740	130	10	-	-	PUNCT
admet-2740	130	11	acetylaspartylglutamic	acetylaspartylglutamic	ADJ
admet-2740	130	12	acid	acid	NOUN
admet-2740	130	13	,	,	PUNCT
admet-2740	130	14	erythritol	erythritol	NOUN
admet-2740	130	15	,	,	PUNCT
admet-2740	130	16	n	n	CCONJ
admet-2740	130	17	-	-	PUNCT
admet-2740	130	18	methylhydantoin	methylhydantoin	NOUN
admet-2740	130	19	,	,	PUNCT
admet-2740	130	20	n	n	CCONJ
admet-2740	130	21	-	-	PUNCT
admet-2740	130	22	acetyltaurine	acetyltaurine	ADJ
admet-2740	130	23	,	,	PUNCT
admet-2740	130	24	4	4	NUM
admet-2740	130	25	-	-	PUNCT
admet-2740	130	26	guanidinobutanoate	guanidinobutanoate	NOUN
admet-2740	130	27	,	,	PUNCT
admet-2740	130	28	glycerol	glycerol	NOUN
admet-2740	130	29	3	3	NUM
admet-2740	130	30	-	-	NOUN
admet-2740	130	31	phosphate	phosphate	ADJ
admet-2740	130	32	,	,	PUNCT
admet-2740	130	33	dopamine	dopamine	NOUN
admet-2740	130	34	,	,	PUNCT
admet-2740	130	35	l-3	l-3	PROPN
admet-2740	130	36	-	-	PUNCT
admet-2740	130	37	hydroxykynurenine	hydroxykynurenine	PROPN
admet-2740	130	38	,	,	PUNCT
admet-2740	130	39	and	and	CCONJ
admet-2740	130	40	n'-formylkynurenine	n'-formylkynurenine	PROPN
admet-2740	130	41	.	.	PUNCT
admet-2740	131	1	multivariate	multivariate	VERB
admet-2740	131	2	exploratory	exploratory	ADJ
admet-2740	131	3	receiver	receiver	NOUN
admet-2740	131	4	operating	operate	VERB
admet-2740	131	5	characteristic	characteristic	NOUN
admet-2740	131	6	(	(	PUNCT
admet-2740	131	7	roc	roc	PROPN
admet-2740	131	8	)	)	PUNCT
admet-2740	131	9	analysis	analysis	NOUN
admet-2740	131	10	,	,	PUNCT
admet-2740	131	11	which	which	PRON
admet-2740	131	12	is	be	AUX
admet-2740	131	13	based	base	VERB
admet-2740	131	14	on	on	ADP
admet-2740	131	15	cross	cross	ADJ
admet-2740	131	16	-	-	ADJ
admet-2740	131	17	validation	validation	ADJ
admet-2740	131	18	(	(	PUNCT
admet-2740	131	19	cv	cv	NOUN
admet-2740	131	20	)	)	PUNCT
admet-2740	131	21	performance	performance	NOUN
admet-2740	131	22	averaged	average	VERB
admet-2740	131	23	across	across	ADP
admet-2740	131	24	all	all	DET
admet-2740	131	25	models	model	NOUN
admet-2740	131	26	and	and	CCONJ
admet-2740	131	27	cv	cv	PROPN
admet-2740	131	28	runs	run	NOUN
admet-2740	131	29	(	(	PUNCT
admet-2740	131	30	figure	figure	NOUN
admet-2740	131	31	s1c	s1c	NOUN
admet-2740	131	32	,	,	PUNCT
admet-2740	131	33	d	d	NOUN
admet-2740	131	34	)	)	PUNCT
admet-2740	131	35	,	,	PUNCT
admet-2740	131	36	assesses	assess	VERB
admet-2740	131	37	the	the	DET
admet-2740	131	38	diagnostic	diagnostic	ADJ
admet-2740	131	39	accuracy	accuracy	NOUN
admet-2740	131	40	of	of	ADP
admet-2740	131	41	the	the	DET
admet-2740	131	42	model	model	NOUN
admet-2740	131	43	.	.	PUNCT
admet-2740	132	1	the	the	DET
admet-2740	132	2	area	area	NOUN
admet-2740	132	3	under	under	ADP
admet-2740	132	4	the	the	DET
admet-2740	132	5	curve	curve	NOUN
admet-2740	132	6	(	(	PUNCT
admet-2740	132	7	auc	auc	NOUN
admet-2740	132	8	)	)	PUNCT
admet-2740	132	9	of	of	ADP
admet-2740	132	10	0.904	0.904	NUM
admet-2740	132	11	indicates	indicate	VERB
admet-2740	132	12	a	a	DET
admet-2740	132	13	strong	strong	ADJ
admet-2740	132	14	ability	ability	NOUN
admet-2740	132	15	to	to	PART
admet-2740	132	16	differentiate	differentiate	VERB
admet-2740	132	17	between	between	ADP
admet-2740	132	18	the	the	DET
admet-2740	132	19	two	two	NUM
admet-2740	132	20	groups	group	NOUN
admet-2740	132	21	(	(	PUNCT
admet-2740	132	22	95	95	NUM
admet-2740	132	23	%	%	NOUN
admet-2740	132	24	confidence	confidence	NOUN
admet-2740	132	25	interval	interval	NOUN
admet-2740	132	26	[	[	X
admet-2740	132	27	ci	ci	X
admet-2740	132	28	]	]	X
admet-2740	132	29	:	:	PUNCT
admet-2740	132	30	0.729	0.729	NUM
admet-2740	132	31	to	to	ADP
admet-2740	132	32	1.000	1.000	NUM
admet-2740	132	33	)	)	PUNCT
admet-2740	132	34	.	.	PUNCT
admet-2740	133	1			NUM
admet-2740	133	2	/	/	SYM
admet-2740	133	3	ppm	ppm	ADJ
admet-2740	133	4	figure	figure	NOUN
admet-2740	133	5	2	2	NUM
admet-2740	133	6	.	.	NOUN
admet-2740	133	7	results	result	NOUN
admet-2740	133	8	of	of	ADP
admet-2740	133	9	nmr	nmr	NOUN
admet-2740	133	10	-	-	PUNCT
admet-2740	133	11	based	base	VERB
admet-2740	133	12	metabolomics	metabolomic	NOUN
admet-2740	133	13	analysis	analysis	NOUN
admet-2740	133	14	.	.	PUNCT
admet-2740	134	1	the	the	DET
admet-2740	134	2	500	500	NUM
admet-2740	134	3	mhz	mhz	NOUN
admet-2740	134	4	1h	1h	NUM
admet-2740	134	5	-	-	PUNCT
admet-2740	134	6	nmr	nmr	NOUN
admet-2740	134	7	spectra	spectra	NOUN
admet-2740	134	8	of	of	ADP
admet-2740	134	9	plasma	plasma	NOUN
admet-2740	134	10	obtained	obtain	VERB
admet-2740	134	11	from	from	ADP
admet-2740	134	12	patient	patient	ADJ
admet-2740	134	13	1	1	NUM
admet-2740	134	14	are	be	AUX
admet-2740	134	15	presented	present	VERB
admet-2740	134	16	.	.	PUNCT
admet-2740	135	1	the	the	DET
admet-2740	135	2	spectral	spectral	ADJ
admet-2740	135	3	overlay	overlay	NOUN
admet-2740	135	4	reveals	reveal	VERB
admet-2740	135	5	distinct	distinct	ADJ
admet-2740	135	6	differences	difference	NOUN
admet-2740	135	7	between	between	ADP
admet-2740	135	8	samples	sample	NOUN
admet-2740	135	9	collected	collect	VERB
admet-2740	135	10	during	during	ADP
admet-2740	135	11	the	the	DET
admet-2740	135	12	warfarin	warfarin	NOUN
admet-2740	135	13	-	-	PUNCT
admet-2740	135	14	mango	mango	NOUN
admet-2740	135	15	interaction	interaction	NOUN
admet-2740	135	16	,	,	PUNCT
admet-2740	135	17	when	when	SCONJ
admet-2740	135	18	the	the	DET
admet-2740	135	19	inr	inr	PROPN
admet-2740	135	20	was	be	AUX
admet-2740	135	21	supratherapeutic	supratherapeutic	ADJ
admet-2740	135	22	(	(	PUNCT
admet-2740	135	23	depicted	depict	VERB
admet-2740	135	24	in	in	ADP
admet-2740	135	25	red	red	PROPN
admet-2740	135	26	)	)	PUNCT
admet-2740	135	27	,	,	PUNCT
admet-2740	135	28	and	and	CCONJ
admet-2740	135	29	those	those	PRON
admet-2740	135	30	obtained	obtain	VERB
admet-2740	135	31	after	after	ADP
admet-2740	135	32	discontinuing	discontinue	VERB
admet-2740	135	33	mango	mango	PROPN
admet-2740	135	34	consumption	consumption	NOUN
admet-2740	135	35	,	,	PUNCT
admet-2740	135	36	when	when	SCONJ
admet-2740	135	37	the	the	DET
admet-2740	135	38	inr	inr	PROPN
admet-2740	135	39	stabilized	stabilize	VERB
admet-2740	135	40	within	within	ADP
admet-2740	135	41	the	the	DET
admet-2740	135	42	therapeutic	therapeutic	ADJ
admet-2740	135	43	range	range	NOUN
admet-2740	135	44	(	(	PUNCT
admet-2740	135	45	depicted	depict	VERB
admet-2740	135	46	in	in	ADP
admet-2740	135	47	blue	blue	ADJ
admet-2740	135	48	)	)	PUNCT
admet-2740	135	49	.	.	PUNCT
admet-2740	136	1	a	a	DET
admet-2740	136	2	marked	mark	VERB
admet-2740	136	3	reduction	reduction	NOUN
admet-2740	136	4	in	in	ADP
admet-2740	136	5	glycerol	glycerol	NOUN
admet-2740	136	6	3	3	NUM
admet-2740	136	7	-	-	PUNCT
admet-2740	136	8	phosphate	phosphate	NOUN
admet-2740	136	9	concentration	concentration	NOUN
admet-2740	136	10	(	(	PUNCT
admet-2740	136	11	at	at	ADP
admet-2740	136	12	3.62	3.62	NUM
admet-2740	136	13	ppm	ppm	NOUN
admet-2740	136	14	)	)	PUNCT
admet-2740	136	15	during	during	ADP
admet-2740	136	16	the	the	DET
admet-2740	136	17	warfarin	warfarin	NOUN
admet-2740	136	18	-	-	PUNCT
admet-2740	136	19	mango	mango	NOUN
admet-2740	136	20	interaction	interaction	NOUN
admet-2740	136	21	is	be	AUX
admet-2740	136	22	observed	observe	VERB
admet-2740	136	23	,	,	PUNCT
admet-2740	136	24	as	as	SCONJ
admet-2740	136	25	highlighted	highlight	VERB
admet-2740	136	26	by	by	ADP
admet-2740	136	27	the	the	DET
admet-2740	136	28	arrow	arrow	NOUN
admet-2740	136	29	analysis	analysis	NOUN
admet-2740	136	30	of	of	ADP
admet-2740	136	31	related	related	ADJ
admet-2740	136	32	pathways	pathway	NOUN
admet-2740	136	33	pathway	pathway	NOUN
admet-2740	136	34	enrichment	enrichment	NOUN
admet-2740	136	35	analysis	analysis	NOUN
admet-2740	136	36	was	be	AUX
admet-2740	136	37	conducted	conduct	VERB
admet-2740	136	38	using	use	VERB
admet-2740	136	39	metaboanalyst	metaboanalyst	NOUN
admet-2740	136	40	version	version	NOUN
admet-2740	136	41	6.0	6.0	NUM
admet-2740	136	42	to	to	PART
admet-2740	136	43	map	map	VERB
admet-2740	136	44	metabolites	metabolite	NOUN
admet-2740	136	45	to	to	ADP
admet-2740	136	46	specific	specific	ADJ
admet-2740	136	47	pathways	pathway	NOUN
admet-2740	136	48	based	base	VERB
admet-2740	136	49	on	on	ADP
admet-2740	136	50	chemical	chemical	NOUN
admet-2740	136	51	structures	structure	NOUN
admet-2740	136	52	and	and	CCONJ
admet-2740	136	53	the	the	DET
admet-2740	136	54	small	small	ADJ
admet-2740	136	55	molecule	molecule	NOUN
admet-2740	136	56	pathway	pathway	NOUN
admet-2740	136	57	database	database	NOUN
admet-2740	136	58	(	(	PUNCT
admet-2740	136	59	smpdb	smpdb	NOUN
admet-2740	136	60	)	)	PUNCT
admet-2740	136	61	.	.	PUNCT
admet-2740	137	1	this	this	DET
admet-2740	137	2	analysis	analysis	NOUN
admet-2740	137	3	utilized	utilize	VERB
admet-2740	137	4	1,250	1,250	NUM
admet-2740	137	5	sub	sub	ADJ
admet-2740	137	6	-	-	ADJ
admet-2740	137	7	class	class	ADJ
admet-2740	137	8	metabolite	metabolite	NOUN
admet-2740	137	9	sets	set	NOUN
admet-2740	137	10	,	,	PUNCT
admet-2740	137	11	including	include	VERB
admet-2740	137	12	lipid	lipid	NOUN
admet-2740	137	13	-	-	PUNCT
admet-2740	137	14	specific	specific	ADJ
admet-2740	137	15	sets	set	NOUN
admet-2740	137	16	,	,	PUNCT
admet-2740	137	17	and	and	CCONJ
admet-2740	137	18	99	99	NUM
admet-2740	137	19	metabolite	metabolite	NOUN
admet-2740	137	20	sets	set	NOUN
admet-2740	137	21	aligned	align	VERB
admet-2740	137	22	with	with	ADP
admet-2740	137	23	normal	normal	ADJ
admet-2740	137	24	human	human	ADJ
admet-2740	137	25	metabolic	metabolic	NOUN
admet-2740	137	26	pathways	pathway	NOUN
admet-2740	137	27	.	.	PUNCT
admet-2740	138	1	the	the	DET
admet-2740	138	2	top	top	ADJ
admet-2740	138	3	25	25	NUM
admet-2740	138	4	enriched	enrich	VERB
admet-2740	138	5	metabolite	metabolite	NOUN
admet-2740	138	6	sets	set	NOUN
admet-2740	138	7	,	,	PUNCT
admet-2740	138	8	shown	show	VERB
admet-2740	138	9	in	in	ADP
admet-2740	138	10	figure	figure	NOUN
admet-2740	138	11	3a	3a	NUM
admet-2740	138	12	and	and	CCONJ
admet-2740	138	13	3b	3b	NUM
admet-2740	138	14	,	,	PUNCT
admet-2740	138	15	were	be	AUX
admet-2740	138	16	ranked	rank	VERB
admet-2740	138	17	by	by	ADP
admet-2740	138	18	their	their	PRON
admet-2740	138	19	enrichment	enrichment	NOUN
admet-2740	138	20	ratio	ratio	NOUN
admet-2740	138	21	based	base	VERB
admet-2740	138	22	on	on	ADP
admet-2740	138	23	chemical	chemical	ADJ
admet-2740	138	24	structure	structure	NOUN
admet-2740	138	25	and	and	CCONJ
admet-2740	138	26	smpdb	smpdb	NOUN
admet-2740	138	27	,	,	PUNCT
admet-2740	138	28	respectively	respectively	ADV
admet-2740	138	29	.	.	PUNCT
admet-2740	139	1	metabolic	metabolic	NOUN
admet-2740	139	2	disruptions	disruption	NOUN
admet-2740	139	3	were	be	AUX
admet-2740	139	4	identified	identify	VERB
admet-2740	139	5	between	between	ADP
admet-2740	139	6	the	the	DET
admet-2740	139	7	warfarin	warfarin	NOUN
admet-2740	139	8	-	-	PUNCT
admet-2740	139	9	mango	mango	NOUN
admet-2740	139	10	interaction	interaction	NOUN
admet-2740	139	11	group	group	NOUN
admet-2740	139	12	and	and	CCONJ
admet-2740	139	13	the	the	DET
admet-2740	139	14	control	control	NOUN
admet-2740	139	15	group	group	NOUN
admet-2740	139	16	.	.	PUNCT
admet-2740	140	1	the	the	DET
admet-2740	140	2	pathways	pathway	NOUN
admet-2740	140	3	primarily	primarily	ADV
admet-2740	140	4	affected	affect	VERB
admet-2740	140	5	amino	amino	NOUN
admet-2740	140	6	acid	acid	NOUN
admet-2740	140	7	metabolism	metabolism	NOUN
admet-2740	140	8	,	,	PUNCT
admet-2740	140	9	lipid	lipid	ADJ
admet-2740	140	10	metabolism	metabolism	NOUN
admet-2740	140	11	,	,	PUNCT
admet-2740	140	12	mitochondrial	mitochondrial	ADJ
admet-2740	140	13	function	function	NOUN
admet-2740	140	14	,	,	PUNCT
admet-2740	140	15	and	and	CCONJ
admet-2740	140	16	cellular	cellular	ADJ
admet-2740	140	17			NUM
admet-2740	140	18	/	/	SYM
admet-2740	140	19	ppm	ppm	NOUN
admet-2740	140	20	admet	admet	PROPN
admet-2740	140	21	&	&	CCONJ
admet-2740	140	22	dmpk	dmpk	PROPN
admet-2740	140	23	13(3	13(3	NUM
admet-2740	140	24	)	)	PUNCT
admet-2740	140	25	(	(	PUNCT
admet-2740	140	26	2025	2025	NUM
admet-2740	140	27	)	)	PUNCT
admet-2740	140	28	2740	2740	NUM
admet-2740	140	29	metabolic	metabolic	NOUN
admet-2740	140	30	insights	insight	NOUN
admet-2740	140	31	into	into	ADP
admet-2740	140	32	the	the	DET
admet-2740	140	33	warfarin	warfarin	NOUN
admet-2740	140	34	-	-	PUNCT
admet-2740	140	35	mango	mango	NOUN
admet-2740	140	36	interaction	interaction	NOUN
admet-2740	140	37	doi	doi	NOUN
admet-2740	140	38	:	:	PUNCT
admet-2740	140	39	https://doi.org/10.5599/admet.2740	https://doi.org/10.5599/admet.2740	NOUN
admet-2740	140	40	7	7	NUM
admet-2740	140	41	energy	energy	NOUN
admet-2740	140	42	production	production	NOUN
admet-2740	140	43	.	.	PUNCT
admet-2740	141	1	key	key	ADJ
admet-2740	141	2	pathways	pathway	NOUN
admet-2740	141	3	altered	alter	VERB
admet-2740	141	4	include	include	VERB
admet-2740	141	5	histidine	histidine	ADJ
admet-2740	141	6	metabolism	metabolism	NOUN
admet-2740	141	7	,	,	PUNCT
admet-2740	141	8	beta	beta	NOUN
admet-2740	141	9	-	-	PUNCT
admet-2740	141	10	alanine	alanine	NOUN
admet-2740	141	11	metabolism	metabolism	NOUN
admet-2740	141	12	,	,	PUNCT
admet-2740	141	13	ubiquinone	ubiquinone	PROPN
admet-2740	141	14	biosynthesis	biosynthesis	NOUN
admet-2740	141	15	,	,	PUNCT
admet-2740	141	16	plasmalogen	plasmalogen	NOUN
admet-2740	141	17	synthesis	synthesis	NOUN
admet-2740	141	18	,	,	PUNCT
admet-2740	141	19	estrone	estrone	NOUN
admet-2740	141	20	metabolism	metabolism	NOUN
admet-2740	141	21	,	,	PUNCT
admet-2740	141	22	the	the	DET
admet-2740	141	23	glycerol	glycerol	NOUN
admet-2740	141	24	phosphate	phosphate	NOUN
admet-2740	141	25	shuttle	shuttle	NOUN
admet-2740	141	26	,	,	PUNCT
admet-2740	141	27	de	de	X
admet-2740	141	28	novo	novo	NOUN
admet-2740	141	29	triglyceride	triglyceride	ADV
admet-2740	141	30	biosynthesis	biosynthesis	NOUN
admet-2740	141	31	,	,	PUNCT
admet-2740	141	32	cardiolipin	cardiolipin	NOUN
admet-2740	141	33	biosynthesis	biosynthesis	NOUN
admet-2740	141	34	,	,	PUNCT
admet-2740	141	35	fatty	fatty	NOUN
admet-2740	141	36	acid	acid	ADJ
admet-2740	141	37	elongation	elongation	NOUN
admet-2740	141	38	in	in	ADP
admet-2740	141	39	mitochondria	mitochondria	NOUN
admet-2740	141	40	,	,	PUNCT
admet-2740	141	41	and	and	CCONJ
admet-2740	141	42	steroidogenesis	steroidogenesis	NOUN
admet-2740	141	43	.	.	PUNCT
admet-2740	142	1	these	these	DET
admet-2740	142	2	disruptions	disruption	NOUN
admet-2740	142	3	suggest	suggest	VERB
admet-2740	142	4	that	that	SCONJ
admet-2740	142	5	the	the	DET
admet-2740	142	6	warfarin	warfarin	NOUN
admet-2740	142	7	-	-	PUNCT
admet-2740	142	8	mango	mango	NOUN
admet-2740	142	9	interaction	interaction	NOUN
admet-2740	142	10	may	may	AUX
admet-2740	142	11	notably	notably	ADV
admet-2740	142	12	impair	impair	VERB
admet-2740	142	13	mitochondrial	mitochondrial	ADJ
admet-2740	142	14	function	function	NOUN
admet-2740	142	15	and	and	CCONJ
admet-2740	142	16	lipid	lipid	NOUN
admet-2740	142	17	metabolism	metabolism	NOUN
admet-2740	142	18	,	,	PUNCT
admet-2740	142	19	which	which	PRON
admet-2740	142	20	may	may	AUX
admet-2740	142	21	,	,	PUNCT
admet-2740	142	22	in	in	ADP
admet-2740	142	23	turn	turn	NOUN
admet-2740	142	24	,	,	PUNCT
admet-2740	142	25	influence	influence	NOUN
admet-2740	142	26	cellular	cellular	ADJ
admet-2740	142	27	energy	energy	NOUN
admet-2740	142	28	production	production	NOUN
admet-2740	142	29	.	.	PUNCT
admet-2740	143	1	such	such	ADJ
admet-2740	143	2	metabolic	metabolic	NOUN
admet-2740	143	3	alterations	alteration	NOUN
admet-2740	143	4	could	could	AUX
admet-2740	143	5	explain	explain	VERB
admet-2740	143	6	the	the	DET
admet-2740	143	7	observed	observed	ADJ
admet-2740	143	8	increase	increase	NOUN
admet-2740	143	9	in	in	ADP
admet-2740	143	10	inr	inr	PROPN
admet-2740	143	11	levels	level	NOUN
admet-2740	143	12	,	,	PUNCT
admet-2740	143	13	indicating	indicate	VERB
admet-2740	143	14	potential	potential	ADJ
admet-2740	143	15	complications	complication	NOUN
admet-2740	143	16	in	in	ADP
admet-2740	143	17	the	the	DET
admet-2740	143	18	blood	blood	NOUN
admet-2740	143	19	clotting	clot	VERB
admet-2740	143	20	cascade	cascade	NOUN
admet-2740	143	21	associated	associate	VERB
admet-2740	143	22	with	with	ADP
admet-2740	143	23	this	this	DET
admet-2740	143	24	interaction	interaction	NOUN
admet-2740	143	25	.	.	PUNCT
admet-2740	144	1	figure	figure	NOUN
admet-2740	144	2	3	3	NUM
admet-2740	144	3	.	.	PUNCT
admet-2740	144	4	pathway	pathway	NOUN
admet-2740	144	5	enrichment	enrichment	NOUN
admet-2740	144	6	analysis	analysis	NOUN
admet-2740	144	7	mapping	mapping	NOUN
admet-2740	144	8	metabolites	metabolite	NOUN
admet-2740	144	9	to	to	ADP
admet-2740	144	10	specific	specific	ADJ
admet-2740	144	11	metabolic	metabolic	NOUN
admet-2740	144	12	pathways	pathway	NOUN
admet-2740	144	13	using	use	VERB
admet-2740	144	14	(	(	PUNCT
admet-2740	144	15	a	a	PRON
admet-2740	144	16	)	)	PUNCT
admet-2740	144	17	chemical	chemical	NOUN
admet-2740	144	18	structures	structure	NOUN
admet-2740	144	19	and	and	CCONJ
admet-2740	144	20	(	(	PUNCT
admet-2740	144	21	b	b	X
admet-2740	144	22	)	)	PUNCT
admet-2740	144	23	the	the	DET
admet-2740	144	24	small	small	ADJ
admet-2740	144	25	molecule	molecule	NOUN
admet-2740	144	26	pathway	pathway	NOUN
admet-2740	144	27	database	database	NOUN
admet-2740	144	28	.	.	PUNCT
admet-2740	145	1	the	the	DET
admet-2740	145	2	top	top	ADJ
admet-2740	145	3	25	25	NUM
admet-2740	145	4	enriched	enrich	VERB
admet-2740	145	5	metabolite	metabolite	NOUN
admet-2740	145	6	sets	set	NOUN
admet-2740	145	7	are	be	AUX
admet-2740	145	8	ranked	rank	VERB
admet-2740	145	9	in	in	ADP
admet-2740	145	10	accordance	accordance	NOUN
admet-2740	145	11	with	with	ADP
admet-2740	145	12	their	their	PRON
admet-2740	145	13	enrichment	enrichment	NOUN
admet-2740	145	14	ratio	ratio	NOUN
admet-2740	145	15	,	,	PUNCT
admet-2740	145	16	based	base	VERB
admet-2740	145	17	on	on	ADP
admet-2740	145	18	chemical	chemical	NOUN
admet-2740	145	19	structures	structure	NOUN
admet-2740	145	20	and	and	CCONJ
admet-2740	145	21	smpdb	smpdb	NOUN
admet-2740	145	22	,	,	PUNCT
admet-2740	145	23	respectively	respectively	ADV
admet-2740	145	24	metascape	metascape	NOUN
admet-2740	145	25	was	be	AUX
admet-2740	145	26	employed	employ	VERB
admet-2740	145	27	to	to	PART
admet-2740	145	28	investigate	investigate	VERB
admet-2740	145	29	pathway	pathway	NOUN
admet-2740	145	30	enrichment	enrichment	NOUN
admet-2740	145	31	and	and	CCONJ
admet-2740	145	32	clustering	cluster	VERB
admet-2740	145	33	analysis	analysis	NOUN
admet-2740	145	34	to	to	PART
admet-2740	145	35	construct	construct	VERB
admet-2740	145	36	the	the	DET
admet-2740	145	37	metabolite	metabolite	NOUN
admet-2740	145	38	-	-	PUNCT
admet-2740	145	39	metabolite	metabolite	NOUN
admet-2740	145	40	network	network	NOUN
admet-2740	145	41	.	.	PUNCT
admet-2740	146	1	the	the	DET
admet-2740	146	2	top	top	ADJ
admet-2740	146	3	20	20	NUM
admet-2740	146	4	enrichment	enrichment	NOUN
admet-2740	146	5	clusters	cluster	NOUN
admet-2740	146	6	,	,	PUNCT
admet-2740	146	7	shown	show	VERB
admet-2740	146	8	in	in	ADP
admet-2740	146	9	figure	figure	NOUN
admet-2740	146	10	4	4	NUM
admet-2740	146	11	,	,	PUNCT
admet-2740	146	12	were	be	AUX
admet-2740	146	13	ranked	rank	VERB
admet-2740	146	14	based	base	VERB
admet-2740	146	15	on	on	ADP
admet-2740	146	16	their	their	PRON
admet-2740	146	17	-log10	-log10	X
admet-2740	146	18	p	p	NOUN
admet-2740	146	19	values	value	NOUN
admet-2740	146	20	.	.	PUNCT
admet-2740	147	1	-log10	-log10	PUNCT
admet-2740	148	1	p	p	PRON
admet-2740	148	2	figure	figure	NOUN
admet-2740	148	3	4	4	NUM
admet-2740	148	4	.	.	PUNCT
admet-2740	148	5	pathway	pathway	NOUN
admet-2740	148	6	enrichment	enrichment	NOUN
admet-2740	148	7	analysis	analysis	NOUN
admet-2740	148	8	bar	bar	NOUN
admet-2740	148	9	chart	chart	NOUN
admet-2740	148	10	illustrating	illustrate	VERB
admet-2740	148	11	the	the	DET
admet-2740	148	12	top	top	ADJ
admet-2740	148	13	20	20	NUM
admet-2740	148	14	enrichment	enrichment	NOUN
admet-2740	148	15	clusters	cluster	NOUN
admet-2740	148	16	,	,	PUNCT
admet-2740	148	17	ranked	rank	VERB
admet-2740	148	18	by	by	ADP
admet-2740	148	19	their	their	PRON
admet-2740	148	20	-log10	-log10	PUNCT
admet-2740	148	21	(	(	PUNCT
admet-2740	148	22	p	p	NOUN
admet-2740	148	23	)	)	PUNCT
admet-2740	148	24	values	value	NOUN
admet-2740	148	25	,	,	PUNCT
admet-2740	148	26	highlighting	highlight	VERB
admet-2740	148	27	metabolic	metabolic	NOUN
admet-2740	148	28	disruptions	disruption	NOUN
admet-2740	148	29	during	during	ADP
admet-2740	148	30	warfarin	warfarin	NOUN
admet-2740	148	31	-	-	PUNCT
admet-2740	148	32	mango	mango	NOUN
admet-2740	148	33	interactions	interaction	NOUN
admet-2740	148	34	https://doi.org/10.5599/admet.2740	https://doi.org/10.5599/admet.2740	NOUN
admet-2740	148	35	p.	p.	NOUN
admet-2740	148	36	rattanasuwan	rattanasuwan	PROPN
admet-2740	148	37	et	et	PROPN
admet-2740	148	38	al	al	PROPN
admet-2740	148	39	.	.	PROPN
admet-2740	148	40	admet	admet	PROPN
admet-2740	148	41	&	&	CCONJ
admet-2740	148	42	dmpk	dmpk	PROPN
admet-2740	148	43	13(3	13(3	NUM
admet-2740	148	44	)	)	PUNCT
admet-2740	148	45	(	(	PUNCT
admet-2740	148	46	2025	2025	NUM
admet-2740	148	47	)	)	PUNCT
admet-2740	148	48	2740	2740	NUM
admet-2740	148	49	8	8	NUM
admet-2740	148	50	metabolic	metabolic	NOUN
admet-2740	148	51	disruptions	disruption	NOUN
admet-2740	148	52	were	be	AUX
admet-2740	148	53	observed	observe	VERB
admet-2740	148	54	in	in	ADP
admet-2740	148	55	warfarin	warfarin	NOUN
admet-2740	148	56	-	-	PUNCT
admet-2740	148	57	mango	mango	NOUN
admet-2740	148	58	interactions	interaction	NOUN
admet-2740	148	59	.	.	PUNCT
admet-2740	149	1	the	the	DET
admet-2740	149	2	altered	altered	ADJ
admet-2740	149	3	pathways	pathway	NOUN
admet-2740	149	4	identified	identify	VERB
admet-2740	149	5	in	in	ADP
admet-2740	149	6	the	the	DET
admet-2740	149	7	enrichment	enrichment	NOUN
admet-2740	149	8	analysis	analysis	NOUN
admet-2740	149	9	bar	bar	NOUN
admet-2740	149	10	chart	chart	NOUN
admet-2740	149	11	included	include	VERB
admet-2740	149	12	fatty	fatty	NOUN
admet-2740	149	13	acid	acid	NOUN
admet-2740	149	14	oxidation	oxidation	NOUN
admet-2740	149	15	,	,	PUNCT
admet-2740	149	16	response	response	NOUN
admet-2740	149	17	to	to	ADP
admet-2740	149	18	xenobiotic	xenobiotic	ADJ
admet-2740	149	19	stimulus	stimulus	NOUN
admet-2740	149	20	,	,	PUNCT
admet-2740	149	21	response	response	NOUN
admet-2740	149	22	to	to	ADP
admet-2740	149	23	alcohol	alcohol	NOUN
admet-2740	149	24	,	,	PUNCT
admet-2740	149	25	acetyl	acetyl	NOUN
admet-2740	149	26	-	-	PUNCT
admet-2740	149	27	coa	coa	NOUN
admet-2740	149	28	metabolic	metabolic	NOUN
admet-2740	149	29	process	process	NOUN
admet-2740	149	30	,	,	PUNCT
admet-2740	149	31	transport	transport	NOUN
admet-2740	149	32	of	of	ADP
admet-2740	149	33	small	small	ADJ
admet-2740	149	34	molecules	molecule	NOUN
admet-2740	149	35	,	,	PUNCT
admet-2740	149	36	regulation	regulation	NOUN
admet-2740	149	37	of	of	ADP
admet-2740	149	38	small	small	ADJ
admet-2740	149	39	molecule	molecule	NOUN
admet-2740	149	40	metabolic	metabolic	NOUN
admet-2740	149	41	processes	process	NOUN
admet-2740	149	42	,	,	PUNCT
admet-2740	149	43	biological	biological	ADJ
admet-2740	149	44	oxidations	oxidation	NOUN
admet-2740	149	45	,	,	PUNCT
admet-2740	149	46	platelet	platelet	NOUN
admet-2740	149	47	activation	activation	NOUN
admet-2740	149	48	,	,	PUNCT
admet-2740	149	49	signalling	signalling	NOUN
admet-2740	149	50	and	and	CCONJ
admet-2740	149	51	aggregation	aggregation	NOUN
admet-2740	149	52	,	,	PUNCT
admet-2740	149	53	response	response	NOUN
admet-2740	149	54	to	to	ADP
admet-2740	149	55	iron	iron	NOUN
admet-2740	149	56	ion	ion	NOUN
admet-2740	149	57	,	,	PUNCT
admet-2740	149	58	and	and	CCONJ
admet-2740	149	59	neutrophil	neutrophil	ADJ
admet-2740	149	60	degranulation	degranulation	NOUN
admet-2740	149	61	.	.	PUNCT
admet-2740	150	1	the	the	DET
admet-2740	150	2	pathway	pathway	NOUN
admet-2740	150	3	analysis	analysis	NOUN
admet-2740	150	4	results	result	NOUN
admet-2740	150	5	presented	present	VERB
admet-2740	150	6	in	in	ADP
admet-2740	150	7	figure	figure	NOUN
admet-2740	150	8	5	5	NUM
admet-2740	150	9	,	,	PUNCT
admet-2740	150	10	conducted	conduct	VERB
admet-2740	150	11	using	use	VERB
admet-2740	150	12	metaboanalyst	metaboanalyst	NOUN
admet-2740	150	13	version	version	NOUN
admet-2740	150	14	6.0	6.0	NUM
admet-2740	150	15	,	,	PUNCT
admet-2740	150	16	were	be	AUX
admet-2740	150	17	based	base	VERB
admet-2740	150	18	on	on	ADP
admet-2740	150	19	-log10	-log10	PUNCT
admet-2740	150	20	p	p	NOUN
admet-2740	150	21	values	value	NOUN
admet-2740	150	22	and	and	CCONJ
admet-2740	150	23	pathway	pathway	NOUN
admet-2740	150	24	impact	impact	NOUN
admet-2740	150	25	scores	score	NOUN
admet-2740	150	26	.	.	PUNCT
admet-2740	151	1	the	the	DET
admet-2740	151	2	analysis	analysis	NOUN
admet-2740	151	3	identified	identify	VERB
admet-2740	151	4	four	four	NUM
admet-2740	151	5	significantly	significantly	ADV
admet-2740	151	6	disrupted	disrupt	VERB
admet-2740	151	7	metabolic	metabolic	NOUN
admet-2740	151	8	pathways	pathway	NOUN
admet-2740	151	9	:	:	PUNCT
admet-2740	151	10	histidine	histidine	ADJ
admet-2740	151	11	metabolism	metabolism	NOUN
admet-2740	151	12	,	,	PUNCT
admet-2740	151	13	glycerol	glycerol	NOUN
admet-2740	151	14	phosphate	phosphate	NOUN
admet-2740	151	15	shuttle	shuttle	NOUN
admet-2740	151	16	,	,	PUNCT
admet-2740	151	17	cardiolipin	cardiolipin	NOUN
admet-2740	151	18	biosynthesis	biosynthesis	NOUN
admet-2740	151	19	,	,	PUNCT
admet-2740	151	20	and	and	CCONJ
admet-2740	151	21	de	de	ADP
admet-2740	151	22	novo	novo	NOUN
admet-2740	151	23	triglyceride	triglyceride	ADV
admet-2740	151	24	biosynthesis	biosynthesis	VERB
admet-2740	151	25	,	,	PUNCT
admet-2740	151	26	which	which	PRON
admet-2740	151	27	are	be	AUX
admet-2740	151	28	all	all	ADV
admet-2740	151	29	consistent	consistent	ADJ
admet-2740	151	30	with	with	ADP
admet-2740	151	31	the	the	DET
admet-2740	151	32	pathway	pathway	NOUN
admet-2740	151	33	enrichment	enrichment	NOUN
admet-2740	151	34	findings	finding	NOUN
admet-2740	151	35	.	.	PUNCT
admet-2740	152	1	subsequently	subsequently	ADV
admet-2740	152	2	,	,	PUNCT
admet-2740	152	3	we	we	PRON
admet-2740	152	4	used	use	VERB
admet-2740	152	5	metascape	metascape	NOUN
admet-2740	152	6	to	to	PART
admet-2740	152	7	construct	construct	VERB
admet-2740	152	8	a	a	DET
admet-2740	152	9	metabolic	metabolic	NOUN
admet-2740	152	10	network	network	NOUN
admet-2740	152	11	aimed	aim	VERB
admet-2740	152	12	at	at	ADP
admet-2740	152	13	elucidating	elucidate	VERB
admet-2740	152	14	potential	potential	ADJ
admet-2740	152	15	crosstalk	crosstalk	NOUN
admet-2740	152	16	among	among	ADP
admet-2740	152	17	these	these	DET
admet-2740	152	18	pathways	pathway	NOUN
admet-2740	152	19	during	during	ADP
admet-2740	152	20	the	the	DET
admet-2740	152	21	interaction	interaction	NOUN
admet-2740	152	22	period	period	NOUN
admet-2740	152	23	between	between	ADP
admet-2740	152	24	warfarin	warfarin	NOUN
admet-2740	152	25	and	and	CCONJ
admet-2740	152	26	mango	mango	NOUN
admet-2740	152	27	.	.	PUNCT
admet-2740	153	1	the	the	DET
admet-2740	153	2	metascape	metascape	NOUN
admet-2740	153	3	enrichment	enrichment	NOUN
admet-2740	153	4	network	network	NOUN
admet-2740	153	5	visualization	visualization	NOUN
admet-2740	153	6	further	further	ADJ
admet-2740	153	7	highlights	highlight	NOUN
admet-2740	153	8	intraand	intraand	CCONJ
admet-2740	153	9	inter	inter	ADJ
admet-2740	153	10	-	-	ADJ
admet-2740	153	11	cluster	cluster	ADJ
admet-2740	153	12	similarities	similarity	NOUN
admet-2740	153	13	of	of	ADP
admet-2740	153	14	enriched	enriched	ADJ
admet-2740	153	15	terms	term	NOUN
admet-2740	153	16	,	,	PUNCT
admet-2740	153	17	with	with	ADP
admet-2740	153	18	up	up	ADP
admet-2740	153	19	to	to	PART
admet-2740	153	20	ten	ten	NUM
admet-2740	153	21	terms	term	NOUN
admet-2740	153	22	per	per	ADP
admet-2740	153	23	cluster	cluster	NOUN
admet-2740	153	24	,	,	PUNCT
admet-2740	153	25	each	each	PRON
admet-2740	153	26	color	color	NOUN
admet-2740	153	27	-	-	PUNCT
admet-2740	153	28	coded	code	VERB
admet-2740	153	29	for	for	ADP
admet-2740	153	30	annotation	annotation	NOUN
admet-2740	153	31	,	,	PUNCT
admet-2740	153	32	as	as	SCONJ
admet-2740	153	33	shown	show	VERB
admet-2740	153	34	in	in	ADP
admet-2740	153	35	figure	figure	NOUN
admet-2740	153	36	6	6	NUM
admet-2740	153	37	.	.	PUNCT
admet-2740	154	1	this	this	DET
admet-2740	154	2	methodological	methodological	ADJ
admet-2740	154	3	approach	approach	NOUN
admet-2740	154	4	may	may	AUX
admet-2740	154	5	facilitate	facilitate	VERB
admet-2740	154	6	the	the	DET
admet-2740	154	7	identification	identification	NOUN
admet-2740	154	8	of	of	ADP
admet-2740	154	9	key	key	ADJ
admet-2740	154	10	novel	novel	ADJ
admet-2740	154	11	metabolic	metabolic	NOUN
admet-2740	154	12	pathways	pathway	NOUN
admet-2740	154	13	,	,	PUNCT
admet-2740	154	14	thereby	thereby	ADV
admet-2740	154	15	enhancing	enhance	VERB
admet-2740	154	16	our	our	PRON
admet-2740	154	17	understanding	understanding	NOUN
admet-2740	154	18	of	of	ADP
admet-2740	154	19	metabolic	metabolic	NOUN
admet-2740	154	20	regulation	regulation	NOUN
admet-2740	154	21	during	during	ADP
admet-2740	154	22	the	the	DET
admet-2740	154	23	warfarin	warfarin	NOUN
admet-2740	154	24	-	-	PUNCT
admet-2740	154	25	mango	mango	NOUN
admet-2740	154	26	interaction	interaction	NOUN
admet-2740	154	27	.	.	PUNCT
admet-2740	155	1	these	these	DET
admet-2740	155	2	findings	finding	NOUN
admet-2740	155	3	emphasize	emphasize	VERB
admet-2740	155	4	the	the	DET
admet-2740	155	5	importance	importance	NOUN
admet-2740	155	6	of	of	ADP
admet-2740	155	7	understanding	understand	VERB
admet-2740	155	8	dietary	dietary	ADJ
admet-2740	155	9	interactions	interaction	NOUN
admet-2740	155	10	with	with	ADP
admet-2740	155	11	medicine	medicine	NOUN
admet-2740	155	12	to	to	PART
admet-2740	155	13	ensure	ensure	VERB
admet-2740	155	14	safe	safe	ADJ
admet-2740	155	15	and	and	CCONJ
admet-2740	155	16	effective	effective	ADJ
admet-2740	155	17	therapeutic	therapeutic	ADJ
admet-2740	155	18	outcomes	outcome	NOUN
admet-2740	155	19	.	.	PUNCT
admet-2740	156	1	pathway	pathway	NOUN
admet-2740	156	2	impact	impact	NOUN
admet-2740	156	3	figure	figure	NOUN
admet-2740	156	4	5	5	NUM
admet-2740	156	5	.	.	PUNCT
admet-2740	157	1	pathway	pathway	NOUN
admet-2740	157	2	analysis	analysis	NOUN
admet-2740	157	3	results	result	NOUN
admet-2740	157	4	,	,	PUNCT
admet-2740	157	5	based	base	VERB
admet-2740	157	6	on	on	ADP
admet-2740	157	7	-log10(p	-log10(p	NOUN
admet-2740	157	8	)	)	PUNCT
admet-2740	157	9	values	value	NOUN
admet-2740	157	10	and	and	CCONJ
admet-2740	157	11	pathway	pathway	NOUN
admet-2740	157	12	impact	impact	NOUN
admet-2740	157	13	scores	score	NOUN
admet-2740	157	14	,	,	PUNCT
admet-2740	157	15	identified	identify	VERB
admet-2740	157	16	four	four	NUM
admet-2740	157	17	significantly	significantly	ADV
admet-2740	157	18	disrupted	disrupt	VERB
admet-2740	157	19	metabolic	metabolic	NOUN
admet-2740	157	20	pathways	pathway	NOUN
admet-2740	157	21	:	:	PUNCT
admet-2740	157	22	histidine	histidine	ADJ
admet-2740	157	23	metabolism	metabolism	NOUN
admet-2740	157	24	,	,	PUNCT
admet-2740	157	25	glycerol	glycerol	NOUN
admet-2740	157	26	phosphate	phosphate	NOUN
admet-2740	157	27	shuttle	shuttle	NOUN
admet-2740	157	28	,	,	PUNCT
admet-2740	157	29	cardiolipin	cardiolipin	NOUN
admet-2740	157	30	biosynthesis	biosynthesis	NOUN
admet-2740	157	31	,	,	PUNCT
admet-2740	157	32	and	and	CCONJ
admet-2740	157	33	de	de	ADP
admet-2740	157	34	novo	novo	NOUN
admet-2740	157	35	triglyceride	triglyceride	ADV
admet-2740	157	36	biosynthesis	biosynthesis	VERB
admet-2740	157	37	.	.	PUNCT
admet-2740	158	1	these	these	DET
admet-2740	158	2	findings	finding	NOUN
admet-2740	158	3	align	align	VERB
admet-2740	158	4	with	with	ADP
admet-2740	158	5	the	the	DET
admet-2740	158	6	results	result	NOUN
admet-2740	158	7	from	from	ADP
admet-2740	158	8	the	the	DET
admet-2740	158	9	pathway	pathway	NOUN
admet-2740	158	10	enrichment	enrichment	NOUN
admet-2740	158	11	analysis	analysis	NOUN
admet-2740	158	12	-l	-l	X
admet-2740	158	13	o	o	NOUN
admet-2740	158	14	g	g	NOUN
admet-2740	158	15	1	1	NUM
admet-2740	158	16	0	0	NUM
admet-2740	158	17	p	p	NOUN
admet-2740	158	18	admet	admet	PROPN
admet-2740	158	19	&	&	CCONJ
admet-2740	158	20	dmpk	dmpk	PROPN
admet-2740	158	21	13(3	13(3	NUM
admet-2740	158	22	)	)	PUNCT
admet-2740	158	23	(	(	PUNCT
admet-2740	158	24	2025	2025	NUM
admet-2740	158	25	)	)	PUNCT
admet-2740	158	26	2740	2740	NUM
admet-2740	158	27	metabolic	metabolic	NOUN
admet-2740	158	28	insights	insight	NOUN
admet-2740	158	29	into	into	ADP
admet-2740	158	30	the	the	DET
admet-2740	158	31	warfarin	warfarin	NOUN
admet-2740	158	32	-	-	PUNCT
admet-2740	158	33	mango	mango	NOUN
admet-2740	158	34	interaction	interaction	NOUN
admet-2740	158	35	doi	doi	NOUN
admet-2740	158	36	:	:	PUNCT
admet-2740	158	37	https://doi.org/10.5599/admet.2740	https://doi.org/10.5599/admet.2740	NOUN
admet-2740	158	38	9	9	NUM
admet-2740	158	39	figure	figure	NOUN
admet-2740	158	40	6	6	NUM
admet-2740	158	41	.	.	PUNCT
admet-2740	158	42	metabolic	metabolic	NOUN
admet-2740	158	43	network	network	NOUN
admet-2740	158	44	illustrating	illustrate	VERB
admet-2740	158	45	potential	potential	ADJ
admet-2740	158	46	crosstalk	crosstalk	NOUN
admet-2740	158	47	between	between	ADP
admet-2740	158	48	various	various	ADJ
admet-2740	158	49	pathways	pathway	NOUN
admet-2740	158	50	during	during	ADP
admet-2740	158	51	the	the	DET
admet-2740	158	52	warfarin	warfarin	NOUN
admet-2740	158	53	-	-	PUNCT
admet-2740	158	54	mango	mango	NOUN
admet-2740	158	55	interaction	interaction	NOUN
admet-2740	158	56	.	.	PUNCT
admet-2740	159	1	the	the	DET
admet-2740	159	2	enrichment	enrichment	NOUN
admet-2740	159	3	network	network	NOUN
admet-2740	159	4	visualization	visualization	NOUN
admet-2740	159	5	highlights	highlight	NOUN
admet-2740	159	6	both	both	DET
admet-2740	159	7	intraand	intraand	CCONJ
admet-2740	159	8	inter	inter	ADJ
admet-2740	159	9	-	-	ADJ
admet-2740	159	10	cluster	cluster	NOUN
admet-2740	159	11	similarities	similarity	NOUN
admet-2740	159	12	among	among	ADP
admet-2740	159	13	enriched	enriched	ADJ
admet-2740	159	14	terms	term	NOUN
admet-2740	159	15	,	,	PUNCT
admet-2740	159	16	with	with	ADP
admet-2740	159	17	up	up	ADP
admet-2740	159	18	to	to	PART
admet-2740	159	19	ten	ten	NUM
admet-2740	159	20	terms	term	NOUN
admet-2740	159	21	per	per	ADP
admet-2740	159	22	cluster	cluster	NOUN
admet-2740	159	23	,	,	PUNCT
admet-2740	159	24	each	each	PRON
admet-2740	159	25	uniquely	uniquely	ADV
admet-2740	159	26	color	color	NOUN
admet-2740	159	27	-	-	PUNCT
admet-2740	159	28	coded	code	VERB
admet-2740	159	29	for	for	ADP
admet-2740	159	30	annotation	annotation	NOUN
admet-2740	159	31	alterations	alteration	NOUN
admet-2740	159	32	in	in	ADP
admet-2740	159	33	metabolic	metabolic	NOUN
admet-2740	159	34	profiles	profile	NOUN
admet-2740	159	35	during	during	ADP
admet-2740	159	36	warfarin	warfarin	NOUN
admet-2740	159	37	-	-	PUNCT
admet-2740	159	38	mango	mango	NOUN
admet-2740	159	39	interaction	interaction	NOUN
admet-2740	159	40	the	the	DET
admet-2740	159	41	heatmaps	heatmap	NOUN
admet-2740	159	42	(	(	PUNCT
admet-2740	159	43	figure	figure	NOUN
admet-2740	159	44	7a	7a	NUM
admet-2740	159	45	)	)	PUNCT
admet-2740	159	46	illustrate	illustrate	VERB
admet-2740	159	47	the	the	DET
admet-2740	159	48	differential	differential	ADJ
admet-2740	159	49	abundance	abundance	NOUN
admet-2740	159	50	of	of	ADP
admet-2740	159	51	metabolites	metabolite	NOUN
admet-2740	159	52	between	between	ADP
admet-2740	159	53	the	the	DET
admet-2740	159	54	warfarinmango	warfarinmango	NOUN
admet-2740	159	55	interaction	interaction	NOUN
admet-2740	159	56	and	and	CCONJ
admet-2740	159	57	control	control	NOUN
admet-2740	159	58	data	datum	NOUN
admet-2740	159	59	,	,	PUNCT
admet-2740	159	60	highlighting	highlight	VERB
admet-2740	159	61	metabolites	metabolite	NOUN
admet-2740	159	62	that	that	PRON
admet-2740	159	63	exhibit	exhibit	VERB
admet-2740	159	64	either	either	CCONJ
admet-2740	159	65	increasing	increase	VERB
admet-2740	159	66	or	or	CCONJ
admet-2740	159	67	decreasing	decrease	VERB
admet-2740	159	68	trends	trend	NOUN
admet-2740	159	69	during	during	ADP
admet-2740	159	70	the	the	DET
admet-2740	159	71	interaction	interaction	NOUN
admet-2740	159	72	.	.	PUNCT
admet-2740	160	1	figure	figure	NOUN
admet-2740	160	2	7	7	NUM
admet-2740	160	3	.	.	PUNCT
admet-2740	161	1	(	(	PUNCT
admet-2740	161	2	a	a	X
admet-2740	161	3	)	)	PUNCT
admet-2740	161	4	heatmaps	heatmap	NOUN
admet-2740	161	5	illustrating	illustrate	VERB
admet-2740	161	6	the	the	DET
admet-2740	161	7	differential	differential	ADJ
admet-2740	161	8	abundance	abundance	NOUN
admet-2740	161	9	of	of	ADP
admet-2740	161	10	metabolites	metabolite	NOUN
admet-2740	161	11	between	between	ADP
admet-2740	161	12	the	the	DET
admet-2740	161	13	warfarin	warfarin	NOUN
admet-2740	161	14	-	-	PUNCT
admet-2740	161	15	mango	mango	NOUN
admet-2740	161	16	interaction	interaction	NOUN
admet-2740	161	17	and	and	CCONJ
admet-2740	161	18	control	control	NOUN
admet-2740	161	19	data	datum	NOUN
admet-2740	161	20	,	,	PUNCT
admet-2740	161	21	highlighting	highlight	VERB
admet-2740	161	22	metabolites	metabolite	NOUN
admet-2740	161	23	that	that	PRON
admet-2740	161	24	display	display	VERB
admet-2740	161	25	increasing	increase	VERB
admet-2740	161	26	or	or	CCONJ
admet-2740	161	27	decreasing	decrease	VERB
admet-2740	161	28	trends	trend	NOUN
admet-2740	161	29	during	during	ADP
admet-2740	161	30	the	the	DET
admet-2740	161	31	interaction	interaction	NOUN
admet-2740	161	32	.	.	PUNCT
admet-2740	162	1	in	in	ADP
admet-2740	162	2	these	these	DET
admet-2740	162	3	heatmaps	heatmap	NOUN
admet-2740	162	4	,	,	PUNCT
admet-2740	162	5	columns	column	NOUN
admet-2740	162	6	represent	represent	VERB
admet-2740	162	7	individual	individual	ADJ
admet-2740	162	8	samples	sample	NOUN
admet-2740	162	9	divided	divide	VERB
admet-2740	162	10	into	into	ADP
admet-2740	162	11	two	two	NUM
admet-2740	162	12	groups	group	NOUN
admet-2740	162	13	:	:	PUNCT
admet-2740	162	14	the	the	DET
admet-2740	162	15	warfarin	warfarin	NOUN
admet-2740	162	16	-	-	PUNCT
admet-2740	162	17	mango	mango	NOUN
admet-2740	162	18	interaction	interaction	NOUN
admet-2740	162	19	and	and	CCONJ
admet-2740	162	20	the	the	DET
admet-2740	162	21	control	control	NOUN
admet-2740	162	22	data	datum	NOUN
admet-2740	162	23	,	,	PUNCT
admet-2740	162	24	while	while	SCONJ
admet-2740	162	25	rows	row	NOUN
admet-2740	162	26	display	display	VERB
admet-2740	162	27	the	the	DET
admet-2740	162	28	top	top	ADJ
admet-2740	162	29	25	25	NUM
admet-2740	162	30	metabolites	metabolite	NOUN
admet-2740	162	31	ranked	rank	VERB
admet-2740	162	32	by	by	ADP
admet-2740	162	33	their	their	PRON
admet-2740	162	34	correlation	correlation	NOUN
admet-2740	162	35	coefficients	coefficient	NOUN
admet-2740	162	36	.	.	PUNCT
admet-2740	163	1	normalized	normalize	VERB
admet-2740	163	2	metabolite	metabolite	NOUN
admet-2740	163	3	intensities	intensity	NOUN
admet-2740	163	4	are	be	AUX
admet-2740	163	5	visualized	visualize	VERB
admet-2740	163	6	using	use	VERB
admet-2740	163	7	a	a	DET
admet-2740	163	8	colour	colour	NOUN
admet-2740	163	9	scale	scale	NOUN
admet-2740	163	10	ranging	range	VERB
admet-2740	163	11	from	from	ADP
admet-2740	163	12	red	red	ADJ
admet-2740	163	13	to	to	ADP
admet-2740	163	14	green	green	ADJ
admet-2740	163	15	,	,	PUNCT
admet-2740	163	16	where	where	SCONJ
admet-2740	163	17	red	red	ADJ
admet-2740	163	18	signifies	signify	VERB
admet-2740	163	19	higher	high	ADJ
admet-2740	163	20	intensities	intensity	NOUN
admet-2740	163	21	and	and	CCONJ
admet-2740	163	22	green	green	NOUN
admet-2740	163	23	represents	represent	VERB
admet-2740	163	24	lower	low	ADJ
admet-2740	163	25	intensities	intensity	NOUN
admet-2740	163	26	.	.	PUNCT
admet-2740	164	1	(	(	PUNCT
admet-2740	164	2	b	b	X
admet-2740	164	3	)	)	PUNCT
admet-2740	164	4	bar	bar	NOUN
admet-2740	164	5	graph	graph	NOUN
admet-2740	164	6	depicting	depict	VERB
admet-2740	164	7	metabolic	metabolic	NOUN
admet-2740	164	8	alterations	alteration	NOUN
admet-2740	164	9	,	,	PUNCT
admet-2740	164	10	with	with	ADP
admet-2740	164	11	pearson	pearson	PROPN
admet-2740	164	12	correlation	correlation	NOUN
admet-2740	164	13	coefficients	coefficient	NOUN
admet-2740	164	14	calculated	calculate	VERB
admet-2740	164	15	to	to	PART
admet-2740	164	16	assess	assess	VERB
admet-2740	164	17	the	the	DET
admet-2740	164	18	relationships	relationship	NOUN
admet-2740	164	19	among	among	ADP
admet-2740	164	20	metabolites	metabolite	NOUN
admet-2740	164	21	.	.	PUNCT
admet-2740	165	1	this	this	DET
admet-2740	165	2	analysis	analysis	NOUN
admet-2740	165	3	reveals	reveal	VERB
admet-2740	165	4	distinct	distinct	ADJ
admet-2740	165	5	patterns	pattern	NOUN
admet-2740	165	6	during	during	ADP
admet-2740	165	7	the	the	DET
admet-2740	165	8	warfarin	warfarin	NOUN
admet-2740	165	9	-	-	PUNCT
admet-2740	165	10	mango	mango	NOUN
admet-2740	165	11	interaction	interaction	NOUN
admet-2740	165	12	,	,	PUNCT
admet-2740	165	13	which	which	PRON
admet-2740	165	14	are	be	AUX
admet-2740	165	15	consistent	consistent	ADJ
admet-2740	165	16	with	with	ADP
admet-2740	165	17	the	the	DET
admet-2740	165	18	trends	trend	NOUN
admet-2740	165	19	observed	observe	VERB
admet-2740	165	20	in	in	ADP
admet-2740	165	21	the	the	DET
admet-2740	165	22	heatmap	heatmap	NOUN
admet-2740	165	23	https://doi.org/10.5599/admet.2740	https://doi.org/10.5599/admet.2740	NOUN
admet-2740	165	24	p.	p.	NOUN
admet-2740	165	25	rattanasuwan	rattanasuwan	PROPN
admet-2740	165	26	et	et	PROPN
admet-2740	165	27	al	al	PROPN
admet-2740	165	28	.	.	PROPN
admet-2740	165	29	admet	admet	PROPN
admet-2740	165	30	&	&	CCONJ
admet-2740	165	31	dmpk	dmpk	PROPN
admet-2740	165	32	13(3	13(3	NUM
admet-2740	165	33	)	)	PUNCT
admet-2740	165	34	(	(	PUNCT
admet-2740	165	35	2025	2025	NUM
admet-2740	165	36	)	)	PUNCT
admet-2740	165	37	2740	2740	NUM
admet-2740	165	38	10	10	NUM
admet-2740	165	39	in	in	ADP
admet-2740	165	40	these	these	DET
admet-2740	165	41	heatmaps	heatmap	NOUN
admet-2740	165	42	,	,	PUNCT
admet-2740	165	43	columns	column	NOUN
admet-2740	165	44	represent	represent	VERB
admet-2740	165	45	individual	individual	ADJ
admet-2740	165	46	samples	sample	NOUN
admet-2740	165	47	,	,	PUNCT
admet-2740	165	48	divided	divide	VERB
admet-2740	165	49	into	into	ADP
admet-2740	165	50	two	two	NUM
admet-2740	165	51	groups	group	NOUN
admet-2740	165	52	:	:	PUNCT
admet-2740	165	53	the	the	DET
admet-2740	165	54	warfarin	warfarin	NOUN
admet-2740	165	55	-	-	PUNCT
admet-2740	165	56	mango	mango	NOUN
admet-2740	165	57	interaction	interaction	NOUN
admet-2740	165	58	and	and	CCONJ
admet-2740	165	59	control	control	NOUN
admet-2740	165	60	,	,	PUNCT
admet-2740	165	61	while	while	SCONJ
admet-2740	165	62	rows	row	NOUN
admet-2740	165	63	display	display	VERB
admet-2740	165	64	the	the	DET
admet-2740	165	65	top	top	ADJ
admet-2740	165	66	25	25	NUM
admet-2740	165	67	metabolites	metabolite	NOUN
admet-2740	165	68	,	,	PUNCT
admet-2740	165	69	ranked	rank	VERB
admet-2740	165	70	by	by	ADP
admet-2740	165	71	their	their	PRON
admet-2740	165	72	correlation	correlation	NOUN
admet-2740	165	73	coefficients	coefficient	NOUN
admet-2740	165	74	.	.	PUNCT
admet-2740	166	1	the	the	DET
admet-2740	166	2	normalized	normalize	VERB
admet-2740	166	3	metabolite	metabolite	NOUN
admet-2740	166	4	intensities	intensity	NOUN
admet-2740	166	5	are	be	AUX
admet-2740	166	6	visualized	visualize	VERB
admet-2740	166	7	using	use	VERB
admet-2740	166	8	a	a	DET
admet-2740	166	9	colour	colour	NOUN
admet-2740	166	10	scale	scale	NOUN
admet-2740	166	11	ranging	range	VERB
admet-2740	166	12	from	from	ADP
admet-2740	166	13	red	red	ADJ
admet-2740	166	14	to	to	ADP
admet-2740	166	15	blue	blue	ADJ
admet-2740	166	16	,	,	PUNCT
admet-2740	166	17	where	where	SCONJ
admet-2740	166	18	red	red	ADJ
admet-2740	166	19	signifies	signify	VERB
admet-2740	166	20	higher	high	ADJ
admet-2740	166	21	intensities	intensity	NOUN
admet-2740	166	22	and	and	CCONJ
admet-2740	166	23	blue	blue	NOUN
admet-2740	166	24	represents	represent	VERB
admet-2740	166	25	lower	low	ADJ
admet-2740	166	26	intensities	intensity	NOUN
admet-2740	166	27	.	.	PUNCT
admet-2740	167	1	to	to	PART
admet-2740	167	2	further	far	ADV
admet-2740	167	3	investigate	investigate	VERB
admet-2740	167	4	the	the	DET
admet-2740	167	5	metabolic	metabolic	NOUN
admet-2740	167	6	alterations	alteration	NOUN
admet-2740	167	7	,	,	PUNCT
admet-2740	167	8	pearson	pearson	PROPN
admet-2740	167	9	correlation	correlation	NOUN
admet-2740	167	10	coefficients	coefficient	NOUN
admet-2740	167	11	were	be	AUX
admet-2740	167	12	calculated	calculate	VERB
admet-2740	167	13	to	to	PART
admet-2740	167	14	assess	assess	VERB
admet-2740	167	15	the	the	DET
admet-2740	167	16	relationships	relationship	NOUN
admet-2740	167	17	among	among	ADP
admet-2740	167	18	metabolites	metabolite	NOUN
admet-2740	167	19	,	,	PUNCT
admet-2740	167	20	revealing	reveal	VERB
admet-2740	167	21	distinct	distinct	ADJ
admet-2740	167	22	patterns	pattern	NOUN
admet-2740	167	23	during	during	ADP
admet-2740	167	24	the	the	DET
admet-2740	167	25	warfarin	warfarin	NOUN
admet-2740	167	26	-	-	PUNCT
admet-2740	167	27	mango	mango	NOUN
admet-2740	167	28	interaction	interaction	NOUN
admet-2740	167	29	.	.	PUNCT
admet-2740	168	1	these	these	DET
admet-2740	168	2	correlations	correlation	NOUN
admet-2740	168	3	are	be	AUX
admet-2740	168	4	depicted	depict	VERB
admet-2740	168	5	in	in	ADP
admet-2740	168	6	the	the	DET
admet-2740	168	7	bar	bar	NOUN
admet-2740	168	8	graph	graph	NOUN
admet-2740	168	9	(	(	PUNCT
admet-2740	168	10	figure	figure	NOUN
admet-2740	168	11	7b	7b	NOUN
admet-2740	168	12	)	)	PUNCT
admet-2740	168	13	,	,	PUNCT
admet-2740	168	14	which	which	PRON
admet-2740	168	15	aligns	align	VERB
admet-2740	168	16	with	with	ADP
admet-2740	168	17	the	the	DET
admet-2740	168	18	trends	trend	NOUN
admet-2740	168	19	observed	observe	VERB
admet-2740	168	20	in	in	ADP
admet-2740	168	21	the	the	DET
admet-2740	168	22	heatmap	heatmap	NOUN
admet-2740	168	23	.	.	PUNCT
admet-2740	169	1	collectively	collectively	ADV
admet-2740	169	2	,	,	PUNCT
admet-2740	169	3	the	the	DET
admet-2740	169	4	data	datum	NOUN
admet-2740	169	5	suggest	suggest	VERB
admet-2740	169	6	significant	significant	ADJ
admet-2740	169	7	alterations	alteration	NOUN
admet-2740	169	8	in	in	ADP
admet-2740	169	9	metabolite	metabolite	NOUN
admet-2740	169	10	profiles	profile	NOUN
admet-2740	169	11	,	,	PUNCT
admet-2740	169	12	indicating	indicate	VERB
admet-2740	169	13	that	that	SCONJ
admet-2740	169	14	the	the	DET
admet-2740	169	15	warfarin	warfarin	NOUN
admet-2740	169	16	-	-	PUNCT
admet-2740	169	17	mango	mango	NOUN
admet-2740	169	18	interaction	interaction	NOUN
admet-2740	169	19	induces	induce	VERB
admet-2740	169	20	notable	notable	ADJ
admet-2740	169	21	metabolic	metabolic	NOUN
admet-2740	169	22	changes	change	NOUN
admet-2740	169	23	.	.	PUNCT
admet-2740	170	1	key	key	ADJ
admet-2740	170	2	metabolites	metabolite	NOUN
admet-2740	170	3	highlighted	highlight	VERB
admet-2740	170	4	as	as	ADP
admet-2740	170	5	a	a	DET
admet-2740	170	6	potential	potential	ADJ
admet-2740	170	7	biomarker	biomarker	NOUN
admet-2740	170	8	univariate	univariate	ADJ
admet-2740	170	9	receiver	receiver	ADJ
admet-2740	170	10	operating	operate	VERB
admet-2740	170	11	characteristic	characteristic	NOUN
admet-2740	170	12	(	(	PUNCT
admet-2740	170	13	roc	roc	PROPN
admet-2740	170	14	)	)	PUNCT
admet-2740	170	15	curve	curve	NOUN
admet-2740	170	16	analyses	analysis	NOUN
admet-2740	170	17	were	be	AUX
admet-2740	170	18	performed	perform	VERB
admet-2740	170	19	to	to	PART
admet-2740	170	20	evaluate	evaluate	VERB
admet-2740	170	21	the	the	DET
admet-2740	170	22	area	area	NOUN
admet-2740	170	23	under	under	ADP
admet-2740	170	24	the	the	DET
admet-2740	170	25	roc	roc	PROPN
admet-2740	170	26	curve	curve	NOUN
admet-2740	170	27	(	(	PUNCT
admet-2740	170	28	auroc	auroc	NOUN
admet-2740	170	29	)	)	PUNCT
admet-2740	170	30	and	and	CCONJ
admet-2740	170	31	calculate	calculate	VERB
admet-2740	170	32	the	the	DET
admet-2740	170	33	95	95	NUM
admet-2740	170	34	%	%	NOUN
admet-2740	170	35	confidence	confidence	NOUN
admet-2740	170	36	intervals	interval	NOUN
admet-2740	170	37	for	for	ADP
admet-2740	170	38	individual	individual	ADJ
admet-2740	170	39	biomarkers	biomarker	NOUN
admet-2740	170	40	.	.	PUNCT
admet-2740	171	1	the	the	DET
admet-2740	171	2	results	result	NOUN
admet-2740	171	3	of	of	ADP
admet-2740	171	4	the	the	DET
admet-2740	171	5	roc	roc	PROPN
admet-2740	171	6	curve	curve	NOUN
admet-2740	171	7	analysis	analysis	NOUN
admet-2740	171	8	ranked	rank	VERB
admet-2740	171	9	the	the	DET
admet-2740	171	10	biomarkers	biomarker	NOUN
admet-2740	171	11	based	base	VERB
admet-2740	171	12	on	on	ADP
admet-2740	171	13	their	their	PRON
admet-2740	171	14	auroc	auroc	NOUN
admet-2740	171	15	,	,	PUNCT
admet-2740	171	16	t	t	PROPN
admet-2740	171	17	-	-	PUNCT
admet-2740	171	18	statistics	statistic	NOUN
admet-2740	171	19	,	,	PUNCT
admet-2740	171	20	and	and	CCONJ
admet-2740	171	21	log2	log2	PROPN
admet-2740	171	22	fold	fold	NOUN
admet-2740	171	23	change	change	NOUN
admet-2740	171	24	(	(	PUNCT
admet-2740	171	25	fc	fc	INTJ
admet-2740	171	26	)	)	PUNCT
admet-2740	171	27	,	,	PUNCT
admet-2740	171	28	as	as	SCONJ
admet-2740	171	29	shown	show	VERB
admet-2740	171	30	in	in	ADP
admet-2740	171	31	table	table	NOUN
admet-2740	171	32	2	2	NUM
admet-2740	171	33	.	.	PUNCT
admet-2740	171	34	key	key	ADJ
admet-2740	171	35	metabolites	metabolite	NOUN
admet-2740	171	36	were	be	AUX
admet-2740	171	37	selected	select	VERB
admet-2740	171	38	based	base	VERB
admet-2740	171	39	on	on	ADP
admet-2740	171	40	an	an	DET
admet-2740	171	41	auc	auc	ADJ
admet-2740	171	42	value	value	NOUN
admet-2740	171	43	of	of	ADP
admet-2740	171	44	0.7	0.7	NUM
admet-2740	171	45	and	and	CCONJ
admet-2740	171	46	statistically	statistically	ADV
admet-2740	171	47	significant	significant	ADJ
admet-2740	171	48	differences	difference	NOUN
admet-2740	171	49	between	between	ADP
admet-2740	171	50	the	the	DET
admet-2740	171	51	two	two	NUM
admet-2740	171	52	groups	group	NOUN
admet-2740	171	53	:	:	PUNCT
admet-2740	171	54	warfarin	warfarin	NOUN
admet-2740	171	55	-	-	PUNCT
admet-2740	171	56	mango	mango	NOUN
admet-2740	171	57	interaction	interaction	NOUN
admet-2740	171	58	and	and	CCONJ
admet-2740	171	59	control	control	NOUN
admet-2740	171	60	.	.	PUNCT
admet-2740	172	1	eight	eight	NUM
admet-2740	172	2	key	key	ADJ
admet-2740	172	3	metabolites	metabolite	NOUN
admet-2740	172	4	were	be	AUX
admet-2740	172	5	identified	identify	VERB
admet-2740	172	6	,	,	PUNCT
admet-2740	172	7	including	include	VERB
admet-2740	172	8	n	n	CCONJ
admet-2740	172	9	-	-	PUNCT
admet-2740	172	10	acetylaspartylglutamic	acetylaspartylglutamic	ADJ
admet-2740	172	11	acid	acid	NOUN
admet-2740	172	12	,	,	PUNCT
admet-2740	172	13	cyclic	cyclic	ADJ
admet-2740	172	14	amp	amp	NOUN
admet-2740	172	15	,	,	PUNCT
admet-2740	172	16	erythritol	erythritol	NOUN
admet-2740	172	17	,	,	PUNCT
admet-2740	172	18	n	n	CCONJ
admet-2740	172	19	-	-	PUNCT
admet-2740	172	20	methylhydantoin	methylhydantoin	NOUN
admet-2740	172	21	,	,	PUNCT
admet-2740	172	22	4	4	NUM
admet-2740	172	23	-	-	PUNCT
admet-2740	172	24	guanidinobutanoate	guanidinobutanoate	NOUN
admet-2740	172	25	,	,	PUNCT
admet-2740	172	26	glycerol	glycerol	NOUN
admet-2740	172	27	3	3	NUM
admet-2740	172	28	-	-	NOUN
admet-2740	172	29	phosphate	phosphate	ADJ
admet-2740	172	30	,	,	PUNCT
admet-2740	172	31	n	n	CCONJ
admet-2740	172	32	-	-	PUNCT
admet-2740	172	33	acetyltaurine	acetyltaurine	ADJ
admet-2740	172	34	,	,	PUNCT
admet-2740	172	35	and	and	CCONJ
admet-2740	172	36	dopamine	dopamine	NOUN
admet-2740	172	37	.	.	PUNCT
admet-2740	173	1	among	among	ADP
admet-2740	173	2	these	these	PRON
admet-2740	173	3	,	,	PUNCT
admet-2740	173	4	glycerol	glycerol	NOUN
admet-2740	173	5	3	3	NUM
admet-2740	173	6	-	-	NOUN
admet-2740	173	7	phosphate	phosphate	NOUN
admet-2740	173	8	was	be	AUX
admet-2740	173	9	chosen	choose	VERB
admet-2740	173	10	as	as	ADP
admet-2740	173	11	a	a	DET
admet-2740	173	12	potential	potential	ADJ
admet-2740	173	13	biomarker	biomarker	NOUN
admet-2740	173	14	to	to	PART
admet-2740	173	15	elucidate	elucidate	VERB
admet-2740	173	16	the	the	DET
admet-2740	173	17	metabolic	metabolic	NOUN
admet-2740	173	18	alterations	alteration	NOUN
admet-2740	173	19	occurring	occur	VERB
admet-2740	173	20	during	during	ADP
admet-2740	173	21	the	the	DET
admet-2740	173	22	warfarin	warfarin	NOUN
admet-2740	173	23	-	-	PUNCT
admet-2740	173	24	mango	mango	NOUN
admet-2740	173	25	interaction	interaction	NOUN
admet-2740	173	26	.	.	PUNCT
admet-2740	174	1	glycerol	glycerol	NOUN
admet-2740	174	2	3	3	NUM
admet-2740	174	3	-	-	NOUN
admet-2740	174	4	phosphate	phosphate	NOUN
admet-2740	174	5	is	be	AUX
admet-2740	174	6	involved	involve	VERB
admet-2740	174	7	in	in	ADP
admet-2740	174	8	key	key	ADJ
admet-2740	174	9	metabolic	metabolic	NOUN
admet-2740	174	10	pathways	pathway	NOUN
admet-2740	174	11	,	,	PUNCT
admet-2740	174	12	including	include	VERB
admet-2740	174	13	the	the	DET
admet-2740	174	14	glycerol	glycerol	NOUN
admet-2740	174	15	phosphate	phosphate	NOUN
admet-2740	174	16	shuttle	shuttle	NOUN
admet-2740	174	17	,	,	PUNCT
admet-2740	174	18	cardiolipin	cardiolipin	NOUN
admet-2740	174	19	biosynthesis	biosynthesis	NOUN
admet-2740	174	20	,	,	PUNCT
admet-2740	174	21	and	and	CCONJ
admet-2740	174	22	de	de	ADP
admet-2740	174	23	novo	novo	NOUN
admet-2740	174	24	triglyceride	triglyceride	ADV
admet-2740	174	25	biosynthesis	biosynthesis	VERB
admet-2740	174	26	,	,	PUNCT
admet-2740	174	27	findings	finding	NOUN
admet-2740	174	28	which	which	PRON
admet-2740	174	29	align	align	VERB
admet-2740	174	30	with	with	ADP
admet-2740	174	31	those	those	PRON
admet-2740	174	32	from	from	ADP
admet-2740	174	33	pathway	pathway	NOUN
admet-2740	174	34	enrichment	enrichment	NOUN
admet-2740	174	35	analyses	analysis	NOUN
admet-2740	174	36	.	.	PUNCT
admet-2740	175	1	the	the	DET
admet-2740	175	2	roc	roc	PROPN
admet-2740	175	3	curve	curve	NOUN
admet-2740	175	4	for	for	ADP
admet-2740	175	5	glycerol	glycerol	NOUN
admet-2740	175	6	3	3	NUM
admet-2740	175	7	-	-	NOUN
admet-2740	175	8	phosphate	phosphate	NOUN
admet-2740	175	9	is	be	AUX
admet-2740	175	10	presented	present	VERB
admet-2740	175	11	in	in	ADP
admet-2740	175	12	figure	figure	NOUN
admet-2740	175	13	8	8	NUM
admet-2740	175	14	,	,	PUNCT
admet-2740	175	15	with	with	ADP
admet-2740	175	16	an	an	DET
admet-2740	175	17	auroc	auroc	NOUN
admet-2740	175	18	of	of	ADP
admet-2740	175	19	0.72889	0.72889	NUM
admet-2740	175	20	,	,	PUNCT
admet-2740	175	21	indicating	indicate	VERB
admet-2740	175	22	its	its	PRON
admet-2740	175	23	potential	potential	NOUN
admet-2740	175	24	as	as	ADP
admet-2740	175	25	a	a	DET
admet-2740	175	26	good	good	ADJ
admet-2740	175	27	biomarker	biomarker	NOUN
admet-2740	175	28	(	(	PUNCT
admet-2740	175	29	p	p	X
admet-2740	175	30	=	=	NOUN
admet-2740	175	31	0.041216	0.041216	NUM
admet-2740	175	32	)	)	PUNCT
admet-2740	175	33	.	.	PUNCT
admet-2740	176	1	table	table	NOUN
admet-2740	176	2	2	2	NUM
admet-2740	176	3	.	.	X
admet-2740	177	1	receiver	receiver	ADJ
admet-2740	177	2	operating	operate	VERB
admet-2740	177	3	characteristic	characteristic	NOUN
admet-2740	177	4	(	(	PUNCT
admet-2740	177	5	roc	roc	PROPN
admet-2740	177	6	)	)	PUNCT
admet-2740	177	7	curve	curve	NOUN
admet-2740	177	8	analysis	analysis	NOUN
admet-2740	177	9	of	of	ADP
admet-2740	177	10	individual	individual	ADJ
admet-2740	177	11	biomarkers	biomarker	NOUN
admet-2740	177	12	biomarkers	biomarker	NOUN
admet-2740	177	13	auroc	auroc	NOUN
admet-2740	177	14	t	t	PROPN
admet-2740	177	15	-	-	PUNCT
admet-2740	177	16	test	test	NOUN
admet-2740	177	17	log2	log2	PROPN
admet-2740	177	18	fc	fc	PROPN
admet-2740	177	19	n	n	CCONJ
admet-2740	177	20	-	-	PUNCT
admet-2740	177	21	acetylaspartylglutamic	acetylaspartylglutamic	ADJ
admet-2740	177	22	acid	acid	NOUN
admet-2740	177	23	0.81778	0.81778	NUM
admet-2740	177	24	0.016876	0.016876	NUM
admet-2740	177	25	-0.23413	-0.23413	PROPN
admet-2740	177	26	cyclic	cyclic	ADJ
admet-2740	177	27	amp	amp	NOUN
admet-2740	177	28	0.80000	0.80000	NUM
admet-2740	177	29	0.004005	0.004005	NUM
admet-2740	177	30	-0.54444	-0.54444	NOUN
admet-2740	177	31	erythritol	erythritol	VERB
admet-2740	177	32	0.78222	0.78222	NUM
admet-2740	177	33	0.017716	0.017716	NUM
admet-2740	177	34	0.54163	0.54163	NUM
admet-2740	177	35	n	n	CCONJ
admet-2740	177	36	-	-	PUNCT
admet-2740	177	37	methylhydantoin	methylhydantoin	NOUN
admet-2740	177	38	0.73333	0.73333	NUM
admet-2740	177	39	0.018364	0.018364	NUM
admet-2740	177	40	-0.15266	-0.15266	NOUN
admet-2740	177	41	4	4	NUM
admet-2740	177	42	-	-	NOUN
admet-2740	177	43	guanidinobutanoate	guanidinobutanoate	VERB
admet-2740	177	44	0.72889	0.72889	NUM
admet-2740	177	45	0.027884	0.027884	NUM
admet-2740	177	46	0.22892	0.22892	NUM
admet-2740	177	47	glycerol	glycerol	NOUN
admet-2740	177	48	3	3	NUM
admet-2740	177	49	-	-	NOUN
admet-2740	177	50	phosphate	phosphate	NOUN
admet-2740	177	51	0.72889	0.72889	NUM
admet-2740	177	52	0.041216	0.041216	NUM
admet-2740	177	53	-0.49244	-0.49244	NOUN
admet-2740	177	54	n	n	CCONJ
admet-2740	177	55	-	-	PUNCT
admet-2740	177	56	acetyltaurine	acetyltaurine	VERB
admet-2740	177	57	0.72000	0.72000	NUM
admet-2740	177	58	0.019383	0.019383	NUM
admet-2740	177	59	0.5282	0.5282	NUM
admet-2740	177	60	dopamine	dopamine	NOUN
admet-2740	177	61	0.71111	0.71111	NUM
admet-2740	177	62	0.045276	0.045276	NUM
admet-2740	177	63	0.31138	0.31138	NUM
admet-2740	177	64	auroc	auroc	NOUN
admet-2740	177	65	=	=	NOUN
admet-2740	177	66	area	area	NOUN
admet-2740	177	67	under	under	ADP
admet-2740	177	68	roc	roc	PROPN
admet-2740	177	69	curve	curve	NOUN
admet-2740	177	70	;	;	PUNCT
admet-2740	177	71	fc	fc	PROPN
admet-2740	177	72	=	=	PUNCT
admet-2740	177	73	fold	fold	VERB
admet-2740	177	74	change	change	NOUN
admet-2740	177	75	roc	roc	PROPN
admet-2740	177	76	curve	curve	NOUN
admet-2740	177	77	analyses	analysis	NOUN
admet-2740	177	78	were	be	AUX
admet-2740	177	79	then	then	ADV
admet-2740	177	80	conducted	conduct	VERB
admet-2740	177	81	to	to	PART
admet-2740	177	82	assess	assess	VERB
admet-2740	177	83	the	the	DET
admet-2740	177	84	auc	auc	NOUN
admet-2740	177	85	and	and	CCONJ
admet-2740	177	86	determine	determine	VERB
admet-2740	177	87	the	the	DET
admet-2740	177	88	95	95	NUM
admet-2740	177	89	%	%	NOUN
admet-2740	177	90	confidence	confidence	NOUN
admet-2740	177	91	intervals	interval	NOUN
admet-2740	177	92	for	for	ADP
admet-2740	177	93	the	the	DET
admet-2740	177	94	inr	inr	PROPN
admet-2740	177	95	values	value	NOUN
admet-2740	177	96	in	in	ADP
admet-2740	177	97	comparison	comparison	NOUN
admet-2740	177	98	to	to	ADP
admet-2740	177	99	glycerol	glycerol	NOUN
admet-2740	177	100	3	3	NUM
admet-2740	177	101	-	-	PUNCT
admet-2740	177	102	phosphate	phosphate	NOUN
admet-2740	177	103	concentrations	concentration	NOUN
admet-2740	177	104	during	during	ADP
admet-2740	177	105	the	the	DET
admet-2740	177	106	warfarin	warfarin	NOUN
admet-2740	177	107	-	-	PUNCT
admet-2740	177	108	mango	mango	NOUN
admet-2740	177	109	interaction	interaction	NOUN
admet-2740	177	110	and	and	CCONJ
admet-2740	177	111	following	follow	VERB
admet-2740	177	112	mango	mango	NOUN
admet-2740	177	113	discontinuation	discontinuation	NOUN
admet-2740	177	114	(	(	PUNCT
admet-2740	177	115	control	control	NOUN
admet-2740	177	116	)	)	PUNCT
admet-2740	177	117	,	,	PUNCT
admet-2740	177	118	as	as	SCONJ
admet-2740	177	119	shown	show	VERB
admet-2740	177	120	in	in	ADP
admet-2740	177	121	figure	figure	NOUN
admet-2740	177	122	9a	9a	NOUN
admet-2740	177	123	and	and	CCONJ
admet-2740	177	124	9b	9b	NUM
admet-2740	177	125	,	,	PUNCT
admet-2740	177	126	respectively	respectively	ADV
admet-2740	177	127	.	.	PUNCT
admet-2740	178	1	the	the	DET
admet-2740	178	2	aucs	aucs	NOUN
admet-2740	178	3	were	be	AUX
admet-2740	178	4	0.9911	0.9911	NUM
admet-2740	178	5	(	(	PUNCT
admet-2740	178	6	95	95	NUM
admet-2740	178	7	%	%	NOUN
admet-2740	178	8	ci	ci	NOUN
admet-2740	178	9	:	:	PUNCT
admet-2740	178	10	0.9679	0.9679	NUM
admet-2740	178	11	to	to	PART
admet-2740	178	12	1.000	1.000	NUM
admet-2740	178	13	)	)	PUNCT
admet-2740	178	14	and	and	CCONJ
admet-2740	178	15	0.9422	0.9422	NUM
admet-2740	178	16	(	(	PUNCT
admet-2740	178	17	95	95	NUM
admet-2740	178	18	%	%	NOUN
admet-2740	178	19	ci	ci	NOUN
admet-2740	178	20	:	:	PUNCT
admet-2740	178	21	0.8317	0.8317	NUM
admet-2740	178	22	to	to	ADP
admet-2740	178	23	1.000	1.000	NUM
admet-2740	178	24	)	)	PUNCT
admet-2740	178	25	,	,	PUNCT
admet-2740	178	26	respectively	respectively	ADV
admet-2740	178	27	,	,	PUNCT
admet-2740	178	28	further	far	ADV
admet-2740	178	29	confirming	confirm	VERB
admet-2740	178	30	the	the	DET
admet-2740	178	31	potential	potential	NOUN
admet-2740	178	32	of	of	ADP
admet-2740	178	33	glycerol	glycerol	NOUN
admet-2740	178	34	3	3	NUM
admet-2740	178	35	-	-	NOUN
admet-2740	178	36	phosphate	phosphate	NOUN
admet-2740	178	37	as	as	ADP
admet-2740	178	38	a	a	DET
admet-2740	178	39	reliable	reliable	ADJ
admet-2740	178	40	biomarker	biomarker	NOUN
admet-2740	178	41	.	.	PUNCT
admet-2740	179	1	admet	admet	PROPN
admet-2740	179	2	&	&	CCONJ
admet-2740	179	3	dmpk	dmpk	PROPN
admet-2740	179	4	13(3	13(3	NUM
admet-2740	179	5	)	)	PUNCT
admet-2740	179	6	(	(	PUNCT
admet-2740	179	7	2025	2025	NUM
admet-2740	179	8	)	)	PUNCT
admet-2740	179	9	2740	2740	NUM
admet-2740	179	10	metabolic	metabolic	NOUN
admet-2740	179	11	insights	insight	NOUN
admet-2740	179	12	into	into	ADP
admet-2740	179	13	the	the	DET
admet-2740	179	14	warfarin	warfarin	NOUN
admet-2740	179	15	-	-	PUNCT
admet-2740	179	16	mango	mango	NOUN
admet-2740	179	17	interaction	interaction	NOUN
admet-2740	179	18	doi	doi	NOUN
admet-2740	179	19	:	:	PUNCT
admet-2740	179	20	https://doi.org/10.5599/admet.2740	https://doi.org/10.5599/admet.2740	NOUN
admet-2740	179	21	11	11	NUM
admet-2740	179	22	figure	figure	NOUN
admet-2740	179	23	8	8	NUM
admet-2740	179	24	.	.	PUNCT
admet-2740	180	1	(	(	PUNCT
admet-2740	180	2	a	a	X
admet-2740	180	3	)	)	PUNCT
admet-2740	180	4	the	the	DET
admet-2740	180	5	roc	roc	PROPN
admet-2740	180	6	curve	curve	NOUN
admet-2740	180	7	for	for	ADP
admet-2740	180	8	glycerol	glycerol	NOUN
admet-2740	180	9	3	3	NUM
admet-2740	180	10	-	-	NOUN
admet-2740	180	11	phosphate	phosphate	NOUN
admet-2740	180	12	,	,	PUNCT
admet-2740	180	13	demonstrating	demonstrate	VERB
admet-2740	180	14	an	an	DET
admet-2740	180	15	area	area	NOUN
admet-2740	180	16	under	under	ADP
admet-2740	180	17	the	the	DET
admet-2740	180	18	roc	roc	PROPN
admet-2740	180	19	curve	curve	NOUN
admet-2740	180	20	(	(	PUNCT
admet-2740	180	21	auroc	auroc	NOUN
admet-2740	180	22	)	)	PUNCT
admet-2740	180	23	of	of	ADP
admet-2740	180	24	0.72889	0.72889	NUM
admet-2740	180	25	,	,	PUNCT
admet-2740	180	26	suggesting	suggest	VERB
admet-2740	180	27	its	its	PRON
admet-2740	180	28	potential	potential	NOUN
admet-2740	180	29	as	as	ADP
admet-2740	180	30	a	a	DET
admet-2740	180	31	reliable	reliable	ADJ
admet-2740	180	32	biomarker	biomarker	NOUN
admet-2740	180	33	(	(	PUNCT
admet-2740	180	34	p	p	X
admet-2740	180	35	=	=	NOUN
admet-2740	180	36	0.041216	0.041216	NUM
admet-2740	180	37	)	)	PUNCT
admet-2740	180	38	.	.	PUNCT
admet-2740	181	1	(	(	PUNCT
admet-2740	181	2	b	b	X
admet-2740	181	3	)	)	PUNCT
admet-2740	181	4	comparison	comparison	NOUN
admet-2740	181	5	of	of	ADP
admet-2740	181	6	glycerol	glycerol	NOUN
admet-2740	181	7	3	3	NUM
admet-2740	181	8	-	-	PUNCT
admet-2740	181	9	phosphate	phosphate	ADJ
admet-2740	181	10	concentrations	concentration	NOUN
admet-2740	181	11	during	during	ADP
admet-2740	181	12	the	the	DET
admet-2740	181	13	warfarin	warfarin	NOUN
admet-2740	181	14	-	-	PUNCT
admet-2740	181	15	mango	mango	NOUN
admet-2740	181	16	interaction	interaction	NOUN
admet-2740	181	17	(	(	PUNCT
admet-2740	181	18	red	red	NOUN
admet-2740	181	19	)	)	PUNCT
admet-2740	181	20	versus	versus	ADP
admet-2740	181	21	after	after	ADP
admet-2740	181	22	discontinuing	discontinue	VERB
admet-2740	181	23	mango	mango	PROPN
admet-2740	181	24	consumption	consumption	NOUN
admet-2740	181	25	(	(	PUNCT
admet-2740	181	26	control	control	NOUN
admet-2740	181	27	,	,	PUNCT
admet-2740	181	28	green	green	ADJ
admet-2740	181	29	)	)	PUNCT
admet-2740	181	30	,	,	PUNCT
admet-2740	181	31	indicating	indicate	VERB
admet-2740	181	32	a	a	DET
admet-2740	181	33	significant	significant	ADJ
admet-2740	181	34	reduction	reduction	NOUN
admet-2740	181	35	in	in	ADP
admet-2740	181	36	glycerol	glycerol	NOUN
admet-2740	181	37	3	3	NUM
admet-2740	181	38	-	-	NOUN
admet-2740	181	39	phosphate	phosphate	NOUN
admet-2740	181	40	during	during	ADP
admet-2740	181	41	the	the	DET
admet-2740	181	42	drug	drug	NOUN
admet-2740	181	43	interaction	interaction	NOUN
admet-2740	181	44	figure	figure	NOUN
admet-2740	181	45	9	9	NUM
admet-2740	181	46	.	.	PUNCT
admet-2740	182	1	receiver	receiver	ADJ
admet-2740	182	2	operating	operate	VERB
admet-2740	182	3	characteristic	characteristic	NOUN
admet-2740	182	4	(	(	PUNCT
admet-2740	182	5	roc	roc	PROPN
admet-2740	182	6	)	)	PUNCT
admet-2740	182	7	curve	curve	NOUN
admet-2740	182	8	analyses	analysis	NOUN
admet-2740	182	9	enable	enable	VERB
admet-2740	182	10	assessment	assessment	NOUN
admet-2740	182	11	of	of	ADP
admet-2740	182	12	the	the	DET
admet-2740	182	13	area	area	NOUN
admet-2740	182	14	under	under	ADP
admet-2740	182	15	the	the	DET
admet-2740	182	16	curve	curve	NOUN
admet-2740	182	17	(	(	PUNCT
admet-2740	182	18	auc	auc	NOUN
admet-2740	182	19	)	)	PUNCT
admet-2740	182	20	and	and	CCONJ
admet-2740	182	21	determine	determine	VERB
admet-2740	182	22	the	the	DET
admet-2740	182	23	95	95	NUM
admet-2740	182	24	%	%	NOUN
admet-2740	182	25	confidence	confidence	NOUN
admet-2740	182	26	intervals	interval	NOUN
admet-2740	182	27	for	for	ADP
admet-2740	182	28	the	the	DET
admet-2740	182	29	international	international	ADJ
admet-2740	182	30	normalized	normalize	VERB
admet-2740	182	31	ratio	ratio	NOUN
admet-2740	182	32	(	(	PUNCT
admet-2740	182	33	inr	inr	PROPN
admet-2740	182	34	)	)	PUNCT
admet-2740	182	35	values	value	NOUN
admet-2740	182	36	in	in	ADP
admet-2740	182	37	comparison	comparison	NOUN
admet-2740	182	38	to	to	ADP
admet-2740	182	39	glycerol	glycerol	NOUN
admet-2740	182	40	3	3	NUM
admet-2740	182	41	-	-	PUNCT
admet-2740	182	42	phosphate	phosphate	NOUN
admet-2740	182	43	concentrations	concentration	NOUN
admet-2740	182	44	during	during	ADP
admet-2740	182	45	the	the	DET
admet-2740	182	46	warfarin	warfarin	NOUN
admet-2740	182	47	-	-	PUNCT
admet-2740	182	48	mango	mango	NOUN
admet-2740	182	49	interaction	interaction	NOUN
admet-2740	182	50	and	and	CCONJ
admet-2740	182	51	after	after	ADP
admet-2740	182	52	mango	mango	NOUN
admet-2740	182	53	discontinuation	discontinuation	NOUN
admet-2740	182	54	(	(	PUNCT
admet-2740	182	55	control	control	NOUN
admet-2740	182	56	)	)	PUNCT
admet-2740	182	57	.	.	PUNCT
admet-2740	183	1	(	(	PUNCT
admet-2740	183	2	a	a	X
admet-2740	183	3	)	)	PUNCT
admet-2740	183	4	the	the	DET
admet-2740	183	5	auc	auc	NOUN
admet-2740	183	6	during	during	ADP
admet-2740	183	7	the	the	DET
admet-2740	183	8	warfarin	warfarin	NOUN
admet-2740	183	9	-	-	PUNCT
admet-2740	183	10	mango	mango	NOUN
admet-2740	183	11	interaction	interaction	NOUN
admet-2740	183	12	was	be	AUX
admet-2740	183	13	0.9911	0.9911	NUM
admet-2740	183	14	(	(	PUNCT
admet-2740	183	15	95	95	NUM
admet-2740	183	16	%	%	NOUN
admet-2740	183	17	ci	ci	NOUN
admet-2740	183	18	:	:	PUNCT
admet-2740	183	19	0.9679	0.9679	NUM
admet-2740	183	20	to1.000	to1.000	NOUN
admet-2740	183	21	)	)	PUNCT
admet-2740	183	22	.	.	PUNCT
admet-2740	184	1	(	(	PUNCT
admet-2740	184	2	b	b	X
admet-2740	184	3	)	)	PUNCT
admet-2740	184	4	the	the	DET
admet-2740	184	5	auc	auc	NOUN
admet-2740	184	6	following	follow	VERB
admet-2740	184	7	mango	mango	NOUN
admet-2740	184	8	discontinuation	discontinuation	NOUN
admet-2740	184	9	(	(	PUNCT
admet-2740	184	10	control	control	NOUN
admet-2740	184	11	)	)	PUNCT
admet-2740	184	12	was	be	AUX
admet-2740	184	13	0.9422	0.9422	NUM
admet-2740	184	14	(	(	PUNCT
admet-2740	184	15	95	95	NUM
admet-2740	184	16	%	%	NOUN
admet-2740	184	17	ci	ci	NOUN
admet-2740	184	18	:	:	PUNCT
admet-2740	184	19	0.8317	0.8317	NUM
admet-2740	184	20	to	to	ADP
admet-2740	184	21	1.000	1.000	NUM
admet-2740	184	22	)	)	PUNCT
admet-2740	184	23	.	.	PUNCT
admet-2740	185	1	this	this	PRON
admet-2740	185	2	further	far	ADV
admet-2740	185	3	supports	support	VERB
admet-2740	185	4	the	the	DET
admet-2740	185	5	potential	potential	NOUN
admet-2740	185	6	of	of	ADP
admet-2740	185	7	glycerol	glycerol	NOUN
admet-2740	185	8	3	3	NUM
admet-2740	185	9	-	-	NOUN
admet-2740	185	10	phosphate	phosphate	NOUN
admet-2740	185	11	as	as	ADP
admet-2740	185	12	a	a	DET
admet-2740	185	13	reliable	reliable	ADJ
admet-2740	185	14	biomarker	biomarker	NOUN
admet-2740	185	15	discussion	discussion	NOUN
admet-2740	185	16	in	in	ADP
admet-2740	185	17	our	our	PRON
admet-2740	185	18	study	study	NOUN
admet-2740	185	19	,	,	PUNCT
admet-2740	185	20	all	all	DET
admet-2740	185	21	patients	patient	NOUN
admet-2740	185	22	experienced	experience	VERB
admet-2740	185	23	an	an	DET
admet-2740	185	24	increase	increase	NOUN
admet-2740	185	25	in	in	ADP
admet-2740	185	26	inr	inr	PROPN
admet-2740	185	27	following	follow	VERB
admet-2740	185	28	mango	mango	PROPN
admet-2740	185	29	consumption	consumption	NOUN
admet-2740	185	30	.	.	PUNCT
admet-2740	186	1	as	as	ADV
admet-2740	186	2	soon	soon	ADV
admet-2740	186	3	as	as	SCONJ
admet-2740	186	4	the	the	DET
admet-2740	186	5	consumption	consumption	NOUN
admet-2740	186	6	of	of	ADP
admet-2740	186	7	mango	mango	NOUN
admet-2740	186	8	was	be	AUX
admet-2740	186	9	identified	identify	VERB
admet-2740	186	10	as	as	ADP
admet-2740	186	11	a	a	DET
admet-2740	186	12	possible	possible	ADJ
admet-2740	186	13	cause	cause	NOUN
admet-2740	186	14	of	of	ADP
admet-2740	186	15	the	the	DET
admet-2740	186	16	supratherapeutic	supratherapeutic	ADJ
admet-2740	186	17	inr	inr	PROPN
admet-2740	186	18	,	,	PUNCT
admet-2740	186	19	the	the	DET
admet-2740	186	20	patients	patient	NOUN
admet-2740	186	21	were	be	AUX
admet-2740	186	22	advised	advise	VERB
admet-2740	186	23	to	to	PART
admet-2740	186	24	discontinue	discontinue	VERB
admet-2740	186	25	it	it	PRON
admet-2740	186	26	.	.	PUNCT
admet-2740	187	1	subsequently	subsequently	ADV
admet-2740	187	2	,	,	PUNCT
admet-2740	187	3	the	the	DET
admet-2740	187	4	mean	mean	NOUN
admet-2740	187	5	inr	inr	PROPN
admet-2740	187	6	decreased	decrease	VERB
admet-2740	187	7	from	from	ADP
admet-2740	187	8	4.57	4.57	NUM
admet-2740	187	9	±	±	NUM
admet-2740	187	10	1.46	1.46	NUM
admet-2740	187	11	to	to	ADP
admet-2740	187	12	2.45	2.45	NUM
admet-2740	187	13	±	±	NUM
admet-2740	187	14	0.39	0.39	NUM
admet-2740	187	15	,	,	PUNCT
admet-2740	187	16	with	with	ADP
admet-2740	187	17	a	a	DET
admet-2740	187	18	statistically	statistically	ADV
admet-2740	187	19	https://doi.org/10.5599/admet.2740	https://doi.org/10.5599/admet.2740	NOUN
admet-2740	187	20	p.	p.	NOUN
admet-2740	187	21	rattanasuwan	rattanasuwan	PROPN
admet-2740	187	22	et	et	PROPN
admet-2740	187	23	al	al	PROPN
admet-2740	187	24	.	.	PROPN
admet-2740	187	25	admet	admet	PROPN
admet-2740	187	26	&	&	CCONJ
admet-2740	187	27	dmpk	dmpk	PROPN
admet-2740	187	28	13(3	13(3	NUM
admet-2740	187	29	)	)	PUNCT
admet-2740	187	30	(	(	PUNCT
admet-2740	187	31	2025	2025	NUM
admet-2740	187	32	)	)	PUNCT
admet-2740	187	33	2740	2740	NUM
admet-2740	187	34	12	12	NUM
admet-2740	187	35	significant	significant	ADJ
admet-2740	187	36	difference	difference	NOUN
admet-2740	187	37	in	in	ADP
admet-2740	187	38	inr	inr	PROPN
admet-2740	187	39	levels	level	NOUN
admet-2740	187	40	between	between	ADP
admet-2740	187	41	periods	period	NOUN
admet-2740	187	42	of	of	ADP
admet-2740	187	43	mango	mango	NOUN
admet-2740	187	44	ingestion	ingestion	NOUN
admet-2740	187	45	and	and	CCONJ
admet-2740	187	46	post	post	NOUN
admet-2740	187	47	-	-	NOUN
admet-2740	187	48	discontinuation	discontinuation	NOUN
admet-2740	187	49	(	(	PUNCT
admet-2740	187	50	p	p	X
admet-2740	187	51	<	<	X
admet-2740	187	52	0.0001	0.0001	NUM
admet-2740	187	53	)	)	PUNCT
admet-2740	187	54	.	.	PUNCT
admet-2740	188	1	these	these	DET
admet-2740	188	2	results	result	NOUN
admet-2740	188	3	suggest	suggest	VERB
admet-2740	188	4	that	that	SCONJ
admet-2740	188	5	mango	mango	PROPN
admet-2740	188	6	consumption	consumption	NOUN
admet-2740	188	7	may	may	AUX
admet-2740	188	8	influence	influence	VERB
admet-2740	188	9	the	the	PRON
admet-2740	188	10	of	of	ADP
admet-2740	188	11	warfarin	warfarin	NOUN
admet-2740	188	12	,	,	PUNCT
admet-2740	188	13	a	a	DET
admet-2740	188	14	finding	finding	NOUN
admet-2740	188	15	which	which	PRON
admet-2740	188	16	is	be	AUX
admet-2740	188	17	in	in	ADP
admet-2740	188	18	alignment	alignment	NOUN
admet-2740	188	19	with	with	ADP
admet-2740	188	20	previous	previous	ADJ
admet-2740	188	21	studies	study	NOUN
admet-2740	188	22	[	[	X
admet-2740	188	23	5,7	5,7	NUM
admet-2740	188	24	]	]	PUNCT
admet-2740	188	25	.	.	PUNCT
admet-2740	189	1	however	however	ADV
admet-2740	189	2	,	,	PUNCT
admet-2740	189	3	the	the	DET
admet-2740	189	4	mechanisms	mechanism	NOUN
admet-2740	189	5	underlying	underlie	VERB
admet-2740	189	6	this	this	DET
admet-2740	189	7	drug	drug	NOUN
admet-2740	189	8	interaction	interaction	NOUN
admet-2740	189	9	remain	remain	AUX
admet-2740	189	10	poorly	poorly	ADV
admet-2740	189	11	understood	understand	VERB
admet-2740	189	12	[	[	PUNCT
admet-2740	189	13	5,7	5,7	NUM
admet-2740	189	14	]	]	PUNCT
admet-2740	189	15	.	.	PUNCT
admet-2740	190	1	therefore	therefore	ADV
admet-2740	190	2	,	,	PUNCT
admet-2740	190	3	this	this	DET
admet-2740	190	4	study	study	NOUN
admet-2740	190	5	aimed	aim	VERB
admet-2740	190	6	to	to	PART
admet-2740	190	7	further	far	ADV
admet-2740	190	8	elucidate	elucidate	VERB
admet-2740	190	9	the	the	DET
admet-2740	190	10	interaction	interaction	NOUN
admet-2740	190	11	between	between	ADP
admet-2740	190	12	warfarin	warfarin	NOUN
admet-2740	190	13	and	and	CCONJ
admet-2740	190	14	mango	mango	NOUN
admet-2740	190	15	by	by	ADP
admet-2740	190	16	integrating	integrate	VERB
admet-2740	190	17	clinical	clinical	ADJ
admet-2740	190	18	findings	finding	NOUN
admet-2740	190	19	with	with	ADP
admet-2740	190	20	molecular	molecular	ADJ
admet-2740	190	21	insights	insight	NOUN
admet-2740	190	22	derived	derive	VERB
admet-2740	190	23	from	from	ADP
admet-2740	190	24	1h	1h	NUM
admet-2740	190	25	-	-	PUNCT
admet-2740	190	26	nmr	nmr	NOUN
admet-2740	190	27	analysis	analysis	NOUN
admet-2740	190	28	.	.	PUNCT
admet-2740	191	1	metabolomic	metabolomic	ADJ
admet-2740	191	2	analysis	analysis	NOUN
admet-2740	191	3	identified	identify	VERB
admet-2740	191	4	glycerol	glycerol	NOUN
admet-2740	191	5	3	3	NUM
admet-2740	191	6	-	-	NOUN
admet-2740	191	7	phosphate	phosphate	NOUN
admet-2740	191	8	as	as	ADP
admet-2740	191	9	a	a	DET
admet-2740	191	10	potential	potential	ADJ
admet-2740	191	11	biomarker	biomarker	NOUN
admet-2740	191	12	for	for	ADP
admet-2740	191	13	elucidating	elucidate	VERB
admet-2740	191	14	the	the	DET
admet-2740	191	15	metabolic	metabolic	NOUN
admet-2740	191	16	alterations	alteration	NOUN
admet-2740	191	17	associated	associate	VERB
admet-2740	191	18	with	with	ADP
admet-2740	191	19	the	the	DET
admet-2740	191	20	warfarin	warfarin	NOUN
admet-2740	191	21	-	-	PUNCT
admet-2740	191	22	mango	mango	NOUN
admet-2740	191	23	interaction	interaction	NOUN
admet-2740	191	24	.	.	PUNCT
admet-2740	192	1	glycerol	glycerol	NOUN
admet-2740	192	2	3	3	NUM
admet-2740	192	3	-	-	PUNCT
admet-2740	192	4	phosphate	phosphate	NOUN
admet-2740	192	5	plays	play	VERB
admet-2740	192	6	a	a	DET
admet-2740	192	7	critical	critical	ADJ
admet-2740	192	8	role	role	NOUN
admet-2740	192	9	in	in	ADP
admet-2740	192	10	several	several	ADJ
admet-2740	192	11	metabolic	metabolic	NOUN
admet-2740	192	12	pathways	pathway	NOUN
admet-2740	192	13	,	,	PUNCT
admet-2740	192	14	including	include	VERB
admet-2740	192	15	the	the	DET
admet-2740	192	16	glycerol	glycerol	NOUN
admet-2740	192	17	phosphate	phosphate	NOUN
admet-2740	192	18	shuttle	shuttle	NOUN
admet-2740	192	19	,	,	PUNCT
admet-2740	192	20	cardiolipin	cardiolipin	NOUN
admet-2740	192	21	biosynthesis	biosynthesis	NOUN
admet-2740	192	22	,	,	PUNCT
admet-2740	192	23	and	and	CCONJ
admet-2740	192	24	de	de	ADP
admet-2740	192	25	novo	novo	NOUN
admet-2740	192	26	triglyceride	triglyceride	ADV
admet-2740	192	27	biosynthesis	biosynthesis	VERB
admet-2740	192	28	,	,	PUNCT
admet-2740	192	29	which	which	PRON
admet-2740	192	30	were	be	AUX
admet-2740	192	31	highlighted	highlight	VERB
admet-2740	192	32	in	in	ADP
admet-2740	192	33	our	our	PRON
admet-2740	192	34	pathway	pathway	NOUN
admet-2740	192	35	enrichment	enrichment	NOUN
admet-2740	192	36	analyses	analysis	NOUN
admet-2740	192	37	.	.	PUNCT
admet-2740	193	1	the	the	DET
admet-2740	193	2	enrichment	enrichment	NOUN
admet-2740	193	3	analysis	analysis	NOUN
admet-2740	193	4	and	and	CCONJ
admet-2740	193	5	metabolite	metabolite	NOUN
admet-2740	193	6	-	-	PUNCT
admet-2740	193	7	metabolite	metabolite	NOUN
admet-2740	193	8	network	network	NOUN
admet-2740	193	9	from	from	ADP
admet-2740	193	10	metascape	metascape	NOUN
admet-2740	193	11	also	also	ADV
admet-2740	193	12	revealed	reveal	VERB
admet-2740	193	13	a	a	DET
admet-2740	193	14	connection	connection	NOUN
admet-2740	193	15	to	to	ADP
admet-2740	193	16	platelet	platelet	NOUN
admet-2740	193	17	activation	activation	NOUN
admet-2740	193	18	signalling	signal	VERB
admet-2740	193	19	and	and	CCONJ
admet-2740	193	20	aggregation	aggregation	NOUN
admet-2740	193	21	.	.	PUNCT
admet-2740	194	1	additionally	additionally	ADV
admet-2740	194	2	,	,	PUNCT
admet-2740	194	3	roc	roc	PROPN
admet-2740	194	4	curve	curve	NOUN
admet-2740	194	5	analyses	analysis	NOUN
admet-2740	194	6	were	be	AUX
admet-2740	194	7	performed	perform	VERB
admet-2740	194	8	to	to	PART
admet-2740	194	9	evaluate	evaluate	VERB
admet-2740	194	10	the	the	DET
admet-2740	194	11	auc	auc	NOUN
admet-2740	194	12	of	of	ADP
admet-2740	194	13	inr	inr	PROPN
admet-2740	194	14	values	value	NOUN
admet-2740	194	15	in	in	ADP
admet-2740	194	16	relation	relation	NOUN
admet-2740	194	17	to	to	PART
admet-2740	194	18	glycerol	glycerol	VERB
admet-2740	194	19	3	3	NUM
admet-2740	194	20	-	-	PUNCT
admet-2740	194	21	phosphate	phosphate	ADJ
admet-2740	194	22	concentrations	concentration	NOUN
admet-2740	194	23	,	,	PUNCT
admet-2740	194	24	further	far	ADV
admet-2740	194	25	supporting	support	VERB
admet-2740	194	26	its	its	PRON
admet-2740	194	27	potential	potential	NOUN
admet-2740	194	28	as	as	ADP
admet-2740	194	29	a	a	DET
admet-2740	194	30	reliable	reliable	ADJ
admet-2740	194	31	biomarker	biomarker	NOUN
admet-2740	194	32	.	.	PUNCT
admet-2740	195	1	our	our	PRON
admet-2740	195	2	findings	finding	NOUN
admet-2740	195	3	demonstrated	demonstrate	VERB
admet-2740	195	4	a	a	DET
admet-2740	195	5	decrease	decrease	NOUN
admet-2740	195	6	in	in	ADP
admet-2740	195	7	the	the	DET
admet-2740	195	8	concentration	concentration	NOUN
admet-2740	195	9	of	of	ADP
admet-2740	195	10	glycerol	glycerol	NOUN
admet-2740	195	11	3	3	NUM
admet-2740	195	12	-	-	NOUN
admet-2740	195	13	phosphate	phosphate	NOUN
admet-2740	195	14	during	during	ADP
admet-2740	195	15	the	the	DET
admet-2740	195	16	warfarin	warfarin	NOUN
admet-2740	195	17	-	-	PUNCT
admet-2740	195	18	mango	mango	NOUN
admet-2740	195	19	interaction	interaction	NOUN
admet-2740	195	20	,	,	PUNCT
admet-2740	195	21	consistent	consistent	ADJ
admet-2740	195	22	with	with	ADP
admet-2740	195	23	a	a	DET
admet-2740	195	24	previous	previous	ADJ
admet-2740	195	25	study	study	NOUN
admet-2740	195	26	that	that	PRON
admet-2740	195	27	reported	report	VERB
admet-2740	195	28	a	a	DET
admet-2740	195	29	significant	significant	ADJ
admet-2740	195	30	increase	increase	NOUN
admet-2740	195	31	in	in	ADP
admet-2740	195	32	glycerol	glycerol	NOUN
admet-2740	195	33	3	3	NUM
admet-2740	195	34	-	-	PUNCT
admet-2740	195	35	phosphate	phosphate	NOUN
admet-2740	195	36	concentrations	concentration	NOUN
admet-2740	195	37	during	during	ADP
admet-2740	195	38	platelet	platelet	NOUN
admet-2740	195	39	activation	activation	NOUN
admet-2740	195	40	[	[	X
admet-2740	195	41	23	23	NUM
admet-2740	195	42	]	]	PUNCT
admet-2740	195	43	.	.	PUNCT
admet-2740	196	1	this	this	DET
admet-2740	196	2	inverse	inverse	NOUN
admet-2740	196	3	relationship	relationship	NOUN
admet-2740	196	4	suggests	suggest	VERB
admet-2740	196	5	that	that	SCONJ
admet-2740	196	6	the	the	DET
admet-2740	196	7	mechanism	mechanism	NOUN
admet-2740	196	8	underlying	underlie	VERB
admet-2740	196	9	this	this	DET
admet-2740	196	10	interaction	interaction	NOUN
admet-2740	196	11	may	may	AUX
admet-2740	196	12	be	be	AUX
admet-2740	196	13	attributable	attributable	ADJ
admet-2740	196	14	to	to	PART
admet-2740	196	15	interference	interference	VERB
admet-2740	196	16	with	with	ADP
admet-2740	196	17	platelet	platelet	NOUN
admet-2740	196	18	metabolism	metabolism	NOUN
admet-2740	196	19	associated	associate	VERB
admet-2740	196	20	with	with	ADP
admet-2740	196	21	alterations	alteration	NOUN
admet-2740	196	22	in	in	ADP
admet-2740	196	23	glycerol	glycerol	NOUN
admet-2740	196	24	3	3	NUM
admet-2740	196	25	-	-	PUNCT
admet-2740	196	26	phosphate	phosphate	ADJ
admet-2740	196	27	concentrations	concentration	NOUN
admet-2740	196	28	.	.	PUNCT
admet-2740	197	1	additionally	additionally	ADV
admet-2740	197	2	,	,	PUNCT
admet-2740	197	3	a	a	DET
admet-2740	197	4	previous	previous	ADJ
admet-2740	197	5	study	study	NOUN
admet-2740	197	6	suggests	suggest	VERB
admet-2740	197	7	that	that	SCONJ
admet-2740	197	8	glycolysis	glycolysis	NOUN
admet-2740	197	9	serves	serve	VERB
admet-2740	197	10	as	as	ADP
admet-2740	197	11	a	a	DET
admet-2740	197	12	major	major	ADJ
admet-2740	197	13	connecting	connect	VERB
admet-2740	197	14	link	link	NOUN
admet-2740	197	15	between	between	ADP
admet-2740	197	16	various	various	ADJ
admet-2740	197	17	metabolic	metabolic	NOUN
admet-2740	197	18	pathways	pathway	NOUN
admet-2740	197	19	in	in	ADP
admet-2740	197	20	platelets	platelet	NOUN
admet-2740	197	21	[	[	X
admet-2740	197	22	23	23	NUM
admet-2740	197	23	]	]	PUNCT
admet-2740	197	24	.	.	PUNCT
admet-2740	198	1	glycolytic	glycolytic	ADJ
admet-2740	198	2	intermediates	intermediate	NOUN
admet-2740	198	3	produced	produce	VERB
admet-2740	198	4	during	during	ADP
admet-2740	198	5	metabolic	metabolic	NOUN
admet-2740	198	6	switching	switch	VERB
admet-2740	198	7	facilitate	facilitate	NOUN
admet-2740	198	8	lipid	lipid	NOUN
admet-2740	198	9	,	,	PUNCT
admet-2740	198	10	nucleotide	nucleotide	NOUN
admet-2740	198	11	,	,	PUNCT
admet-2740	198	12	and	and	CCONJ
admet-2740	198	13	amino	amino	NOUN
admet-2740	198	14	acid	acid	NOUN
admet-2740	198	15	metabolism	metabolism	NOUN
admet-2740	198	16	,	,	PUNCT
admet-2740	198	17	thereby	thereby	ADV
admet-2740	198	18	supporting	support	VERB
admet-2740	198	19	platelet	platelet	NOUN
admet-2740	198	20	activation	activation	NOUN
admet-2740	198	21	[	[	X
admet-2740	198	22	23	23	NUM
admet-2740	198	23	]	]	PUNCT
admet-2740	198	24	.	.	PUNCT
admet-2740	199	1	notably	notably	ADV
admet-2740	199	2	,	,	PUNCT
admet-2740	199	3	glycerol	glycerol	NOUN
admet-2740	199	4	3	3	NOUN
admet-2740	199	5	-	-	NOUN
admet-2740	199	6	phosphate	phosphate	NOUN
admet-2740	199	7	,	,	PUNCT
admet-2740	199	8	a	a	DET
admet-2740	199	9	key	key	ADJ
admet-2740	199	10	metabolite	metabolite	NOUN
admet-2740	199	11	,	,	PUNCT
admet-2740	199	12	promotes	promote	VERB
admet-2740	199	13	the	the	DET
admet-2740	199	14	synthesis	synthesis	NOUN
admet-2740	199	15	of	of	ADP
admet-2740	199	16	other	other	ADJ
admet-2740	199	17	cellular	cellular	ADJ
admet-2740	199	18	phospholipids	phospholipid	NOUN
admet-2740	199	19	essential	essential	ADJ
admet-2740	199	20	for	for	ADP
admet-2740	199	21	platelet	platelet	NOUN
admet-2740	199	22	activation	activation	NOUN
admet-2740	199	23	[	[	X
admet-2740	199	24	23	23	NUM
admet-2740	199	25	]	]	PUNCT
admet-2740	199	26	.	.	PUNCT
admet-2740	200	1	platelet	platelet	NOUN
admet-2740	200	2	activation	activation	NOUN
admet-2740	200	3	is	be	AUX
admet-2740	200	4	a	a	DET
admet-2740	200	5	highly	highly	ADV
admet-2740	200	6	dynamic	dynamic	ADJ
admet-2740	200	7	process	process	NOUN
admet-2740	200	8	characterized	characterize	VERB
admet-2740	200	9	by	by	ADP
admet-2740	200	10	the	the	DET
admet-2740	200	11	activation	activation	NOUN
admet-2740	200	12	of	of	ADP
admet-2740	200	13	integrin	integrin	NOUN
admet-2740	200	14	αiibβ3	αiibβ3	PROPN
admet-2740	200	15	,	,	PUNCT
admet-2740	200	16	degranulation	degranulation	NOUN
admet-2740	200	17	,	,	PUNCT
admet-2740	200	18	aggregation	aggregation	NOUN
admet-2740	200	19	,	,	PUNCT
admet-2740	200	20	and	and	CCONJ
admet-2740	200	21	cytoskeletal	cytoskeletal	ADJ
admet-2740	200	22	rearrangement	rearrangement	NOUN
admet-2740	201	1	[	[	X
admet-2740	201	2	23	23	NUM
admet-2740	201	3	-	-	SYM
admet-2740	201	4	25	25	NUM
admet-2740	201	5	]	]	PUNCT
admet-2740	201	6	.	.	PUNCT
admet-2740	202	1	these	these	DET
admet-2740	202	2	events	event	NOUN
admet-2740	202	3	arise	arise	VERB
admet-2740	202	4	from	from	ADP
admet-2740	202	5	a	a	DET
admet-2740	202	6	synergistic	synergistic	ADJ
admet-2740	202	7	interplay	interplay	NOUN
admet-2740	202	8	between	between	ADP
admet-2740	202	9	platelet	platelet	NOUN
admet-2740	202	10	signalling	signalling	ADJ
admet-2740	202	11	and	and	CCONJ
admet-2740	202	12	metabolic	metabolic	NOUN
admet-2740	202	13	pathways	pathway	NOUN
admet-2740	203	1	[	[	X
admet-2740	203	2	23	23	NUM
admet-2740	203	3	-	-	SYM
admet-2740	203	4	25	25	NUM
admet-2740	203	5	]	]	PUNCT
admet-2740	203	6	.	.	PUNCT
admet-2740	204	1	in	in	ADP
admet-2740	204	2	their	their	PRON
admet-2740	204	3	resting	rest	VERB
admet-2740	204	4	state	state	NOUN
admet-2740	204	5	,	,	PUNCT
admet-2740	204	6	platelets	platelet	VERB
admet-2740	204	7	rely	rely	VERB
admet-2740	204	8	on	on	ADP
admet-2740	204	9	both	both	PRON
admet-2740	204	10	glycolysis	glycolysis	NOUN
admet-2740	204	11	and	and	CCONJ
admet-2740	204	12	oxidative	oxidative	ADJ
admet-2740	204	13	phosphorylation	phosphorylation	NOUN
admet-2740	204	14	to	to	PART
admet-2740	204	15	meet	meet	VERB
admet-2740	204	16	their	their	PRON
admet-2740	204	17	energy	energy	NOUN
admet-2740	204	18	requirements	requirement	NOUN
admet-2740	204	19	[	[	X
admet-2740	204	20	23,26	23,26	NUM
admet-2740	204	21	]	]	X
admet-2740	204	22	.	.	PUNCT
admet-2740	205	1	although	although	SCONJ
admet-2740	205	2	activated	activate	VERB
admet-2740	205	3	platelets	platelet	NOUN
admet-2740	205	4	preferentially	preferentially	ADV
admet-2740	205	5	shift	shift	VERB
admet-2740	205	6	their	their	PRON
admet-2740	205	7	energy	energy	NOUN
admet-2740	205	8	metabolism	metabolism	NOUN
admet-2740	205	9	towards	towards	ADP
admet-2740	205	10	glycolysis	glycolysis	NOUN
admet-2740	205	11	,	,	PUNCT
admet-2740	205	12	mitochondrial	mitochondrial	ADJ
admet-2740	205	13	oxidation	oxidation	NOUN
admet-2740	205	14	remains	remain	VERB
admet-2740	205	15	essential	essential	ADJ
admet-2740	205	16	,	,	PUNCT
admet-2740	205	17	effectively	effectively	ADV
admet-2740	205	18	compensating	compensate	VERB
admet-2740	205	19	for	for	ADP
admet-2740	205	20	any	any	DET
admet-2740	205	21	impairment	impairment	NOUN
admet-2740	205	22	in	in	ADP
admet-2740	205	23	glycolysis	glycolysis	NOUN
admet-2740	205	24	and	and	CCONJ
admet-2740	205	25	ensuring	ensure	VERB
admet-2740	205	26	adequate	adequate	ADJ
admet-2740	205	27	energy	energy	NOUN
admet-2740	205	28	supply	supply	NOUN
admet-2740	205	29	[	[	X
admet-2740	205	30	23,27	23,27	NUM
admet-2740	205	31	-	-	SYM
admet-2740	205	32	32	32	NUM
admet-2740	205	33	]	]	PUNCT
admet-2740	205	34	.	.	PUNCT
admet-2740	206	1	recent	recent	ADJ
admet-2740	206	2	studies	study	NOUN
admet-2740	206	3	suggest	suggest	VERB
admet-2740	206	4	that	that	SCONJ
admet-2740	206	5	targeting	target	VERB
admet-2740	206	6	specific	specific	ADJ
admet-2740	206	7	metabolic	metabolic	NOUN
admet-2740	206	8	pathways	pathway	NOUN
admet-2740	206	9	in	in	ADP
admet-2740	206	10	platelets	platelet	NOUN
admet-2740	206	11	may	may	AUX
admet-2740	206	12	provide	provide	VERB
admet-2740	206	13	therapeutic	therapeutic	ADJ
admet-2740	206	14	strategies	strategy	NOUN
admet-2740	206	15	to	to	PART
admet-2740	206	16	mitigate	mitigate	VERB
admet-2740	206	17	platelet	platelet	NOUN
admet-2740	206	18	activation	activation	NOUN
admet-2740	206	19	and	and	CCONJ
admet-2740	206	20	thrombosis	thrombosis	NOUN
admet-2740	207	1	[	[	X
admet-2740	207	2	27,28,31,33	27,28,31,33	NUM
admet-2740	207	3	]	]	PUNCT
admet-2740	207	4	.	.	PUNCT
admet-2740	208	1	platelet	platelet	NOUN
admet-2740	208	2	activation	activation	NOUN
admet-2740	208	3	is	be	AUX
admet-2740	208	4	known	know	VERB
admet-2740	208	5	to	to	PART
admet-2740	208	6	be	be	AUX
admet-2740	208	7	associated	associate	VERB
admet-2740	208	8	with	with	ADP
admet-2740	208	9	enhanced	enhanced	ADJ
admet-2740	208	10	aerobic	aerobic	ADJ
admet-2740	208	11	glycolysis	glycolysis	NOUN
admet-2740	208	12	,	,	PUNCT
admet-2740	208	13	and	and	CCONJ
admet-2740	208	14	this	this	DET
admet-2740	208	15	process	process	NOUN
admet-2740	208	16	,	,	PUNCT
admet-2740	208	17	along	along	ADP
admet-2740	208	18	with	with	ADP
admet-2740	208	19	the	the	DET
admet-2740	208	20	key	key	ADJ
admet-2740	208	21	substrates	substrate	NOUN
admet-2740	208	22	derived	derive	VERB
admet-2740	208	23	from	from	ADP
admet-2740	208	24	onecarbon	onecarbon	NOUN
admet-2740	208	25	metabolism	metabolism	NOUN
admet-2740	208	26	,	,	PUNCT
admet-2740	208	27	plays	play	VERB
admet-2740	208	28	an	an	DET
admet-2740	208	29	important	important	ADJ
admet-2740	208	30	role	role	NOUN
admet-2740	208	31	in	in	ADP
admet-2740	208	32	facilitating	facilitate	VERB
admet-2740	208	33	platelet	platelet	NOUN
admet-2740	208	34	activation	activation	NOUN
admet-2740	208	35	[	[	X
admet-2740	208	36	23	23	NUM
admet-2740	208	37	]	]	PUNCT
admet-2740	208	38	.	.	PUNCT
admet-2740	209	1	glycerol-3	glycerol-3	NOUN
admet-2740	209	2	-	-	PUNCT
admet-2740	209	3	phosphate	phosphate	NOUN
admet-2740	209	4	is	be	AUX
admet-2740	209	5	a	a	DET
admet-2740	209	6	central	central	ADJ
admet-2740	209	7	metabolite	metabolite	NOUN
admet-2740	209	8	intersecting	intersect	VERB
admet-2740	209	9	four	four	NUM
admet-2740	209	10	critical	critical	ADJ
admet-2740	209	11	pathways	pathway	NOUN
admet-2740	209	12	in	in	ADP
admet-2740	209	13	cellular	cellular	ADJ
admet-2740	209	14	metabolism	metabolism	NOUN
admet-2740	209	15	:	:	PUNCT
admet-2740	209	16	1	1	NUM
admet-2740	209	17	)	)	PUNCT
admet-2740	209	18	glycolysis	glycolysis	NOUN
admet-2740	209	19	,	,	PUNCT
admet-2740	209	20	2	2	X
admet-2740	209	21	)	)	PUNCT
admet-2740	209	22	glycerolipid	glycerolipid	ADJ
admet-2740	209	23	synthesis	synthesis	NOUN
admet-2740	209	24	and	and	CCONJ
admet-2740	209	25	the	the	DET
admet-2740	209	26	glycerolipid	glycerolipid	ADJ
admet-2740	209	27	/	/	SYM
admet-2740	209	28	free	free	ADJ
admet-2740	209	29	fatty	fatty	NOUN
admet-2740	209	30	acid	acid	NOUN
admet-2740	209	31	cycle	cycle	NOUN
admet-2740	209	32	,	,	PUNCT
admet-2740	209	33	3	3	X
admet-2740	209	34	)	)	PUNCT
admet-2740	209	35	gluconeogenesis	gluconeogenesis	NOUN
admet-2740	209	36	,	,	PUNCT
admet-2740	209	37	and	and	CCONJ
admet-2740	209	38	4	4	X
admet-2740	209	39	)	)	PUNCT
admet-2740	209	40	energy	energy	NOUN
admet-2740	209	41	metabolism	metabolism	NOUN
admet-2740	209	42	via	via	ADP
admet-2740	209	43	the	the	DET
admet-2740	209	44	glycerol	glycerol	NOUN
admet-2740	209	45	phosphate	phosphate	NOUN
admet-2740	209	46	shuttle	shuttle	NOUN
admet-2740	209	47	,	,	PUNCT
admet-2740	209	48	which	which	PRON
admet-2740	209	49	facilitates	facilitate	VERB
admet-2740	209	50	electron	electron	NOUN
admet-2740	209	51	transfer	transfer	NOUN
admet-2740	209	52	to	to	ADP
admet-2740	209	53	mitochondria	mitochondria	PROPN
admet-2740	209	54	[	[	X
admet-2740	209	55	34	34	NUM
admet-2740	209	56	]	]	PUNCT
admet-2740	209	57	.	.	PUNCT
admet-2740	210	1	cytoplasmic	cytoplasmic	ADJ
admet-2740	210	2	glycerol-3	glycerol-3	NOUN
admet-2740	210	3	-	-	PUNCT
admet-2740	210	4	phosphate	phosphate	NOUN
admet-2740	210	5	dehydrogenase	dehydrogenase	NOUN
admet-2740	210	6	(	(	PUNCT
admet-2740	210	7	cg3pdh	cg3pdh	NOUN
admet-2740	210	8	)	)	PUNCT
admet-2740	210	9	reduces	reduce	VERB
admet-2740	210	10	dihydroxyacetone	dihydroxyacetone	NOUN
admet-2740	210	11	phosphate	phosphate	NOUN
admet-2740	210	12	(	(	PUNCT
admet-2740	210	13	dhap	dhap	NOUN
admet-2740	210	14	)	)	PUNCT
admet-2740	210	15	to	to	ADP
admet-2740	210	16	glycerol-3	glycerol-3	NOUN
admet-2740	210	17	-	-	PUNCT
admet-2740	210	18	phosphate	phosphate	NOUN
admet-2740	210	19	,	,	PUNCT
admet-2740	210	20	utilizing	utilize	VERB
admet-2740	210	21	nadh	nadh	NOUN
admet-2740	210	22	[	[	X
admet-2740	210	23	34	34	NUM
admet-2740	210	24	-	-	SYM
admet-2740	210	25	37	37	NUM
admet-2740	210	26	]	]	PUNCT
admet-2740	210	27	.	.	PUNCT
admet-2740	211	1	glycerol-3	glycerol-3	NOUN
admet-2740	211	2	-	-	PUNCT
admet-2740	211	3	phosphate	phosphate	NOUN
admet-2740	211	4	is	be	AUX
admet-2740	211	5	subsequently	subsequently	ADV
admet-2740	211	6	oxidized	oxidize	VERB
admet-2740	211	7	back	back	ADV
admet-2740	211	8	to	to	ADP
admet-2740	211	9	dhap	dhap	NOUN
admet-2740	211	10	by	by	ADP
admet-2740	211	11	mitochondrial	mitochondrial	ADJ
admet-2740	211	12	glycerol-3	glycerol-3	NOUN
admet-2740	211	13	-	-	PUNCT
admet-2740	211	14	phosphate	phosphate	NOUN
admet-2740	211	15	dehydrogenase	dehydrogenase	NOUN
admet-2740	211	16	(	(	PUNCT
admet-2740	211	17	mg3pdh	mg3pdh	NOUN
admet-2740	211	18	)	)	PUNCT
admet-2740	211	19	,	,	PUNCT
admet-2740	211	20	transferring	transfer	VERB
admet-2740	211	21	electrons	electron	NOUN
admet-2740	211	22	to	to	PART
admet-2740	211	23	fad	fad	VERB
admet-2740	211	24	to	to	PART
admet-2740	211	25	generate	generate	VERB
admet-2740	211	26	fadh2	fadh2	PROPN
admet-2740	211	27	,	,	PUNCT
admet-2740	211	28	which	which	PRON
admet-2740	211	29	enters	enter	VERB
admet-2740	211	30	the	the	DET
admet-2740	211	31	electron	electron	NOUN
admet-2740	211	32	transport	transport	NOUN
admet-2740	211	33	chain	chain	NOUN
admet-2740	211	34	for	for	ADP
admet-2740	211	35	oxidative	oxidative	ADJ
admet-2740	211	36	phosphorylation	phosphorylation	NOUN
admet-2740	211	37	[	[	X
admet-2740	211	38	34	34	NUM
admet-2740	211	39	-	-	SYM
admet-2740	211	40	37	37	NUM
admet-2740	211	41	]	]	PUNCT
admet-2740	211	42	.	.	PUNCT
admet-2740	212	1	this	this	DET
admet-2740	212	2	process	process	NOUN
admet-2740	212	3	effectively	effectively	ADV
admet-2740	212	4	transfers	transfer	VERB
admet-2740	212	5	electrons	electron	NOUN
admet-2740	212	6	from	from	ADP
admet-2740	212	7	cytosolic	cytosolic	NOUN
admet-2740	212	8	nadh	nadh	NOUN
admet-2740	212	9	to	to	ADP
admet-2740	212	10	mitochondrial	mitochondrial	ADJ
admet-2740	212	11	fad+	fad+	NOUN
admet-2740	212	12	,	,	PUNCT
admet-2740	212	13	contributing	contribute	VERB
admet-2740	212	14	to	to	ADP
admet-2740	212	15	atp	atp	PROPN
admet-2740	212	16	production	production	NOUN
admet-2740	212	17	[	[	X
admet-2740	212	18	34	34	NUM
admet-2740	212	19	-	-	SYM
admet-2740	212	20	37	37	NUM
admet-2740	212	21	]	]	PUNCT
admet-2740	212	22	.	.	PUNCT
admet-2740	213	1	concurrently	concurrently	ADV
admet-2740	213	2	,	,	PUNCT
admet-2740	213	3	glycerol-3	glycerol-3	NOUN
admet-2740	213	4	-	-	PUNCT
admet-2740	213	5	phosphate	phosphate	NOUN
admet-2740	213	6	serves	serve	VERB
admet-2740	213	7	as	as	ADP
admet-2740	213	8	a	a	DET
admet-2740	213	9	precursor	precursor	NOUN
admet-2740	213	10	for	for	ADP
admet-2740	213	11	cardiolipin	cardiolipin	NOUN
admet-2740	213	12	biosynthesis	biosynthesis	NOUN
admet-2740	213	13	,	,	PUNCT
admet-2740	213	14	an	an	DET
admet-2740	213	15	essential	essential	ADJ
admet-2740	213	16	phospholipid	phospholipid	NOUN
admet-2740	213	17	that	that	PRON
admet-2740	213	18	constitutes	constitute	VERB
admet-2740	213	19	a	a	DET
admet-2740	213	20	significant	significant	ADJ
admet-2740	213	21	portion	portion	NOUN
admet-2740	213	22	of	of	ADP
admet-2740	213	23	the	the	DET
admet-2740	213	24	inner	inner	ADJ
admet-2740	213	25	mitochondrial	mitochondrial	ADJ
admet-2740	213	26	membrane	membrane	NOUN
admet-2740	213	27	[	[	X
admet-2740	213	28	38	38	NUM
admet-2740	213	29	-	-	SYM
admet-2740	213	30	43	43	NUM
admet-2740	213	31	]	]	PUNCT
admet-2740	213	32	.	.	PUNCT
admet-2740	214	1	this	this	DET
admet-2740	214	2	pathway	pathway	NOUN
admet-2740	214	3	involves	involve	VERB
admet-2740	214	4	multiple	multiple	ADJ
admet-2740	214	5	enzymatic	enzymatic	ADJ
admet-2740	214	6	steps	step	NOUN
admet-2740	214	7	,	,	PUNCT
admet-2740	214	8	starting	start	VERB
admet-2740	214	9	with	with	ADP
admet-2740	214	10	the	the	DET
admet-2740	214	11	formation	formation	NOUN
admet-2740	214	12	of	of	ADP
admet-2740	214	13	glycerol-3	glycerol-3	NOUN
admet-2740	214	14	-	-	PUNCT
admet-2740	214	15	phosphate	phosphate	NOUN
admet-2740	214	16	,	,	PUNCT
admet-2740	214	17	followed	follow	VERB
admet-2740	214	18	by	by	ADP
admet-2740	214	19	acylation	acylation	NOUN
admet-2740	214	20	reactions	reaction	NOUN
admet-2740	214	21	that	that	PRON
admet-2740	214	22	lead	lead	VERB
admet-2740	214	23	to	to	PART
admet-2740	214	24	cardiolipin	cardiolipin	NOUN
admet-2740	214	25	production	production	NOUN
admet-2740	214	26	[	[	X
admet-2740	214	27	38	38	NUM
admet-2740	214	28	-	-	SYM
admet-2740	214	29	43	43	NUM
admet-2740	214	30	]	]	PUNCT
admet-2740	214	31	.	.	PUNCT
admet-2740	215	1	this	this	DET
admet-2740	215	2	synthesis	synthesis	NOUN
admet-2740	215	3	pathway	pathway	NOUN
admet-2740	215	4	is	be	AUX
admet-2740	215	5	essential	essential	ADJ
admet-2740	215	6	for	for	ADP
admet-2740	215	7	mitochondrial	mitochondrial	ADJ
admet-2740	215	8	function	function	NOUN
admet-2740	215	9	and	and	CCONJ
admet-2740	215	10	the	the	DET
admet-2740	215	11	integrity	integrity	NOUN
admet-2740	215	12	of	of	ADP
admet-2740	215	13	the	the	DET
admet-2740	215	14	electron	electron	NOUN
admet-2740	215	15	transport	transport	NOUN
admet-2740	215	16	chain	chain	NOUN
admet-2740	216	1	[	[	X
admet-2740	216	2	38	38	NUM
admet-2740	216	3	-	-	SYM
admet-2740	216	4	43	43	NUM
admet-2740	216	5	]	]	PUNCT
admet-2740	216	6	.	.	PUNCT
admet-2740	217	1	additionally	additionally	ADV
admet-2740	217	2	,	,	PUNCT
admet-2740	217	3	de	de	X
admet-2740	217	4	novo	novo	NOUN
admet-2740	217	5	triglyceride	triglyceride	ADJ
admet-2740	217	6	biosynthesis	biosynthesis	NOUN
admet-2740	217	7	begins	begin	VERB
admet-2740	217	8	with	with	ADP
admet-2740	217	9	admet	admet	PROPN
admet-2740	217	10	&	&	CCONJ
admet-2740	217	11	dmpk	dmpk	PROPN
admet-2740	217	12	13(3	13(3	NUM
admet-2740	217	13	)	)	PUNCT
admet-2740	217	14	(	(	PUNCT
admet-2740	217	15	2025	2025	NUM
admet-2740	217	16	)	)	PUNCT
admet-2740	217	17	2740	2740	NUM
admet-2740	217	18	metabolic	metabolic	NOUN
admet-2740	217	19	insights	insight	NOUN
admet-2740	217	20	into	into	ADP
admet-2740	217	21	the	the	DET
admet-2740	217	22	warfarin	warfarin	NOUN
admet-2740	217	23	-	-	PUNCT
admet-2740	217	24	mango	mango	NOUN
admet-2740	217	25	interaction	interaction	NOUN
admet-2740	217	26	doi	doi	NOUN
admet-2740	217	27	:	:	PUNCT
admet-2740	217	28	https://doi.org/10.5599/admet.2740	https://doi.org/10.5599/admet.2740	NOUN
admet-2740	217	29	13	13	NUM
admet-2740	217	30	glycerol-3	glycerol-3	NUM
admet-2740	217	31	-	-	PUNCT
admet-2740	217	32	phosphate	phosphate	NOUN
admet-2740	217	33	derived	derive	VERB
admet-2740	217	34	from	from	ADP
admet-2740	217	35	glycolysis	glycolysis	NOUN
admet-2740	217	36	,	,	PUNCT
admet-2740	217	37	which	which	PRON
admet-2740	217	38	is	be	AUX
admet-2740	217	39	then	then	ADV
admet-2740	217	40	processed	process	VERB
admet-2740	217	41	enzymatically	enzymatically	ADV
admet-2740	217	42	to	to	PART
admet-2740	217	43	form	form	VERB
admet-2740	217	44	triacylglycerol	triacylglycerol	NOUN
admet-2740	217	45	,	,	PUNCT
admet-2740	217	46	a	a	DET
admet-2740	217	47	key	key	ADJ
admet-2740	217	48	energy	energy	NOUN
admet-2740	217	49	storage	storage	NOUN
admet-2740	217	50	molecule	molecule	NOUN
admet-2740	217	51	[	[	X
admet-2740	217	52	44	44	NUM
admet-2740	217	53	-	-	SYM
admet-2740	217	54	47	47	NUM
admet-2740	217	55	]	]	PUNCT
admet-2740	217	56	.	.	PUNCT
admet-2740	218	1	together	together	ADV
admet-2740	218	2	,	,	PUNCT
admet-2740	218	3	the	the	DET
admet-2740	218	4	glycerol	glycerol	NOUN
admet-2740	218	5	phosphate	phosphate	NOUN
admet-2740	218	6	shuttle	shuttle	NOUN
admet-2740	218	7	,	,	PUNCT
admet-2740	218	8	cardiolipin	cardiolipin	NOUN
admet-2740	218	9	biosynthesis	biosynthesis	NOUN
admet-2740	218	10	,	,	PUNCT
admet-2740	218	11	and	and	CCONJ
admet-2740	218	12	de	de	ADP
admet-2740	218	13	novo	novo	NOUN
admet-2740	218	14	triglyceride	triglyceride	ADJ
admet-2740	218	15	biosynthesis	biosynthesis	NOUN
admet-2740	218	16	are	be	AUX
admet-2740	218	17	interconnected	interconnect	VERB
admet-2740	218	18	through	through	ADP
admet-2740	218	19	glycerol-3	glycerol-3	NOUN
admet-2740	218	20	-	-	PUNCT
admet-2740	218	21	phosphate	phosphate	NOUN
admet-2740	218	22	,	,	PUNCT
admet-2740	218	23	highlighting	highlight	VERB
admet-2740	218	24	its	its	PRON
admet-2740	218	25	essential	essential	ADJ
admet-2740	218	26	role	role	NOUN
admet-2740	218	27	in	in	ADP
admet-2740	218	28	cellular	cellular	ADJ
admet-2740	218	29	metabolism	metabolism	NOUN
admet-2740	218	30	,	,	PUNCT
admet-2740	218	31	including	include	VERB
admet-2740	218	32	platelet	platelet	NOUN
admet-2740	218	33	activation	activation	NOUN
admet-2740	218	34	(	(	PUNCT
admet-2740	218	35	figure	figure	NOUN
admet-2740	218	36	10	10	NUM
admet-2740	218	37	)	)	PUNCT
admet-2740	218	38	.	.	PUNCT
admet-2740	219	1	figure	figure	NOUN
admet-2740	219	2	10	10	NUM
admet-2740	219	3	.	.	PUNCT
admet-2740	219	4	proposed	propose	VERB
admet-2740	219	5	mechanism	mechanism	NOUN
admet-2740	219	6	of	of	ADP
admet-2740	219	7	warfarin	warfarin	NOUN
admet-2740	219	8	and	and	CCONJ
admet-2740	219	9	mango	mango	NOUN
admet-2740	219	10	interaction	interaction	NOUN
admet-2740	219	11	interconnected	interconnect	VERB
admet-2740	219	12	through	through	ADP
admet-2740	219	13	glycerol-3	glycerol-3	NOUN
admet-2740	219	14	-	-	PUNCT
admet-2740	219	15	phosphate	phosphate	NOUN
admet-2740	219	16	via	via	ADP
admet-2740	219	17	the	the	DET
admet-2740	219	18	glycerol	glycerol	NOUN
admet-2740	219	19	phosphate	phosphate	NOUN
admet-2740	219	20	shuttle	shuttle	NOUN
admet-2740	219	21	,	,	PUNCT
admet-2740	219	22	cardiolipin	cardiolipin	NOUN
admet-2740	219	23	biosynthesis	biosynthesis	NOUN
admet-2740	219	24	,	,	PUNCT
admet-2740	219	25	and	and	CCONJ
admet-2740	219	26	de	de	ADP
admet-2740	219	27	novo	novo	NOUN
admet-2740	219	28	triglyceride	triglyceride	ADV
admet-2740	219	29	biosynthesis	biosynthesis	VERB
admet-2740	219	30	.	.	PUNCT
admet-2740	220	1	the	the	DET
admet-2740	220	2	decrease	decrease	NOUN
admet-2740	220	3	in	in	ADP
admet-2740	220	4	glycerol-3	glycerol-3	NOUN
admet-2740	220	5	-	-	PUNCT
admet-2740	220	6	phosphate	phosphate	NOUN
admet-2740	220	7	may	may	AUX
admet-2740	220	8	impair	impair	VERB
admet-2740	220	9	energy	energy	NOUN
admet-2740	220	10	production	production	NOUN
admet-2740	220	11	in	in	ADP
admet-2740	220	12	glycolysis	glycolysis	NOUN
admet-2740	220	13	,	,	PUNCT
admet-2740	220	14	potentially	potentially	ADV
admet-2740	220	15	disrupting	disrupt	VERB
admet-2740	220	16	platelet	platelet	NOUN
admet-2740	220	17	function	function	NOUN
admet-2740	220	18	and	and	CCONJ
admet-2740	220	19	contributing	contribute	VERB
admet-2740	220	20	to	to	ADP
admet-2740	220	21	the	the	DET
admet-2740	220	22	observed	observed	ADJ
admet-2740	220	23	increase	increase	NOUN
admet-2740	220	24	in	in	ADP
admet-2740	220	25	inr	inr	PROPN
admet-2740	220	26	levels	level	NOUN
admet-2740	220	27	in	in	ADP
admet-2740	220	28	all	all	DET
admet-2740	220	29	patients	patient	NOUN
admet-2740	220	30	to	to	ADP
admet-2740	220	31	date	date	NOUN
admet-2740	220	32	,	,	PUNCT
admet-2740	220	33	this	this	DET
admet-2740	220	34	study	study	NOUN
admet-2740	220	35	is	be	AUX
admet-2740	220	36	the	the	DET
admet-2740	220	37	first	first	ADJ
admet-2740	220	38	to	to	PART
admet-2740	220	39	employ	employ	VERB
admet-2740	220	40	1h	1h	NUM
admet-2740	220	41	-	-	PUNCT
admet-2740	220	42	nmr	nmr	NOUN
admet-2740	220	43	metabolomics	metabolomic	NOUN
admet-2740	220	44	analysis	analysis	NOUN
admet-2740	220	45	to	to	PART
admet-2740	220	46	elucidate	elucidate	VERB
admet-2740	220	47	the	the	DET
admet-2740	220	48	mechanisms	mechanism	NOUN
admet-2740	220	49	of	of	ADP
admet-2740	220	50	drug	drug	NOUN
admet-2740	220	51	interaction	interaction	NOUN
admet-2740	220	52	,	,	PUNCT
admet-2740	220	53	integrating	integrate	VERB
admet-2740	220	54	clinical	clinical	ADJ
admet-2740	220	55	findings	finding	NOUN
admet-2740	220	56	with	with	ADP
admet-2740	220	57	molecular	molecular	ADJ
admet-2740	220	58	insights	insight	NOUN
admet-2740	220	59	.	.	PUNCT
admet-2740	221	1	our	our	PRON
admet-2740	221	2	results	result	NOUN
admet-2740	221	3	suggest	suggest	VERB
admet-2740	221	4	specific	specific	ADJ
admet-2740	221	5	molecular	molecular	ADJ
admet-2740	221	6	mechanisms	mechanism	NOUN
admet-2740	221	7	through	through	ADP
admet-2740	221	8	which	which	PRON
admet-2740	221	9	the	the	DET
admet-2740	221	10	warfarin	warfarin	NOUN
admet-2740	221	11	-	-	PUNCT
admet-2740	221	12	mango	mango	NOUN
admet-2740	221	13	interaction	interaction	NOUN
admet-2740	221	14	disrupts	disrupt	VERB
admet-2740	221	15	platelet	platelet	NOUN
admet-2740	221	16	energy	energy	NOUN
admet-2740	221	17	metabolism	metabolism	NOUN
admet-2740	221	18	,	,	PUNCT
admet-2740	221	19	with	with	ADP
admet-2740	221	20	glycerol	glycerol	NOUN
admet-2740	221	21	3	3	NUM
admet-2740	221	22	-	-	PUNCT
admet-2740	221	23	phosphate	phosphate	NOUN
admet-2740	221	24	identified	identify	VERB
admet-2740	221	25	as	as	ADP
admet-2740	221	26	a	a	DET
admet-2740	221	27	potential	potential	ADJ
admet-2740	221	28	biomarker	biomarker	NOUN
admet-2740	221	29	.	.	PUNCT
admet-2740	222	1	our	our	PRON
admet-2740	222	2	findings	finding	NOUN
admet-2740	222	3	highlight	highlight	VERB
admet-2740	222	4	that	that	SCONJ
admet-2740	222	5	the	the	DET
admet-2740	222	6	decrease	decrease	NOUN
admet-2740	222	7	in	in	ADP
admet-2740	222	8	glycerol	glycerol	NOUN
admet-2740	222	9	3	3	NUM
admet-2740	222	10	-	-	PUNCT
admet-2740	222	11	phosphate	phosphate	NOUN
admet-2740	222	12	may	may	AUX
admet-2740	222	13	impair	impair	VERB
admet-2740	222	14	energy	energy	NOUN
admet-2740	222	15	production	production	NOUN
admet-2740	222	16	in	in	ADP
admet-2740	222	17	glycolysis	glycolysis	NOUN
admet-2740	222	18	,	,	PUNCT
admet-2740	222	19	potentially	potentially	ADV
admet-2740	222	20	disrupting	disrupt	VERB
admet-2740	222	21	platelet	platelet	NOUN
admet-2740	222	22	function	function	NOUN
admet-2740	222	23	and	and	CCONJ
admet-2740	222	24	contributing	contribute	VERB
admet-2740	222	25	to	to	ADP
admet-2740	222	26	the	the	DET
admet-2740	222	27	observable	observable	ADJ
admet-2740	222	28	increase	increase	NOUN
admet-2740	222	29	in	in	ADP
admet-2740	222	30	inr	inr	PROPN
admet-2740	222	31	levels	level	NOUN
admet-2740	222	32	in	in	ADP
admet-2740	222	33	all	all	DET
admet-2740	222	34	patients	patient	NOUN
admet-2740	222	35	.	.	PUNCT
admet-2740	223	1	furthermore	furthermore	ADV
admet-2740	223	2	,	,	PUNCT
admet-2740	223	3	this	this	DET
admet-2740	223	4	interaction	interaction	NOUN
admet-2740	223	5	may	may	AUX
admet-2740	223	6	synergistically	synergistically	ADV
admet-2740	223	7	influence	influence	VERB
admet-2740	223	8	the	the	DET
admet-2740	223	9	clearance	clearance	NOUN
admet-2740	223	10	of	of	ADP
admet-2740	223	11	warfarin	warfarin	NOUN
admet-2740	223	12	,	,	PUNCT
admet-2740	223	13	as	as	SCONJ
admet-2740	223	14	mango	mango	NOUN
admet-2740	223	15	inhibits	inhibit	VERB
admet-2740	223	16	cyp450	cyp450	NOUN
admet-2740	223	17	enzymes	enzyme	NOUN
admet-2740	223	18	.	.	PUNCT
admet-2740	224	1	however	however	ADV
admet-2740	224	2	,	,	PUNCT
admet-2740	224	3	further	further	ADJ
admet-2740	224	4	investigations	investigation	NOUN
admet-2740	224	5	are	be	AUX
admet-2740	224	6	essential	essential	ADJ
admet-2740	224	7	to	to	PART
admet-2740	224	8	clarify	clarify	VERB
admet-2740	224	9	the	the	DET
admet-2740	224	10	precise	precise	ADJ
admet-2740	224	11	pathways	pathway	NOUN
admet-2740	224	12	involved	involve	VERB
admet-2740	224	13	.	.	PUNCT
admet-2740	225	1	future	future	ADJ
admet-2740	225	2	studies	study	NOUN
admet-2740	225	3	should	should	AUX
admet-2740	225	4	include	include	VERB
admet-2740	225	5	larger	large	ADJ
admet-2740	225	6	sample	sample	NOUN
admet-2740	225	7	sizes	size	NOUN
admet-2740	225	8	and	and	CCONJ
admet-2740	225	9	be	be	AUX
admet-2740	225	10	conducted	conduct	VERB
admet-2740	225	11	across	across	ADP
admet-2740	225	12	multiple	multiple	ADJ
admet-2740	225	13	centres	centre	NOUN
admet-2740	225	14	to	to	PART
admet-2740	225	15	enhance	enhance	VERB
admet-2740	225	16	generalizability	generalizability	NOUN
admet-2740	225	17	.	.	PUNCT
admet-2740	226	1	the	the	DET
admet-2740	226	2	application	application	NOUN
admet-2740	226	3	of	of	ADP
admet-2740	226	4	1hnmr	1hnmr	NUM
admet-2740	226	5	metabolomic	metabolomic	ADJ
admet-2740	226	6	analysis	analysis	NOUN
admet-2740	226	7	holds	hold	VERB
admet-2740	226	8	promise	promise	NOUN
admet-2740	226	9	for	for	ADP
admet-2740	226	10	providing	provide	VERB
admet-2740	226	11	valuable	valuable	ADJ
admet-2740	226	12	insights	insight	NOUN
admet-2740	226	13	into	into	ADP
admet-2740	226	14	these	these	DET
admet-2740	226	15	interactions	interaction	NOUN
admet-2740	226	16	,	,	PUNCT
admet-2740	226	17	as	as	SCONJ
admet-2740	226	18	demonstrated	demonstrate	VERB
admet-2740	226	19	by	by	ADP
admet-2740	226	20	the	the	DET
admet-2740	226	21	success	success	NOUN
admet-2740	226	22	of	of	ADP
admet-2740	226	23	previous	previous	ADJ
admet-2740	226	24	investigations	investigation	NOUN
admet-2740	226	25	[	[	X
admet-2740	226	26	16	16	NUM
admet-2740	226	27	]	]	PUNCT
admet-2740	226	28	.	.	PUNCT
admet-2740	227	1	conclusions	conclusion	NOUN
admet-2740	227	2	this	this	DET
admet-2740	227	3	study	study	NOUN
admet-2740	227	4	is	be	AUX
admet-2740	227	5	the	the	DET
admet-2740	227	6	first	first	ADJ
admet-2740	227	7	to	to	PART
admet-2740	227	8	employ	employ	VERB
admet-2740	227	9	1h	1h	NUM
admet-2740	227	10	-	-	PUNCT
admet-2740	227	11	nmr	nmr	NOUN
admet-2740	227	12	metabolomics	metabolomic	NOUN
admet-2740	227	13	analysis	analysis	NOUN
admet-2740	227	14	to	to	PART
admet-2740	227	15	investigate	investigate	VERB
admet-2740	227	16	the	the	DET
admet-2740	227	17	molecular	molecular	ADJ
admet-2740	227	18	mechanisms	mechanism	NOUN
admet-2740	227	19	underlying	underlie	VERB
admet-2740	227	20	drug	drug	NOUN
admet-2740	227	21	interactions	interaction	NOUN
admet-2740	227	22	,	,	PUNCT
admet-2740	227	23	specifically	specifically	ADV
admet-2740	227	24	focusing	focus	VERB
admet-2740	227	25	on	on	ADP
admet-2740	227	26	the	the	DET
admet-2740	227	27	warfarin	warfarin	NOUN
admet-2740	227	28	-	-	PUNCT
admet-2740	227	29	mango	mango	NOUN
admet-2740	227	30	interaction	interaction	NOUN
admet-2740	227	31	.	.	PUNCT
admet-2740	228	1	by	by	ADP
admet-2740	228	2	integrating	integrate	VERB
admet-2740	228	3	clinical	clinical	ADJ
admet-2740	228	4	outcomes	outcome	NOUN
admet-2740	228	5	with	with	ADP
admet-2740	228	6	molecular	molecular	ADJ
admet-2740	228	7	insights	insight	NOUN
admet-2740	228	8	,	,	PUNCT
admet-2740	228	9	our	our	PRON
admet-2740	228	10	findings	finding	NOUN
admet-2740	228	11	suggest	suggest	VERB
admet-2740	228	12	that	that	SCONJ
admet-2740	228	13	this	this	DET
admet-2740	228	14	interaction	interaction	NOUN
admet-2740	228	15	disrupts	disrupt	VERB
admet-2740	228	16	platelet	platelet	NOUN
admet-2740	228	17	energy	energy	NOUN
admet-2740	228	18	metabolism	metabolism	NOUN
admet-2740	228	19	,	,	PUNCT
admet-2740	228	20	with	with	ADP
admet-2740	228	21	glycerol	glycerol	NOUN
admet-2740	228	22	3	3	NUM
admet-2740	228	23	-	-	PUNCT
admet-2740	228	24	phosphate	phosphate	NOUN
admet-2740	228	25	emerging	emerge	VERB
admet-2740	228	26	as	as	ADP
admet-2740	228	27	a	a	DET
admet-2740	228	28	potential	potential	ADJ
admet-2740	228	29	biomarker	biomarker	NOUN
admet-2740	228	30	.	.	PUNCT
admet-2740	229	1	the	the	DET
admet-2740	229	2	reduction	reduction	NOUN
admet-2740	229	3	in	in	ADP
admet-2740	229	4	glycerol	glycerol	NOUN
admet-2740	229	5	3phosphate	3phosphate	NUM
admet-2740	229	6	may	may	AUX
admet-2740	229	7	disrupt	disrupt	VERB
admet-2740	229	8	energy	energy	NOUN
admet-2740	229	9	production	production	NOUN
admet-2740	229	10	through	through	ADP
admet-2740	229	11	glycolysis	glycolysis	NOUN
admet-2740	229	12	,	,	PUNCT
admet-2740	229	13	potentially	potentially	ADV
admet-2740	229	14	affecting	affect	VERB
admet-2740	229	15	platelet	platelet	NOUN
admet-2740	229	16	activation	activation	NOUN
admet-2740	229	17	and	and	CCONJ
admet-2740	229	18	contributing	contribute	VERB
admet-2740	229	19	to	to	ADP
admet-2740	229	20	the	the	DET
admet-2740	229	21	elevated	elevated	ADJ
admet-2740	229	22	inr	inr	PROPN
admet-2740	229	23	levels	level	NOUN
admet-2740	229	24	observed	observe	VERB
admet-2740	229	25	in	in	ADP
admet-2740	229	26	all	all	DET
admet-2740	229	27	patients	patient	NOUN
admet-2740	229	28	.	.	PUNCT
admet-2740	230	1	the	the	DET
admet-2740	230	2	use	use	NOUN
admet-2740	230	3	of	of	ADP
admet-2740	230	4	1h	1h	NUM
admet-2740	230	5	-	-	PUNCT
admet-2740	230	6	nmr	nmr	NOUN
admet-2740	230	7	to	to	PART
admet-2740	230	8	monitor	monitor	VERB
admet-2740	230	9	metabolites	metabolite	NOUN
admet-2740	230	10	during	during	ADP
admet-2740	230	11	the	the	DET
admet-2740	230	12	interaction	interaction	NOUN
admet-2740	230	13	between	between	ADP
admet-2740	230	14	warfarin	warfarin	NOUN
admet-2740	230	15	and	and	CCONJ
admet-2740	230	16	mango	mango	NOUN
admet-2740	230	17	presents	present	VERB
admet-2740	230	18	a	a	DET
admet-2740	230	19	promising	promising	ADJ
admet-2740	230	20	approach	approach	NOUN
admet-2740	230	21	for	for	ADP
admet-2740	230	22	gaining	gain	VERB
admet-2740	230	23	a	a	DET
admet-2740	230	24	more	more	ADV
admet-2740	230	25	comprehensive	comprehensive	ADJ
admet-2740	230	26	understanding	understanding	NOUN
admet-2740	230	27	of	of	ADP
admet-2740	230	28	such	such	ADJ
admet-2740	230	29	drug	drug	NOUN
admet-2740	230	30	interactions	interaction	NOUN
admet-2740	230	31	.	.	PUNCT
admet-2740	231	1	https://doi.org/10.5599/admet.2740	https://doi.org/10.5599/admet.2740	NOUN
admet-2740	231	2	p.	p.	PROPN
admet-2740	231	3	rattanasuwan	rattanasuwan	PROPN
admet-2740	231	4	et	et	PROPN
admet-2740	231	5	al	al	PROPN
admet-2740	231	6	.	.	PROPN
admet-2740	231	7	admet	admet	PROPN
admet-2740	231	8	&	&	CCONJ
admet-2740	231	9	dmpk	dmpk	PROPN
admet-2740	231	10	13(3	13(3	NUM
admet-2740	231	11	)	)	PUNCT
admet-2740	231	12	(	(	PUNCT
admet-2740	231	13	2025	2025	NUM
admet-2740	231	14	)	)	PUNCT
admet-2740	231	15	2740	2740	NUM
admet-2740	231	16	14	14	NUM
admet-2740	231	17	acknowledgements	acknowledgement	NOUN
admet-2740	231	18	:	:	PUNCT
admet-2740	231	19	this	this	DET
admet-2740	231	20	study	study	NOUN
admet-2740	231	21	was	be	AUX
admet-2740	231	22	supported	support	VERB
admet-2740	231	23	by	by	ADP
admet-2740	231	24	the	the	DET
admet-2740	231	25	faculty	faculty	NOUN
admet-2740	231	26	of	of	ADP
admet-2740	231	27	medicine	medicine	NOUN
admet-2740	231	28	,	,	PUNCT
admet-2740	231	29	chiang	chiang	PROPN
admet-2740	231	30	mai	mai	PROPN
admet-2740	231	31	university	university	PROPN
admet-2740	231	32	,	,	PUNCT
admet-2740	231	33	grant	grant	VERB
admet-2740	231	34	no	no	DET
admet-2740	231	35	.	.	NOUN
admet-2740	231	36	135	135	NUM
admet-2740	231	37	-	-	SYM
admet-2740	231	38	66	66	NUM
admet-2740	231	39	.	.	PUNCT
admet-2740	232	1	the	the	DET
admet-2740	232	2	authors	author	NOUN
admet-2740	232	3	extend	extend	VERB
admet-2740	232	4	their	their	PRON
admet-2740	232	5	gratitude	gratitude	NOUN
admet-2740	232	6	to	to	ADP
admet-2740	232	7	hua	hua	PROPN
admet-2740	232	8	hin	hin	PROPN
admet-2740	232	9	hospital	hospital	NOUN
admet-2740	232	10	,	,	PUNCT
admet-2740	232	11	prachuap	prachuap	NOUN
admet-2740	232	12	khiri	khiri	PROPN
admet-2740	232	13	khan	khan	PROPN
admet-2740	232	14	,	,	PUNCT
admet-2740	232	15	thailand	thailand	PROPN
admet-2740	232	16	,	,	PUNCT
admet-2740	232	17	for	for	ADP
admet-2740	232	18	their	their	PRON
admet-2740	232	19	invaluable	invaluable	ADJ
admet-2740	232	20	guidance	guidance	NOUN
admet-2740	232	21	and	and	CCONJ
admet-2740	232	22	insightful	insightful	ADJ
admet-2740	232	23	discussions	discussion	NOUN
admet-2740	232	24	.	.	PUNCT
admet-2740	233	1	they	they	PRON
admet-2740	233	2	acknowledge	acknowledge	VERB
admet-2740	233	3	that	that	PRON
admet-2740	233	4	part	part	NOUN
admet-2740	233	5	of	of	ADP
admet-2740	233	6	the	the	DET
admet-2740	233	7	data	datum	NOUN
admet-2740	233	8	presented	present	VERB
admet-2740	233	9	in	in	ADP
admet-2740	233	10	this	this	DET
admet-2740	233	11	paper	paper	NOUN
admet-2740	233	12	was	be	AUX
admet-2740	233	13	previously	previously	ADV
admet-2740	233	14	shared	share	VERB
admet-2740	233	15	at	at	ADP
admet-2740	233	16	the	the	DET
admet-2740	233	17	2nd	2nd	PROPN
admet-2740	233	18	thailand	thailand	PROPN
admet-2740	233	19	bioinformatics	bioinformatics	PROPN
admet-2740	233	20	research	research	NOUN
admet-2740	233	21	network	network	NOUN
admet-2740	233	22	(	(	PUNCT
admet-2740	233	23	tbrn	tbrn	NOUN
admet-2740	233	24	)	)	PUNCT
admet-2740	233	25	international	international	ADJ
admet-2740	233	26	conference	conference	NOUN
admet-2740	233	27	2025	2025	NUM
admet-2740	233	28	,	,	PUNCT
admet-2740	233	29	held	hold	VERB
admet-2740	233	30	on	on	ADP
admet-2740	233	31	january	january	PROPN
admet-2740	233	32	22	22	NUM
admet-2740	233	33	24	24	NUM
admet-2740	233	34	,	,	PUNCT
admet-2740	233	35	2025	2025	NUM
admet-2740	233	36	,	,	PUNCT
admet-2740	233	37	in	in	ADP
admet-2740	233	38	chiang	chiang	PROPN
admet-2740	233	39	mai	mai	PROPN
admet-2740	233	40	,	,	PUNCT
admet-2740	233	41	thailand	thailand	PROPN
admet-2740	233	42	.	.	PUNCT
admet-2740	234	1	the	the	DET
admet-2740	234	2	figures	figure	NOUN
admet-2740	234	3	were	be	AUX
admet-2740	234	4	created	create	VERB
admet-2740	234	5	using	use	VERB
admet-2740	234	6	biorender.com	biorender.com	X
admet-2740	234	7	(	(	PUNCT
admet-2740	234	8	accessed	access	VERB
admet-2740	234	9	on	on	ADP
admet-2740	234	10	march	march	PROPN
admet-2740	234	11	1	1	NUM
admet-2740	234	12	,	,	PUNCT
admet-2740	234	13	2024	2024	NUM
admet-2740	234	14	)	)	PUNCT
admet-2740	234	15	,	,	PUNCT
admet-2740	234	16	and	and	CCONJ
admet-2740	234	17	chemical	chemical	NOUN
admet-2740	234	18	structures	structure	NOUN
admet-2740	234	19	were	be	AUX
admet-2740	234	20	prepared	prepare	VERB
admet-2740	234	21	using	use	VERB
admet-2740	234	22	chemdraw	chemdraw	NOUN
admet-2740	234	23	(	(	PUNCT
admet-2740	234	24	version	version	NOUN
admet-2740	234	25	23.1.1.3	23.1.1.3	NUM
admet-2740	234	26	,	,	PUNCT
admet-2740	234	27	revvity	revvity	NOUN
admet-2740	234	28	signals	signal	NOUN
admet-2740	234	29	software	software	NOUN
admet-2740	234	30	)	)	PUNCT
admet-2740	234	31	.	.	PUNCT
admet-2740	235	1	the	the	DET
admet-2740	235	2	authors	author	NOUN
admet-2740	235	3	also	also	ADV
admet-2740	235	4	wish	wish	VERB
admet-2740	235	5	to	to	PART
admet-2740	235	6	express	express	VERB
admet-2740	235	7	their	their	PRON
admet-2740	235	8	appreciation	appreciation	NOUN
admet-2740	235	9	to	to	ADP
admet-2740	235	10	the	the	DET
admet-2740	235	11	faculty	faculty	NOUN
admet-2740	235	12	of	of	ADP
admet-2740	235	13	medicine	medicine	NOUN
admet-2740	235	14	,	,	PUNCT
admet-2740	235	15	chiang	chiang	PROPN
admet-2740	235	16	mai	mai	PROPN
admet-2740	235	17	university	university	PROPN
admet-2740	235	18	,	,	PUNCT
admet-2740	235	19	thailand	thailand	PROPN
admet-2740	235	20	,	,	PUNCT
admet-2740	235	21	for	for	ADP
admet-2740	235	22	supporting	support	VERB
admet-2740	235	23	the	the	DET
admet-2740	235	24	publication	publication	NOUN
admet-2740	235	25	charges	charge	NOUN
admet-2740	235	26	.	.	PUNCT
admet-2740	236	1	conflict	conflict	NOUN
admet-2740	236	2	of	of	ADP
admet-2740	236	3	interest	interest	NOUN
admet-2740	236	4	:	:	PUNCT
admet-2740	236	5	the	the	DET
admet-2740	236	6	authors	author	NOUN
admet-2740	236	7	declare	declare	VERB
admet-2740	236	8	that	that	SCONJ
admet-2740	236	9	they	they	PRON
admet-2740	236	10	have	have	VERB
admet-2740	236	11	no	no	DET
admet-2740	236	12	known	know	VERB
admet-2740	236	13	competing	compete	VERB
admet-2740	236	14	financial	financial	ADJ
admet-2740	236	15	interests	interest	NOUN
admet-2740	236	16	or	or	CCONJ
admet-2740	236	17	personal	personal	ADJ
admet-2740	236	18	relationships	relationship	NOUN
admet-2740	236	19	that	that	PRON
admet-2740	236	20	could	could	AUX
admet-2740	236	21	have	have	AUX
admet-2740	236	22	appeared	appear	VERB
admet-2740	236	23	to	to	PART
admet-2740	236	24	influence	influence	VERB
admet-2740	236	25	the	the	DET
admet-2740	236	26	work	work	NOUN
admet-2740	236	27	reported	report	VERB
admet-2740	236	28	in	in	ADP
admet-2740	236	29	this	this	DET
admet-2740	236	30	paper	paper	NOUN
admet-2740	236	31	.	.	PUNCT
admet-2740	237	1	supplementary	supplementary	ADJ
admet-2740	237	2	material	material	NOUN
admet-2740	237	3	additional	additional	ADJ
admet-2740	237	4	data	datum	NOUN
admet-2740	237	5	are	be	AUX
admet-2740	237	6	available	available	ADJ
admet-2740	237	7	at	at	ADP
admet-2740	237	8	https://pub.iapchem.org/ojs/index.php/admet/article/view/2740	https://pub.iapchem.org/ojs/index.php/admet/article/view/2740	PROPN
admet-2740	237	9	,	,	PUNCT
admet-2740	237	10	or	or	CCONJ
admet-2740	237	11	from	from	ADP
admet-2740	237	12	the	the	DET
admet-2740	237	13	corresponding	corresponding	ADJ
admet-2740	237	14	author	author	NOUN
admet-2740	237	15	on	on	ADP
admet-2740	237	16	request	request	NOUN
admet-2740	237	17	.	.	PUNCT
admet-2740	238	1	references	reference	NOUN
admet-2740	238	2	[	[	X
admet-2740	238	3	1	1	X
admet-2740	238	4	]	]	PUNCT
admet-2740	238	5	j.	j.	PROPN
admet-2740	238	6	lähteenmäki	lähteenmäki	PROPN
admet-2740	238	7	,	,	PUNCT
admet-2740	238	8	a.l	a.l	PROPN
admet-2740	238	9	.	.	PROPN
admet-2740	238	10	vuorinen	vuorinen	PROPN
admet-2740	238	11	,	,	PUNCT
admet-2740	238	12	m.	m.	NOUN
admet-2740	238	13	lehto	lehto	PROPN
admet-2740	238	14	,	,	PUNCT
admet-2740	238	15	m.	m.	PROPN
admet-2740	238	16	niemi	niemi	PROPN
admet-2740	238	17	,	,	PUNCT
admet-2740	238	18	m.m	m.m	PROPN
admet-2740	238	19	.	.	PROPN
admet-2740	238	20	forsberg	forsberg	PROPN
admet-2740	238	21	.	.	PUNCT
admet-2740	239	1	pharmacogenetics	pharmacogenetic	NOUN
admet-2740	239	2	of	of	ADP
admet-2740	239	3	warfarin	warfarin	NOUN
admet-2740	239	4	and	and	CCONJ
admet-2740	239	5	healthcare	healthcare	NOUN
admet-2740	239	6	costs	cost	VERB
admet-2740	239	7	real	real	ADJ
admet-2740	239	8	-	-	PUNCT
admet-2740	239	9	world	world	NOUN
admet-2740	239	10	data	datum	NOUN
admet-2740	239	11	analysis	analysis	NOUN
admet-2740	239	12	.	.	PUNCT
admet-2740	240	1	pharmacoepidemiology	pharmacoepidemiology	NOUN
admet-2740	240	2	and	and	CCONJ
admet-2740	240	3	drug	drug	NOUN
admet-2740	240	4	safety	safety	NOUN
admet-2740	240	5	32	32	NUM
admet-2740	240	6	(	(	PUNCT
admet-2740	240	7	2023	2023	NUM
admet-2740	240	8	)	)	PUNCT
admet-2740	240	9	382386	382386	NUM
admet-2740	240	10	.	.	PUNCT
admet-2740	241	1	https://doi.org/10.1002/pds.5585	https://doi.org/10.1002/pds.5585	PROPN
admet-2740	241	2	[	[	X
admet-2740	241	3	2	2	NUM
admet-2740	241	4	]	]	X
admet-2740	241	5	b.	b.	PROPN
admet-2740	241	6	sombat	sombat	PROPN
admet-2740	241	7	,	,	PUNCT
admet-2740	241	8	s.	s.	PROPN
admet-2740	241	9	tongkaew	tongkaew	PROPN
admet-2740	241	10	,	,	PUNCT
admet-2740	241	11	a.	a.	NOUN
admet-2740	241	12	nilwaranon	nilwaranon	NOUN
admet-2740	241	13	,	,	PUNCT
admet-2740	241	14	m.	m.	NOUN
admet-2740	241	15	mungthin	mungthin	PROPN
admet-2740	241	16	,	,	PUNCT
admet-2740	241	17	k.	k.	PROPN
admet-2740	241	18	jongcherdchootrakul	jongcherdchootrakul	PROPN
admet-2740	241	19	,	,	PUNCT
admet-2740	241	20	t.	t.	PROPN
admet-2740	241	21	lertwanichwattana	lertwanichwattana	PROPN
admet-2740	241	22	.	.	PUNCT
admet-2740	242	1	incidence	incidence	NOUN
admet-2740	242	2	and	and	CCONJ
admet-2740	242	3	risk	risk	NOUN
admet-2740	242	4	factors	factor	NOUN
admet-2740	242	5	of	of	ADP
admet-2740	242	6	warfarin	warfarin	NOUN
admet-2740	242	7	therapy	therapy	NOUN
admet-2740	242	8	complications	complication	NOUN
admet-2740	242	9	in	in	ADP
admet-2740	242	10	community	community	NOUN
admet-2740	242	11	hospitals	hospital	NOUN
admet-2740	242	12	,	,	PUNCT
admet-2740	242	13	central	central	ADJ
admet-2740	242	14	and	and	CCONJ
admet-2740	242	15	eastern	eastern	ADJ
admet-2740	242	16	regions	region	NOUN
admet-2740	242	17	,	,	PUNCT
admet-2740	242	18	thailand	thailand	PROPN
admet-2740	242	19	:	:	PUNCT
admet-2740	242	20	a	a	DET
admet-2740	242	21	retrospective	retrospective	ADJ
admet-2740	242	22	,	,	PUNCT
admet-2740	242	23	multicenter	multicenter	NOUN
admet-2740	242	24	,	,	PUNCT
admet-2740	242	25	cohort	cohort	NOUN
admet-2740	242	26	study	study	NOUN
admet-2740	242	27	.	.	PUNCT
admet-2740	243	1	bmc	bmc	PROPN
admet-2740	243	2	research	research	NOUN
admet-2740	243	3	notes	note	VERB
admet-2740	243	4	16	16	NUM
admet-2740	243	5	(	(	PUNCT
admet-2740	243	6	2023	2023	NUM
admet-2740	243	7	)	)	PUNCT
admet-2740	243	8	104	104	NUM
admet-2740	243	9	.	.	PUNCT
admet-2740	243	10	https://doi.org/10.1186/s13104-023-06383-2	https://doi.org/10.1186/s13104-023-06383-2	PUNCT
admet-2740	244	1	[	[	X
admet-2740	244	2	3	3	X
admet-2740	244	3	]	]	X
admet-2740	244	4	s.s	s.s	PROPN
admet-2740	244	5	.	.	PROPN
admet-2740	244	6	ng	ng	PROPN
admet-2740	244	7	,	,	PUNCT
admet-2740	244	8	s.	s.	PROPN
admet-2740	244	9	nathisuwan	nathisuwan	PROPN
admet-2740	244	10	,	,	PUNCT
admet-2740	244	11	a.	a.	NOUN
admet-2740	244	12	phrommintikul	phrommintikul	NOUN
admet-2740	244	13	,	,	PUNCT
admet-2740	244	14	n.	n.	PROPN
admet-2740	244	15	chaiyakunapruk	chaiyakunapruk	PROPN
admet-2740	244	16	.	.	PUNCT
admet-2740	245	1	cost	cost	NOUN
admet-2740	245	2	-	-	PUNCT
admet-2740	245	3	effectiveness	effectiveness	NOUN
admet-2740	245	4	of	of	ADP
admet-2740	245	5	warfarin	warfarin	NOUN
admet-2740	245	6	care	care	NOUN
admet-2740	245	7	bundles	bundle	NOUN
admet-2740	245	8	and	and	CCONJ
admet-2740	245	9	novel	novel	ADJ
admet-2740	245	10	oral	oral	ADJ
admet-2740	245	11	anticoagulants	anticoagulant	NOUN
admet-2740	245	12	for	for	ADP
admet-2740	245	13	stroke	stroke	NOUN
admet-2740	245	14	prevention	prevention	NOUN
admet-2740	245	15	in	in	ADP
admet-2740	245	16	patients	patient	NOUN
admet-2740	245	17	with	with	ADP
admet-2740	245	18	atrial	atrial	ADJ
admet-2740	245	19	fibrillation	fibrillation	NOUN
admet-2740	245	20	in	in	ADP
admet-2740	245	21	thailand	thailand	PROPN
admet-2740	245	22	.	.	PUNCT
admet-2740	246	1	thrombosis	thrombosis	PROPN
admet-2740	246	2	research	research	NOUN
admet-2740	246	3	185	185	NUM
admet-2740	246	4	(	(	PUNCT
admet-2740	246	5	2020	2020	NUM
admet-2740	246	6	)	)	PUNCT
admet-2740	246	7	63	63	NUM
admet-2740	246	8	-	-	SYM
admet-2740	246	9	71	71	NUM
admet-2740	246	10	.	.	PUNCT
admet-2740	247	1	https://doi.org/10.1016/j.thromres.2019.11.012	https://doi.org/10.1016/j.thromres.2019.11.012	PROPN
admet-2740	248	1	[	[	X
admet-2740	248	2	4	4	NUM
admet-2740	248	3	]	]	X
admet-2740	248	4	i.	i.	PROPN
admet-2740	248	5	piatkov	piatkov	PROPN
admet-2740	248	6	,	,	PUNCT
admet-2740	248	7	c.	c.	PROPN
admet-2740	248	8	rochester	rochester	PROPN
admet-2740	248	9	,	,	PUNCT
admet-2740	248	10	t.	t.	PROPN
admet-2740	248	11	jones	jones	PROPN
admet-2740	248	12	,	,	PUNCT
admet-2740	248	13	s.	s.	PROPN
admet-2740	248	14	boyages	boyages	PROPN
admet-2740	248	15	.	.	PUNCT
admet-2740	249	1	warfarin	warfarin	NOUN
admet-2740	249	2	toxicity	toxicity	NOUN
admet-2740	249	3	and	and	CCONJ
admet-2740	249	4	individual	individual	ADJ
admet-2740	249	5	variability	variability	NOUN
admet-2740	249	6	-	-	PUNCT
admet-2740	249	7	clinical	clinical	ADJ
admet-2740	249	8	case	case	NOUN
admet-2740	249	9	.	.	PUNCT
admet-2740	250	1	toxins	toxin	NOUN
admet-2740	250	2	(	(	PUNCT
admet-2740	250	3	basel	basel	NOUN
admet-2740	250	4	)	)	PUNCT
admet-2740	250	5	2	2	NUM
admet-2740	250	6	(	(	PUNCT
admet-2740	250	7	2010	2010	NUM
admet-2740	250	8	)	)	PUNCT
admet-2740	250	9	2584	2584	NUM
admet-2740	250	10	-	-	SYM
admet-2740	250	11	2592	2592	NUM
admet-2740	250	12	.	.	PUNCT
admet-2740	251	1	https://doi.org/10.3390/toxins2112584	https://doi.org/10.3390/toxins2112584	PROPN
admet-2740	252	1	[	[	X
admet-2740	252	2	5	5	X
admet-2740	252	3	]	]	PUNCT
admet-2740	252	4	j.	j.	PROPN
admet-2740	252	5	monterrey	monterrey	PROPN
admet-2740	252	6	-	-	PUNCT
admet-2740	252	7	rodríguez	rodríguez	NOUN
admet-2740	252	8	.	.	PUNCT
admet-2740	253	1	interaction	interaction	NOUN
admet-2740	253	2	between	between	ADP
admet-2740	253	3	warfarin	warfarin	NOUN
admet-2740	253	4	and	and	CCONJ
admet-2740	253	5	mango	mango	PROPN
admet-2740	253	6	fruit	fruit	NOUN
admet-2740	253	7	.	.	PUNCT
admet-2740	254	1	the	the	DET
admet-2740	254	2	annals	annal	NOUN
admet-2740	254	3	of	of	ADP
admet-2740	254	4	pharmacotherapy	pharmacotherapy	NOUN
admet-2740	254	5	36	36	NUM
admet-2740	254	6	(	(	PUNCT
admet-2740	254	7	2002	2002	NUM
admet-2740	254	8	)	)	PUNCT
admet-2740	254	9	940	940	NUM
admet-2740	254	10	-	-	SYM
admet-2740	254	11	941	941	NUM
admet-2740	254	12	.	.	PUNCT
admet-2740	255	1	https://doi.org/10.1177/106002800203600504	https://doi.org/10.1177/106002800203600504	NOUN
admet-2740	256	1	[	[	X
admet-2740	256	2	6	6	NUM
admet-2740	256	3	]	]	X
admet-2740	256	4	d.a	d.a	PROPN
admet-2740	256	5	.	.	PROPN
admet-2740	256	6	norwood	norwood	PROPN
admet-2740	256	7	,	,	PUNCT
admet-2740	256	8	c.k	c.k	PROPN
admet-2740	256	9	.	.	PROPN
admet-2740	256	10	parke	parke	PROPN
admet-2740	256	11	,	,	PUNCT
admet-2740	256	12	l.r	l.r	PROPN
admet-2740	256	13	.	.	PROPN
admet-2740	256	14	rappa	rappa	PROPN
admet-2740	256	15	.	.	PUNCT
admet-2740	257	1	a	a	DET
admet-2740	257	2	comprehensive	comprehensive	ADJ
admet-2740	257	3	review	review	NOUN
admet-2740	257	4	of	of	ADP
admet-2740	257	5	potential	potential	ADJ
admet-2740	257	6	warfarin	warfarin	NOUN
admet-2740	257	7	-	-	PUNCT
admet-2740	257	8	fruit	fruit	NOUN
admet-2740	257	9	interactions	interaction	NOUN
admet-2740	257	10	.	.	PUNCT
admet-2740	258	1	journal	journal	NOUN
admet-2740	258	2	of	of	ADP
admet-2740	258	3	pharmacy	pharmacy	NOUN
admet-2740	258	4	practice	practice	NOUN
admet-2740	258	5	28	28	NUM
admet-2740	258	6	(	(	PUNCT
admet-2740	258	7	2015	2015	NUM
admet-2740	258	8	)	)	PUNCT
admet-2740	258	9	561	561	NUM
admet-2740	258	10	-	-	SYM
admet-2740	258	11	571	571	NUM
admet-2740	258	12	.	.	PUNCT
admet-2740	259	1	https://doi.org/10.1177/0897190014544823	https://doi.org/10.1177/0897190014544823	X
admet-2740	260	1	[	[	X
admet-2740	260	2	7	7	NUM
admet-2740	260	3	]	]	X
admet-2740	260	4	c.s.s	c.s.s	PROPN
admet-2740	260	5	.	.	PUNCT
admet-2740	260	6	tan	tan	PROPN
admet-2740	260	7	,	,	PUNCT
admet-2740	260	8	s.w.h	s.w.h	PROPN
admet-2740	260	9	.	.	PUNCT
admet-2740	260	10	lee	lee	PROPN
admet-2740	260	11	.	.	PROPN
admet-2740	260	12	warfarin	warfarin	NOUN
admet-2740	260	13	and	and	CCONJ
admet-2740	260	14	food	food	NOUN
admet-2740	260	15	,	,	PUNCT
admet-2740	260	16	herbal	herbal	ADJ
admet-2740	260	17	or	or	CCONJ
admet-2740	260	18	dietary	dietary	ADJ
admet-2740	260	19	supplement	supplement	NOUN
admet-2740	260	20	interactions	interaction	NOUN
admet-2740	260	21	:	:	PUNCT
admet-2740	260	22	a	a	DET
admet-2740	260	23	systematic	systematic	ADJ
admet-2740	260	24	review	review	NOUN
admet-2740	260	25	.	.	PUNCT
admet-2740	261	1	british	british	ADJ
admet-2740	261	2	journal	journal	PROPN
admet-2740	261	3	of	of	ADP
admet-2740	261	4	clinical	clinical	ADJ
admet-2740	261	5	pharmacology	pharmacology	NOUN
admet-2740	261	6	87	87	NUM
admet-2740	261	7	(	(	PUNCT
admet-2740	261	8	2021	2021	NUM
admet-2740	261	9	)	)	PUNCT
admet-2740	261	10	352	352	NUM
admet-2740	261	11	-	-	SYM
admet-2740	261	12	374	374	NUM
admet-2740	261	13	.	.	PUNCT
admet-2740	262	1	https://doi.org/10.1111/bcp.14404	https://doi.org/10.1111/bcp.14404	NOUN
admet-2740	263	1	[	[	X
admet-2740	263	2	8	8	NUM
admet-2740	263	3	]	]	SYM
admet-2740	263	4	p.m.	p.m.	NOUN
admet-2740	264	1	leite	leite	PROPN
admet-2740	264	2	,	,	PUNCT
admet-2740	264	3	m.a.p	m.a.p	NOUN
admet-2740	264	4	.	.	PUNCT
admet-2740	264	5	martins	martin	NOUN
admet-2740	264	6	,	,	PUNCT
admet-2740	264	7	m.d.g	m.d.g	NOUN
admet-2740	264	8	.	.	PUNCT
admet-2740	265	1	carvalho	carvalho	PROPN
admet-2740	265	2	,	,	PUNCT
admet-2740	265	3	r.o	r.o	PROPN
admet-2740	265	4	.	.	PROPN
admet-2740	265	5	castilho	castilho	PROPN
admet-2740	265	6	.	.	PUNCT
admet-2740	266	1	mechanisms	mechanism	NOUN
admet-2740	266	2	and	and	CCONJ
admet-2740	266	3	interactions	interaction	NOUN
admet-2740	266	4	in	in	ADP
admet-2740	266	5	concomitant	concomitant	ADJ
admet-2740	266	6	use	use	NOUN
admet-2740	266	7	of	of	ADP
admet-2740	266	8	herbs	herb	NOUN
admet-2740	266	9	and	and	CCONJ
admet-2740	266	10	warfarin	warfarin	NOUN
admet-2740	266	11	therapy	therapy	NOUN
admet-2740	266	12	:	:	PUNCT
admet-2740	266	13	an	an	DET
admet-2740	266	14	updated	update	VERB
admet-2740	266	15	review	review	NOUN
admet-2740	266	16	.	.	PUNCT
admet-2740	267	1	biomedicine	biomedicine	PROPN
admet-2740	267	2	&	&	CCONJ
admet-2740	267	3	pharmacotherapy	pharmacotherapy	NOUN
admet-2740	267	4	143	143	NUM
admet-2740	267	5	(	(	PUNCT
admet-2740	267	6	2021	2021	NUM
admet-2740	267	7	)	)	PUNCT
admet-2740	267	8	112103	112103	NUM
admet-2740	267	9	.	.	PUNCT
admet-2740	268	1	https://doi.org/https://doi.org/10.1016/j.biopha.2021.112103	https://doi.org/https://doi.org/10.1016/j.biopha.2021.112103	NUM
admet-2740	268	2	[	[	X
admet-2740	268	3	9	9	NUM
admet-2740	268	4	]	]	PUNCT
admet-2740	268	5	j.	j.	PROPN
admet-2740	268	6	hirsh	hirsh	PROPN
admet-2740	268	7	,	,	PUNCT
admet-2740	268	8	v.	v.	PROPN
admet-2740	268	9	fuster	fuster	PROPN
admet-2740	268	10	,	,	PUNCT
admet-2740	268	11	j.	j.	PROPN
admet-2740	268	12	ansell	ansell	PROPN
admet-2740	268	13	,	,	PUNCT
admet-2740	268	14	j.l	j.l	PROPN
admet-2740	268	15	.	.	PROPN
admet-2740	268	16	halperin	halperin	PROPN
admet-2740	268	17	.	.	PUNCT
admet-2740	269	1	american	american	PROPN
admet-2740	269	2	heart	heart	PROPN
admet-2740	269	3	association	association	PROPN
admet-2740	269	4	/	/	SYM
admet-2740	269	5	american	american	PROPN
admet-2740	269	6	college	college	PROPN
admet-2740	269	7	of	of	ADP
admet-2740	269	8	cardiology	cardiology	NOUN
admet-2740	269	9	foundation	foundation	NOUN
admet-2740	269	10	guide	guide	NOUN
admet-2740	269	11	to	to	ADP
admet-2740	269	12	warfarin	warfarin	NOUN
admet-2740	269	13	therapy	therapy	NOUN
admet-2740	269	14	.	.	PUNCT
admet-2740	270	1	circulation	circulation	NOUN
admet-2740	270	2	107	107	NUM
admet-2740	270	3	(	(	PUNCT
admet-2740	270	4	2003	2003	NUM
admet-2740	270	5	)	)	PUNCT
admet-2740	270	6	1692	1692	NUM
admet-2740	270	7	-	-	SYM
admet-2740	270	8	1711	1711	NUM
admet-2740	270	9	.	.	PUNCT
admet-2740	271	1	https://doi.org/doi:10.1161/01.cir.0000063575.17904.4e	https://doi.org/doi:10.1161/01.cir.0000063575.17904.4e	X
admet-2740	271	2	[	[	X
admet-2740	271	3	10	10	NUM
admet-2740	271	4	]	]	X
admet-2740	271	5	s.y	s.y	PROPN
admet-2740	271	6	.	.	PUNCT
admet-2740	272	1	kim	kim	PROPN
admet-2740	272	2	,	,	PUNCT
admet-2740	272	3	j.y	j.y	PROPN
admet-2740	272	4	.	.	PROPN
admet-2740	272	5	kang	kang	PROPN
admet-2740	272	6	,	,	PUNCT
admet-2740	272	7	j.h	j.h	PROPN
admet-2740	272	8	.	.	PROPN
admet-2740	272	9	hartman	hartman	PROPN
admet-2740	272	10	,	,	PUNCT
admet-2740	272	11	s.h	s.h	PROPN
admet-2740	272	12	.	.	PROPN
admet-2740	272	13	park	park	PROPN
admet-2740	272	14	,	,	PUNCT
admet-2740	272	15	d.r	d.r	PROPN
admet-2740	272	16	.	.	PROPN
admet-2740	272	17	jones	jones	PROPN
admet-2740	272	18	,	,	PUNCT
admet-2740	272	19	c.h	c.h	PROPN
admet-2740	272	20	.	.	PROPN
admet-2740	272	21	yun	yun	PROPN
admet-2740	272	22	,	,	PUNCT
admet-2740	272	23	g.	g.	PROPN
admet-2740	272	24	boysen	boysen	PROPN
admet-2740	272	25	,	,	PUNCT
admet-2740	272	26	g.p	g.p	PROPN
admet-2740	272	27	.	.	PROPN
admet-2740	272	28	miller	miller	PROPN
admet-2740	272	29	.	.	PUNCT
admet-2740	273	1	metabolism	metabolism	NOUN
admet-2740	273	2	of	of	ADP
admet-2740	273	3	rand	rand	NOUN
admet-2740	273	4	s	s	NOUN
admet-2740	273	5	-	-	NOUN
admet-2740	273	6	warfarin	warfarin	NOUN
admet-2740	273	7	by	by	ADP
admet-2740	273	8	cyp2c19	cyp2c19	NOUN
admet-2740	273	9	into	into	ADP
admet-2740	273	10	four	four	NUM
admet-2740	273	11	hydroxywarfarins	hydroxywarfarin	NOUN
admet-2740	273	12	.	.	PUNCT
admet-2740	274	1	drug	drug	NOUN
admet-2740	274	2	metabolism	metabolism	NOUN
admet-2740	274	3	letters	letter	NOUN
admet-2740	274	4	6	6	NUM
admet-2740	274	5	(	(	PUNCT
admet-2740	274	6	2012	2012	NUM
admet-2740	274	7	)	)	PUNCT
admet-2740	274	8	157	157	NUM
admet-2740	274	9	-	-	SYM
admet-2740	274	10	164	164	NUM
admet-2740	274	11	.	.	PUNCT
admet-2740	275	1	https://doi.org/10.2174/1872312811206030002	https://doi.org/10.2174/1872312811206030002	X
admet-2740	276	1	[	[	X
admet-2740	276	2	11	11	NUM
admet-2740	276	3	]	]	X
admet-2740	276	4	a.a	a.a	PROPN
admet-2740	276	5	.	.	PROPN
admet-2740	276	6	izzo	izzo	PROPN
admet-2740	276	7	,	,	PUNCT
admet-2740	276	8	g.	g.	PROPN
admet-2740	276	9	di	di	PROPN
admet-2740	276	10	carlo	carlo	PROPN
admet-2740	276	11	,	,	PUNCT
admet-2740	276	12	f.	f.	PROPN
admet-2740	276	13	borrelli	borrelli	PROPN
admet-2740	276	14	,	,	PUNCT
admet-2740	276	15	e.	e.	PROPN
admet-2740	276	16	ernst	ernst	PROPN
admet-2740	276	17	.	.	PUNCT
admet-2740	277	1	cardiovascular	cardiovascular	ADJ
admet-2740	277	2	pharmacotherapy	pharmacotherapy	NOUN
admet-2740	277	3	and	and	CCONJ
admet-2740	277	4	herbal	herbal	ADJ
admet-2740	277	5	medicines	medicine	NOUN
admet-2740	277	6	:	:	PUNCT
admet-2740	277	7	the	the	DET
admet-2740	277	8	risk	risk	NOUN
admet-2740	277	9	of	of	ADP
admet-2740	277	10	drug	drug	NOUN
admet-2740	277	11	interaction	interaction	NOUN
admet-2740	277	12	.	.	PUNCT
admet-2740	278	1	international	international	ADJ
admet-2740	278	2	journal	journal	PROPN
admet-2740	278	3	of	of	ADP
admet-2740	278	4	cardiology	cardiology	NOUN
admet-2740	278	5	98	98	NUM
admet-2740	278	6	(	(	PUNCT
admet-2740	278	7	2005	2005	NUM
admet-2740	278	8	)	)	PUNCT
admet-2740	278	9	1	1	NUM
admet-2740	278	10	-	-	SYM
admet-2740	278	11	14	14	NUM
admet-2740	278	12	.	.	PUNCT
admet-2740	279	1	https://doi.org/https://doi.org/10.1016/j.ijcard.2003.06.039	https://doi.org/https://doi.org/10.1016/j.ijcard.2003.06.039	NOUN
admet-2740	279	2	[	[	X
admet-2740	279	3	12	12	NUM
admet-2740	279	4	]	]	PUNCT
admet-2740	279	5	h.	h.	PROPN
admet-2740	279	6	kim	kim	PROPN
admet-2740	279	7	,	,	PUNCT
admet-2740	279	8	m.j	m.j	PROPN
admet-2740	279	9	.	.	PROPN
admet-2740	279	10	castellon	castellon	NOUN
admet-2740	279	11	-	-	PUNCT
admet-2740	279	12	chicas	chicas	PROPN
admet-2740	279	13	,	,	PUNCT
admet-2740	279	14	s.	s.	PROPN
admet-2740	279	15	arbizu	arbizu	PROPN
admet-2740	279	16	,	,	PUNCT
admet-2740	279	17	s.t	s.t	PROPN
admet-2740	279	18	.	.	PROPN
admet-2740	279	19	talcott	talcott	PROPN
admet-2740	279	20	,	,	PUNCT
admet-2740	279	21	n.l	n.l	PROPN
admet-2740	279	22	.	.	PROPN
admet-2740	279	23	drury	drury	PROPN
admet-2740	279	24	,	,	PUNCT
admet-2740	279	25	s.	s.	PROPN
admet-2740	279	26	smith	smith	PROPN
admet-2740	279	27	,	,	PUNCT
admet-2740	279	28	s.u	s.u	PROPN
admet-2740	279	29	.	.	PROPN
admet-2740	279	30	mertens	mertens	PROPN
admet-2740	279	31	-	-	PUNCT
admet-2740	279	32	talcott	talcott	PROPN
admet-2740	279	33	.	.	PUNCT
admet-2740	280	1	mango	mango	PROPN
admet-2740	280	2	(	(	PUNCT
admet-2740	280	3	mangifera	mangifera	PROPN
admet-2740	280	4	indica	indica	PROPN
admet-2740	280	5	l.	l.	PROPN
admet-2740	280	6	)	)	PUNCT
admet-2740	280	7	polyphenols	polyphenol	NOUN
admet-2740	280	8	:	:	PUNCT
admet-2740	280	9	anti	anti	ADJ
admet-2740	280	10	-	-	ADJ
admet-2740	280	11	inflammatory	inflammatory	ADJ
admet-2740	280	12	intestinal	intestinal	ADJ
admet-2740	280	13	microbial	microbial	ADJ
admet-2740	280	14	health	health	NOUN
admet-2740	280	15	benefits	benefit	NOUN
admet-2740	280	16	,	,	PUNCT
admet-2740	280	17	and	and	CCONJ
admet-2740	280	18	©	©	PROPN
admet-2740	280	19	2025	2025	NUM
admet-2740	280	20	by	by	ADP
admet-2740	280	21	the	the	DET
admet-2740	280	22	authors	author	NOUN
admet-2740	280	23	;	;	PUNCT
admet-2740	280	24	licensee	licensee	PROPN
admet-2740	280	25	iapc	iapc	PROPN
admet-2740	280	26	,	,	PUNCT
admet-2740	280	27	zagreb	zagreb	PROPN
admet-2740	280	28	,	,	PUNCT
admet-2740	280	29	croatia	croatia	PROPN
admet-2740	280	30	.	.	PUNCT
admet-2740	281	1	this	this	DET
admet-2740	281	2	article	article	NOUN
admet-2740	281	3	is	be	AUX
admet-2740	281	4	an	an	DET
admet-2740	281	5	open	open	ADJ
admet-2740	281	6	-	-	PUNCT
admet-2740	281	7	access	access	NOUN
admet-2740	281	8	article	article	NOUN
admet-2740	281	9	distributed	distribute	VERB
admet-2740	281	10	under	under	ADP
admet-2740	281	11	the	the	DET
admet-2740	281	12	terms	term	NOUN
admet-2740	281	13	and	and	CCONJ
admet-2740	281	14	conditions	condition	NOUN
admet-2740	281	15	of	of	ADP
admet-2740	281	16	the	the	DET
admet-2740	281	17	creative	creative	ADJ
admet-2740	281	18	commons	common	NOUN
admet-2740	281	19	attribution	attribution	NOUN
admet-2740	281	20	license	license	NOUN
admet-2740	281	21	(	(	PUNCT
admet-2740	281	22	http://creativecommons.org/licenses/by/3.0/	http://creativecommons.org/licenses/by/3.0/	PROPN
admet-2740	281	23	)	)	PUNCT
admet-2740	281	24	https://pub.iapchem.org/ojs/index.php/admet/article/view/2740	https://pub.iapchem.org/ojs/index.php/admet/article/view/2740	NOUN
admet-2740	281	25	https://doi.org/10.1002/pds.5585	https://doi.org/10.1002/pds.5585	PROPN
admet-2740	281	26	https://doi.org/10.1186/s13104-023-06383-2	https://doi.org/10.1186/s13104-023-06383-2	PROPN
admet-2740	282	1	https://doi.org/10.1016/j.thromres.2019.11.012	https://doi.org/10.1016/j.thromres.2019.11.012	PROPN
admet-2740	282	2	https://doi.org/10.3390/toxins2112584	https://doi.org/10.3390/toxins2112584	PROPN
admet-2740	282	3	https://doi.org/10.1177/106002800203600504	https://doi.org/10.1177/106002800203600504	PROPN
admet-2740	282	4	https://doi.org/10.1177/0897190014544823	https://doi.org/10.1177/0897190014544823	ADJ
admet-2740	282	5	https://doi.org/10.1111/bcp.14404	https://doi.org/10.1111/bcp.14404	NOUN
admet-2740	282	6	https://doi.org/https:/doi.org/10.1016/j.biopha.2021.112103	https://doi.org/https:/doi.org/10.1016/j.biopha.2021.112103	NOUN
admet-2740	282	7	https://doi.org/doi:10.1161/01.cir.0000063575.17904.4e	https://doi.org/doi:10.1161/01.cir.0000063575.17904.4e	ADV
admet-2740	282	8	https://doi.org/10.2174/1872312811206030002	https://doi.org/10.2174/1872312811206030002	ADV
admet-2740	282	9	https://doi.org/https:/doi.org/10.1016/j.ijcard.2003.06.039	https://doi.org/https:/doi.org/10.1016/j.ijcard.2003.06.039	PROPN
admet-2740	282	10	http://creativecommons.org/licenses/by/3.0/	http://creativecommons.org/licenses/by/3.0/	PROPN
admet-2740	282	11	admet	admet	PROPN
admet-2740	282	12	&	&	CCONJ
admet-2740	282	13	dmpk	dmpk	PROPN
admet-2740	282	14	13(3	13(3	NUM
admet-2740	282	15	)	)	PUNCT
admet-2740	282	16	(	(	PUNCT
admet-2740	282	17	2025	2025	NUM
admet-2740	282	18	)	)	PUNCT
admet-2740	282	19	2740	2740	NUM
admet-2740	282	20	metabolic	metabolic	NOUN
admet-2740	282	21	insights	insight	NOUN
admet-2740	282	22	into	into	ADP
admet-2740	282	23	the	the	DET
admet-2740	282	24	warfarin	warfarin	NOUN
admet-2740	282	25	-	-	PUNCT
admet-2740	282	26	mango	mango	NOUN
admet-2740	282	27	interaction	interaction	NOUN
admet-2740	282	28	doi	doi	NOUN
admet-2740	282	29	:	:	PUNCT
admet-2740	282	30	https://doi.org/10.5599/admet.2740	https://doi.org/10.5599/admet.2740	NOUN
admet-2740	282	31	15	15	NUM
admet-2740	282	32	associated	associate	VERB
admet-2740	282	33	mechanisms	mechanism	NOUN
admet-2740	282	34	of	of	ADP
admet-2740	282	35	actions	action	NOUN
admet-2740	282	36	.	.	PUNCT
admet-2740	283	1	molecules	molecule	NOUN
admet-2740	283	2	(	(	PUNCT
admet-2740	283	3	basel	basel	PROPN
admet-2740	283	4	,	,	PUNCT
admet-2740	283	5	switzerland	switzerland	PROPN
admet-2740	283	6	)	)	PUNCT
admet-2740	283	7	26	26	NUM
admet-2740	283	8	(	(	PUNCT
admet-2740	283	9	2021	2021	NUM
admet-2740	283	10	)	)	PUNCT
admet-2740	283	11	.	.	PUNCT
admet-2740	284	1	https://doi.org/10.3390/molecules26092732	https://doi.org/10.3390/molecules26092732	PROPN
admet-2740	284	2	[	[	X
admet-2740	284	3	13	13	NUM
admet-2740	284	4	]	]	PUNCT
admet-2740	284	5	h.	h.	PROPN
admet-2740	284	6	yamazaki	yamazaki	PROPN
admet-2740	284	7	,	,	PUNCT
admet-2740	284	8	t.	t.	PROPN
admet-2740	284	9	shimada	shimada	PROPN
admet-2740	284	10	.	.	PUNCT
admet-2740	285	1	effects	effect	NOUN
admet-2740	285	2	of	of	ADP
admet-2740	285	3	arachidonic	arachidonic	ADJ
admet-2740	285	4	acid	acid	NOUN
admet-2740	285	5	,	,	PUNCT
admet-2740	285	6	prostaglandins	prostaglandin	NOUN
admet-2740	285	7	,	,	PUNCT
admet-2740	285	8	retinol	retinol	NOUN
admet-2740	285	9	,	,	PUNCT
admet-2740	285	10	retinoic	retinoic	ADJ
admet-2740	285	11	acid	acid	PROPN
admet-2740	285	12	and	and	CCONJ
admet-2740	285	13	cholecalciferol	cholecalciferol	NOUN
admet-2740	285	14	on	on	ADP
admet-2740	285	15	xenobiotic	xenobiotic	ADJ
admet-2740	285	16	oxidations	oxidation	NOUN
admet-2740	285	17	catalysed	catalyse	VERB
admet-2740	285	18	by	by	ADP
admet-2740	285	19	human	human	ADJ
admet-2740	285	20	cytochrome	cytochrome	NOUN
admet-2740	285	21	p450	p450	NUM
admet-2740	285	22	enzymes	enzyme	NOUN
admet-2740	285	23	.	.	PUNCT
admet-2740	286	1	xenobiotica	xenobiotica	PROPN
admet-2740	286	2	29	29	NUM
admet-2740	286	3	(	(	PUNCT
admet-2740	286	4	1999	1999	NUM
admet-2740	286	5	)	)	PUNCT
admet-2740	286	6	231	231	NUM
admet-2740	286	7	-	-	SYM
admet-2740	286	8	241	241	NUM
admet-2740	286	9	.	.	PUNCT
admet-2740	287	1	https://doi.org/10.1080/004982599238632	https://doi.org/10.1080/004982599238632	X
admet-2740	288	1	[	[	X
admet-2740	288	2	14	14	NUM
admet-2740	288	3	]	]	PUNCT
admet-2740	288	4	a.	a.	NOUN
admet-2740	288	5	duda	duda	PROPN
admet-2740	288	6	-	-	PUNCT
admet-2740	288	7	chodak	chodak	NOUN
admet-2740	288	8	,	,	PUNCT
admet-2740	288	9	t.	t.	PROPN
admet-2740	288	10	tarko	tarko	PROPN
admet-2740	288	11	.	.	PUNCT
admet-2740	289	1	possible	possible	ADJ
admet-2740	289	2	side	side	NOUN
admet-2740	289	3	effects	effect	NOUN
admet-2740	289	4	of	of	ADP
admet-2740	289	5	polyphenols	polyphenol	NOUN
admet-2740	289	6	and	and	CCONJ
admet-2740	289	7	their	their	PRON
admet-2740	289	8	interactions	interaction	NOUN
admet-2740	289	9	with	with	ADP
admet-2740	289	10	medicines	medicine	NOUN
admet-2740	289	11	.	.	PUNCT
admet-2740	290	1	molecules	molecule	NOUN
admet-2740	290	2	(	(	PUNCT
admet-2740	290	3	basel	basel	PROPN
admet-2740	290	4	,	,	PUNCT
admet-2740	290	5	switzerland	switzerland	PROPN
admet-2740	290	6	)	)	PUNCT
admet-2740	290	7	28	28	NUM
admet-2740	290	8	(	(	PUNCT
admet-2740	290	9	2023	2023	NUM
admet-2740	290	10	)	)	PUNCT
admet-2740	290	11	.	.	PUNCT
admet-2740	291	1	https://doi.org/10.3390/molecules28062536	https://doi.org/10.3390/molecules28062536	NOUN
admet-2740	292	1	[	[	X
admet-2740	292	2	15	15	NUM
admet-2740	292	3	]	]	X
admet-2740	292	4	e.	e.	PROPN
admet-2740	292	5	fliszár	fliszár	PROPN
admet-2740	292	6	-	-	PUNCT
admet-2740	292	7	nyúl	nyúl	NOUN
admet-2740	292	8	,	,	PUNCT
admet-2740	292	9	v.	v.	ADP
admet-2740	292	10	mohos	mohos	PROPN
admet-2740	292	11	,	,	PUNCT
admet-2740	292	12	r.	r.	PROPN
admet-2740	292	13	csepregi	csepregi	PROPN
admet-2740	292	14	,	,	PUNCT
admet-2740	292	15	p.	p.	NOUN
admet-2740	292	16	mladěnka	mladěnka	NOUN
admet-2740	292	17	,	,	PUNCT
admet-2740	292	18	m.	m.	NOUN
admet-2740	292	19	poór	poór	PROPN
admet-2740	292	20	.	.	PUNCT
admet-2740	293	1	inhibitory	inhibitory	ADJ
admet-2740	293	2	effects	effect	NOUN
admet-2740	293	3	of	of	ADP
admet-2740	293	4	polyphenols	polyphenol	NOUN
admet-2740	293	5	and	and	CCONJ
admet-2740	293	6	their	their	PRON
admet-2740	293	7	colonic	colonic	ADJ
admet-2740	293	8	metabolites	metabolite	NOUN
admet-2740	293	9	on	on	ADP
admet-2740	293	10	cyp2d6	cyp2d6	NOUN
admet-2740	293	11	enzyme	enzyme	NOUN
admet-2740	293	12	using	use	VERB
admet-2740	293	13	two	two	NUM
admet-2740	293	14	different	different	ADJ
admet-2740	293	15	substrates	substrate	NOUN
admet-2740	293	16	.	.	PUNCT
admet-2740	294	1	biomedicine	biomedicine	NOUN
admet-2740	294	2	&	&	CCONJ
admet-2740	294	3	pharmacotherapy	pharmacotherapy	NOUN
admet-2740	294	4	131	131	NUM
admet-2740	294	5	(	(	PUNCT
admet-2740	294	6	2020	2020	NUM
admet-2740	294	7	)	)	PUNCT
admet-2740	294	8	110732	110732	NUM
admet-2740	294	9	.	.	PUNCT
admet-2740	295	1	https://doi.org/10.1016/j.biopha.2020.110732	https://doi.org/10.1016/j.biopha.2020.110732	NOUN
admet-2740	295	2	[	[	X
admet-2740	295	3	16	16	NUM
admet-2740	295	4	]	]	PUNCT
admet-2740	295	5	p.	p.	NOUN
admet-2740	295	6	tajai	tajai	PROPN
admet-2740	295	7	,	,	PUNCT
admet-2740	295	8	g.	g.	PROPN
admet-2740	295	9	konguthaithip	konguthaithip	PROPN
admet-2740	295	10	,	,	PUNCT
admet-2740	295	11	t.	t.	PROPN
admet-2740	295	12	chaikhaeng	chaikhaeng	PROPN
admet-2740	295	13	,	,	PUNCT
admet-2740	295	14	c.	c.	PROPN
admet-2740	295	15	jaikang	jaikang	PROPN
admet-2740	295	16	.	.	PUNCT
admet-2740	296	1	glyphosate	glyphosate	NOUN
admet-2740	296	2	-	-	PUNCT
admet-2740	296	3	based	base	VERB
admet-2740	296	4	herbicide	herbicide	NOUN
admet-2740	296	5	metabolic	metabolic	NOUN
admet-2740	296	6	profiles	profile	NOUN
admet-2740	296	7	in	in	ADP
admet-2740	296	8	human	human	ADJ
admet-2740	296	9	urine	urine	NOUN
admet-2740	296	10	samples	sample	NOUN
admet-2740	296	11	through	through	ADP
admet-2740	296	12	proton	proton	NOUN
admet-2740	296	13	nuclear	nuclear	ADJ
admet-2740	296	14	magnetic	magnetic	ADJ
admet-2740	296	15	resonance	resonance	NOUN
admet-2740	296	16	analysis	analysis	NOUN
admet-2740	296	17	.	.	PUNCT
admet-2740	297	1	admet	admet	PROPN
admet-2740	297	2	&	&	CCONJ
admet-2740	297	3	dmpk	dmpk	PROPN
admet-2740	297	4	12	12	NUM
admet-2740	297	5	(	(	PUNCT
admet-2740	297	6	2024	2024	NUM
admet-2740	297	7	)	)	PUNCT
admet-2740	297	8	957	957	NUM
admet-2740	297	9	-	-	SYM
admet-2740	297	10	970	970	NUM
admet-2740	297	11	.	.	PUNCT
admet-2740	297	12	https://doi.org/10.5599/admet.2476	https://doi.org/10.5599/admet.2476	PROPN
admet-2740	297	13	[	[	X
admet-2740	297	14	17	17	NUM
admet-2740	297	15	]	]	X
admet-2740	297	16	a.c	a.c	PROPN
admet-2740	297	17	.	.	PROPN
admet-2740	297	18	dona	dona	PROPN
admet-2740	297	19	,	,	PUNCT
admet-2740	297	20	m.	m.	NOUN
admet-2740	297	21	kyriakides	kyriakides	PROPN
admet-2740	297	22	,	,	PUNCT
admet-2740	297	23	f.	f.	PROPN
admet-2740	297	24	scott	scott	PROPN
admet-2740	297	25	,	,	PUNCT
admet-2740	297	26	e.a	e.a	PROPN
admet-2740	297	27	.	.	PROPN
admet-2740	297	28	shephard	shephard	PROPN
admet-2740	297	29	,	,	PUNCT
admet-2740	297	30	d.	d.	PROPN
admet-2740	297	31	varshavi	varshavi	PROPN
admet-2740	297	32	,	,	PUNCT
admet-2740	297	33	k.	k.	PROPN
admet-2740	297	34	veselkov	veselkov	PROPN
admet-2740	297	35	,	,	PUNCT
admet-2740	297	36	j.r	j.r	PROPN
admet-2740	297	37	.	.	PROPN
admet-2740	297	38	everett	everett	PROPN
admet-2740	297	39	.	.	PUNCT
admet-2740	298	1	a	a	DET
admet-2740	298	2	guide	guide	NOUN
admet-2740	298	3	to	to	ADP
admet-2740	298	4	the	the	DET
admet-2740	298	5	identification	identification	NOUN
admet-2740	298	6	of	of	ADP
admet-2740	298	7	metabolites	metabolite	NOUN
admet-2740	298	8	in	in	ADP
admet-2740	298	9	nmr	nmr	NOUN
admet-2740	298	10	-	-	PUNCT
admet-2740	298	11	based	base	VERB
admet-2740	298	12	metabonomics	metabonomic	NOUN
admet-2740	298	13	/	/	SYM
admet-2740	298	14	metabolomics	metabolomic	NOUN
admet-2740	298	15	experiments	experiment	NOUN
admet-2740	298	16	.	.	PUNCT
admet-2740	299	1	computational	computational	ADJ
admet-2740	299	2	and	and	CCONJ
admet-2740	299	3	structural	structural	ADJ
admet-2740	299	4	biotechnology	biotechnology	NOUN
admet-2740	299	5	journal	journal	NOUN
admet-2740	299	6	14	14	NUM
admet-2740	299	7	(	(	PUNCT
admet-2740	299	8	2016	2016	NUM
admet-2740	299	9	)	)	PUNCT
admet-2740	299	10	135	135	NUM
admet-2740	299	11	-	-	SYM
admet-2740	299	12	153	153	NUM
admet-2740	299	13	.	.	PUNCT
admet-2740	300	1	https://doi.org/https://doi.org/10.1016/j.csbj.2016.02.005	https://doi.org/https://doi.org/10.1016/j.csbj.2016.02.005	PROPN
admet-2740	300	2	[	[	X
admet-2740	300	3	18	18	NUM
admet-2740	300	4	]	]	X
admet-2740	300	5	d.s	d.s	PROPN
admet-2740	300	6	.	.	PROPN
admet-2740	300	7	wishart	wishart	PROPN
admet-2740	300	8	,	,	PUNCT
admet-2740	300	9	t.	t.	PROPN
admet-2740	300	10	jewison	jewison	PROPN
admet-2740	300	11	,	,	PUNCT
admet-2740	300	12	a.c	a.c	PROPN
admet-2740	300	13	.	.	PROPN
admet-2740	300	14	guo	guo	PROPN
admet-2740	300	15	,	,	PUNCT
admet-2740	300	16	m.	m.	PROPN
admet-2740	300	17	wilson	wilson	PROPN
admet-2740	300	18	,	,	PUNCT
admet-2740	300	19	c.	c.	PROPN
admet-2740	300	20	knox	knox	PROPN
admet-2740	300	21	,	,	PUNCT
admet-2740	300	22	y.	y.	PROPN
admet-2740	300	23	liu	liu	PROPN
admet-2740	300	24	,	,	PUNCT
admet-2740	300	25	y.	y.	PROPN
admet-2740	300	26	djoumbou	djoumbou	PROPN
admet-2740	300	27	,	,	PUNCT
admet-2740	300	28	r.	r.	PROPN
admet-2740	300	29	mandal	mandal	PROPN
admet-2740	300	30	,	,	PUNCT
admet-2740	300	31	f.	f.	PROPN
admet-2740	300	32	aziat	aziat	PROPN
admet-2740	300	33	,	,	PUNCT
admet-2740	300	34	e.	e.	PROPN
admet-2740	300	35	dong	dong	PROPN
admet-2740	300	36	,	,	PUNCT
admet-2740	300	37	s.	s.	PROPN
admet-2740	300	38	bouatra	bouatra	PROPN
admet-2740	300	39	,	,	PUNCT
admet-2740	300	40	i.	i.	PROPN
admet-2740	300	41	sinelnikov	sinelnikov	PROPN
admet-2740	300	42	,	,	PUNCT
admet-2740	300	43	d.	d.	PROPN
admet-2740	300	44	arndt	arndt	PROPN
admet-2740	300	45	,	,	PUNCT
admet-2740	300	46	j.	j.	PROPN
admet-2740	300	47	xia	xia	PROPN
admet-2740	300	48	,	,	PUNCT
admet-2740	300	49	p.	p.	PROPN
admet-2740	300	50	liu	liu	PROPN
admet-2740	300	51	,	,	PUNCT
admet-2740	300	52	f.	f.	PROPN
admet-2740	300	53	yallou	yallou	PROPN
admet-2740	300	54	,	,	PUNCT
admet-2740	300	55	t.	t.	PROPN
admet-2740	300	56	bjorndahl	bjorndahl	PROPN
admet-2740	300	57	,	,	PUNCT
admet-2740	300	58	r.	r.	PROPN
admet-2740	300	59	perez	perez	PROPN
admet-2740	300	60	-	-	PUNCT
admet-2740	300	61	pineiro	pineiro	PROPN
admet-2740	300	62	,	,	PUNCT
admet-2740	300	63	r.	r.	PROPN
admet-2740	300	64	eisner	eisner	PROPN
admet-2740	300	65	,	,	PUNCT
admet-2740	300	66	f.	f.	PROPN
admet-2740	300	67	allen	allen	PROPN
admet-2740	300	68	,	,	PUNCT
admet-2740	300	69	v.	v.	PROPN
admet-2740	300	70	neveu	neveu	PROPN
admet-2740	300	71	,	,	PUNCT
admet-2740	300	72	r.	r.	PROPN
admet-2740	300	73	greiner	greiner	PROPN
admet-2740	300	74	,	,	PUNCT
admet-2740	300	75	a.	a.	NOUN
admet-2740	300	76	scalbert	scalbert	NOUN
admet-2740	300	77	.	.	PUNCT
admet-2740	301	1	hmdb	hmdb	PROPN
admet-2740	301	2	3.0	3.0	NUM
admet-2740	301	3	—	—	PUNCT
admet-2740	301	4	the	the	DET
admet-2740	301	5	human	human	ADJ
admet-2740	301	6	metabolome	metabolome	PROPN
admet-2740	301	7	database	database	NOUN
admet-2740	301	8	in	in	ADP
admet-2740	301	9	2013	2013	NUM
admet-2740	301	10	.	.	PUNCT
admet-2740	302	1	nucleic	nucleic	ADJ
admet-2740	302	2	acids	acid	NOUN
admet-2740	302	3	research	research	NOUN
admet-2740	302	4	41	41	NUM
admet-2740	302	5	(	(	PUNCT
admet-2740	302	6	2012	2012	NUM
admet-2740	302	7	)	)	PUNCT
admet-2740	303	1	d801	d801	PROPN
admet-2740	303	2	-	-	SYM
admet-2740	303	3	d807	d807	PROPN
admet-2740	303	4	.	.	PUNCT
admet-2740	304	1	https://doi.org/10.1093/nar/gks1065	https://doi.org/10.1093/nar/gks1065	NOUN
admet-2740	305	1	[	[	X
admet-2740	305	2	19	19	NUM
admet-2740	305	3	]	]	PUNCT
admet-2740	305	4	t.	t.	NOUN
admet-2740	305	5	claridge	claridge	PROPN
admet-2740	305	6	.	.	PUNCT
admet-2740	306	1	software	software	PROPN
admet-2740	306	2	review	review	PROPN
admet-2740	306	3	of	of	ADP
admet-2740	306	4	mnova	mnova	PROPN
admet-2740	306	5	:	:	PUNCT
admet-2740	306	6	nmr	nmr	NOUN
admet-2740	306	7	data	datum	NOUN
admet-2740	306	8	processing	processing	NOUN
admet-2740	306	9	,	,	PUNCT
admet-2740	306	10	analysis	analysis	NOUN
admet-2740	306	11	,	,	PUNCT
admet-2740	306	12	and	and	CCONJ
admet-2740	306	13	prediction	prediction	NOUN
admet-2740	306	14	software	software	NOUN
admet-2740	306	15	.	.	PUNCT
admet-2740	307	1	journal	journal	PROPN
admet-2740	307	2	of	of	ADP
admet-2740	307	3	chemical	chemical	ADJ
admet-2740	307	4	information	information	NOUN
admet-2740	307	5	and	and	CCONJ
admet-2740	307	6	modeling	model	VERB
admet-2740	307	7	49	49	NUM
admet-2740	307	8	(	(	PUNCT
admet-2740	307	9	2009	2009	NUM
admet-2740	307	10	)	)	PUNCT
admet-2740	307	11	1136	1136	NUM
admet-2740	307	12	-	-	SYM
admet-2740	307	13	1137	1137	NUM
admet-2740	307	14	.	.	PUNCT
admet-2740	308	1	https://doi.org/10.1021/ci900090d	https://doi.org/10.1021/ci900090d	NOUN
admet-2740	309	1	[	[	X
admet-2740	309	2	20	20	NUM
admet-2740	309	3	]	]	PUNCT
admet-2740	309	4	z.	z.	PROPN
admet-2740	309	5	pang	pang	PROPN
admet-2740	309	6	,	,	PUNCT
admet-2740	309	7	y.	y.	PROPN
admet-2740	309	8	lu	lu	PROPN
admet-2740	309	9	,	,	PUNCT
admet-2740	309	10	g.	g.	PROPN
admet-2740	309	11	zhou	zhou	PROPN
admet-2740	309	12	,	,	PUNCT
admet-2740	309	13	f.	f.	PROPN
admet-2740	309	14	hui	hui	PROPN
admet-2740	309	15	,	,	PUNCT
admet-2740	309	16	l.	l.	PROPN
admet-2740	309	17	xu	xu	PROPN
admet-2740	309	18	,	,	PUNCT
admet-2740	309	19	c.	c.	PROPN
admet-2740	309	20	viau	viau	PROPN
admet-2740	309	21	,	,	PUNCT
admet-2740	309	22	aliya	aliya	PROPN
admet-2740	309	23	f.	f.	PROPN
admet-2740	309	24	spigelman	spigelman	PROPN
admet-2740	309	25	,	,	PUNCT
admet-2740	309	26	patrick	patrick	PROPN
admet-2740	309	27	e.	e.	PROPN
admet-2740	309	28	macdonald	macdonald	PROPN
admet-2740	309	29	,	,	PUNCT
admet-2740	309	30	david	david	PROPN
admet-2740	309	31	s.	s.	PROPN
admet-2740	309	32	wishart	wishart	PROPN
admet-2740	309	33	,	,	PUNCT
admet-2740	309	34	s.	s.	PROPN
admet-2740	309	35	li	li	PROPN
admet-2740	309	36	,	,	PUNCT
admet-2740	309	37	j.	j.	PROPN
admet-2740	309	38	xia	xia	PROPN
admet-2740	309	39	.	.	PUNCT
admet-2740	310	1	metaboanalyst	metaboanalyst	NOUN
admet-2740	310	2	6.0	6.0	NUM
admet-2740	310	3	:	:	PUNCT
admet-2740	310	4	towards	towards	ADP
admet-2740	310	5	a	a	DET
admet-2740	310	6	unified	unified	ADJ
admet-2740	310	7	platform	platform	NOUN
admet-2740	310	8	for	for	ADP
admet-2740	310	9	metabolomics	metabolomic	NOUN
admet-2740	310	10	data	datum	NOUN
admet-2740	310	11	processing	processing	NOUN
admet-2740	310	12	,	,	PUNCT
admet-2740	310	13	analysis	analysis	NOUN
admet-2740	310	14	and	and	CCONJ
admet-2740	310	15	interpretation	interpretation	NOUN
admet-2740	310	16	.	.	PUNCT
admet-2740	311	1	nucleic	nucleic	ADJ
admet-2740	311	2	acids	acid	NOUN
admet-2740	311	3	research	research	NOUN
admet-2740	311	4	52	52	NUM
admet-2740	311	5	(	(	PUNCT
admet-2740	311	6	2024	2024	NUM
admet-2740	311	7	)	)	PUNCT
admet-2740	311	8	w398	w398	PROPN
admet-2740	311	9	-	-	PUNCT
admet-2740	311	10	w406	w406	PROPN
admet-2740	311	11	.	.	PUNCT
admet-2740	312	1	https://doi.org/10.1093/nar/gkae253	https://doi.org/10.1093/nar/gkae253	PROPN
admet-2740	313	1	[	[	X
admet-2740	313	2	21	21	NUM
admet-2740	313	3	]	]	X
admet-2740	313	4	y.	y.	PROPN
admet-2740	313	5	zhou	zhou	PROPN
admet-2740	313	6	,	,	PUNCT
admet-2740	313	7	b.	b.	PROPN
admet-2740	313	8	zhou	zhou	PROPN
admet-2740	313	9	,	,	PUNCT
admet-2740	313	10	l.	l.	PROPN
admet-2740	313	11	pache	pache	PROPN
admet-2740	313	12	,	,	PUNCT
admet-2740	313	13	m.	m.	PROPN
admet-2740	313	14	chang	chang	PROPN
admet-2740	313	15	,	,	PUNCT
admet-2740	313	16	a.h	a.h	PROPN
admet-2740	313	17	.	.	PROPN
admet-2740	313	18	khodabakhshi	khodabakhshi	PROPN
admet-2740	313	19	,	,	PUNCT
admet-2740	313	20	o.	o.	PROPN
admet-2740	313	21	tanaseichuk	tanaseichuk	PROPN
admet-2740	313	22	,	,	PUNCT
admet-2740	313	23	c.	c.	PROPN
admet-2740	313	24	benner	benner	PROPN
admet-2740	313	25	,	,	PUNCT
admet-2740	313	26	s.k	s.k	PROPN
admet-2740	313	27	.	.	PROPN
admet-2740	313	28	chanda	chanda	PROPN
admet-2740	313	29	.	.	PUNCT
admet-2740	313	30	metascape	metascape	PROPN
admet-2740	313	31	provides	provide	VERB
admet-2740	313	32	a	a	DET
admet-2740	313	33	biologist	biologist	NOUN
admet-2740	313	34	-	-	PUNCT
admet-2740	313	35	oriented	orient	VERB
admet-2740	313	36	resource	resource	NOUN
admet-2740	313	37	for	for	ADP
admet-2740	313	38	the	the	DET
admet-2740	313	39	analysis	analysis	NOUN
admet-2740	313	40	of	of	ADP
admet-2740	313	41	systems	system	NOUN
admet-2740	313	42	-	-	PUNCT
admet-2740	313	43	level	level	NOUN
admet-2740	313	44	datasets	dataset	NOUN
admet-2740	313	45	.	.	PUNCT
admet-2740	314	1	nature	nature	NOUN
admet-2740	314	2	communications	communication	NOUN
admet-2740	314	3	10	10	NUM
admet-2740	314	4	(	(	PUNCT
admet-2740	314	5	2019	2019	NUM
admet-2740	314	6	)	)	PUNCT
admet-2740	314	7	1523	1523	NUM
admet-2740	314	8	.	.	PUNCT
admet-2740	315	1	https://doi.org/10.1038/s41467-019-09234-6	https://doi.org/10.1038/s41467-019-09234-6	PUNCT
admet-2740	316	1	[	[	X
admet-2740	316	2	22	22	NUM
admet-2740	316	3	]	]	PUNCT
admet-2740	316	4	p.	p.	NOUN
admet-2740	316	5	tajai	tajai	PROPN
admet-2740	316	6	,	,	PUNCT
admet-2740	316	7	b.i	b.i	PROPN
admet-2740	316	8	.	.	PROPN
admet-2740	316	9	fedeles	fedeles	PROPN
admet-2740	316	10	,	,	PUNCT
admet-2740	316	11	t.	t.	PROPN
admet-2740	316	12	suriyo	suriyo	PROPN
admet-2740	316	13	,	,	PUNCT
admet-2740	316	14	p.	p.	PROPN
admet-2740	316	15	navasumrit	navasumrit	PROPN
admet-2740	316	16	,	,	PUNCT
admet-2740	316	17	j.	j.	PROPN
admet-2740	316	18	kanitwithayanun	kanitwithayanun	PROPN
admet-2740	316	19	,	,	PUNCT
admet-2740	316	20	j.m	j.m	PROPN
admet-2740	316	21	.	.	PROPN
admet-2740	316	22	essigmann	essigmann	PROPN
admet-2740	316	23	,	,	PUNCT
admet-2740	316	24	j.	j.	PROPN
admet-2740	316	25	satayavivad	satayavivad	PROPN
admet-2740	316	26	.	.	PUNCT
admet-2740	317	1	an	an	DET
admet-2740	317	2	engineered	engineer	VERB
admet-2740	317	3	cell	cell	NOUN
admet-2740	317	4	line	line	NOUN
admet-2740	317	5	lacking	lack	VERB
admet-2740	317	6	ogg1	ogg1	NOUN
admet-2740	317	7	and	and	CCONJ
admet-2740	317	8	mutyh	mutyh	PROPN
admet-2740	317	9	glycosylases	glycosylase	NOUN
admet-2740	317	10	implicates	implicate	VERB
admet-2740	317	11	the	the	DET
admet-2740	317	12	accumulation	accumulation	NOUN
admet-2740	317	13	of	of	ADP
admet-2740	317	14	genomic	genomic	NOUN
admet-2740	317	15	8oxoguanine	8oxoguanine	NUM
admet-2740	317	16	as	as	ADP
admet-2740	317	17	the	the	DET
admet-2740	317	18	basis	basis	NOUN
admet-2740	317	19	for	for	ADP
admet-2740	317	20	paraquat	paraquat	NOUN
admet-2740	317	21	mutagenicity	mutagenicity	NOUN
admet-2740	317	22	.	.	PUNCT
admet-2740	318	1	free	free	ADJ
admet-2740	318	2	radical	radical	ADJ
admet-2740	318	3	biology	biology	NOUN
admet-2740	318	4	&	&	CCONJ
admet-2740	318	5	medicine	medicine	NOUN
admet-2740	318	6	116	116	NUM
admet-2740	318	7	(	(	PUNCT
admet-2740	318	8	2018	2018	NUM
admet-2740	318	9	)	)	PUNCT
admet-2740	318	10	64	64	NUM
admet-2740	318	11	-	-	SYM
admet-2740	318	12	72	72	NUM
admet-2740	318	13	.	.	PUNCT
admet-2740	319	1	https://doi.org/10.1016/j.freeradbiomed.2017.12.035	https://doi.org/10.1016/j.freeradbiomed.2017.12.035	PRON
admet-2740	319	2	[	[	X
admet-2740	319	3	23	23	NUM
admet-2740	319	4	]	]	PUNCT
admet-2740	319	5	m.	m.	NOUN
admet-2740	319	6	ghatge	ghatge	NOUN
admet-2740	319	7	,	,	PUNCT
admet-2740	319	8	g.d	g.d	PROPN
admet-2740	319	9	.	.	PROPN
admet-2740	319	10	flora	flora	PROPN
admet-2740	319	11	,	,	PUNCT
admet-2740	319	12	m.k	m.k	PROPN
admet-2740	319	13	.	.	PROPN
admet-2740	319	14	nayak	nayak	PROPN
admet-2740	319	15	,	,	PUNCT
admet-2740	319	16	a.k	a.k	PROPN
admet-2740	319	17	.	.	PROPN
admet-2740	319	18	chauhan	chauhan	PROPN
admet-2740	319	19	.	.	PROPN
admet-2740	320	1	platelet	platelet	NOUN
admet-2740	320	2	metabolic	metabolic	NOUN
admet-2740	320	3	profiling	profiling	NOUN
admet-2740	320	4	reveals	reveal	VERB
admet-2740	320	5	glycolytic	glycolytic	ADJ
admet-2740	320	6	and	and	CCONJ
admet-2740	320	7	1	1	NUM
admet-2740	320	8	-	-	PUNCT
admet-2740	320	9	carbon	carbon	NOUN
admet-2740	320	10	metabolites	metabolite	NOUN
admet-2740	320	11	are	be	AUX
admet-2740	320	12	essential	essential	ADJ
admet-2740	320	13	for	for	ADP
admet-2740	320	14	gp	gp	NOUN
admet-2740	320	15	vi	vi	PROPN
admet-2740	320	16	–	–	PUNCT
admet-2740	320	17	stimulated	stimulate	VERB
admet-2740	320	18	human	human	ADJ
admet-2740	320	19	platelets	platelet	NOUN
admet-2740	320	20	—	—	PUNCT
admet-2740	320	21	brief	brief	ADJ
admet-2740	320	22	report	report	NOUN
admet-2740	320	23	.	.	PUNCT
admet-2740	321	1	arteriosclerosis	arteriosclerosis	NOUN
admet-2740	321	2	,	,	PUNCT
admet-2740	321	3	thrombosis	thrombosis	NOUN
admet-2740	321	4	,	,	PUNCT
admet-2740	321	5	and	and	CCONJ
admet-2740	321	6	vascular	vascular	ADJ
admet-2740	321	7	biology	biology	NOUN
admet-2740	321	8	44	44	NUM
admet-2740	321	9	(	(	PUNCT
admet-2740	321	10	2024	2024	NUM
admet-2740	321	11	)	)	PUNCT
admet-2740	321	12	409	409	NUM
admet-2740	321	13	-	-	SYM
admet-2740	321	14	416	416	NUM
admet-2740	321	15	.	.	PUNCT
admet-2740	322	1	https://doi.org/doi:10.1161/atvbaha.123.319821	https://doi.org/doi:10.1161/atvbaha.123.319821	NOUN
admet-2740	322	2	[	[	X
admet-2740	322	3	24	24	NUM
admet-2740	322	4	]	]	SYM
admet-2740	322	5	p.p	p.p	PROPN
admet-2740	322	6	.	.	PROPN
admet-2740	322	7	kulkarni	kulkarni	PROPN
admet-2740	322	8	,	,	PUNCT
admet-2740	322	9	m.	m.	NOUN
admet-2740	322	10	ekhlak	ekhlak	PROPN
admet-2740	322	11	,	,	PUNCT
admet-2740	322	12	d.	d.	NOUN
admet-2740	322	13	dash	dash	NOUN
admet-2740	322	14	.	.	PUNCT
admet-2740	323	1	energy	energy	NOUN
admet-2740	323	2	metabolism	metabolism	NOUN
admet-2740	323	3	in	in	ADP
admet-2740	323	4	platelets	platelet	NOUN
admet-2740	323	5	fuels	fuel	NOUN
admet-2740	323	6	thrombus	thrombus	VERB
admet-2740	323	7	formation	formation	NOUN
admet-2740	323	8	:	:	PUNCT
admet-2740	323	9	halting	halt	VERB
admet-2740	323	10	the	the	DET
admet-2740	323	11	thrombosis	thrombosis	NOUN
admet-2740	323	12	engine	engine	NOUN
admet-2740	323	13	with	with	ADP
admet-2740	323	14	small	small	ADJ
admet-2740	323	15	-	-	PUNCT
admet-2740	323	16	molecule	molecule	NOUN
admet-2740	323	17	modulators	modulator	NOUN
admet-2740	323	18	of	of	ADP
admet-2740	323	19	platelet	platelet	ADJ
admet-2740	323	20	metabolism	metabolism	NOUN
admet-2740	323	21	.	.	PUNCT
admet-2740	324	1	metabolism	metabolism	NOUN
admet-2740	324	2	145	145	NUM
admet-2740	324	3	(	(	PUNCT
admet-2740	324	4	2023	2023	NUM
admet-2740	324	5	)	)	PUNCT
admet-2740	324	6	155596	155596	NUM
admet-2740	324	7	.	.	PUNCT
admet-2740	325	1	https://doi.org/10.1016/j.metabol.2023.155596	https://doi.org/10.1016/j.metabol.2023.155596	NOUN
admet-2740	325	2	[	[	X
admet-2740	325	3	25	25	NUM
admet-2740	325	4	]	]	X
admet-2740	325	5	g.d	g.d	PROPN
admet-2740	325	6	.	.	PROPN
admet-2740	325	7	flora	flora	PROPN
admet-2740	325	8	,	,	PUNCT
admet-2740	325	9	m.k	m.k	PROPN
admet-2740	325	10	.	.	PUNCT
admet-2740	325	11	nayak	nayak	PROPN
admet-2740	325	12	,	,	PUNCT
admet-2740	325	13	m.	m.	NOUN
admet-2740	325	14	ghatge	ghatge	NOUN
admet-2740	325	15	,	,	PUNCT
admet-2740	325	16	a.k	a.k	PROPN
admet-2740	325	17	.	.	PROPN
admet-2740	325	18	chauhan	chauhan	PROPN
admet-2740	325	19	.	.	PROPN
admet-2740	325	20	metabolic	metabolic	PROPN
admet-2740	325	21	targeting	target	VERB
admet-2740	325	22	of	of	ADP
admet-2740	325	23	platelets	platelet	NOUN
admet-2740	325	24	to	to	PART
admet-2740	325	25	combat	combat	NOUN
admet-2740	325	26	thrombosis	thrombosis	NOUN
admet-2740	325	27	:	:	PUNCT
admet-2740	325	28	dawn	dawn	NOUN
admet-2740	325	29	of	of	ADP
admet-2740	325	30	a	a	DET
admet-2740	325	31	new	new	ADJ
admet-2740	325	32	paradigm	paradigm	NOUN
admet-2740	325	33	?	?	PUNCT
admet-2740	326	1	cardiovascular	cardiovascular	ADJ
admet-2740	326	2	research	research	NOUN
admet-2740	326	3	119	119	NUM
admet-2740	326	4	(	(	PUNCT
admet-2740	326	5	2023	2023	NUM
admet-2740	326	6	)	)	PUNCT
admet-2740	326	7	2497	2497	NUM
admet-2740	326	8	-	-	SYM
admet-2740	326	9	2507	2507	NUM
admet-2740	326	10	.	.	PUNCT
admet-2740	327	1	https://doi.org/10.1093/cvr/cvad149	https://doi.org/10.1093/cvr/cvad149	NOUN
admet-2740	328	1	[	[	X
admet-2740	328	2	26	26	NUM
admet-2740	328	3	]	]	X
admet-2740	328	4	c.l	c.l	PROPN
admet-2740	328	5	.	.	PROPN
admet-2740	328	6	sake	sake	NOUN
admet-2740	328	7	,	,	PUNCT
admet-2740	328	8	a.j	a.j	PROPN
admet-2740	328	9	.	.	PROPN
admet-2740	328	10	metcalf	metcalf	PROPN
admet-2740	328	11	,	,	PUNCT
admet-2740	328	12	m.	m.	PROPN
admet-2740	328	13	meagher	meagher	PROPN
admet-2740	328	14	,	,	PUNCT
admet-2740	328	15	j.	j.	PROPN
admet-2740	328	16	di	di	PROPN
admet-2740	328	17	paola	paola	PROPN
admet-2740	328	18	,	,	PUNCT
admet-2740	328	19	k.b	k.b	PROPN
admet-2740	328	20	.	.	PROPN
admet-2740	328	21	neeves	neeves	PROPN
admet-2740	328	22	,	,	PUNCT
admet-2740	328	23	n.r	n.r	PROPN
admet-2740	328	24	.	.	PROPN
admet-2740	328	25	boyle	boyle	PROPN
admet-2740	328	26	.	.	PUNCT
admet-2740	329	1	isotopically	isotopically	ADV
admet-2740	329	2	nonstationary	nonstationary	ADJ
admet-2740	329	3	(	(	PUNCT
admet-2740	329	4	13)c	13)c	NUM
admet-2740	329	5	metabolic	metabolic	NOUN
admet-2740	329	6	flux	flux	NOUN
admet-2740	329	7	analysis	analysis	NOUN
admet-2740	329	8	in	in	ADP
admet-2740	329	9	resting	rest	VERB
admet-2740	329	10	and	and	CCONJ
admet-2740	329	11	activated	activate	VERB
admet-2740	329	12	human	human	ADJ
admet-2740	329	13	platelets	platelet	NOUN
admet-2740	329	14	.	.	PUNCT
admet-2740	330	1	metabolic	metabolic	NOUN
admet-2740	330	2	engineering	engineering	NOUN
admet-2740	330	3	69	69	NUM
admet-2740	330	4	(	(	PUNCT
admet-2740	330	5	2022	2022	NUM
admet-2740	330	6	)	)	PUNCT
admet-2740	330	7	313	313	NUM
admet-2740	330	8	-	-	SYM
admet-2740	330	9	322	322	NUM
admet-2740	330	10	.	.	PUNCT
admet-2740	331	1	https://doi.org/10.1016/j.ymben.2021.12.007	https://doi.org/10.1016/j.ymben.2021.12.007	VERB
admet-2740	331	2	[	[	PUNCT
admet-2740	331	3	27	27	NUM
admet-2740	331	4	]	]	X
admet-2740	331	5	p.p	p.p	PROPN
admet-2740	331	6	.	.	PROPN
admet-2740	331	7	kulkarni	kulkarni	PROPN
admet-2740	331	8	,	,	PUNCT
admet-2740	331	9	a.	a.	PROPN
admet-2740	331	10	tiwari	tiwari	PROPN
admet-2740	331	11	,	,	PUNCT
admet-2740	331	12	n.	n.	PROPN
admet-2740	331	13	singh	singh	PROPN
admet-2740	331	14	,	,	PUNCT
admet-2740	331	15	d.	d.	PROPN
admet-2740	331	16	gautam	gautam	PROPN
admet-2740	331	17	,	,	PUNCT
admet-2740	331	18	v.k	v.k	PROPN
admet-2740	331	19	.	.	PROPN
admet-2740	331	20	sonkar	sonkar	PROPN
admet-2740	331	21	,	,	PUNCT
admet-2740	331	22	v.	v.	ADP
admet-2740	331	23	agarwal	agarwal	PROPN
admet-2740	331	24	,	,	PUNCT
admet-2740	331	25	d.	d.	NOUN
admet-2740	331	26	dash	dash	NOUN
admet-2740	331	27	.	.	PUNCT
admet-2740	332	1	aerobic	aerobic	ADJ
admet-2740	332	2	glycolysis	glycolysis	NOUN
admet-2740	332	3	fuels	fuel	NOUN
admet-2740	332	4	platelet	platelet	NOUN
admet-2740	332	5	activation	activation	NOUN
admet-2740	332	6	:	:	PUNCT
admet-2740	332	7	small	small	ADJ
admet-2740	332	8	-	-	PUNCT
admet-2740	332	9	molecule	molecule	NOUN
admet-2740	332	10	modulators	modulator	NOUN
admet-2740	332	11	of	of	ADP
admet-2740	332	12	platelet	platelet	NOUN
admet-2740	332	13	metabolism	metabolism	NOUN
admet-2740	332	14	as	as	ADP
admet-2740	332	15	anti	anti	ADJ
admet-2740	332	16	-	-	ADJ
admet-2740	332	17	thrombotic	thrombotic	ADJ
admet-2740	332	18	agents	agent	NOUN
admet-2740	332	19	.	.	PUNCT
admet-2740	333	1	haematologica	haematologica	PROPN
admet-2740	333	2	104	104	NUM
admet-2740	333	3	(	(	PUNCT
admet-2740	333	4	2019	2019	NUM
admet-2740	333	5	)	)	PUNCT
admet-2740	333	6	806	806	NUM
admet-2740	333	7	-	-	SYM
admet-2740	333	8	818	818	NUM
admet-2740	333	9	.	.	PUNCT
admet-2740	334	1	https://doi.org/10.3324/haematol.2018.205724	https://doi.org/10.3324/haematol.2018.205724	PROPN
admet-2740	335	1	[	[	X
admet-2740	335	2	28	28	NUM
admet-2740	335	3	]	]	X
admet-2740	335	4	p.p	p.p	PROPN
admet-2740	335	5	.	.	PROPN
admet-2740	335	6	kulkarni	kulkarni	PROPN
admet-2740	335	7	,	,	PUNCT
admet-2740	335	8	m.	m.	NOUN
admet-2740	335	9	ekhlak	ekhlak	PROPN
admet-2740	335	10	,	,	PUNCT
admet-2740	335	11	v.	v.	CCONJ
admet-2740	335	12	singh	singh	PROPN
admet-2740	335	13	,	,	PUNCT
admet-2740	335	14	v.	v.	ADP
admet-2740	335	15	kailashiya	kailashiya	PROPN
admet-2740	335	16	,	,	PUNCT
admet-2740	335	17	n.	n.	PROPN
admet-2740	335	18	singh	singh	PROPN
admet-2740	335	19	,	,	PUNCT
admet-2740	335	20	d.	d.	NOUN
admet-2740	335	21	dash	dash	NOUN
admet-2740	335	22	.	.	PUNCT
admet-2740	336	1	fatty	fatty	NOUN
admet-2740	336	2	acid	acid	NOUN
admet-2740	336	3	oxidation	oxidation	NOUN
admet-2740	336	4	fuels	fuel	NOUN
admet-2740	336	5	agonistinduced	agonistinduce	VERB
admet-2740	336	6	platelet	platelet	NOUN
admet-2740	336	7	activation	activation	NOUN
admet-2740	336	8	and	and	CCONJ
admet-2740	336	9	thrombus	thrombus	NOUN
admet-2740	336	10	formation	formation	NOUN
admet-2740	336	11	:	:	PUNCT
admet-2740	336	12	targeting	target	VERB
admet-2740	336	13	β	β	NOUN
admet-2740	336	14	-	-	NOUN
admet-2740	336	15	oxidation	oxidation	NOUN
admet-2740	336	16	of	of	ADP
admet-2740	336	17	fatty	fatty	NOUN
admet-2740	336	18	acids	acid	NOUN
admet-2740	336	19	as	as	ADP
admet-2740	336	20	an	an	DET
admet-2740	336	21	https://doi.org/10.5599/admet.2740	https://doi.org/10.5599/admet.2740	NOUN
admet-2740	336	22	https://doi.org/10.3390/molecules26092732	https://doi.org/10.3390/molecules26092732	X
admet-2740	336	23	https://doi.org/10.1080/004982599238632	https://doi.org/10.1080/004982599238632	ADJ
admet-2740	336	24	https://doi.org/10.3390/molecules28062536	https://doi.org/10.3390/molecules28062536	NOUN
admet-2740	336	25	https://doi.org/10.1016/j.biopha.2020.110732	https://doi.org/10.1016/j.biopha.2020.110732	NOUN
admet-2740	336	26	https://doi.org/10.5599/admet.2476	https://doi.org/10.5599/admet.2476	ADP
admet-2740	336	27	https://doi.org/https:/doi.org/10.1016/j.csbj.2016.02.005	https://doi.org/https:/doi.org/10.1016/j.csbj.2016.02.005	PRON
admet-2740	336	28	https://doi.org/10.1093/nar/gks1065	https://doi.org/10.1093/nar/gks1065	NOUN
admet-2740	336	29	https://doi.org/10.1021/ci900090d	https://doi.org/10.1021/ci900090d	NOUN
admet-2740	336	30	https://doi.org/10.1093/nar/gkae253	https://doi.org/10.1093/nar/gkae253	PROPN
admet-2740	336	31	https://doi.org/10.1038/s41467-019-09234-6	https://doi.org/10.1038/s41467-019-09234-6	NUM
admet-2740	336	32	https://doi.org/10.1016/j.freeradbiomed.2017.12.035	https://doi.org/10.1016/j.freeradbiomed.2017.12.035	PROPN
admet-2740	336	33	https://doi.org/doi:10.1161/atvbaha.123.319821	https://doi.org/doi:10.1161/atvbaha.123.319821	PROPN
admet-2740	336	34	https://doi.org/10.1016/j.metabol.2023.155596	https://doi.org/10.1016/j.metabol.2023.155596	PROPN
admet-2740	336	35	https://doi.org/10.1093/cvr/cvad149	https://doi.org/10.1093/cvr/cvad149	NOUN
admet-2740	336	36	https://doi.org/10.1016/j.ymben.2021.12.007	https://doi.org/10.1016/j.ymben.2021.12.007	VERB
admet-2740	337	1	https://doi.org/10.3324/haematol.2018.205724	https://doi.org/10.3324/haematol.2018.205724	PROPN
admet-2740	337	2	p.	p.	NOUN
admet-2740	337	3	rattanasuwan	rattanasuwan	NOUN
admet-2740	337	4	et	et	PROPN
admet-2740	337	5	al	al	PROPN
admet-2740	337	6	.	.	PROPN
admet-2740	337	7	admet	admet	PROPN
admet-2740	337	8	&	&	CCONJ
admet-2740	337	9	dmpk	dmpk	PROPN
admet-2740	337	10	13(3	13(3	NUM
admet-2740	337	11	)	)	PUNCT
admet-2740	337	12	(	(	PUNCT
admet-2740	337	13	2025	2025	NUM
admet-2740	337	14	)	)	PUNCT
admet-2740	337	15	2740	2740	NUM
admet-2740	337	16	16	16	NUM
admet-2740	337	17	effective	effective	ADJ
admet-2740	337	18	anti	anti	ADJ
admet-2740	337	19	-	-	ADJ
admet-2740	337	20	platelet	platelet	ADJ
admet-2740	337	21	strategy	strategy	NOUN
admet-2740	337	22	.	.	PUNCT
admet-2740	338	1	faseb	faseb	PROPN
admet-2740	338	2	journal	journal	PROPN
admet-2740	338	3	:	:	PUNCT
admet-2740	338	4	official	official	ADJ
admet-2740	338	5	publication	publication	NOUN
admet-2740	338	6	of	of	ADP
admet-2740	338	7	the	the	DET
admet-2740	338	8	federation	federation	PROPN
admet-2740	338	9	of	of	ADP
admet-2740	338	10	american	american	ADJ
admet-2740	338	11	societies	society	NOUN
admet-2740	338	12	for	for	ADP
admet-2740	338	13	experimental	experimental	ADJ
admet-2740	338	14	biology	biology	NOUN
admet-2740	338	15	37	37	NUM
admet-2740	338	16	(	(	PUNCT
admet-2740	338	17	2023	2023	NUM
admet-2740	338	18	)	)	PUNCT
admet-2740	338	19	e22768	e22768	NOUN
admet-2740	338	20	.	.	PUNCT
admet-2740	339	1	https://doi.org/10.1096/fj.202201321rr	https://doi.org/10.1096/fj.202201321rr	PROPN
admet-2740	339	2	.	.	PUNCT
admet-2740	340	1	[	[	X
admet-2740	340	2	29	29	NUM
admet-2740	340	3	]	]	X
admet-2740	340	4	m.	m.	NOUN
admet-2740	340	5	aibibula	aibibula	PROPN
admet-2740	340	6	,	,	PUNCT
admet-2740	340	7	k.m	k.m	PROPN
admet-2740	340	8	.	.	PROPN
admet-2740	340	9	naseem	naseem	PROPN
admet-2740	340	10	,	,	PUNCT
admet-2740	340	11	r.g	r.g	PROPN
admet-2740	340	12	.	.	PROPN
admet-2740	340	13	sturmey	sturmey	PROPN
admet-2740	340	14	.	.	PUNCT
admet-2740	341	1	glucose	glucose	NOUN
admet-2740	341	2	metabolism	metabolism	NOUN
admet-2740	341	3	and	and	CCONJ
admet-2740	341	4	metabolic	metabolic	NOUN
admet-2740	341	5	flexibility	flexibility	NOUN
admet-2740	341	6	in	in	ADP
admet-2740	341	7	blood	blood	NOUN
admet-2740	341	8	platelets	platelet	NOUN
admet-2740	341	9	.	.	PUNCT
admet-2740	342	1	journal	journal	NOUN
admet-2740	342	2	of	of	ADP
admet-2740	342	3	thrombosis	thrombosis	NOUN
admet-2740	342	4	and	and	CCONJ
admet-2740	342	5	haemostasis	haemostasis	NOUN
admet-2740	342	6	:	:	PUNCT
admet-2740	342	7	jth	jth	PROPN
admet-2740	342	8	16	16	NUM
admet-2740	342	9	(	(	PUNCT
admet-2740	342	10	2018	2018	NUM
admet-2740	342	11	)	)	PUNCT
admet-2740	342	12	2300	2300	NUM
admet-2740	342	13	-	-	SYM
admet-2740	342	14	2314	2314	NUM
admet-2740	342	15	.	.	PUNCT
admet-2740	343	1	https://doi.org/10.1111/jth.14274	https://doi.org/10.1111/jth.14274	NOUN
admet-2740	344	1	[	[	X
admet-2740	344	2	30	30	NUM
admet-2740	344	3	]	]	X
admet-2740	344	4	s.	s.	PROPN
admet-2740	344	5	ravi	ravi	PROPN
admet-2740	344	6	,	,	PUNCT
admet-2740	344	7	b.	b.	PROPN
admet-2740	344	8	chacko	chacko	PROPN
admet-2740	344	9	,	,	PUNCT
admet-2740	344	10	h.	h.	PROPN
admet-2740	344	11	sawada	sawada	PROPN
admet-2740	344	12	,	,	PUNCT
admet-2740	344	13	p.a	p.a	PROPN
admet-2740	344	14	.	.	PUNCT
admet-2740	344	15	kramer	kramer	PROPN
admet-2740	344	16	,	,	PUNCT
admet-2740	344	17	m.s	m.s	PROPN
admet-2740	344	18	.	.	PROPN
admet-2740	344	19	johnson	johnson	PROPN
admet-2740	344	20	,	,	PUNCT
admet-2740	344	21	g.a	g.a	PROPN
admet-2740	344	22	.	.	PROPN
admet-2740	344	23	benavides	benavides	PROPN
admet-2740	344	24	,	,	PUNCT
admet-2740	344	25	v.	v.	PROPN
admet-2740	344	26	o'donnell	o'donnell	PROPN
admet-2740	344	27	,	,	PUNCT
admet-2740	344	28	m.b	m.b	PROPN
admet-2740	344	29	.	.	PROPN
admet-2740	344	30	marques	marques	PROPN
admet-2740	344	31	,	,	PUNCT
admet-2740	344	32	v.m	v.m	PROPN
admet-2740	344	33	.	.	PUNCT
admet-2740	344	34	darley	darley	PROPN
admet-2740	344	35	-	-	PUNCT
admet-2740	344	36	usmar	usmar	PROPN
admet-2740	344	37	.	.	PROPN
admet-2740	344	38	metabolic	metabolic	NOUN
admet-2740	344	39	plasticity	plasticity	NOUN
admet-2740	344	40	in	in	ADP
admet-2740	344	41	resting	resting	NOUN
admet-2740	344	42	and	and	CCONJ
admet-2740	344	43	thrombin	thrombin	NOUN
admet-2740	344	44	activated	activate	VERB
admet-2740	344	45	platelets	platelet	NOUN
admet-2740	344	46	.	.	PUNCT
admet-2740	345	1	plos	plos	PROPN
admet-2740	345	2	one	one	NUM
admet-2740	345	3	10	10	NUM
admet-2740	345	4	(	(	PUNCT
admet-2740	345	5	2015	2015	NUM
admet-2740	345	6	)	)	PUNCT
admet-2740	345	7	e0123597	e0123597	NOUN
admet-2740	345	8	.	.	PUNCT
admet-2740	346	1	https://doi.org/10.1371/journal.pone.0123597	https://doi.org/10.1371/journal.pone.0123597	PROPN
admet-2740	347	1	[	[	X
admet-2740	347	2	31	31	NUM
admet-2740	347	3	]	]	X
admet-2740	347	4	p.p	p.p	PROPN
admet-2740	347	5	.	.	PROPN
admet-2740	347	6	kulkarni	kulkarni	PROPN
admet-2740	347	7	,	,	PUNCT
admet-2740	347	8	m.	m.	NOUN
admet-2740	347	9	ekhlak	ekhlak	PROPN
admet-2740	347	10	,	,	PUNCT
admet-2740	347	11	v.k	v.k	PROPN
admet-2740	347	12	.	.	PROPN
admet-2740	347	13	sonkar	sonkar	PROPN
admet-2740	347	14	,	,	PUNCT
admet-2740	347	15	d.	d.	NOUN
admet-2740	347	16	dash	dash	NOUN
admet-2740	347	17	.	.	PUNCT
admet-2740	348	1	mitochondrial	mitochondrial	ADJ
admet-2740	348	2	atp	atp	NOUN
admet-2740	348	3	generation	generation	NOUN
admet-2740	348	4	in	in	ADP
admet-2740	348	5	stimulated	stimulated	ADJ
admet-2740	348	6	platelets	platelet	NOUN
admet-2740	348	7	is	be	AUX
admet-2740	348	8	essential	essential	ADJ
admet-2740	348	9	for	for	ADP
admet-2740	348	10	granule	granule	NOUN
admet-2740	348	11	secretion	secretion	NOUN
admet-2740	348	12	but	but	CCONJ
admet-2740	348	13	dispensable	dispensable	ADJ
admet-2740	348	14	for	for	ADP
admet-2740	348	15	aggregation	aggregation	NOUN
admet-2740	348	16	and	and	CCONJ
admet-2740	348	17	procoagulant	procoagulant	NOUN
admet-2740	348	18	activity	activity	NOUN
admet-2740	348	19	.	.	PUNCT
admet-2740	349	1	haematologica	haematologica	PROPN
admet-2740	349	2	107	107	NUM
admet-2740	349	3	(	(	PUNCT
admet-2740	349	4	2022	2022	NUM
admet-2740	349	5	)	)	PUNCT
admet-2740	349	6	1209	1209	NUM
admet-2740	349	7	-	-	SYM
admet-2740	349	8	1213	1213	NUM
admet-2740	349	9	.	.	PUNCT
admet-2740	350	1	https://doi.org/10.3324/haematol.2021.279847	https://doi.org/10.3324/haematol.2021.279847	PROPN
admet-2740	351	1	[	[	X
admet-2740	351	2	32	32	NUM
admet-2740	351	3	]	]	X
admet-2740	351	4	g.d	g.d	PROPN
admet-2740	351	5	.	.	PROPN
admet-2740	351	6	flora	flora	PROPN
admet-2740	351	7	,	,	PUNCT
admet-2740	351	8	m.k	m.k	PROPN
admet-2740	351	9	.	.	PUNCT
admet-2740	351	10	nayak	nayak	PROPN
admet-2740	351	11	,	,	PUNCT
admet-2740	351	12	m.	m.	NOUN
admet-2740	351	13	ghatge	ghatge	NOUN
admet-2740	351	14	,	,	PUNCT
admet-2740	351	15	m.	m.	NOUN
admet-2740	351	16	kumskova	kumskova	PROPN
admet-2740	351	17	,	,	PUNCT
admet-2740	351	18	r.b	r.b	PROPN
admet-2740	351	19	.	.	PROPN
admet-2740	351	20	patel	patel	PROPN
admet-2740	351	21	,	,	PUNCT
admet-2740	351	22	a.k	a.k	PROPN
admet-2740	351	23	.	.	PROPN
admet-2740	351	24	chauhan	chauhan	PROPN
admet-2740	351	25	.	.	PUNCT
admet-2740	351	26	mitochondrial	mitochondrial	ADJ
admet-2740	351	27	pyruvate	pyruvate	NOUN
admet-2740	351	28	dehydrogenase	dehydrogenase	NOUN
admet-2740	351	29	kinases	kinase	NOUN
admet-2740	351	30	contribute	contribute	VERB
admet-2740	351	31	to	to	ADP
admet-2740	351	32	platelet	platelet	NOUN
admet-2740	351	33	function	function	NOUN
admet-2740	351	34	and	and	CCONJ
admet-2740	351	35	thrombosis	thrombosis	NOUN
admet-2740	351	36	in	in	ADP
admet-2740	351	37	mice	mouse	NOUN
admet-2740	351	38	by	by	ADP
admet-2740	351	39	regulating	regulate	VERB
admet-2740	351	40	aerobic	aerobic	ADJ
admet-2740	351	41	glycolysis	glycolysis	NOUN
admet-2740	351	42	.	.	PUNCT
admet-2740	352	1	blood	blood	NOUN
admet-2740	352	2	advances	advance	VERB
admet-2740	352	3	7	7	NUM
admet-2740	352	4	(	(	PUNCT
admet-2740	352	5	2023	2023	NUM
admet-2740	352	6	)	)	PUNCT
admet-2740	352	7	2347	2347	NUM
admet-2740	352	8	-	-	SYM
admet-2740	352	9	2359	2359	NUM
admet-2740	352	10	.	.	PUNCT
admet-2740	353	1	https://doi.org/10.1182/bloodadvances.2023010100	https://doi.org/10.1182/bloodadvances.2023010100	NOUN
admet-2740	353	2	[	[	X
admet-2740	353	3	33	33	NUM
admet-2740	353	4	]	]	X
admet-2740	353	5	m.k	m.k	PROPN
admet-2740	353	6	.	.	PUNCT
admet-2740	353	7	nayak	nayak	PROPN
admet-2740	353	8	,	,	PUNCT
admet-2740	353	9	m.	m.	NOUN
admet-2740	353	10	ghatge	ghatge	NOUN
admet-2740	353	11	,	,	PUNCT
admet-2740	353	12	g.d	g.d	PROPN
admet-2740	353	13	.	.	PROPN
admet-2740	353	14	flora	flora	PROPN
admet-2740	353	15	,	,	PUNCT
admet-2740	353	16	n.	n.	PROPN
admet-2740	353	17	dhanesha	dhanesha	PROPN
admet-2740	353	18	,	,	PUNCT
admet-2740	353	19	m.	m.	NOUN
admet-2740	353	20	jain	jain	PROPN
admet-2740	353	21	,	,	PUNCT
admet-2740	353	22	k.r	k.r	PROPN
admet-2740	353	23	.	.	PROPN
admet-2740	353	24	markan	markan	PROPN
admet-2740	353	25	,	,	PUNCT
admet-2740	353	26	m.j	m.j	PROPN
admet-2740	353	27	.	.	PROPN
admet-2740	353	28	potthoff	potthoff	PROPN
admet-2740	353	29	,	,	PUNCT
admet-2740	353	30	s.r	s.r	PROPN
admet-2740	353	31	.	.	PROPN
admet-2740	353	32	lentz	lentz	PROPN
admet-2740	353	33	,	,	PUNCT
admet-2740	353	34	a.k	a.k	PROPN
admet-2740	353	35	.	.	PROPN
admet-2740	353	36	chauhan	chauhan	PROPN
admet-2740	353	37	.	.	PUNCT
admet-2740	354	1	the	the	DET
admet-2740	354	2	metabolic	metabolic	NOUN
admet-2740	354	3	enzyme	enzyme	NOUN
admet-2740	354	4	pyruvate	pyruvate	NOUN
admet-2740	354	5	kinase	kinase	NOUN
admet-2740	354	6	m2	m2	PROPN
admet-2740	354	7	regulates	regulate	VERB
admet-2740	354	8	platelet	platelet	NOUN
admet-2740	354	9	function	function	NOUN
admet-2740	354	10	and	and	CCONJ
admet-2740	354	11	arterial	arterial	ADJ
admet-2740	354	12	thrombosis	thrombosis	NOUN
admet-2740	354	13	.	.	PUNCT
admet-2740	355	1	blood	blood	NOUN
admet-2740	355	2	137	137	NUM
admet-2740	355	3	(	(	PUNCT
admet-2740	355	4	2021	2021	NUM
admet-2740	355	5	)	)	PUNCT
admet-2740	355	6	1658	1658	NUM
admet-2740	355	7	-	-	SYM
admet-2740	355	8	1668	1668	NUM
admet-2740	355	9	.	.	PUNCT
admet-2740	356	1	https://doi.org/10.1182/blood.2020007140	https://doi.org/10.1182/blood.2020007140	ADJ
admet-2740	356	2	[	[	X
admet-2740	356	3	34	34	NUM
admet-2740	356	4	]	]	X
admet-2740	356	5	e.	e.	PROPN
admet-2740	356	6	possik	possik	PROPN
admet-2740	356	7	,	,	PUNCT
admet-2740	356	8	a.	a.	PROPN
admet-2740	356	9	al	al	PROPN
admet-2740	356	10	-	-	PUNCT
admet-2740	356	11	mass	mass	PROPN
admet-2740	356	12	,	,	PUNCT
admet-2740	356	13	m.l	m.l	PROPN
admet-2740	356	14	.	.	PROPN
admet-2740	356	15	peyot	peyot	PROPN
admet-2740	356	16	,	,	PUNCT
admet-2740	356	17	r.	r.	PROPN
admet-2740	356	18	ahmad	ahmad	PROPN
admet-2740	356	19	,	,	PUNCT
admet-2740	356	20	f.	f.	PROPN
admet-2740	356	21	al	al	PROPN
admet-2740	356	22	-	-	PUNCT
admet-2740	356	23	mulla	mulla	PROPN
admet-2740	356	24	,	,	PUNCT
admet-2740	356	25	s.r.m	s.r.m	NOUN
admet-2740	356	26	.	.	PUNCT
admet-2740	357	1	madiraju	madiraju	PROPN
admet-2740	357	2	,	,	PUNCT
admet-2740	357	3	m.	m.	NOUN
admet-2740	357	4	prentki	prentki	NOUN
admet-2740	357	5	.	.	PUNCT
admet-2740	358	1	new	new	ADJ
admet-2740	358	2	mammalian	mammalian	ADJ
admet-2740	358	3	glycerol-3	glycerol-3	PROPN
admet-2740	358	4	-	-	PUNCT
admet-2740	358	5	phosphate	phosphate	NOUN
admet-2740	358	6	phosphatase	phosphatase	NOUN
admet-2740	358	7	:	:	PUNCT
admet-2740	358	8	role	role	NOUN
admet-2740	358	9	in	in	ADP
admet-2740	358	10	β	β	NOUN
admet-2740	358	11	-	-	NOUN
admet-2740	358	12	cell	cell	NOUN
admet-2740	358	13	,	,	PUNCT
admet-2740	358	14	liver	liver	NOUN
admet-2740	358	15	and	and	CCONJ
admet-2740	358	16	adipocyte	adipocyte	ADJ
admet-2740	358	17	metabolism	metabolism	NOUN
admet-2740	358	18	.	.	PUNCT
admet-2740	359	1	frontiers	frontier	NOUN
admet-2740	359	2	in	in	ADP
admet-2740	359	3	endocrinology	endocrinology	NOUN
admet-2740	359	4	12	12	NUM
admet-2740	359	5	(	(	PUNCT
admet-2740	359	6	2021	2021	NUM
admet-2740	359	7	)	)	PUNCT
admet-2740	359	8	706607	706607	NUM
admet-2740	359	9	.	.	PUNCT
admet-2740	360	1	https://doi.org/10.3389/fendo.2021.706607	https://doi.org/10.3389/fendo.2021.706607	PROPN
admet-2740	360	2	[	[	X
admet-2740	360	3	35	35	NUM
admet-2740	360	4	]	]	X
admet-2740	360	5	r.a	r.a	PROPN
admet-2740	360	6	.	.	PROPN
admet-2740	360	7	harkness	harkness	PROPN
admet-2740	360	8	.	.	PUNCT
admet-2740	361	1	metabolism	metabolism	NOUN
admet-2740	361	2	at	at	ADP
admet-2740	361	3	a	a	DET
admet-2740	361	4	glance	glance	NOUN
admet-2740	361	5	,	,	PUNCT
admet-2740	361	6	2nd	2nd	ADJ
admet-2740	361	7	edition	edition	NOUN
admet-2740	361	8	.	.	PUNCT
admet-2740	362	1	j.g	j.g	PROPN
admet-2740	362	2	.	.	PROPN
admet-2740	362	3	salway	salway	PROPN
admet-2740	362	4	.	.	PUNCT
admet-2740	363	1	journal	journal	PROPN
admet-2740	363	2	of	of	ADP
admet-2740	363	3	inherited	inherit	VERB
admet-2740	363	4	metabolic	metabolic	NOUN
admet-2740	363	5	disease	disease	NOUN
admet-2740	363	6	22	22	NUM
admet-2740	363	7	(	(	PUNCT
admet-2740	363	8	1999	1999	NUM
admet-2740	363	9	)	)	PUNCT
admet-2740	363	10	914	914	NUM
admet-2740	363	11	-	-	SYM
admet-2740	363	12	914	914	NUM
admet-2740	363	13	.	.	PUNCT
admet-2740	364	1	https://doi.org/10.1023/a:1005641407072	https://doi.org/10.1023/a:1005641407072	NOUN
admet-2740	364	2	[	[	X
admet-2740	364	3	36	36	NUM
admet-2740	364	4	]	]	X
admet-2740	364	5	d.l	d.l	PROPN
admet-2740	364	6	.	.	PROPN
admet-2740	364	7	nelson	nelson	PROPN
admet-2740	364	8	,	,	PUNCT
admet-2740	364	9	lehninger	lehninger	NOUN
admet-2740	364	10	principles	principle	NOUN
admet-2740	364	11	of	of	ADP
admet-2740	364	12	biochemistry	biochemistry	NOUN
admet-2740	364	13	,	,	PUNCT
admet-2740	364	14	fourth	fourth	PROPN
admet-2740	364	15	edition	edition	NOUN
admet-2740	364	16	.	.	PUNCT
admet-2740	365	1	new	new	PROPN
admet-2740	365	2	york	york	PROPN
admet-2740	365	3	:	:	PUNCT
admet-2740	366	1	w.h	w.h	PROPN
admet-2740	366	2	.	.	PROPN
admet-2740	366	3	freeman	freeman	PROPN
admet-2740	366	4	,	,	PUNCT
admet-2740	366	5	2005	2005	NUM
admet-2740	366	6	.	.	PUNCT
admet-2740	366	7	,	,	PUNCT
admet-2740	366	8	2005	2005	NUM
admet-2740	366	9	.	.	PUNCT
admet-2740	366	10	https://search.library.wisc.edu/catalog/999964334502121	https://search.library.wisc.edu/catalog/999964334502121	VERB
admet-2740	366	11	[	[	X
admet-2740	366	12	37	37	NUM
admet-2740	366	13	]	]	X
admet-2740	366	14	a.l	a.l	PROPN
admet-2740	366	15	.	.	PROPN
admet-2740	366	16	orr	orr	PROPN
admet-2740	366	17	,	,	PUNCT
admet-2740	366	18	d.	d.	PROPN
admet-2740	366	19	ashok	ashok	PROPN
admet-2740	366	20	,	,	PUNCT
admet-2740	366	21	m.r	m.r	PROPN
admet-2740	366	22	.	.	PROPN
admet-2740	366	23	sarantos	sarantos	PROPN
admet-2740	366	24	,	,	PUNCT
admet-2740	366	25	r.	r.	PROPN
admet-2740	366	26	ng	ng	PROPN
admet-2740	366	27	,	,	PUNCT
admet-2740	366	28	t.	t.	PROPN
admet-2740	366	29	shi	shi	PROPN
admet-2740	366	30	,	,	PUNCT
admet-2740	366	31	a.a	a.a	PROPN
admet-2740	366	32	.	.	PROPN
admet-2740	366	33	gerencser	gerencser	PROPN
admet-2740	366	34	,	,	PUNCT
admet-2740	366	35	r.e	r.e	PROPN
admet-2740	366	36	.	.	PROPN
admet-2740	366	37	hughes	hughes	PROPN
admet-2740	366	38	,	,	PUNCT
admet-2740	366	39	m.d	m.d	PROPN
admet-2740	366	40	.	.	PROPN
admet-2740	366	41	brand	brand	PROPN
admet-2740	366	42	.	.	PUNCT
admet-2740	367	1	novel	novel	ADJ
admet-2740	367	2	inhibitors	inhibitor	NOUN
admet-2740	367	3	of	of	ADP
admet-2740	367	4	mitochondrial	mitochondrial	ADJ
admet-2740	367	5	sn	sn	NOUN
admet-2740	367	6	-	-	PUNCT
admet-2740	367	7	glycerol	glycerol	NOUN
admet-2740	367	8	3	3	NUM
admet-2740	367	9	-	-	PUNCT
admet-2740	367	10	phosphate	phosphate	NOUN
admet-2740	367	11	dehydrogenase	dehydrogenase	NOUN
admet-2740	367	12	.	.	PUNCT
admet-2740	368	1	plos	plos	PROPN
admet-2740	368	2	one	one	NUM
admet-2740	368	3	9	9	NUM
admet-2740	368	4	(	(	PUNCT
admet-2740	368	5	2014	2014	NUM
admet-2740	368	6	)	)	PUNCT
admet-2740	368	7	e89938	e89938	NOUN
admet-2740	368	8	.	.	PUNCT
admet-2740	369	1	https://doi.org/10.1371/journal.pone.0089938	https://doi.org/10.1371/journal.pone.0089938	PROPN
admet-2740	369	2	[	[	X
admet-2740	369	3	38	38	NUM
admet-2740	369	4	]	]	SYM
admet-2740	369	5	r.h	r.h	PROPN
admet-2740	369	6	.	.	PROPN
admet-2740	369	7	houtkooper	houtkooper	PROPN
admet-2740	369	8	,	,	PUNCT
admet-2740	369	9	h.	h.	PROPN
admet-2740	369	10	akbari	akbari	PROPN
admet-2740	369	11	,	,	PUNCT
admet-2740	369	12	h.	h.	PROPN
admet-2740	369	13	van	van	PROPN
admet-2740	369	14	lenthe	lenthe	PROPN
admet-2740	369	15	,	,	PUNCT
admet-2740	369	16	w.	w.	PROPN
admet-2740	369	17	kulik	kulik	PROPN
admet-2740	369	18	,	,	PUNCT
admet-2740	369	19	r.j	r.j	PROPN
admet-2740	369	20	.	.	PROPN
admet-2740	369	21	wanders	wander	NOUN
admet-2740	369	22	,	,	PUNCT
admet-2740	369	23	m.	m.	NOUN
admet-2740	369	24	frentzen	frentzen	NOUN
admet-2740	369	25	,	,	PUNCT
admet-2740	369	26	f.m	f.m	PROPN
admet-2740	369	27	.	.	PROPN
admet-2740	369	28	vaz	vaz	PROPN
admet-2740	369	29	.	.	PUNCT
admet-2740	370	1	identification	identification	NOUN
admet-2740	370	2	and	and	CCONJ
admet-2740	370	3	characterization	characterization	NOUN
admet-2740	370	4	of	of	ADP
admet-2740	370	5	human	human	ADJ
admet-2740	370	6	cardiolipin	cardiolipin	NOUN
admet-2740	370	7	synthase	synthase	NOUN
admet-2740	370	8	.	.	PUNCT
admet-2740	371	1	febs	febs	NOUN
admet-2740	371	2	letters	letter	NOUN
admet-2740	371	3	580	580	NUM
admet-2740	371	4	(	(	PUNCT
admet-2740	371	5	2006	2006	NUM
admet-2740	371	6	)	)	PUNCT
admet-2740	371	7	3059	3059	NUM
admet-2740	371	8	-	-	SYM
admet-2740	371	9	3064	3064	NUM
admet-2740	371	10	.	.	PUNCT
admet-2740	372	1	https://doi.org/10.1016/j.febslet.2006.04.054	https://doi.org/10.1016/j.febslet.2006.04.054	X
admet-2740	373	1	[	[	X
admet-2740	373	2	39	39	NUM
admet-2740	373	3	]	]	X
admet-2740	373	4	h.f	h.f	PROPN
admet-2740	373	5	.	.	PROPN
admet-2740	373	6	tian	tian	PROPN
admet-2740	373	7	,	,	PUNCT
admet-2740	373	8	j.m	j.m	PROPN
admet-2740	373	9	.	.	PROPN
admet-2740	373	10	feng	feng	PROPN
admet-2740	373	11	,	,	PUNCT
admet-2740	373	12	j.f	j.f	PROPN
admet-2740	373	13	.	.	PROPN
admet-2740	373	14	wen	wen	PROPN
admet-2740	373	15	.	.	PUNCT
admet-2740	374	1	the	the	DET
admet-2740	374	2	evolution	evolution	NOUN
admet-2740	374	3	of	of	ADP
admet-2740	374	4	cardiolipin	cardiolipin	NOUN
admet-2740	374	5	biosynthesis	biosynthesis	NOUN
admet-2740	374	6	and	and	CCONJ
admet-2740	374	7	maturation	maturation	NOUN
admet-2740	374	8	pathways	pathway	NOUN
admet-2740	374	9	and	and	CCONJ
admet-2740	374	10	its	its	PRON
admet-2740	374	11	implications	implication	NOUN
admet-2740	374	12	for	for	ADP
admet-2740	374	13	the	the	DET
admet-2740	374	14	evolution	evolution	NOUN
admet-2740	374	15	of	of	ADP
admet-2740	374	16	eukaryotes	eukaryote	NOUN
admet-2740	374	17	.	.	PUNCT
admet-2740	375	1	bmc	bmc	ADJ
admet-2740	375	2	evolutionary	evolutionary	ADJ
admet-2740	375	3	biology	biology	NOUN
admet-2740	375	4	12	12	NUM
admet-2740	375	5	(	(	PUNCT
admet-2740	375	6	2012	2012	NUM
admet-2740	375	7	)	)	PUNCT
admet-2740	375	8	32	32	NUM
admet-2740	375	9	.	.	PUNCT
admet-2740	376	1	https://doi.org/10.1186/1471-2148-12-32	https://doi.org/10.1186/1471-2148-12-32	PROPN
admet-2740	376	2	[	[	X
admet-2740	376	3	40	40	NUM
admet-2740	376	4	]	]	PUNCT
admet-2740	376	5	x.	x.	NOUN
admet-2740	376	6	ou	ou	PROPN
admet-2740	376	7	,	,	PUNCT
admet-2740	376	8	c.	c.	PROPN
admet-2740	376	9	ji	ji	PROPN
admet-2740	376	10	,	,	PUNCT
admet-2740	376	11	x.	x.	PROPN
admet-2740	376	12	han	han	PROPN
admet-2740	376	13	,	,	PUNCT
admet-2740	376	14	x.	x.	PROPN
admet-2740	376	15	zhao	zhao	PROPN
admet-2740	376	16	,	,	PUNCT
admet-2740	376	17	x.	x.	PROPN
admet-2740	376	18	li	li	PROPN
admet-2740	376	19	,	,	PUNCT
admet-2740	376	20	y.	y.	PROPN
admet-2740	376	21	mao	mao	PROPN
admet-2740	376	22	,	,	PUNCT
admet-2740	376	23	l.l	l.l	PROPN
admet-2740	376	24	.	.	PROPN
admet-2740	376	25	wong	wong	PROPN
admet-2740	376	26	,	,	PUNCT
admet-2740	376	27	m.	m.	PROPN
admet-2740	376	28	bartlam	bartlam	PROPN
admet-2740	376	29	,	,	PUNCT
admet-2740	376	30	z.	z.	PROPN
admet-2740	376	31	rao	rao	PROPN
admet-2740	376	32	.	.	PUNCT
admet-2740	377	1	crystal	crystal	NOUN
admet-2740	377	2	structures	structure	NOUN
admet-2740	377	3	of	of	ADP
admet-2740	377	4	human	human	ADJ
admet-2740	377	5	glycerol	glycerol	NOUN
admet-2740	377	6	3	3	NUM
admet-2740	377	7	-	-	PUNCT
admet-2740	377	8	phosphate	phosphate	NOUN
admet-2740	377	9	dehydrogenase	dehydrogenase	NOUN
admet-2740	377	10	1	1	NUM
admet-2740	377	11	(	(	PUNCT
admet-2740	377	12	gpd1	gpd1	PROPN
admet-2740	377	13	)	)	PUNCT
admet-2740	377	14	.	.	PUNCT
admet-2740	378	1	journal	journal	NOUN
admet-2740	378	2	of	of	ADP
admet-2740	378	3	molecular	molecular	ADJ
admet-2740	378	4	biology	biology	NOUN
admet-2740	378	5	357	357	NUM
admet-2740	378	6	(	(	PUNCT
admet-2740	378	7	2006	2006	NUM
admet-2740	378	8	)	)	PUNCT
admet-2740	378	9	858	858	NUM
admet-2740	378	10	-	-	SYM
admet-2740	378	11	869	869	NUM
admet-2740	378	12	.	.	PUNCT
admet-2740	379	1	https://doi.org/10.1016/j.jmb.2005.12.074	https://doi.org/10.1016/j.jmb.2005.12.074	PROPN
admet-2740	380	1	[	[	X
admet-2740	380	2	41	41	NUM
admet-2740	380	3	]	]	X
admet-2740	380	4	y.q	y.q	PROPN
admet-2740	380	5	.	.	PUNCT
admet-2740	381	1	chen	chen	PROPN
admet-2740	381	2	,	,	PUNCT
admet-2740	381	3	m.s	m.s	PROPN
admet-2740	381	4	.	.	PROPN
admet-2740	381	5	kuo	kuo	PROPN
admet-2740	381	6	,	,	PUNCT
admet-2740	381	7	s.	s.	PROPN
admet-2740	381	8	li	li	PROPN
admet-2740	381	9	,	,	PUNCT
admet-2740	381	10	h.h	h.h	PROPN
admet-2740	381	11	.	.	PROPN
admet-2740	381	12	bui	bui	PROPN
admet-2740	381	13	,	,	PUNCT
admet-2740	381	14	d.a	d.a	PROPN
admet-2740	381	15	.	.	PROPN
admet-2740	381	16	peake	peake	PROPN
admet-2740	381	17	,	,	PUNCT
admet-2740	381	18	p.e	p.e	PROPN
admet-2740	381	19	.	.	PROPN
admet-2740	381	20	sanders	sanders	PROPN
admet-2740	381	21	,	,	PUNCT
admet-2740	381	22	s.j	s.j	PROPN
admet-2740	381	23	.	.	PROPN
admet-2740	381	24	thibodeaux	thibodeaux	PROPN
admet-2740	381	25	,	,	PUNCT
admet-2740	381	26	s.	s.	PROPN
admet-2740	381	27	chu	chu	PROPN
admet-2740	381	28	,	,	PUNCT
admet-2740	381	29	y.w	y.w	PROPN
admet-2740	381	30	.	.	PROPN
admet-2740	381	31	qian	qian	PROPN
admet-2740	381	32	,	,	PUNCT
admet-2740	381	33	y.	y.	PROPN
admet-2740	381	34	zhao	zhao	PROPN
admet-2740	381	35	,	,	PUNCT
admet-2740	381	36	d.s	d.s	PROPN
admet-2740	381	37	.	.	PROPN
admet-2740	381	38	bredt	bredt	PROPN
admet-2740	381	39	,	,	PUNCT
admet-2740	381	40	d.e	d.e	PROPN
admet-2740	381	41	.	.	PROPN
admet-2740	381	42	moller	moller	PROPN
admet-2740	381	43	,	,	PUNCT
admet-2740	381	44	r.j	r.j	PROPN
admet-2740	381	45	.	.	PROPN
admet-2740	381	46	konrad	konrad	PROPN
admet-2740	381	47	,	,	PUNCT
admet-2740	381	48	a.p	a.p	PROPN
admet-2740	381	49	.	.	PROPN
admet-2740	381	50	beigneux	beigneux	PROPN
admet-2740	381	51	,	,	PUNCT
admet-2740	381	52	s.g	s.g	PROPN
admet-2740	381	53	.	.	PROPN
admet-2740	381	54	young	young	PROPN
admet-2740	381	55	,	,	PUNCT
admet-2740	381	56	g.	g.	PROPN
admet-2740	381	57	cao	cao	PROPN
admet-2740	381	58	.	.	PUNCT
admet-2740	382	1	agpat6	agpat6	PROPN
admet-2740	382	2	is	be	AUX
admet-2740	382	3	a	a	DET
admet-2740	382	4	novel	novel	ADJ
admet-2740	382	5	microsomal	microsomal	ADJ
admet-2740	382	6	glycerol-3	glycerol-3	NOUN
admet-2740	382	7	-	-	PUNCT
admet-2740	382	8	phosphate	phosphate	NOUN
admet-2740	382	9	acyltransferase	acyltransferase	NOUN
admet-2740	382	10	.	.	PUNCT
admet-2740	383	1	the	the	DET
admet-2740	383	2	journal	journal	NOUN
admet-2740	383	3	of	of	ADP
admet-2740	383	4	biological	biological	ADJ
admet-2740	383	5	chemistry	chemistry	NOUN
admet-2740	383	6	283	283	NUM
admet-2740	383	7	(	(	PUNCT
admet-2740	383	8	2008	2008	NUM
admet-2740	383	9	)	)	PUNCT
admet-2740	383	10	10048	10048	NUM
admet-2740	383	11	-	-	SYM
admet-2740	383	12	10057	10057	NUM
admet-2740	383	13	.	.	PUNCT
admet-2740	384	1	https://doi.org/10.1074/jbc.m708151200	https://doi.org/10.1074/jbc.m708151200	X
admet-2740	385	1	[	[	X
admet-2740	385	2	42	42	NUM
admet-2740	385	3	]	]	PUNCT
admet-2740	385	4	a.	a.	NOUN
admet-2740	385	5	prola	prola	PROPN
admet-2740	385	6	,	,	PUNCT
admet-2740	385	7	f.	f.	PROPN
admet-2740	385	8	pilot	pilot	PROPN
admet-2740	385	9	-	-	PUNCT
admet-2740	385	10	storck	storck	PROPN
admet-2740	385	11	.	.	PUNCT
admet-2740	386	1	cardiolipin	cardiolipin	NOUN
admet-2740	386	2	alterations	alteration	NOUN
admet-2740	386	3	during	during	ADP
admet-2740	386	4	obesity	obesity	NOUN
admet-2740	386	5	:	:	PUNCT
admet-2740	386	6	exploring	explore	VERB
admet-2740	386	7	therapeutic	therapeutic	ADJ
admet-2740	386	8	opportunities	opportunity	NOUN
admet-2740	386	9	.	.	PUNCT
admet-2740	387	1	biology	biology	NOUN
admet-2740	387	2	(	(	PUNCT
admet-2740	387	3	basel	basel	PROPN
admet-2740	387	4	)	)	PUNCT
admet-2740	387	5	11	11	NUM
admet-2740	387	6	(	(	PUNCT
admet-2740	387	7	2022	2022	NUM
admet-2740	387	8	)	)	PUNCT
admet-2740	387	9	1638	1638	NUM
admet-2740	387	10	.	.	PUNCT
admet-2740	388	1	https://www.mdpi.com/2079-7737/11/11/1638	https://www.mdpi.com/2079-7737/11/11/1638	NOUN
admet-2740	388	2	[	[	X
admet-2740	388	3	43	43	NUM
admet-2740	388	4	]	]	X
admet-2740	388	5	k.d	k.d	PROPN
admet-2740	388	6	.	.	PROPN
admet-2740	388	7	hauff	hauff	PROPN
admet-2740	388	8	,	,	PUNCT
admet-2740	388	9	s.y	s.y	PROPN
admet-2740	388	10	.	.	PROPN
admet-2740	388	11	choi	choi	PROPN
admet-2740	388	12	,	,	PUNCT
admet-2740	388	13	m.a	m.a	PROPN
admet-2740	388	14	.	.	PROPN
admet-2740	388	15	frohman	frohman	PROPN
admet-2740	388	16	,	,	PUNCT
admet-2740	388	17	g.m	g.m	PROPN
admet-2740	388	18	.	.	PROPN
admet-2740	388	19	hatch	hatch	PROPN
admet-2740	388	20	.	.	PUNCT
admet-2740	389	1	cardiolipin	cardiolipin	NOUN
admet-2740	389	2	synthesis	synthesis	NOUN
admet-2740	389	3	is	be	AUX
admet-2740	389	4	required	require	VERB
admet-2740	389	5	to	to	PART
admet-2740	389	6	support	support	VERB
admet-2740	389	7	human	human	ADJ
admet-2740	389	8	cholesterol	cholesterol	NOUN
admet-2740	389	9	biosynthesis	biosynthesis	NOUN
admet-2740	389	10	from	from	ADP
admet-2740	389	11	palmitate	palmitate	NOUN
admet-2740	389	12	upon	upon	SCONJ
admet-2740	389	13	serum	serum	NOUN
admet-2740	389	14	removal	removal	NOUN
admet-2740	389	15	in	in	ADP
admet-2740	389	16	hela	hela	ADJ
admet-2740	389	17	cells	cell	NOUN
admet-2740	389	18	.	.	PUNCT
admet-2740	390	1	canadian	canadian	ADJ
admet-2740	390	2	journal	journal	PROPN
admet-2740	390	3	of	of	ADP
admet-2740	390	4	physiology	physiology	NOUN
admet-2740	390	5	and	and	CCONJ
admet-2740	390	6	pharmacology	pharmacology	NOUN
admet-2740	390	7	87	87	NUM
admet-2740	390	8	(	(	PUNCT
admet-2740	390	9	2009	2009	NUM
admet-2740	390	10	)	)	PUNCT
admet-2740	390	11	813	813	NUM
admet-2740	390	12	-	-	SYM
admet-2740	390	13	820	820	NUM
admet-2740	390	14	.	.	PUNCT
admet-2740	390	15	https://doi.org/10.1139/y09-055	https://doi.org/10.1139/y09-055	PUNCT
admet-2740	391	1	[	[	X
admet-2740	391	2	44	44	NUM
admet-2740	391	3	]	]	PUNCT
admet-2740	391	4	r.	r.	PROPN
admet-2740	391	5	lehner	lehner	PROPN
admet-2740	391	6	,	,	PUNCT
admet-2740	391	7	a.	a.	NOUN
admet-2740	391	8	kuksis	kuksis	NOUN
admet-2740	391	9	.	.	PUNCT
admet-2740	391	10	biosynthesis	biosynthesis	NOUN
admet-2740	391	11	of	of	ADP
admet-2740	391	12	triacylglycerols	triacylglycerol	NOUN
admet-2740	391	13	.	.	PUNCT
admet-2740	392	1	progress	progress	NOUN
admet-2740	392	2	in	in	ADP
admet-2740	392	3	lipid	lipid	ADJ
admet-2740	392	4	research	research	NOUN
admet-2740	392	5	35	35	NUM
admet-2740	392	6	(	(	PUNCT
admet-2740	392	7	1996	1996	NUM
admet-2740	392	8	)	)	PUNCT
admet-2740	392	9	169	169	NUM
admet-2740	392	10	-	-	SYM
admet-2740	392	11	201	201	NUM
admet-2740	392	12	.	.	PUNCT
admet-2740	393	1	https://doi.org/10.1016/0163-7827(96)00005-7	https://doi.org/10.1016/0163-7827(96)00005-7	NOUN
admet-2740	393	2	[	[	X
admet-2740	393	3	45	45	NUM
admet-2740	393	4	]	]	PUNCT
admet-2740	393	5	p.	p.	NOUN
admet-2740	393	6	oelkers	oelker	NOUN
admet-2740	393	7	,	,	PUNCT
admet-2740	393	8	a.	a.	PROPN
admet-2740	393	9	behari	behari	PROPN
admet-2740	393	10	,	,	PUNCT
admet-2740	393	11	d.	d.	PROPN
admet-2740	393	12	cromley	cromley	PROPN
admet-2740	393	13	,	,	PUNCT
admet-2740	393	14	j.t	j.t	PROPN
admet-2740	393	15	.	.	PROPN
admet-2740	393	16	billheimer	billheimer	PROPN
admet-2740	393	17	,	,	PUNCT
admet-2740	393	18	s.l	s.l	PROPN
admet-2740	393	19	.	.	PROPN
admet-2740	393	20	sturley	sturley	PROPN
admet-2740	393	21	.	.	PUNCT
admet-2740	394	1	characterization	characterization	NOUN
admet-2740	394	2	of	of	ADP
admet-2740	394	3	two	two	NUM
admet-2740	394	4	human	human	ADJ
admet-2740	394	5	genes	gene	NOUN
admet-2740	394	6	encoding	encode	VERB
admet-2740	394	7	acyl	acyl	NOUN
admet-2740	394	8	coenzyme	coenzyme	PROPN
admet-2740	394	9	a	a	DET
admet-2740	394	10	:	:	PUNCT
admet-2740	394	11	cholesterol	cholesterol	NOUN
admet-2740	394	12	acyltransferase	acyltransferase	NOUN
admet-2740	394	13	-	-	PUNCT
admet-2740	394	14	related	relate	VERB
admet-2740	394	15	enzymes	enzyme	NOUN
admet-2740	394	16	.	.	PUNCT
admet-2740	395	1	the	the	DET
admet-2740	395	2	journal	journal	NOUN
admet-2740	395	3	of	of	ADP
admet-2740	395	4	biological	biological	ADJ
admet-2740	395	5	chemistry	chemistry	NOUN
admet-2740	395	6	273	273	NUM
admet-2740	395	7	(	(	PUNCT
admet-2740	395	8	1998	1998	NUM
admet-2740	395	9	)	)	PUNCT
admet-2740	395	10	26765	26765	NUM
admet-2740	395	11	-	-	SYM
admet-2740	395	12	26771	26771	NUM
admet-2740	395	13	.	.	PUNCT
admet-2740	396	1	https://doi.org/10.1074/jbc.273.41.26765	https://doi.org/10.1074/jbc.273.41.26765	PROPN
admet-2740	397	1	[	[	X
admet-2740	397	2	46	46	NUM
admet-2740	397	3	]	]	PUNCT
admet-2740	397	4	t.	t.	PROPN
admet-2740	397	5	mashima	mashima	PROPN
admet-2740	397	6	,	,	PUNCT
admet-2740	397	7	h.	h.	PROPN
admet-2740	397	8	seimiya	seimiya	PROPN
admet-2740	397	9	,	,	PUNCT
admet-2740	397	10	t.	t.	PROPN
admet-2740	397	11	tsuruo	tsuruo	NOUN
admet-2740	397	12	.	.	PUNCT
admet-2740	398	1	de	de	PROPN
admet-2740	398	2	novo	novo	PROPN
admet-2740	398	3	fatty	fatty	NOUN
admet-2740	398	4	-	-	PUNCT
admet-2740	398	5	acid	acid	NOUN
admet-2740	398	6	synthesis	synthesis	NOUN
admet-2740	398	7	and	and	CCONJ
admet-2740	398	8	related	relate	VERB
admet-2740	398	9	pathways	pathway	NOUN
admet-2740	398	10	as	as	ADP
admet-2740	398	11	molecular	molecular	ADJ
admet-2740	398	12	targets	target	NOUN
admet-2740	398	13	for	for	ADP
admet-2740	398	14	cancer	cancer	NOUN
admet-2740	398	15	therapy	therapy	NOUN
admet-2740	398	16	.	.	PUNCT
admet-2740	399	1	british	british	ADJ
admet-2740	399	2	journal	journal	PROPN
admet-2740	399	3	of	of	ADP
admet-2740	399	4	cancer	cancer	NOUN
admet-2740	399	5	100	100	NUM
admet-2740	399	6	(	(	PUNCT
admet-2740	399	7	2009	2009	NUM
admet-2740	399	8	)	)	PUNCT
admet-2740	399	9	1369	1369	NUM
admet-2740	399	10	-	-	SYM
admet-2740	399	11	1372	1372	NUM
admet-2740	399	12	.	.	PUNCT
admet-2740	400	1	https://doi.org/10.1038/sj.bjc.6605007	https://doi.org/10.1038/sj.bjc.6605007	PROPN
admet-2740	400	2	https://doi.org/10.1096/fj.202201321rr	https://doi.org/10.1096/fj.202201321rr	PROPN
admet-2740	400	3	https://doi.org/10.1111/jth.14274	https://doi.org/10.1111/jth.14274	PROPN
admet-2740	400	4	https://doi.org/10.1371/journal.pone.0123597	https://doi.org/10.1371/journal.pone.0123597	PROPN
admet-2740	400	5	https://doi.org/10.3324/haematol.2021.279847	https://doi.org/10.3324/haematol.2021.279847	PROPN
admet-2740	400	6	https://doi.org/10.1182/bloodadvances.2023010100	https://doi.org/10.1182/bloodadvances.2023010100	NOUN
admet-2740	400	7	https://doi.org/10.1182/blood.2020007140	https://doi.org/10.1182/blood.2020007140	ADJ
admet-2740	400	8	https://doi.org/10.3389/fendo.2021.706607	https://doi.org/10.3389/fendo.2021.706607	PROPN
admet-2740	400	9	https://doi.org/10.1023/a:1005641407072	https://doi.org/10.1023/a:1005641407072	PROPN
admet-2740	400	10	https://search.library.wisc.edu/catalog/999964334502121	https://search.library.wisc.edu/catalog/999964334502121	VERB
admet-2740	400	11	https://doi.org/10.1371/journal.pone.0089938	https://doi.org/10.1371/journal.pone.0089938	ADJ
admet-2740	400	12	https://doi.org/10.1016/j.febslet.2006.04.054	https://doi.org/10.1016/j.febslet.2006.04.054	NOUN
admet-2740	401	1	https://doi.org/10.1186/1471-2148-12-32	https://doi.org/10.1186/1471-2148-12-32	PROPN
admet-2740	401	2	https://doi.org/10.1016/j.jmb.2005.12.074	https://doi.org/10.1016/j.jmb.2005.12.074	PROPN
admet-2740	401	3	https://doi.org/10.1074/jbc.m708151200	https://doi.org/10.1074/jbc.m708151200	X
admet-2740	401	4	https://www.mdpi.com/2079-7737/11/11/1638	https://www.mdpi.com/2079-7737/11/11/1638	NOUN
admet-2740	401	5	https://doi.org/10.1139/y09-055	https://doi.org/10.1139/y09-055	NOUN
admet-2740	401	6	https://doi.org/10.1016/0163-7827(96)00005-7	https://doi.org/10.1016/0163-7827(96)00005-7	PROPN
admet-2740	401	7	https://doi.org/10.1074/jbc.273.41.26765	https://doi.org/10.1074/jbc.273.41.26765	PROPN
admet-2740	401	8	https://doi.org/10.1038/sj.bjc.6605007	https://doi.org/10.1038/sj.bjc.6605007	PROPN
admet-2740	401	9	admet	admet	PROPN
admet-2740	401	10	&	&	CCONJ
admet-2740	401	11	dmpk	dmpk	PROPN
admet-2740	401	12	13(3	13(3	NUM
admet-2740	401	13	)	)	PUNCT
admet-2740	401	14	(	(	PUNCT
admet-2740	401	15	2025	2025	NUM
admet-2740	401	16	)	)	PUNCT
admet-2740	401	17	2740	2740	NUM
admet-2740	401	18	metabolic	metabolic	NOUN
admet-2740	401	19	insights	insight	NOUN
admet-2740	401	20	into	into	ADP
admet-2740	401	21	the	the	DET
admet-2740	401	22	warfarin	warfarin	NOUN
admet-2740	401	23	-	-	PUNCT
admet-2740	401	24	mango	mango	NOUN
admet-2740	401	25	interaction	interaction	NOUN
admet-2740	401	26	doi	doi	NOUN
admet-2740	401	27	:	:	PUNCT
admet-2740	401	28	https://doi.org/10.5599/admet.2740	https://doi.org/10.5599/admet.2740	NOUN
admet-2740	401	29	17	17	NUM
admet-2740	401	30	[	[	X
admet-2740	401	31	47	47	NUM
admet-2740	401	32	]	]	X
admet-2740	401	33	r.a	r.a	PROPN
admet-2740	401	34	.	.	PROPN
admet-2740	401	35	coleman	coleman	PROPN
admet-2740	401	36	,	,	PUNCT
admet-2740	401	37	d.p	d.p	PROPN
admet-2740	401	38	.	.	PROPN
admet-2740	401	39	lee	lee	PROPN
admet-2740	401	40	.	.	PUNCT
admet-2740	402	1	enzymes	enzyme	NOUN
admet-2740	402	2	of	of	ADP
admet-2740	402	3	triacylglycerol	triacylglycerol	NOUN
admet-2740	402	4	synthesis	synthesis	NOUN
admet-2740	402	5	and	and	CCONJ
admet-2740	402	6	their	their	PRON
admet-2740	402	7	regulation	regulation	NOUN
admet-2740	402	8	.	.	PUNCT
admet-2740	403	1	progress	progress	NOUN
admet-2740	403	2	in	in	ADP
admet-2740	403	3	lipid	lipid	ADJ
admet-2740	403	4	research	research	NOUN
admet-2740	403	5	43	43	NUM
admet-2740	403	6	(	(	PUNCT
admet-2740	403	7	2004	2004	NUM
admet-2740	403	8	)	)	PUNCT
admet-2740	403	9	134	134	NUM
admet-2740	403	10	-	-	SYM
admet-2740	403	11	176	176	NUM
admet-2740	403	12	.	.	PUNCT
admet-2740	404	1	https://doi.org/https://doi.org/10.1016/s0163-7827(03)00051-1	https://doi.org/https://doi.org/10.1016/s0163-7827(03)00051-1	X
admet-2740	404	2	©	©	PROPN
admet-2740	404	3	2025	2025	NUM
admet-2740	404	4	by	by	ADP
admet-2740	404	5	the	the	DET
admet-2740	404	6	authors	author	NOUN
admet-2740	404	7	;	;	PUNCT
admet-2740	404	8	licensee	licensee	PROPN
admet-2740	404	9	iapc	iapc	PROPN
admet-2740	404	10	,	,	PUNCT
admet-2740	404	11	zagreb	zagreb	PROPN
admet-2740	404	12	,	,	PUNCT
admet-2740	404	13	croatia	croatia	PROPN
admet-2740	404	14	.	.	PUNCT
admet-2740	405	1	this	this	DET
admet-2740	405	2	article	article	NOUN
admet-2740	405	3	is	be	AUX
admet-2740	405	4	an	an	DET
admet-2740	405	5	open	open	ADJ
admet-2740	405	6	-	-	PUNCT
admet-2740	405	7	access	access	NOUN
admet-2740	405	8	article	article	NOUN
admet-2740	405	9	distributed	distribute	VERB
admet-2740	405	10	under	under	ADP
admet-2740	405	11	the	the	DET
admet-2740	405	12	terms	term	NOUN
admet-2740	405	13	and	and	CCONJ
admet-2740	405	14	conditions	condition	NOUN
admet-2740	405	15	of	of	ADP
admet-2740	405	16	the	the	DET
admet-2740	405	17	creative	creative	ADJ
admet-2740	405	18	commons	common	NOUN
admet-2740	405	19	attribution	attribution	NOUN
admet-2740	405	20	license	license	NOUN
admet-2740	405	21	(	(	PUNCT
admet-2740	405	22	http://creativecommons.org/licenses/by/3.0/	http://creativecommons.org/licenses/by/3.0/	PROPN
admet-2740	405	23	)	)	PUNCT
admet-2740	405	24	https://doi.org/10.5599/admet.2740	https://doi.org/10.5599/admet.2740	NOUN
admet-2740	405	25	https://doi.org/https:/doi.org/10.1016/s0163-7827(03)00051-1	https://doi.org/https:/doi.org/10.1016/s0163-7827(03)00051-1	PROPN
admet-2740	405	26	http://creativecommons.org/licenses/by/3.0/	http://creativecommons.org/licenses/by/3.0/	PROPN